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Zusammenfassung 
Influenzaviren sind membranumhüllte Viren mit segmentiertem, negativsträngigem RNA-
Genom. Sie replizieren im Zellkern und knospen von der apikalen Plasmamembran der 
Wirtszelle. Die Virusassemblierung erfordert den Transport der neu gebildeten viralen 
Komponenten zur Plasmamembran. Die Virionen bestehen aus einer Hüllmembran, einer vom 
viralen Matrixprotein M1 gebildeten Schicht unterhalb der Hüllmembran sowie den viralen 
RNA-Genomsegmenten, die in Form von viralen Ribonukleoprotein (vRNP)-Komplexen 
vorliegen. Die Hüllmembran wird von der Plasmamembran der Wirtszelle abgeleitet und 
enthält die drei viralen Transmembranproteine.Während der apikale Transport der viralen 
Transmembran-Glykoproteine seit vielen Jahren untersucht wird und die intrinsischen Signale 
hierfür identifiziert werden konnten, ist bisher wenig darüber bekannt, wie das virale Genom 
transportiert, an die Knospungszone rekrutiert und in die neu entstehenden Virionen eingebaut 
wird. Ein Ziel dieser Arbeit war es, experimentelle Grundlagen zu etablieren, um neu 
gebildete vRNPs und deren Transport in lebenden, infizierten Zellen zu untersuchen. 
Außerdem wurden mögliche molekulare Mechanismen für den zielgerichteten Transport der 
vRNPs analysiert, insbesondere die Membranassoziation und die intrinsischen 
Lokalisationssignale des Nukleoproteins (NP), eines Hauptbestandteils der vRNPs. 
Im ersten Teil dieser Arbeit wurden die Membranbindungseigenschaften von vRNPs in vitro 
mittels Flotationsversuchen mit großen unilamellaren Vesikeln verschiedener 
Lipidzusammensetzung untersucht. Es wurde festgestellt, dass vRNPs allein nicht in der Lage 
sind, mit Modell-Lipidmembranen zu assoziieren. Vor dem Hintergrund der Hypothese, dass 
vRNPs durch Interaktion mit M1 an zelluläre Membranen binden, wurde zusätzlich M1 in 
diese Versuche eingebracht. Die Ergebnisse zeigen, dass M1 in der Tat eine Bindung der 
vRNPs an negativ geladene Membranen vermittelt und somit in der Lage sein könnte, die 
Assoziation von vRNPs an Transportvesikel oder an die virale Knospungszone zu befördern. 
Des Weiteren wurden Phosphatidylinositole in die Lipidbindungsstudien miteinbezogen. Es 
handelt sich hierbei um eine kleine Gruppe zellulärer Phospholipide, die unter anderem an 
Signaltransduktionsprozessen, Membrantransport und der Festlegung spezifischer 
Charakteristika von Organellen beteiligt sind. Es konnte eine Interaktion zwischen M1 und 
Phosphatidylinositol-4-phosphat (PtdIns(4)P) detektiert werden, welche überraschenderweise 
eine gleichzeitige Interaktion von M1 mit vRNPs auszuschließen scheint. Die physiologische 
Bedeutung dieser Beobachtung für die Virusreplikation wird diskutiert. 
Im Weiteren wurden Transport und Lokalisation von vRNPs im zellulären Kontext betrachtet. 
Hierbei wurden die Lokalisation, die subzelluläre Dynamik sowie ortsspezifische Affinitäten 
von NP charakterisiert, was durch die Expression von fluoreszierenden NP-Fusionsproteinen 
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und Fluoreszenz-Photoaktivierungsmessungen unter Verwendung von obligatorisch 
monomeren NP-Mutanten möglich war. Es wird gezeigt, dass NP keine bevorzugte 
Assoziation mit bestimmten cytoplasmatischen Strukturen oder zellulären Membranen durch 
intrinsische Affinität aufweist. Allerdings konnte eine ausgeprägte Interaktion des NP mit dem 
Zellkern festgestellt werden, sowie unterschiedliche Affinitäten zu verschiedenen 
Kernstrukturen. Ein NP-Konstrukt mit Kernexportsequenz wurde exprimiert, um die NP-
Konzentration im Kern zu senken, wodurch es möglich war, Nucleoli und kleine 
punktförmige NP-reiche Domänen als Kerndomänen mit der höchsten Affinität für NP zu 
identifizieren. Die kleinen punktförmigen Domänen ähneln den Kernkörperchen (engl. 
„nuclear bodies“) und werden daher hier als NP-Körperchen  bezeichnet. Die auffallend 
hohen Affinitäten der beiden Kernstrukturen für NP wurden mittels Fluoreszenz-
Photoaktivierung bestätigt. Die Verringerung der NP-Konzentration im Zellkern erleichterte 
zudem Kolokalisationsstudien und ermöglichte die Beobachtung, dass NP-Körperchen häufig 
in unmittelbarer Nähe zu Cajal-Körperchen und PML-Körperchen zu finden sind. Dies konnte 
auch für das NP-Wildtyp-Protein bestätigt werden.  
Die Rolle der spezifischen Lokalisation des NP in bestimmten Kernstrukturen wird hier im 
Hinblick auf die Virusreplikation und die funktionelle Organisation des Kerns diskutiert. Es 
wird vermutet, dass die starke Bindung des NP an Nucleoli möglicherweise die bereits 
beschriebene Auflösung der Nucleoli während der viralen Replikation erfordert, um 
Komponenten der Nucleoli rekrutieren zu können. Des Weiteren wird in Betracht gezogen, 
dass die gezielte Lokalisation des NP angrenzend an PML-Körperchen für die Lokalisation 
ganzer vRNP-Komplexe in räumlicher Nähe zu Orten der zellulären SUMOylierung und der 
Bildung von Kernexportkomplexen von Bedeutung sein könnte. 
Schlussendlich hatte diese Arbeit zum Ziel, Methoden zu etablieren, um die Dynamik neu 
gebildeter vRNPs während der Virusassemblierung in lebenden Zellen zu studieren. In einem 
ersten Ansatz gelang es, rekombinante Viren mit einem Tetracystein (TC)-Tag in der NP 
Sequenz herzustellen. Diese konnten in infizierten Zellen spezifisch fluoreszenzmarkiert 
werden, erwiesen sich jedoch als ungeeignet für die Beobachtung dynamischer Prozesse, was 
vermutlich auf eine Vernetzung der TC-Tags durch bifunktionale Farbstoffmoleküle 
zurückzuführen ist. In einem zweiten Ansatz wurde die Coexpression von fluoreszierenden 
NP-Fusionsproteinen in infizierten Zellen optimiert, um neu entstehende vRNPs durch 
Inkorporation dieser NP-Konstrukte zu markieren. Die fluoreszenzmarkierten Partikel 
konnten während des cytoplasmatischen und nucleocytoplasmatischen Transports beobachtet 
werden und auch der Co-Transport mit Rab11-positiven Recycling-Endosomen konnte 
verfolgt werden. Die Analysen der Bewegungen einzelner Partikel (engl. Single particle 
tracking) zeigen bisher unbekannte Details des vRNP-Transportes auf. Die Partikel erfahren 
einen relativ schnellen, gerichteten Transport im unmittelbaren Anschluss an den Kernexport, 
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was auf eine direkte Verbindung zwischen dem Kernexport und einem Cytoskelett-
vermittelten cytoplasmatischen Transport schließen lässt. Weiterhin wurde beobachtet, dass 
die markierten Teilchen auch nach Ankunft an der Plasmamembran eine hohe Mobilität 
zeigen und offenbar entlang der Plasmamembran weiter transportiert werden. Auf Grundlage 
dieser Beobachtungen werden hier drei Phasen des cytoplasmatischen vRNP-Transports 
vorgeschlagen: im ersten Schritt ein unmittelbar auf den Kernexport folgender Cytoskelett-
vermittelter gerichteter Transport, im zweiten Schritt ein vesikulärer, Rab11-vermittelter 
Transport zwischen dem Mikrotubuli-organisierenden Zentrum und der Plasmamembran und 
schließlich eine Bewegung entlang der Plasmamembran, was den letzten Schritt im Transport 
zur viralen Knospungszone darstellen könnte. 
 
Summary 
Influenza viruses are negative-stranded enveloped RNA viruses which replicate in the cell 
nucleus and bud from the apical plasma membrane of the host cell. Virus assembly requires 
the delivery of the different viral components to the budding site. The viruses consist of a 
viral membrane, harboring the three viral transmembrane proteins, a matrix layer underneath 
the membrane, formed by the matrix protein M1, and the viral genomic RNA segments which 
are packed in form of viral ribonucleoprotein (vRNP) complexes. While apical targeting of 
the viral transmembrane proteins has been studied for many years and intrinsic targeting 
signals were identified, it is still poorly understood how the viral genome is transported, 
targeted and incorporated into progeny virus particles. It was one major goal of this study to 
establish an experimental system that enables analysis of progeny vRNPs in living infected 
cells. Further, potential targeting mechanisms including membrane association and intrinsic 
targeting of the nucleoprotein (NP), as a major component of vRNP complexes, were 
examined.  
In the first part of this study, membrane binding properties of vRNPs were investigated in 
vitro, performing flotation with large unilamellar vesicles of various lipid compositions. It 
was found that vRNPs alone are not able to associate with model lipid membranes. Since it is 
a long-standing hypothesis that vRNPs might be targeted to cellular membranes through 
interaction with M1, M1 was included in these experiments. The results indicate that M1 is in 
fact able to mediate binding of vRNPs to negatively charged lipid bilayers and may thus 
support association of vRNPs with vesicular transport or with the budding site. 
Phosphoinositides were further included in lipid binding studies. They represent a small 
fraction of cellular phospholipids involved in signaling processes, membrane trafficking and 
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organelle identity. Interaction of M1 with phosphatidylinositol-4-phosphate (PtdIns(4)P) was 
detected, and surprisingly, this interaction seems to exclude simultaneous binding of M1 to 
vRNPs. The physiological relevance of this observation for viral replication is discussed.  
Targeting and transport of vRNPs were then addressed in a cellular context. Expression of 
fluorescent NP fusion proteins and fluorescence photoactivation studies in combination with 
the use of obligate monomeric NP mutants allowed characterizing the localization, the 
subcellular dynamics and site-specific affinities of NP. The results show that NP does not 
target to specific cytoplasmic structures or cellular membranes by intrinsic affinity. However, 
NP extensively interacted with the nuclear compartment and targeted different subnuclear 
domains with different affinities. Expression of an NP construct with a nuclear export 
sequence to lower the nuclear NP concentration revealed nucleoli and small punctate NP-rich 
domains as nuclear domains with the highest affinities for NP. These latter domains resemble 
nuclear bodies and are therefore here termed NP bodies. Their prominent affinities for NP 
were confirmed by fluorescence photoactivation. Nuclear depletion of NP further facilitated 
colocalization analysis and revealed that NP bodies frequently localized in close proximity to 
Cajal bodies and PML bodies. This could be confirmed also for wild-type NP.  
The role of NP subnuclear targeting is discussed in the light of virus replication and in the 
context of functional nuclear organization. It is proposed that high-affinity binding of NP to 
nucleoli might require the previously reported nucleolar fragmentation process in ongoing 
viral replication for recruitment of nucleolar factors. It is further considered that targeting of 
NP to the vicinity of PML NBs might be of importance for the targeting of entire vRNP 
complexes close to sites of cellular SUMOylation and vRNP nuclear export complex 
formation. 
Finally, this study aimed at developing an experimental approach for monitoring the dynamics 
of progeny vRNPs during virus assembly in living cells. In a first approach, recombinant 
viruses encoding a tetracysteine (TC)-tag in the NP coding sequence were successfully 
generated and could be specifically labeled during virus infection. Yet, they proved unsuitable 
for the detection of dynamic processes during virus infection, possibly due to crosslinking of 
TC-tags through the bifunctional dye molecules. In a second approach, coexpression of 
fluorescent NP fusion proteins in infected cells was optimized in order to label progeny 
vRNPs by incorporation of fluorescently tagged NP molecules. Fluorescently tagged 
complexes were successfully monitored during cytoplasmic and nuclear-cytoplasmic 
transport. Further, cotransport with Rab11-positive recycling endosomes was demonstrated. 
An experimental approach is thus provided for investigations of progeny vRNPs in living 
infected cells. Notably, the results from single particle tracking reveal yet unrecognized 
aspects of vRNP transport. Particles were found to undergo relatively rapid directional 
transport immediately subsequent to nuclear export, indicating a link between nuclear export 
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and cytoskeleton-assisted cytoplasmic transport. It was further observed that particles 
continue to move underneath the plasma membrane after arrival. According to these 
observations, three stages of cytoplasmic vRNP transport are suggested: in the first stage, 
cytoskeleton-assisted long-range directional transport subsequent to nuclear exit, in the 
second stage, Rab11-vesicular cytoplasmic transport between the microtubule organizing 
center and the plasma membrane and, finally, transport underneath the plasma membrane, 
which might represent the final step of targeting to the viral budding site.  
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Abbreviations 
Standard abbreviations for units of measurement, metric prefixes, chemical elements, nucleic 
and amino acid sequences are used according to the International system of units (SI) and the 
IUPAC (International Union of Pure and Applied Chemistry) nomenclature and are not 
included in the following list of abbreviations. 
aa  amino acid 
AO  acridine orange 
APS   ammonium persulfate 
ATCC  American Type Culture Collection (resource center) 
A.U.  arbitrary units 
b  bases 
BAL   British Anti-Lewisite (2,3-dimercapto-1-propanol) 
BSA  bovine serum albumin 
BCA  bicinchoninic acid 
C-  carboxy- 
CB  Cajal body 
cDNA  copy DNA (synthesized from RNA template) 
CFP  cyan fluorescent protein 
CHO  chinese hamster ovary (cell line) 
Chol  cholesterol 
CMV  cytomegalovirus 
CPE   cytopathic effect 
cRNA/RNP complementary RNA/RNP (the viral replication intermediate) 
DAB  diaminobenzidine 
DAPI  4′,6-Diamidin-2-phenylindol 
ddH2O  double-distilled water 
DI  defective-interfering 
DMEM  Dulbecco’s Modified Eagle Medium 
DMSO dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
dNTP  desoxyribonucleosidtriphosphate (dATP, dCTP, dGTP, dTTP) 
DO  di-oleoyl 
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DP  di-palmitoyl 
DPBS  Dulbecco`s phosphate buffered saline 
ds  double-stranded 
EDT  1,2-ethanedithiol 
EDTA  ethylenediaminetetraacetic acid 
EM  electron microscopy 
ER  endoplasmic reticulum 
FBS  fetal bovine serum 
FISH  fluorescence in situ hybridization 
FlAsH  fluorescein arsenical hairpin binder 
FPV  fowl plague virus 
FRET  fluorescence resonance energy transfer 
fw  forward (primer sense) 
x g  standard gravitational acceleration (9.81 m s
-2
) 
HA  hemagglutinin 
HEPES 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid 
HRP  horseradish peroxidase 
IF  immunofluorescence 
IFN  interferon 
IgG  immunoglobulin G 
IUPAC International Union of Pure and Applied Chemistry 
KD  dissociation constant 
LUV  large unilamellar vesicle 
M   mol  L
-1 
MAPK mitogen-activated protein kinase 
MDCK Madin-Darby canine kidney (cell line) 
mEYFP monomeric enhanced yellow fluorescent protein 
MOI  multiplicity of infection 
mRNA messenger RNA 
MTOC microtubule organizing center 
MW  molecular weight 
N-  amino- 
NA  neuraminidase 
N.A.  numerical aperture 
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NBD  nitrobenzoxadiazole (7-nitrobenz-2-oxa-1,3-diazol-4-yl) 
NB  nuclear body 
NEP  nuclear export protein 
NES  nuclear export signal 
NLS  nuclear localization sequence 
NP  nucleoprotein 
NS1  non-structural protein 1 
nt  nucleotide 
ORF  open reading frame 
p.i.  post infection 
p.t.  post transfection 
PA  polymerase acidic protein 
PAGE  polyacrylamide gel electrophoresis 
PARP1 poly(ADP-ribose)-polymerase 1 
PB1, PB2 polymerase basic protein 1, polymerase basic protein 2 
PBS  phosphate buffered saline 
PC  phosphatidylcholine 
PCR  polymerase chain reaction 
PE  phosphatidylethanoamine 
PI  propidium iodide 
PML  promyelocytic leukemia (protein) 
PMT  photomultiplier tube 
Pol I  RNA polymerase I 
Pol II  RNA polymerase II  
PARP1 poly(ADP-ribose)-polymerase 1 
PS  phosphatidylserine 
PdtIns  phosphatidylinositol  
PtdIns(x)P  phosphatidylinositol(x)phosphate (x = 3, 4 or 5) 
PtdIns(x,y)P2 phosphatidylinositol(x,y)bisphosphate (x, y = 3, 4 or 5) 
PtdIns(3,4,5)P3   phosphatidylinositol(3,4,5)trisphosphate 
PKR  protein kinase R 
ReAsH resofurin arsenical hairpin binder 
RE  recycling endosome 
rev  reverse (primer sense) 
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RFP  red fluorescent protein 
RNA  ribonucleic acid 
RNP  ribonucleoprotein 
RT  room temperature 
RT-PCR reverse-transcription polymerase chain reaction 
sca  small Cajal body-specific 
SD  standard deviation 
SDS  sodium dodecyl sulfate 
SEM  standard error of the mean 
SI  Système international d’unités (engl. International system of units) 
SIM  SUMO interaction motif 
SM  sphingomyelin 
S/N  signal-to-noise 
sn  small nuclear 
sno  small nucleolar 
SPT  single particle tracking 
ss  single-stranded 
SUMO small ubiquitin-like modifier 
TBS  Tris buffered saline 
TEM  transmission electron microscopy 
TEMED N,N,N’,N’-tetramethyl-ethane-1,2-diamine 
TPCK  N-p-Tosyl-L-phenylalanine chloromethyl ketone 
TREX  transcription/export (multiprotein complex) 
Tris  2-Amino-2-hydroxymethyl-propane-1,3-diol 
UTR  untranslated region 
UV  ultraviolet 
v/v  volume per volume 
vRNA  viral RNA 
vRNP  viral ribonucleoprotein 
w/v  weight per volume 
w/w  weight per weight 
WB  Western blotting 
WSN  Wilson Smith Neurotropic (Influenza virus strain) 
wt  wild-type
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1 Introduction 
1.1 Influenza A viruses 
Influenza viruses are enveloped viruses with a segmented single-stranded negative-sense 
RNA genome. They belong to the family of Orthomyxoviridae and are divided into three 
genera, designated as Influenza A, B and C viruses. While all three genera are human 
pathogens, Influenza A viruses are responsible for the most severe cases of disease, causing 
recurring seasonal epidemics and occasional pandemics. The World Health Organization 
states that three to five million cases of severe illness are caused by Influenza viruses every 
year and up to 500 000 deaths.  
This study focuses on Influenza A viruses. The natural hosts of Influenza A viruses are wild 
aquatic birds, but the host range extends also to domestic birds, pigs, horses and marine 
mammals as well as humans [1].  Influenza A viruses are divided into different subtypes 
according to antigenic variations that occur among the viral surface proteins hemagglutinin 
(HA) and neuraminidase (NA). There are currently 18 known HA-subtypes (H) and 11 known 
NA-subtypes (N). All known Influenza virus subtypes (except for newly discovered H17, 
H18, N10 and N11 which have been isolated from bats [2]) circulate in birds [3]. The 
prevalent circulating strains in the human population are H3N2 and H1N1 subtypes, but also 
H2N2, H5N1, H7N2, H7N3, H7N7, H7N9, H9N2 and H10N8 subtypes have been isolated 
from humans.  
The large reservoir of Influenza viruses in animal populations and the possibility of genetic 
reassortment and crossing of species barriers constitute the major pandemic potential of 
Influenza viruses [4,5]. New Influenza virus strains with unprecedented properties can 
suddenly emerge by reassortment of genetic material from different Influenza A subtypes 
(termed “genetic shift”), but also minor changes in form of mutations can gradually 
accumulate in the viral genome and enable the virus to evade the host immune recognition 
(termed “genetic drift”), causing recurring outbreaks of circulating Influenza virus strains. 
The genetic drift is an important parameter of Influenza virus epidemiology since Influenza 
viruses like many other RNA viruses experience a high mutation frequency due to a high error 
rate of the viral RNA-dependent RNA polymerase. It replicates the viral genome with 
approximately one mutation per replicated genome [6]. 
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1.2 Structure and morphology of Influenza A virions 
The Influenza A virus genome consists of eight single-stranded (ss) RNA segments which are 
packed in form of viral ribonucleoprotein (vRNP) complexes and which are surrounded by 
the viral lipid envelope. Influenza A virions are pleomorphic. They display spherical and 
filamentous shapes with diameters of about 100 nm [7,8]. The length of filamentous particles 
varies widely and can reach more than 20 µm. Viral morphology was shown to be influenced 
by several viral proteins and by the host cell [9,10,11,12,13,14,15]. Cryo-electron microscopy 
images of spherical and filamentous virions are shown in Fig. 1 A–C. 
The viral envelope is derived from the host cell plasma membrane, and – compared to the 
donor membrane – it is specifically enriched in sphingolipids and cholesterol [16]. It also 
harbors the three viral transmembrane proteins: the two glycoproteins, HA and NA, and the 
proton channel M2 (Fig. 1D). While the homotrimeric HA plays a major role during cell 
entry, being responsible for receptor binding and membrane fusion [17], the homotetrameric 
NA supports release and spread of progeny virions by enzymatic cleavage of sialic acids, 
which are the major HA-binding motif on cell surfaces. [18,19]. HA is the most abundant 
among the viral envelope proteins (about 80 %) [20]. Sphingolipid- and cholesterol-rich lipid 
domains in the plasma membrane of infected cells, which are also termed lipid rafts, are 
thought to serve as platforms for virus assembly and envelope fomation since both HA and 
NA are targeted to raft domains by intrinsic affinity, leading to local concentration and 
clustering [21]. In case of M2, only a few copies of the protein are embedded in the viral 
membrane, even though it is abundantly expressed in infected cells [22,23]. Unlike HA and 
NA, M2 does not partition into raft domains [24,25], even though it is a cholesterol-binding 
protein [26]. It forms a homotetrameric proton channel [27,28] and is critically involved in 
pH-dependent uncoating of the viral genome [29]. Furthermore, M2 is required for membrane 
scission and release of budding virus particles [30].  
Underneath the viral membrane, the matrix protein M1 forms a layer in close contact to the 
viral membrane [31,32]. M1 is most highly conserved among Influenza A virus proteins [33] 
and it is also the most abundant protein within virus particles (see Tab. 1). It is considered to 
play a central role during virus assembly since it interacts with all other viral components, 
including the viral membrane and M1 itself [21,34]. It polymerizes underneath the membrane, 
forming a two-dimensional lattice, which is relatively flexible and enables a wide range of 
curvature as shown by cryo-electron microscopy [31]. This seems to be an important basis for 
the reported pleomorphism of Influenza viruses. In filamentous virions, M1 was shown to 
form a highly ordered helical arrangement, yielding a cylindrical shape, while M1 in spherical  
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Fig. 1: Structure and morphology of Influenza A viruses. (A-C) Influenza A viruses are pleomorphic. Cryo-
electronmicrographs show a (A) spherical, (B) elongated and (C) filamentous virus particle (images taken from 
[8] and [31]). (D) Schematic representation of an Influenza A virus particle. (E, F) Scanning transmission electron 
tomography images (from [35]). A transverse section of a virus particle shows the characteristic 7+1 
arrangement of eight vRNPs, which are represented in pseudo color (E). A three-dimensional model, 
reconstructed from tomography data, shows a virus particle along the longitudinal axis of the vRNPs (F). Scale 
bar, 100 nm. 
particles seems to adopt a less ordered conformation and spiral structure. These findings are 
consistent with reports that M1 is an important determinant of viral morphology 
[12,13,36,37]. M1 is thought to be specifically recruited to the site of virus assembly and 
budding through interaction with the cytoplasmic tails of the viral transmembrane proteins 
[24,38,39,40], and upon oligomerization and in intact viral particles, it might crosslink the 
components of the viral envelope [41]. M1 is further a well-established membrane-binding 
protein. In addition to studies demonstrating membrane association via electrostatic 
interaction [42,43,44,45], several studies suggested partial insertion of M1 into lipid 
membranes [46,47,48,49] and M1-membrane interaction of non-electrostatic nature [50,51]. 
Whether M1 might affect viral morphology and virus budding by inducing or stabilizing 
membrane curvature through direct membrane interaction, or whether this requires 
additionally (or primarily) interactions with the viral transmembrane proteins is still unclear 
(reviewed in [34]).  
The viral core underneath the matrix layer comprises the genomic vRNPs. vRNPs are flexible 
double-helical rod-like structures with a diameter of about 12 nm and between 30 and 120 nm 
in length [52,53]. Each vRNP consists of a viral RNA (vRNA) segment, multiple copies of the 
nucleoprotein (NP) and the heterotrimeric viral RNA-dependent RNA polymerase comprising 
subunits PB1, PB2 and PA [54]. vRNPs represent transcription- and replication-competent 
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units [54]. A list of the 8 vRNA segments and their encoded proteins is given in Tab. 1. More 
detailed information on vRNP structure and genome organization is given in section 1.3.  
In a large fraction of virus particles and independent from viral morphology, vRNPs are 
incorporated as a highly organized set of eight vRNPs. The rod-like structures of differing 
lengths are arranged in a distinct pattern: they form a parallel bundle of seven segments 
surrounding a central segment (Fig. 1 E, F). At one end, the multisegmental arrangement is 
attached to the viral envelope, which inside budding virions was found to be the budding tip 
[8,31,35,53,55]. Most virions comprise eight unique vRNAs and thus a complete set of the 
viral genome [56]. Also filamentous particles do not contain more than eight vRNPs, the 
majority of the viral inner volume being empty [31,53].  
A small number of the viral nuclear export protein (NEP), previously known as non-structural 
Tab. 1: RNA segments and proteins of Influenza A viruses (adapted from [59], further including data from 
[60,61,62,63,64,65]). Viral proteins are multifunctional proteins. The main currently known protein functions 
are indicated. 
RNA 
segment 
number of 
nucleotides 
gene 
product(s) 
number of  
amino acids 
molecules  
per virion 
function 
1 2341 PB2 759 30–60 viral polymerase subunit;  
mRNA cap binding 
2 2341 PB1 757 30–60 viral polymerase subunit; 
RNA polymerase activity 
PB1-F2 87 – mitochondrial targeting,  
induction of apoptosis 
PB1-N40 718 – unknown 
3 2233 PA  716 30–60 viral polymerase subunit;  
endonuclease activity 
PA-X 270 – virulence factor 
PA-N155 562 – unknown 
PA-N182 535 – unknown 
4 1778 HA 566 500 envelope glycoprotein;  
receptor binding, membrane fusion 
5 1565 NP 498 1000 encapsidation of vRNA and cRNA,  
nuclear targeting of vRNPs 
6 1413 NA 454 100 envelope glycoprotein;  
neuraminidase activity, virus release 
7 1027 M1 
 
252 3000 matrix protein; virus assembly,  
vRNP nucleocytoplasmic transport 
M2 97 20–60 proton channel; 
viral uncoating, membrane scission 
M42 99 – proton channel 
8 890 NS1 230 – non-structural protein; interferon 
antagonist, posttranscriptional 
regulation 
NS2/NEP 121 130–200 structural protein;  
vRNP nuclear export 
NS3 187 – unknown 
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protein 2 (NS2), can further be found within virus particles [57,58]. NEP mediates the nuclear 
export of vRNPs during infection [66,67]. Its localization within virus particles is yet 
unknown.  
Through interaction with vRNPs, it is assumed that M1 can link the viral genome to the viral 
envelope and promote incorporation of vRNPs into budding virions [68]. This is consistent 
with findings that deletion of HA and NA cytoplasmic tails causes reduction of both M1 and 
vRNP incorporation into virions [9,24]. However, except for the site of vRNP attachment, 
regular contacts between vRNPs and the matrix layer inside virions along the length of 
vRNPs are not observed [31]. On the other hand, it was shown that the interaction strength 
between M1 and vRNPs correlates with viral morphology [69], and furthermore, specific NP 
residues and their interplay with M1 were found to determine viral morphology [14]. This 
suggests that interactions between M1 and vRNPs might indeed play an important role during 
virus formation.  
1.3 Genome organization and structure of vRNP complexes 
The Influenza A virus genome has a total size of about 13,600 nucleotides (nt). It is 
subdivided into eight vRNA segments, which range between 890 and 2341 nt in length (Tab. 
1). Each vRNA segment comprises a central coding region and 3′ and 5′ terminal untranslated 
regions (UTRs) (Fig. 2). Each segment encodes one to four viral proteins. The UTRs can be 
further subdivided into two regions: a segment-specific sequence (845 nt) and furthermore 
12 and 13 highly conserved nucleotides at the 3′ and 5′ end, respectively. These 12 and 13 nt 
are conserved in all vRNA segments and among all Influenza A virus strains [70]. They are 
partially complementary and represent the bipartite viral promoter, which is recognized by the 
viral polymerase in both vRNA and positive-sense complementary RNA (cRNA) [71,72]. 3′ 
and 5′ termini were reported to form a corkscrew structure in both cRNA and vRNA. This 
structure features two short intrastrand hairpin loops, a single bulged unpaired nucleotide and 
a short interstrand base-paired region (Fig. 3A) [73,74,75,76]. Despite similarities, structural 
differences were reported between cRNA and vRNA promoter structures that might explain 
differential recognition by the viral polymerase [77]. Indeed, different regions on PB1 were 
reported to be involved in promoter binding on cRNA and vRNA, respectively [78,79], and 
also subunit PA was reported to be differentially involved in binding of cRNA and vRNA 
promoter regions [80]. (For further information on the promoter structure and its function, see 
also section 1.4.3.2.) 
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Fig. 2: Model of genomic vRNA structure. The eight genomic vRNA segments comprise 8902341 nt and share 
common characteristic features. They all harbour a central coding sequence, which is flanked by terminal 
untranslated regions (UTRs). The first 13 nt at the 5′ end and 12 nt at the 3′ end are highly conserved among 
vRNA segments of all Influenza A virus strains. The UTRs comprise furthermore segment-specific sequences of 
variable lengths (845 nt). Packaging signals for genome incorporation into progeny virions were mapped to 
regions of 100300 nt at both ends, spanning the UTRs and part of the coding sequence.  
Genomic vRNA segments and cRNA replication intermediates are packed in form of RNP 
complexes (Fig. 3) [81,82]. Viral RNPs consist of viral single-stranded RNA, a heterotrimeric 
viral RNA-dependent RNA polymerase complex and multiple copies of NP. They are flexible 
rod-like structures with a diameter of about 12 nm and between 30 and 120 nm in length 
[52,53]. vRNPs reportedly maintain their structural integrity throughout the replication cycle 
and further represent the minimal replicative unit of Influenza viruses [83]. They are capable 
of transcription and replication, and a complete set of eight vRNPs is sufficient to initiate 
infection and virus production in cells [84,85,86]. 
Within RNP complexes, each RNA segment is coated by NP along its phosphate-sugar 
backbone [87], and the RNA-protein strand is folded back on itself and twisted into a 
supercoiled double-helical structure (Fig. 3A) [52,82]. Cryo-electron microscopy studies 
revealed a loop at one end of native vRNPs and binding of the viral polymerase complex to 
the other end. The two antiparallel NP-RNA strands were furthermore shown to associate with 
each other, apparently by interaction between NP molecules, forming a double helical 
structure with a major and a minor groove (Fig. 3 BD)  [88,89].   
NP cooperatively polymerizes onto the RNA strand and forms the protein scaffold, while 
RNA is thought to be wrapped around the NP core on the outside [90,91,92,93]. While the 
RNA backbone electrostatically interacts with NP with high affinity, the RNA nucleotide 
bases are exposed to the solvent, which makes them accessible for viral transcription and 
replication [87,91]. Viral RNPs are consistently sensitive to RNAse digestion [94,95]. NP 
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Fig. 3: Structure of Influenza A virus ribonucleoprotein complexes. (A) Model of a vRNP complex (adapted 
from [54]). Single-stranded vRNA is shown to be wrapped around a double-helical NP core and to associate with 
the heterotrimeric polymerase complex via its 3′ and 5′ terminal sequences. The highly conserved 3′ and 5′ 
terminal sequences are depicted according to the corkscrew model of the viral promoter structure. The position 
of the polyadenylation signal is indicated as oligo-U stretch. (B) Two-dimensional averages of cryo-EM images 
show the polymerase-containing terminus (left), the central region (middle) and the terminal loop region (right) 
of native vRNPs. (C) Model for vRNP structure based on separate three-dimensional cryo-EM reconstruction 
from central and terminal parts of native vRNPs. (D) Docking of the NP crystal structure ([93]) into antiparallel 
strands of the double helical vRNP reconstruction shown in (C). NP subunits of the lower strand are shown with 
electrostatic surface potentials and subunits of the opposite strand are shown as ribbon structure. The position 
of the RNA, inferred from the surface potential, is indicated as yellow line. Note that differing results for 
docking of NP were implicated in [89,92]. Images B, C and D were taken and adapted from [88]. 
binds to RNA without sequence-specificity. It binds with a stoichiometry of about 24 nt per 
NP subunit [52,93,96]. While it was postulated that NP melts RNA secondary structure by 
scaffolding the RNA backbone, susceptibility of model RNPs to double strand-specific 
RNAse nevertheless seems to indicate the existence of some base-paired regions [87,91]. (For 
further information on the role of NP in vRNP formation, see also section 1.5.)  
One copy of the heterotrimeric viral polymerase is attached to the loose ends of each RNP 
complex, thus conferring a closed conformation to viral RNP complexes [88,89,94,97]. The 
presence of the viral polymerase on vRNP complexes enables vRNPs to initiate the first round 
of transcription in newly infected cells. Differential recognition of cRNA and vRNA promoter 
structures was further suggested to enable selective nuclear export of vRNPs, while cRNPs 
are retained in the nucleus [98]. Packaging signals of vRNPs for incorporation into progeny 
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virus particles were further reported to reside within the first 100300 nt at the 3′ and 5′ 
termini of vRNAs, and thus in a region of vRNPs adjacent to the polymerase binding site, 
spanning the UTRs and also part of the coding sequences (Fig. 2) [99,100]. 
Later during infection, vRNPs reportedly interact with several newly synthesized viral 
proteins like NS1, NEP and M1 [101,102] and with numerous host factors [103], which most 
likely contribute to regulation and progression of viral infection. 
1.4 Replication of Influenza A viruses 
In humans, Influenza A viruses infect and replicate in epithelial cells of the respiratory tract. 
Progeny virions are released from the apical cell surfaces into the airway lumen of infected 
persons, spreading the infection to new hosts by airborne transmission [104].  
1.4.1 Attachment, internalization and uncoating 
For replication, Influenza viruses depend on the host cell machinery. They must enter the cell 
and deliver the viral genome to the host cell nucleus where viral transcription and replication 
take place (Fig. 4). Initial attachment to the host cell is mediated by the viral envelope protein 
HA, which recognizes terminal sialic acid residues of cell surface glycoproteins and 
glycolipids [17]. The virus is then internalized by endocytosis. Two different endocytic 
pathways were shown to be involved in the uptake of Influenza viruses. The first 
internalization route identified is the receptor-mediated clathrin-dependent endocytosis [105], 
which is triggered by virus binding and involves epsin-1 as cargo-specific adaptor for clathrin 
recruitment [106]. More recently, macropinocytosis was identified as the second 
internalization route used by Influenzs virions [107]. Macropinocytosis was shown to be the 
primary entry mechansim of filamentous virus particles [108]. Specific receptors and the 
molecular mechanisms triggering viral uptake are still unknown. 
Via both pathways, virions are delivered to the late endosomal compartment in the perinuclear 
region [108,109]. They undergo a three-stage active transport process within endosomal 
vesicles, beginning with an actin-dependent movement in the cell periphery followed by two 
stages of microtubule-dependent transport through the cytoplasm towards the nucleus 
[109,110]. 
Acidification of the endosomal compartment during endosome maturation [111] triggers a 
conformational change in the viral surface protein HA, leading to exposure of a hydrophobic 
fusion peptide, which then inserts into the endosomal membrane and mediates fusion of the
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Fig. 4: Replication cycle of Influenza A virus. Influenza A virions bind via hemagglutinin (HA) to sialic acid 
residues on the cell surface and are internalized into the cell by clathrin-dependent endocytosis or 
macropinocytosis. Acidification of the endosomal lumen during endosome maturation triggers HA-mediated 
membrane fusion between viral and endosomal membranes and disassembly of the matrix protein M1. This 
leads to uncoating and release of the viral genome in the perinuclear region. Via nuclear pore complexes, 
genomic vRNPs are then imported into the nucleus where viral transcription and replication take place. Viral 
proteins are synthesized in the cytoplasm, using the cellular translation machinery, and while the envelope 
proteins undergo apical transport along the secretory pathway, the core proteins NP, PB1, PB2 and PA are 
required within the nucleus for formation of progeny vRNPs and cRNPs. Also M1 and the nuclear export protein 
(NEP) are imported into the nucleus to associate with vRNPs and form vRNP nuclear export complexes. 
Following nuclear export, vRNPs are transported to the apical plasma membrane along with Rab11-positive 
recycling endosomes. Even though it was shown that Rab11 also plays a role in transport of the proton channel 
M2, it is unknown whether M2 might be in part cotransported with vRNPs and Rab11-positive vesicles. M1 
further independently targets to the Golgi complex and to the plasma membrane. It might preassemble with 
the viral envelope proteins, polymerize and crosslink the different viral components. The viral components 
assemble at specific sites of the plasma membrane rich in cholesterol and sphingomyelin, which form the 
budding site. Complete sets of eight distinct vRNPs are packaged into newly forming virions. It is unknown 
though at which stage of the replication cycle vRNP segments specifically assemble into multisegment genomic 
complexes. Bud formation is thought to be mediated by the viral glycoproteins and M1, followed by M2-
mediated membrane scission and virus release. For further information, please refer to the text. NA: 
neuraminidase; NS1: non-structural protein 1; NP: nucleoprotein; PB1, PB2, PA: polymerase subunits. 
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viral envelope with the endosomal membrane [17]. Simultaneously, the viral proton channel 
M2 enables a proton flux across the viral membrane and mediates acidification of the viral 
lumen, leading to pH-triggered disassembly of the viral matrix layer [32,112] and dissociation 
of M1 from vRNPs [113,114]. vRNPs are released into the cytoplasm and are then transported 
into the nucleus independent from M1 [115]. M2 proton channel activity was shown to be 
essential to prime the viral genome for nuclear import. Since M1 is critically involved also in 
nuclear export of progeny vRNPs at late stages of infection, M1 is considered as a factor that 
modulates the bidirectionality of vRNP nuclear-cytoplasmic transport [116]. Exposure to 
acidic pH herein serves as a switch for M1 function [29].  
1.4.2 Nuclear import of the viral genome 
After release into the cytoplasm, vRNPs are rapidly imported into the nucleus via the nuclear 
pore complex (NPC) [85,115,117]. This process is mediated by NP and depends on interaction 
of NP nuclear localization sequences (NLSs) with cellular importins [118,119,120]. NP has at 
least two highly conserved NLSs, the N-terminal unconventional NLS1 (residues 3–13) [121] 
and the classical bipartite NLS2 (residues 198–216) [122]. Both sequences were shown to 
contribute to nuclear localization of vRNPs, but while NLS1 could be shown to be the 
principal mediator of nuclear import of vRNPs (and of NP), contributions from NLS2 were 
limited [118,120,123]. NLS2, on the other hand, was found to be indispensable for targeting 
of newly synthesized NP to nucleoli [123]. A single particle tracking study in living cells 
revealed that, late in infection when M1 is abundantly present, interaction between 
cytoplasmic vRNPs and NPCs is efficiently inhibited, suggesting that M1 by association with 
vRNPs might mask NP-binding sites for nuclear import receptors [117], thereby preventing 
vRNPs from entering the nucleus (as demonstrated in [29,124]).  
Genome-wide RNA interference screenings during the last few years have identified a 
multitude of cellular factors which are critically involved in Influenza virus replication. Their 
specific functions are mostly unknown though [125]. It is possible that yet unidentified 
cellular machinery might further be involved in vRNP transport from the endosome into the 
cell nucleus, as indicated by the work of Su et al. [126]. 
1.4.3 Transcription and replication 
In the nucleus, transcription and replication of the viral genome take place, involving 
numerous host cell factors [127,128]. Influenza viruses extensively interact with the nuclear 
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compartment, not only to hijack cellular machinery (e.g. transcription, splicing and nuclear 
export machinery), but also in order to optimize the cellular environment and cellular 
resources for viral replication, antagonizing the host cell innate immune response and 
downregulating cellular syntheses, which is also known as virus-induced host cell shut-off 
[127,129,130]. Influenza virus infection induces a number of rearrangements of the nuclear 
architecture. The functional significance of these changes is still unknown though [131,132].  
vRNPs are the minimal functional unit for transcription and replication and serve as template 
for both processes [54,86,133]. They act as independent units. The different vRNP species do 
not significantly colocalize with each other inside the nucleus, but spread throughout the 
nucleoplasm [134]. The viral polymerase accomplishes both transcription and replication, 
using different mechanisms of initiation and termination, generating 5′-capped and 3′-
polyadenylated viral mRNAs as well as full-length copies of viral genomic RNA [135].  
1.4.3.1 Viral transcription and protein expression 
For transcription initiation, the viral polymerase requires 5′-capped primers, which are derived 
from host pre-mRNAs by a mechanism termed “cap-snatching”. Therefore, the polymerase 
subunit PB2 binds to the 5′ 7-methyl guanosine cap of cellular mRNA, which is then cleaved 
by endonucleolytic activity of PA 10–13 nucleotides downstream of the cap structure. This 
short nucleotide fragment is then used as primer for mRNA synthesis by the viral polymerase 
subunit PB1. Cap-snatching activity, and thus transcription initiation, requires association of 
the trimeric polymerase with the vRNA template [136]. Viral transcription further depends on 
active cellular transcription, which is mediated by cellular RNA polymerase II (Pol II). Not 
only viral mRNA synthesis [137], but also mRNA nuclear export [138] were shown to depend 
on Pol II activity. Pol II assembles with a plethora of cellular proteins during transcription, 
which cotranscriptionally mediate pre-mRNA processing like capping, splicing, 
polyadenylation and mRNP assembly. Sites of active Pol II transcription are also termed 
“transcription factories”. Direct interaction between the viral polymerase and active Pol II is 
assumed to facilitate access to mRNA cap-structures and to ensure close proximity of viral 
transcription to cellular transcription factories and thus also to cellular machinery for pre-
mRNA splicing and nuclear export [127,139]. In line with this, it was shown by electron 
microscopy that Influenza virus RNAs are synthesized at specific nuclear sites, so-called 
“nuclear cages”,  where also cellular RNAs are synthesized [140]. Fluorescence microcopy 
studies further confirmed accumulation of the viral polymerase at sites of Pol II transcription 
during infection [139]. 
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Elongation of viral transcription by PB1 proceeds until it reaches a sequence of uridine 
residues close to the 5′ end of the vRNA template. This stretch of 5–7 uridine residues is then 
reiteratively copied, serving as template for 3′ polyadenylation [141,142,143]. This process is 
independent from host cell machinery [144], but critically depends on a hairpin loop structure 
within the highly conserved 5′ terminal vRNA promoter sequence [145]. Even though viral 
strategies for polyadenylation and 5′-capping are distinct from cellular mechanisms, Influenza 
viruses generate mRNAs which are structurally indistinguishable from cellular mRNAs and 
thus can access cellular pathways, finally leading to protein expression through the cellular 
translation machinery [146]. The cellular cap-binding complex (CBC) and polyadenylate-
binding protein 1 (PABP1) reportedly associate with both cellular and viral mRNA [147]. The 
CBC protects mRNA from degradation and is essential for cellular mRNA maturation and 
assembly of mRNPs [148]. 
Nuclear export of cellular mRNA is tightly coupled to cotranscriptional mRNA maturation, 
which includes the recruitment of numerous RNA-binding proteins to nascent mRNA, namely 
the CBC, the exon-junction complex (EJC) and the transcription/export (TREX) complex. 
These proteins function as adapter proteins for the recruitment of the major cellular mRNA 
nuclear export receptor NXF-1. NXF-1 is the primary export pathway known to be implicated 
also in Influenza A virus mRNA export [146]. Yet, a differential dependence of distinct viral 
mRNA species on NXF-1 was reported [149]. The molecular details of viral mRNP assembly 
and nuclear export are still poorly understood. It is believed that – also in case of viral mRNA 
– transcription, mRNA maturation, assembly and nuclear export are closely linked processes 
[135].  
The eight genomic vRNA segments encode up to 17 viral proteins (Tab. 1). Ten of these 
proteins have been known for several decades and are well characterized. They are known as 
key players of the viral replications cycle. They comprise the nine structural proteins HA, NA, 
M2, M1, NP, PB1, PB2, PA and NEP, as described in section 1.2, and the non-structural 
protein 1 (NS1). The cellular splicing machinery is required for generation of M2 and NEP by 
splicing of segment 7 and segment 8 mRNA, respectively. Another 7 virally encoded proteins 
were discovered only in recent years: PB1-F2, PB1-N40, PA-N155 and PA-N182 are 
generated from segment 2 and segment 3 mRNAs by use of alternative translation initiation 
sites [60,62,63]; PA-X is synthesized from segment 3 mRNA by ribosomal frameshifting [61], 
and proteins M42 and NS3 are generated from segment 7 and segment 8 mRNAs by 
alternative splicing, respectively [64,65]. The functions of these proteins are currently poorly 
understood, and their general significance for Influenza A virus infections yet remains to be 
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demonstrated. They may act as strain-specific virulence factors like PB1-F2 [150,151] and 
PA-X [61] or play a role in adaption to mammalian hosts as suggested for NS3.  
The ten major viral proteins are subdivided into early and late proteins according to their 
temporal expression patterns during infection [149,152,153,154]. The core proteins NP, PA, 
PB1, PB2 as well as NS1 are synthesized first, followed by expression of M1, NEP and the 
envelope proteins. The viral transmembrane proteins are synthesized at the rough 
endoplasmic reticulum (ER) where they enter the secretory pathway to the plasma membrane. 
The other proteins, except for NEP, contain nuclear localization signals and are transported 
into the nucleus after synthesis at cytoplasmic ribosomes [155]. NEP, with only 14 kDa, can 
enter the nucleus through passive diffusion [156]. While nuclear import of NP and polymerase 
subunits is required for the formation of progeny vRNPs, M1 and NEP have to enter the 
nucleus to mediate nuclear export of the newly formed vRNPs.  
NS1, on the other hand, is an important virulence factor and a multifunctional protein 
(reviewed in [129,157]). It is the major viral interferon antagonist and further modulates both 
cellular and viral protein expression. NS1 was shown to associate with viral mRNAs 
[147,158] and has been implicated in the regulation of viral mRNA splicing [159], viral 
mRNA nuclear export [157] and selective enhancement of translation initiation 
[160,161,162]. It is not required though for primary viral transcription and protein expression 
since it is not present in incoming virus particles. Further, NS1 contributes to the virus-
induced downregulation of cellular syntheses. It reportedly interferes with several steps of 
host mRNA maturation, including mRNA elongation, splicing and nuclear export. By 
association with transcription elongation complex hPAF1C, NS1 was shown to specifically 
impair transcription elongation of inducible antiviral genes [163]. NS1 was further shown to 
interact extensively with the host cell splicing machinery [164,165,166] and to inhibit host 
pre-mRNA splicing [167,168,169]. By interaction with the cellular cleavage and 
polyadenylation specificity factor (CPSF) and the poly(A)-binding protein 2 (PABP2), NS1 
furthermore inhibits polyadenylation and 3′ end formation of host pre-mRNA and thus 
selectively impairs the formation of mature export-competent cellular mRNPs [170,171]. 
Synthesis of viral mRNA peaks between 2 and 6 h p.i. Thereafter, mRNA synthesis declines 
rapidly, but nevertheless viral protein synthesis continues at maximum rates from previously 
synthesized mRNA [152,172]. It has been suggested that the drop in viral mRNA production 
might be due to exhaustion of mRNA-cap structures and to virus-induced inhibition and 
degradation of cellular Pol II [130]. Unlike mRNA generation, the synthesis of genomic 
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vRNA continues also late in infection. Production of the different viral RNA species is 
apparently differentially regulated. The molecular basis that controls the activity of the viral 
RNP complexes and the switch from viral transcription to replication is currently still 
unknown and subject of ongoing research (see also 1.4.3.2).  
1.4.3.2 Viral replication 
Viral replication involves the generation of full-length complementary RNA (cRNA) as 
positive-strand replication intermediates. cRNAs – just like vRNAs – are encapsidated by NP 
and the viral polymerase, forming cRNP complexes, which then in turn serve as templates for 
the generation of new vRNA molecules. Full-length replication products are neither 5′ capped 
nor 3′ polyadenylated. Their synthesis requires mechanisms of initiation and termination that 
are distinct from those of viral transcription [54,135]. Triphosphate groups at the 5′ ends of 
cRNA and vRNA segments suggest a primer-independent initiation mechanism [173]. 
Since encapsidation with NP is selective for viral replication products, but not for viral 
mRNA, it was proposed that encapsidation and initiation mechanisms might be coupled [174]. 
While the 5′ cap structure of mRNA leads to cotranscriptional recruitment of mRNA 
processing machinery, it was suggested that the highly conserved 5′ terminal promoter 
sequence of nascent full-length RNA instead might associate with the viral polymerase due to 
specific recognition and trigger (by interaction between NP and the polymerase) the 
recruitment of NP, thereby initiating co-replicational RNA encapsidation in 5′ to 3′ direction 
[89,175]. Subsequent incorporation of other NP molecules into RNP complexes was found to 
be driven by NP-NP homooligomerization, but not by NP binding to RNA [90]. A functional 
relationship between NP oligomerization and RNA-binding was reported though, and also a 
role of NP (de)phosphorylation for oligomerization and RNA-binding has been indicated 
[92,176]. Replication elongation and encapsidation with NP were further reported to be 
facilitated by cellular factors like UAP56, Tat-SF1 and MCM, which may act as chaperones 
[177,178,179]. Consistent with co-replicational RNA encapsidation, Moeller et al. reported 
detection of branched RNP structures by electron microscopy, featuring a polymerase at the 
junction between the smaller (nascent) RNP and the full-length RNP [89]. 
Various models have been proposed for the regulation of viral replication versus transcription, 
but numerous aspects are still unclear (reviewed in [54]). It was initially hypothesized that 
accumulation of free NP might be a regulatory viral factor that can switch polymerase activity 
from transcription to replication. This was based on the finding that viral protein expression is 
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critically required for the onset of cRNA synthesis in infection. Replication in the presence of 
a protein synthesis inhibitor was further shown to be be rescued by preexpression of NP and 
the viral polymerase [180,181]. Evidence was moreover provided for a direct functional 
interaction between NP and polymerase subunits PB1 and PB2, supporting the assumption 
that newly synthesized NP might be able to modulate polymerase activity by direct interaction 
[182,183,184]. It was also proposed that interaction of soluble NP with vRNP templates or 
with nascent RNPs might bias the specific activity of vRNPs [71,185].  
Today, however, the perception of the role of NP has changed. Accumulating evidence 
suggests that NP does not determine the mode of initiation and termination performed by the 
viral polymerase. It was demonstrated that purified vRNPs can synthesize both mRNA and 
cRNA in the absence of added protein in vitro [186], and that the viral polymerase produces 
full-length positive- and negative-strand copies from short vRNA-like templates in the 
absence of NP in vivo [90]. Nevertheless, NP might be an important contributor to efficient 
replication since it was shown to facilitate promoter escape of the viral polymerase when 
exogenously added, promoting elongation of full-length transcripts [177]. It was further 
shown to protect newly formed replication products from degradation in cells [187].  
Importantly though, interaction of NP with the viral polymerase was found to be essential for 
polymerase activity in general. Highly conserved residues in the NP head domain, which were 
shown to interact with the polymerase, were found to be critically required for both mRNA 
and full-length RNA synthesis in cells [188]. Other temperature-sensitive NP mutants, on the 
other hand, were reported to selectively support mRNA and vRNA synthesis, but not cRNA 
synthesis [183], and vice versa [189].   
More recently, a trans-complementation study shifted the focus from NP towards the role of 
the viral polymerase itself and suggested that two distinct populations of the viral polymerase 
might be responsible for transcription and replication [175]. A model was proposed according 
to which the vRNP-bound polymerase complex mediates transcription in cis, while newly 
synthesized soluble trans-acting polymerase complexes are responsible for replication (from 
cRNPs into vRNPs). This model has increasingly gained support by then following studies, 
but it is also consistent with data from earlier studies [180,181,187]. The model provides a 
possible explanation how initiation, encapsidation and termination might be mechanistically 
coupled [54,89], and it is consistent with the observation of different conformational states 
reported for free, vRNA-bound and RNP-bound polymerase complexes, indicating distinct 
functional states [54].  
INTRODUCTION 
16 
 
Apart from NP and the viral polymerase, also other viral factors were reported to be 
implicated in replication regulation (reviewed in [54]). NS1 associates with vRNPs by 
interaction with NP, and a temperature-sensitive mutant of NS1 was shown to affect vRNA 
synthesis, but not the production of positive-strand viral RNA species [102,190]. 
Accumulating evidence furthermore supports a role of NEP as co-factor of the viral 
polymerase. NEP interacts with polymerase subunits PB1 and PB2 and enhances the 
formation of unprimed full-length replications products, while reducing accumulation of 
mRNA, which is independent from its function as nuclear export factor [191,192,193]. 
Differential regulation of all three viral RNA species during infection is thus apparently 
accomplished by complex interplay of a variety of factors. 
Not only transcription versus replication, but also full-length cRNA and vRNA synthesis were 
shown to be differentially regulated. While cRNAs are synthesized early in infection during a 
short period of time, vRNA synthesis continues also late in infection and yields considerably 
higher copy numbers [152,172]. vRNPs are then selectively exported to the cytoplasm and 
become incorporated into progeny virions, while cRNPs are retained in the nucleus, where 
they serve as templates for continued vRNA synthesis [98,152]. Even though cRNAs and 
vRNAs seem to form identical structural complexes with NP and the viral polymerase, they 
must contain structural features that enable their discrimination as functionally different 
classes of molecules. Differences in the conserved terminal RNA sequences and their 
recognition by the viral polymerase were suggested to enable differential regulation and 
functioning. 
cRNAs and vRNAs contain short terminal sequences which are highly conserved among all 
segments [70]. These sequences comprise 13 nucleotides at the 5′ end and 12 nucleotides at 
the 3′ end of vRNA. Together both ends constitute the viral promoter which is bound by the 
viral polymerase [71,72]. The polymerase associates with both positive- and negative-strand 
promoter sequences, yet, different regions on PB1 were reported to be involved in recognition 
of the specific cRNA and vRNA sequences [78,79]. The promoter structure of both cRNA and 
vRNA has been described by a corkscrew model, containing two short intrastrand hairpin 
loops, a single bulged unpaired nucleotide and a short interstrand base-paired region 
[73,74,75,76]. Despite similarities, structural differences were reported that might explain 
differential recognition by the viral polymerase [77]. The polymerase, and specifically subunit 
PB1, was shown to display a higher affinity for the 5′ end of vRNA than for the 3′ end 
[72,79], while it interacts with both 5′ and 3′ ends of cRNA with similar affinities [78]. 
Furthermore, also a requirement of the PA subunit for cRNA and vRNA promoter binding has 
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been indicated. PA seems to contribute more importantly to cRNA promoter binding than to 
vRNA promoter binding [80].  
Transcription initiation was shown to critically require interaction of the viral polymerase 
with both termini of vRNA [71,136]. vRNA terminal sequences apparently serve as essential 
polymerase cofactors during cap-snatching. Polymerase cap binding activity was shown to 
require association with the vRNA 5′ end, while its endonuclease activity requires the vRNA 
3′ end [194,195]. Notably, when associated with the cRNA promoter instead, the polymerase 
was shown to be unable to perform cap-snatching [194,196]. Specific recognition of the 
vRNA promoter thus seems to determine that transcription is initiated only on negative-strand 
genomic templates and that only vRNAs serve as template for viral mRNA synthesis.  
Differences between cRNA and vRNA promoter regions were furthermore suggested to be 
responsible also for distinct initiation mechanisms of cRNA and vRNA synthesis. It was 
shown that vRNA synthesis is initiated internally at positions 4 and 5 of the 3′ end of cRNA 
and that a synthesized dinucleotide is then realigned to position 1 and 2 for full-length 
replication. In contrast, cRNA synthesis was reported to be initiated at position 2 of the vRNA 
3′ end without the need of realignment [197,198,199]. The dinstinct mechanisms were 
suggested to be involved in differential regulation of cRNA and vRNA levels. The molecular 
details are still unknown though. 
Taken together, allosteric modulation of polymerase activity through different RNA promoter 
structures is thus currently considered to be a determinant of vRNP-specific transcription and 
to be an important aspect of vRNA and cRNA synthesis, but also recognition of vRNPs for 
nuclear export and packaging might be closely related to these processes. Extensive further 
investigations are still required to understand functioning and regulation of the viral 
replication machinery.  
1.4.4 Viral protein trafficking and virus assembly 
To participate in virus formation, the different newly synthesized viral components, including 
M1, vRNP complexes and the viral transmembrane proteins, need to be transported to the 
apical plasma membrane of infected cells. For this purpose, viral envelope proteins and the 
viral genome use different transport pathways.  
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1.4.4.1 Viral envelope proteins and the role of lipid rafts 
The transmembrane proteins are synthesized at membrane-bound ribosomes of the rough 
endoplasmic reticulum (ER) and travel through the Golgi apparatus to the plasma membrane. 
Soon after synthesis, HA assembles into homotrimers [200], while NA and M2 form 
homotetramers [201,202,203]. During their passage through ER and Golgi, HA, NA and M2 
acquire a number of posttranslational modifications: HA and NA become glycosylated 
[204,205], HA and M2 are S-acylated [206,207].  
It was initially thought that the viral envelope proteins, and in particular HA as major viral 
envelope protein, might be determinants of polarized virus budding since they are intrinsically 
sorted to the apical plasma membrane of polarized epithelial cells [208,209,210]. 
Recombinant viruses, however, expressing HA mutants that are sorted to the basolateral 
plasma membrane or distribute in a non-polarized fashion, were still found to bud almost 
exclusively from the apical cell surface, suggesting a minor role for HA alone for selection of 
the budding site [211,212]. The determinant of the budding site is currently unknown, but 
might result from interaction of distinct apically targeted viral proteins and their ability to 
establish the viral budzone. The signals for apical transport of HA and NA reside in the 
protein transmembrane domains. They were identified not as discrete motifs, but as dispersed 
residues within the transmembrane regions [39,213,214,215]. The apical targeting signal of 
M2 has not been identified yet.  
HA and NA were further shown to associate with lipid rafts domains, specific membrane 
domains enriched in cholesterol and sphingolipids. (For further information on membrane 
organization and lipid rafts see 1.6). Targeting of HA and NA to lipid rafts plays a central role 
during viral replication, contributing to several steps of the replication cycle, e.g. protein 
trafficking and processing, virus assembly, virus budding and fusion of viral and endosomal 
membranes during virus entry into the host cell (reviewed in [21]).  
HA is one of the best characterized examples of raft-associated proteins. Its association with 
lipid raft domains was demonstrated by a variety of methods: In early studies, HA lipid raft 
targeting was based on biochemical analyses, demonstrating cofractionation of HA with 
detergent-resistant membrane fractions, which were considered as the biochemical equivalent 
of lipid raft domains in cells [24,216,217,218]. Later on, more advanced techniques with high 
spatial and temporal resolution were applied, which confirmed cholesterol-sensitive clustering 
of HA in fixed and living cells [219,220,221,222,223]. 
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The concept of lipid rafts in biological membranes for lateral organization and functional 
compartmentalization has been known for almost three decades [224,225]. It was originally 
introduced to explain selective sorting of lipids and proteins to the apical or basolateral 
plasma membrane in polarized epithelial cells [226,227]. The propensity of sphingolipids, 
cholesterol and specific proteins to self-assemble was suggested to promote lateral 
segregation of apical membrane constituents with increasing cholesterol and sphingolipid 
concentrations within the Golgi and facilitate sorting of apical and basolateral components 
into separate transport vesicles. Accordingly, raft association was suggested to play a role also 
in intracellular trafficking of HA and NA. HA was consistently found to fractionate with lipid 
raft components during late stages of transport to the cell surface [218].  
The raft targeting signals of HA and NA were mapped to the protein transmembrane domains, 
in particular to amino acids located at the exoplasmic leaflet of the lipid bilayer, and to the 
cytoplasmic tails [24,39,215,217,223,228,229]. Notably, though, raft targeting signals 
overlap, but are not identical with the apical targeting signals of the proteins. Several 
mutations of HA or NA were described which disrupt association with lipid rafts, but do not 
affect apical targeting, indicating interactions with the apical sorting machinery independent 
from lipid raft localization [39,215,223,229]. Conversely, also HA mutants could be generated 
which associate with lipid rafts, but which are not properly sorted to the apical surface [214]. 
Evidence thus suggests that lipid raft targeting and apical localization are independent 
features of the viral glycoproteins.  
Nonetheless, lipid raft association was shown to accelerate apical transport of HA and NA, 
presumably by its ability to promote clustering of HA and NA during transport [230]. 
Partitioning into lipid rafts was further reported to play a role for  Golgi-localized processing 
of HA: Acquisition of Endo-H resistant carbohydrates, proteolytic cleavage and transport 
across the Golgi were shown to be severely retarded by mutation of the raft targeting signal in 
the HA transmembrane domain, while HA-trimerization in the ER and apical targeting were 
not affected by the same mutation [231].  
Lipid raft domains further appear to be used by many enveloped viruses, such as HIV-1, 
Ebola and Influenza virus, as a platform for virus assembly. They are thought to facilitate 
concentration of viral proteins and the formation of functionalized domains for virus budding 
[232,233]. The envelope of Influenza viruses was shown to be selectively enriched in 
cholesterol and sphingolipids as compared to the host cell plasma membrane [16,234]. This 
and the fact that HA and NA form large clusters at the cell surface, which are sensitive to 
cholesterol extraction, sensitive to disruption of lipid raft targeting and furthermore colocalize 
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with a lipid raft marker, strongly support the notion that Influenza viruses assemble in and bud 
from lipid raft domains [25,220,221,223]. HA clusters range from 20 to 900 nm in size as 
observed by immunoelectron microscopy and between 40 nm and several micrometers 
according to super-resolution fluorescence microscopy in living cells [220,221]. Very small 
and highly dynamic raft domains (~10 nm–100 nm) are thought to be activated by the 
presence of viral proteins, leading to stabilization and coalescence of lipid rafts into larger 
functional domains which are the precursor of the viral membrane. Targeting of HA and NA 
to lipid rafts is thought to play a central role in this process. Disruption of lipid raft targeting 
signals in HA and/or NA was shown to cause severe replication defects, to decrease 
incorporation of the respective glycoprotein(s) into progeny virus particles and to alter the 
viral lipid composition [24,223,228]. 
Also viral M1 and the actin cytoskeleton were suggested to be involved in stabilization of 
lipid raft-based viral protein clusters and organization of the viral budzone. Accumulating 
evidence supports that actin plays a key role in organizing lipid raft domains and modulating 
their stability [235,236,237]. A link between the cytoskeleton and lipid rafts is well 
documented [238,239]. Upon expression of HA in the absence of infection, HA was shown to 
be organized in elongated and irregular membrane domains, which colocalize with cellular 
actin on the nanoscale. Dynamics measurements further revealed confinement and reduced 
mobility of HA in areas of high actin density, indicating a role for actin in stabilization of HA 
clusters. Exclusion of the actin-remodelling protein cofilin from these HA clusters further 
implied that HA itself influences actin organization [240]. It was speculated that actin 
organization might be affected by HA through its ability to activate Raf/MEK/ERK signaling, 
which depends on accumulation of HA at the cell membrane and tight association with lipid 
raft domains [241,242]. In infected cells, also M1 and NP were shown to accumulate at 
elongated plasma membrane domains and to redistribute together with HA in response to 
actin disruption, correlating with the underlying cortical actin filaments [243]. A role for 
cortical actin in virus assembly and budding was further indicated by proteomic analysis, 
demonstrating the presence of actin inside virus particles [244], and by perturbations of 
cellular actin, leading to inhibition of filamentous, but not spherical virus particle formation 
[15,243]. Strong evidence for functional involvement of actin in lipid-raft based formation of 
the viral budzone was further given by a fluorescence resonance energy transfer (FRET) 
study, demonstrating close association of HA and M2 upon coexpression, even though M2 is a 
non-raft protein. This association was shown to depend on the lipid raft targeting signal of HA 
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and on an intact actin cytoskeleton, suggesting actin-dependent association of M2 with 
preformed lipid raft-based membrane clusters of HA [245].  
Apart from actin, also the matrix protein M1 is believed to promote stabilization and 
coalescence of lipid raft-based viral protein clusters by its ability to oligomerize [44] and to 
interact with the transmembrane protein cytoplasmic tails [38,39]. M1 does not intrinsically 
target to lipid raft domains, but is recruited to lipid rafts in the presence of HA and NA 
[24,38,39]. During infection, M1 becomes increasingly associated with lipid raft domains 
[38], and it was proposed to link the viral ion channel M2 to the viral budzone, which 
likewise was shown to acquire raft association during infection [30]. Nevertheless, it seems 
that M2 in reverse is required for incorporation of M1 and the viral genome. It directly 
interacts with M1 via its cytoplasmic tail [40,246]. M2 might hence be recruited to the viral 
budzone by the presence of HA (and possibly M1) and play an important role itself to 
incorporate the internal viral components.  
M2 further contains two motifs in its cytoplasmic tail that typically support lipid raft 
targeting: a cholesterol-binding site and a palmitoylation site [11,26,207]. Nevertheless, M2 
was shown to be excluded from lipid raft domains and from lipid raft-based clusters of HA 
and NA at the plasma membrane of infected cells [24,25]. The relatively short transmembrane 
domain of M2 (with 19 amino acids (aa) as compared to HA and NA with about 27 and 30 aa) 
might impair partitioning of M2 into lipid raft domains since cholesterol-rich membrane 
domains are comparably thick and favor incorporation of proteins with long transmembrane 
domains [247,248]. It was therefore proposed that M2 might localize at the raft/non-raft 
interface of the viral budzone where the transmembrane region would reside in the non-raft 
bilayer while the cytoplasmic tail would immerge into the lipid raft domain [26]. Consistently, 
it was observed that M2 is excluded from protruding viral filaments at the cell surface and 
specifically localizes only to the budding neck of these filaments [11,30]. This could further 
explain why M2 is largely excluded from virus particles [22,23].  
The function of cholesterol binding by M2 has been the subject of several studies, but still 
remains elusive. Loss of cholesterol-binding by mutation of the M2 cytoplasmic tail did not 
affect recruitment of M2 to the budding site and only slightly reduced cofractionation with 
lipid raft domains in infected cells, suggesting that cholesterol-binding is not required for 
association of M2 with the viral budzone [11]. FRET measurements confirmed that neither the 
acylation nor cholesterol binding motif is required for apical targeting of M2 or for clustering 
of M2 with HA microdomains upon coexpression [249].  
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A crucial role for M2 cholesterol-binding was then revealed by the finding that M2 can 
modulate membrane curvature in a cholesterol-dependent manner: It was shown that M2 by 
itself is capable of mediating membrane budding in cells and in model membranes with low 
cholesterol content. The amphipathic helix of the M2 cytoplasmic tail was furthermore shown 
to be both necessary and sufficient to mediate membrane scission [30]. It was proposed that 
the amphipathic helix might be able to induce membrane curvature by wedge-like insertion 
into membranes or by modulating the line tension that occurs at the boundary between 
membrane domains.  
Since M2 was found to localize specifically to the budding neck of virus particles, it was 
hypothesized that the M2-cholesterol interplay might regulate membrane curvature during the 
budding process, either stabilizing the viral budzone and enabling filamentous virion 
formation or inducing positive curvature and promoting membrane scission [11]. The 
hypothesis is supported by numerous experimental findings: The cholesterol-binding motif in 
the M2 amphipathic helix as well as plasma membrane cholesterol were shown to be essential 
for the formation of filamentous virus particles, suggesting stabilization of budding filaments 
by M2 and cholesterol [11]. Similarly, depletion of cholesterol from the plasma membrane 
was found to cause rapid release of virus particles [250]. Numerous virus strains, including 
spherical and filamentous viruses, further seem to require M2 for membrane scission since 
deletion of M2 or mutation of the M2 cytoplasmic tail were shown to reduce virus particle 
release and to cause morphological changes that display the characteristics of incomplete 
virus budding (e.g. incompletely budded virions appear as “beads on a chain”) [10,30,246]. 
These observations clearly demonstrate that M2 is not necessary for initiation of virus 
budding, but for its completion. According to the current view, M2 is thus considered as a 
viral factor that is essential for efficient membrane scission and virus release. 
How the different functions of the M2 cytoplasmic tail (i.e. sensing of cholesterol, regulation 
of membrane curvature, ability to support filament formation, interaction with M1 and 
incorporation of internal viral components) might be interrelated is unclear.  
Transport of M2 to the viral budding site is currently not well understood. Systematic analysis 
of the transport pathway is missing, and the intrinsic apical targeting signal of M2 has not yet 
been identified. Evidence suggests though that M2 is not transported along the classical 
secretory pathway together with HA and NA, but that it takes an alternative route from the 
trans-Golgi network to the plasma membrane along with Rab11-dependent recycling 
endosomes: M2 localizes to the trans-Golgi network, to apical recycling endosomes and to 
the apical plasma membrane by intrinsic targeting [251], and accumulation of M2 at the cell 
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surface was shown to depend on expression of the small GTPase Rab11 [30]. Upon depletion 
of Rab11, a failure of budding virions to pinch-off was observed, consistent with a failure in 
membrane scission due to lack of M2 [252]. M2 has further been assigned a role in raising the 
intralumenal pH of the Golgi apparatus to prevent untimely, low pH-induced conformational 
change of HA [253,254,255], and also an effect of M2 on recycling endosomal trafficking was 
reported [251]. Ion channel activity of M2 was shown to delay transport of HA and other 
glycoproteins specifically in compartments involved in apical delivery, including the trans-
Golgi network, secretory vesicles and recycling endosomes, while other acidified 
compartments were not affected, correlating with the localization of M2 [203,251,256]. 
Whether apical transport of the viral genome – which likewise depends on Rab11 – might be 
functionally linked to or coordinated with transport of M2 is unknown.  
1.4.4.2 Matrix protein M1 – functions in nuclear export and virus assembly 
The matrix protein M1, which is the most abundant protein in virus particles, does not contain 
intrinsic signals for apical targeting and accumulation at the viral budding site. Upon 
expression in the absence of infection, M1 localizes to the cell nucleus, to the cytosol and to 
intracellular membranes [257]. Since M1 is a central structural element of virus particles and 
able to interact with each of the other viral constituents, it is assumed that M1 preassembles 
with individual viral components in infected cells already during transport. M1 might be 
transported to the viral budding site piggy-back through interaction with the viral 
transmembrane protein cytoplasmic tails, through direct membrane interaction or by 
association with vRNPs [20,41].  
1.4.4.2.1 Role of M1 in vRNP nuclear export 
Part of the newly synthesized M1 accumulates in the nucleus of infected cells due to its NLS 
(aa 101105) [258] where it is required to mediate nuclear export of the viral genome 
[116,259]. Phospohorylation was further reported to play a role in nuclear localization of M1 
and to affect nuclear export of vRNPs [260,261,262,263]. 
Also viral NEP [66,264] and the cellular nuclear export receptor CRM1 [265,266,267,268] 
were shown to be required for vRNP nuclear export. M1 interacts with NEP via its N-
terminus (aa 1164) [57,269,270,271] and with vRNPs presumably via its C-terminal domain 
(aa 165252) [42] why it was suggested that vRNPs, M1 and NEP form a “daisy chain” type 
complex, which is recognized by the export receptor CRM1 [83,272]. While M1 does not 
functionally interact with CRM1 [269], NEP contains two nuclear export sequences (NESs) 
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which are both recognized by CRM1 [67]. NEP thus seems to bridge the interaction between 
vRNP/M1 complexes and export factor CRM1, binding to M1 via its C-terminus [269,270] 
and interacting with CRM1 via the NESs in its N-terminus [67].  
In addition to NEP, also M1 and NP contain NESs [273,274]. The relative contributions of 
these NESs to vRNP nuclear export are not clear though. The identified NES of M1 is highly 
conserved and recognized by a CRM1-independent nuclear export mechanism.  
It should further be noted that attempts to identify the M1 domain for vRNP-binding yielded 
conflicting results, which were not all in accordance with the daisy chain model. Instead of 
the M1 C-terminus – as mentioned above –, it was also reported that the M1 N-terminus 
might be required for interaction with vRNPs [68,275]. Data further seem to suggest that the 
M1 NLS could be involved in interaction with both NEP [269] and vRNPs [275]. The 
molecular basis of vRNP-M1 interaction is thus currently not well understood.  
A refined and more complex model for nuclear export complex formation was proposed very 
recently, suggesting that NEP does not only recruit CRM1 to vRNP/M1 complexes, but that it 
is also required for association of M1 with vRNPs. It was shown that M1 alone is unable to 
establish interaction with vRNPs within the nucleus [101]. NEP by itself, on the other hand, 
can associate with vRNPs via the viral polymerase and enhances vRNA replication [191,192]. 
Notably, the same residues of NEP involved in regulation of polymerase activity were shown 
to be required also for assembly of vRNP/M1/NEP nuclear export complexes, indicating a 
close coordination of these two functions; consistently, the presence of M1 interferes with the 
polymerase-enhancing function of NEP [101]. A model was thus suggested according to 
which M1 attaches to vRNP-bound NEP, which becomes involved in ternary interaction with 
M1, vRNPs and CRM1, neutralizing the polymerase-enhancing function of NEP, stabilizing 
interaction between vRNPs and M1 and recruiting CRM1 to vRNPs. Intriguingly, the C-
terminus of NEP was demonstrated to be sufficient to stabilize vRNP/M1 complexes or to 
constitutively enhance polymerase activity. The NEP N-terminus, on the other hand, impairs 
the C-terminal functions by autoregulatory intramolecular interaction, suggesting an 
additional layer of complexity for regulation of vRNP export complex formation and vRNA 
replication. It was thus speculated that binding of CRM1 to the N-terminal domain of NEP 
might prevent those intramolecular interactions and stabilize M1 binding during export. 
Release of CRM1, on the other hand, subsequent to nuclear export was proposed to enable the 
NEP N-terminus to disrupt M1 binding [101,193]. 
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On the molecular level, numerous details on the interaction between M1 and vRNPs are still 
unknown: neither stoichiometry, nor stability within cells, nor the binding sites have been 
characterized. 
SUMOylation (the attachment of a small ubiquitin-like modifier (SUMO)) at residue K242 
was found to be an essential posttranslational modification of M1 that is required for vRNP-
M1 interaction and vRNP nuclear export [276]. Consistently, M1 and also NEP (another 
SUMOylation target) were found to localize to nuclear promyelocytic leukemia (PML) bodies 
during infection, which are known as hot spots of cellular SUMOylation [277]. A 
SUMOylated form of M1 was however not detected in mature virions, which might be due to 
rapid turnover of SUMO-conjugations [276]. Previous work suggests involvement of 
SUMOylation in CRM1-mediated nuclear export processes [278].  
Physical association between M1 and vRNPs was previously demonstrated by purification of 
complexes from intact virions [275,279]. Yet, no such complexes have so far been isolated 
from cells [101]. It is unclear whether vRNP/M1/NEP complexes rapidly disassemble after 
nuclear export and release of CRM1, or whether they undergo cotransport to the budding site. 
In this context, it should be noted that M1 was not only shown to promote nuclear export but 
also to prevent reimport of vRNPs into the nucleus [116,124]. And since further NEP was 
detected as component of mature virus particles that is attached to the viral core together with 
M1, it was inferred that vRNPs, M1 and NEP remain associated during cytoplasmic transport 
and become incorporated into virions as complexes [57,58]. However, it was also reported 
that vRNPs do not contain detectable amounts of M1 during Rab11-dependent apical transport 
[280]. 
1.4.4.2.2 Role of M1 oligomerization and membrane binding in virus budding 
Apart from its role in nulear export of vRNPs, M1 plays a central role also in viral budzone 
formation and the budding process.  
M1 is a membrane-binding protein that associates with both cellular [51,281] and model 
membranes [42,43,45,47]. It is an unusual peripheral membrane protein, which tightly 
associates with membranes, most likely involving extended surface regions or multiple 
binding sites [47,50,51,257,282]. In some studies, a predominantly electrostatic nature of M1-
membrane interaction was reported [42,45]. In other studies also non-electrostatic 
contributions [43,44,282] and association by partial insertion of M1 into the membrane were 
demonstrated [46,47,282]. It was further reported that M1 could not be detached from cellular 
membranes under high-salt conditions, which usually leads to release of peripheral membrane 
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proteins [50,51,281]. In agreement with partial insertion of M1 into the membrane, it was 
further reported that recruitment of M1 to detergent-resistant membranes by HA is not only 
mediated by the HA cytoplasmic tail, but also by its transmembrane region [38]. A more 
recently developed computational model based on tritium planigraphy data from intact virus 
particles suggests interaction of M1 with the viral membrane via a large part of the protein, 
involving also considerable electrostatic interactions [282].  
Within cells, M1 can be found to accumulate at the Golgi membrane by intrinsic affinity 
[257]. The molecular basis of this interaction is unknown. During infection and upon 
coexpression of HA, M1 and HA colocalize at the Golgi membrane, and both proteins 
apparently undergo cotransport, indicating the possibility that M1 might preassemble with 
viral envelope proteins at the Golgi membrane [38].  
It was suggested that M1 within cells is either soluble and monomeric or has a higher affinity 
for membranes and tends to oligomerize [283]. More recent work reports that M1 forms a 
stable dimer in solution by interaction of the C-terminal domains. The N-terminus, on the 
other hand, seems to be responsible for pH-dependent oligomerization [112]. The ability of 
M1 to homooligomerize is essential for the formation of the viral matrix layer underneath the 
viral membrane [45,284]; the matrix layer is thought to crosslink and concentrate viral 
proteins at the viral budzone and to promote membrane bending during the budding process 
[34]. It is not clear, however, which factors drive and coordinate M1 polymerization.  
Polymerization of M1 should be a regulated process that is locally restricted and functionally 
linked to virus assembly. Only recently, evidence was provided that membrane binding in fact 
strongly enhances oligomerization of M1. Data obtained by fluorescence correlation 
spectroscopy, raster image correlation spectroscopy, atomic force microscopy and use of 
negatively charged model membranes suggest a model according to which M1 associates with 
lipid membranes first and then multimerizes by recruitment of M1 molecules from solution 
[285]. Most notably, number and brightness microcopy performed on M1-expressing cells 
demonstrated further that M1 multimerizes specifically underneath the plasma membrane 
rather than on intracellular membranes or in the cytosol. This observation indicates that M1 – 
even though it is apparently not enriched at the plasma membrane – nevertheless associates 
with the plasma membrane. M1 acts possibly similar to a cationic biosensor, detecting the 
strongly negative surface charge of the plasma membrane [286].  
During virus infection, M1 might be increasingly recruited to the viral budzone by interaction 
with the viral envelope proteins HA, NA and M2, which by promoting M1 membrane 
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association might enhance also M1 polymerization. Clusters of HA and NA thus could 
function as nucleation points of M1 polymerization. Diverging results were reported though 
on the quantitative effect of HA and NA on M1 membrane association. While some studies 
show significant stimulation of M1 membrane binding in the presence of viral glycoproteins 
[281,287], others found no such enhancement [50,51]. By recruitment of M1 to lipid raft 
domains, HA and NA might nonetheless locally concentrate M1 on the plasma membrane 
even if the overall amount of membrane-bound M1 might not change [24,38,39]. 
The hypothesis of enhanced M1 membrane-binding and M1 polymerization due to the 
presence of viral transmembrane proteins is further supported by results from transfection-
based virus-like particle (VLP) production. This assay is commonly applied to test the ability 
of single viral proteins to induce membrane budding, comprising the ability for bud initiation 
and bud completion. Using this approach, it could be shown that M1 alone is unable cause 
budding of VLPs from cells [288,289]. More detailed analyses suggested though that most 
likely the lack of intrinsic plasma membrane targeting is responsible for the failure of M1 to 
induce budding: In fact, targeting of M1 to the plasma membrane by addition of a membrane 
anchor in form of acylation was shown to be sufficient to enable M1-driven VLP budding 
[289]. Viral transmembrane proteins are thought to act analogously as membrane anchors for 
M1 in infected cells, and consistently, it was reported that the presence of M2 leads to 
relocalization of M1 to the plasma membrane and allows formation of VLPs, critically 
requiring the M2 cytoplasmic tail for M1 binding [289]. Similarly, cytoplasmic tails of HA 
and NA were shown to be required for efficient incorporation of M1 into HA- and NA-driven 
VLPs. Notably, HA and NA are able to mediate VLP budding in the absence of other viral 
proteins [288]. It was demonstrated though that M1 significantly enhances the ability of HA 
to produce VLPs upon coexpression, underlining the capacity of M1 to support budding and 
to function synergistically with HA [287,288]. 
A current model of virus budding was described by Rossman et al., summarizing the findings 
from VLP budding assays [34]. Considering that several viral proteins (including HA, NA, 
M2 and membrane-targeted M1) were found to be capable of mediating VLP budding, they 
suggest that each protein might “provide its additive effect on budding in a sequential manner 
driving budding in a defined, organized fashion”.  
They conclude that HA and NA seem to be the only driving forces that are able to initiate 
virus budding, possibly by concentrating in lipid rafts domains and inducing local membrane 
curvature, and that further recruitment of M1 to these membrane domains stimulates M1 
polymerization, which promotes membrane bending and drives progression of the budding 
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process. The helical structure of polymerized M1 might further determine membrane 
curvature [31]. Finally, M2 seems to be most efficient to mediate membrane scission and to 
complete the budding process [34].  
The ability of M2 to associate with M1 [40] and HA [245] seems to suggest that M2 might be 
recruited to the viral budding site by interaction with either M1 and/or HA. The implied 
hierarchy in protein assembly during virus budding is less clear though, seeing that mutations 
of the M2 cytoplasmic tails (which impair M1-M2 interaction) significantly reduce 
incorporation of M1 into virus particles and severely affect further incorporation of the viral 
genome [40,246,290]. Also mutation of HA and NA cytoplasmic tails were shown to cause 
greatly reduced M1 and vRNP packing into newly forming virions [9,291]. According to these 
findings, it is a possible scenario that M2 is recruited to the viral budzone defined by HA and 
NA and drives membrane scission independent from the presence of M1. Interaction between 
M1 and M2, however, might strongly increase the probability of proper packing of the viral 
core components. Furthermore, not only M1, but also interaction between M1 and M2 were 
reported to be determinants of virus morphology, stressing the central function of this 
interaction during the budding process [10,11,37,246]. 
Since defective incorporation of M1 into virus particles is typically accompanied by reduced 
genome packing, it is commonly hypothesized that M1 mediates incorporation of vRNPs into 
virions by bridging the interaction between viral envelope and viral genome. Specific 
interactions between vRNPs and the M1 layer have not yet been identified though, i.e. no 
evidence has been provided whether vRNPs interact directly with the M1 layer or whether 
they might interact (also) with the transmembrane protein cytoplasmic tails. 
Notably, the role of the viral genome during virus budding has not been characterized until 
today and is mostly neglected in current models. vRNPs might have a yet unrecognized 
mechanistic or regulatory function during the budding process in order to ensure production 
of infectious virus particles. It was suggested earlier that the interaction strength between 
vRNPs and M1 might be related to virus morphology [69]. More recent work strongly 
supports the idea of functional involvement of vRNPs in virus budding, showing that NP 
affects virus morphology by interplay with M1 involving specific NP residues [14]. No 
mechanistic function of NP has however been determined in this process. How virus budding 
is coordinated with the arrival and incorporation of the viral genome remains thus issue of 
investigations.  
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1.4.4.3 The viral genome – from the nucleus to the budding site – vRNP transport 
and genome packaging 
Only in the last few years, it has become apparent that efficient delivery of vRNPs from the 
site of vRNP formation to the site of virus assembly requires a well-organized sequence of 
events and the concerted action of different mechanisms. This includes the complex process 
of nuclear export, the apical targeting mechanism, which is closely related to the underlying 
mechanisms of cytoplasmic transport, and finally, assembly of vRNPs during or prior to 
genome incorporation and assembly of virus particles.  
Upon formation in the cell nucleus, vRNPs assemble with M1 and NEP and undergo CRM1-
dependent nuclear export, as described in section 1.4.4.2.1. Additional cellular factors and 
signaling cascades were further reported to be involved in vRNP nuclear export, suggesting a 
complex interplay between host cell and vRNPs. According to biochemical fractionation 
experiments, it appears that vRNPs become tightly associated with host cell chromatin prior 
to nuclear export, which was proposed to facilitate access to the cellular nuclear export 
machinery [292]. The mitogen-activated protein kinase (MAPK) signaling cascade and also 
apoptosis-regulating caspase 3 were further shown to promote vRNP nuclear export in 
infected cells [293,294]. Intriguingly, it was reported that accumulation of HA in lipid raft 
domains of the plasma membrane results in activation of MAPK signaling and thus triggers 
enhanced nuclear export of vRNPs, suggesting a mechanism to coordinate nuclear export of 
the viral genome with viral envelope formation [241].  
The cellular vRNP-binding protein YB-1 was reported to relocate from the cytoplasm to 
nuclear PML bodies during virus infection where it assumedly associates with vRNP nuclear 
export complexes. Evidence was presented that YB-1 is required subsequent to nuclear export 
to target vRNPs to microtubules and to the microtubule organizing center (MTOC), ensuring 
efficient cytoplasmic transport and progeny virus production [295].  
vRNPs reportedly use Rab11- and microtubule-dependent recycling endosomal transport 
machinery across the cytoplasm to reach the apical plasma membrane [280,296,297,298]. 
They transiently accumulate at the MTOC early during infection and, later on, redistribute to 
the cell periphery, colocalizing with Rab11 and adopting a punctate appearance. Pull-down 
experiments suggest that association between vRNPs and recycling endosomes is mediated by 
direct interaction between the active GTP-bound form of Rab11 and the viral polymerase 
subunit PB2 [280,296].  
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In earlier work, also lipid raft-dependent apical targeting of vRNPs was proposed, based on 
the observation that NP was found to be intrinsically targeted to the apical cell periphery in a 
cholesterol-dependent manner [299]. The molecular basis of this observation was not 
identified though, and the significance of lipid rafts for transport of internal viral components 
has been paid little attention since. Possible contributions of NP to vesicular transport of 
vRNPs or virus assembly cannot be excluded. Lipid-raft based targeting of intact vRNPs 
remains to be demonstrated though. 
Speculations that M1 might mediate apical transport of vRNPs by forming a piggy-back 
complex with the viral transmembrane proteins were not confirmed [300]. 
Another important aspect of virus assembly is the process of genome packaging. Due to the 
segmented nature of the viral genome, genome packaging has been a matter of debate over 
many years. Genome segmentation into eight distinct vRNP species provides evolutionary 
advantages like the reassortment of genetic material, but it also challenges viral infectivity 
since efficient viral replication requires the complete viral genome.  
At the beginning of this debate, two opposing models of Influenza virus genome packaging 
were suggested, both of which seemed to be supported by experimental data: the random 
versus the selective packaging model [100,301]. In both cases, a mechanism is required to 
discriminate genomic vRNA from positive-sense viral cRNA and other RNA species. The 
random packaging model implies that sufficient numbers of vRNPs need to be incorporated 
into virions for the production of infectious virus particles, which would further be 
accompanied by the formation of a high proportion of noninfectious virus particles. Specific 
packaging, however, requires specific packaging signals to distinguish between the different 
vRNA segments and to ensure that one copy of each vRNA species is incorporated into 
budding virus particles. First strong evidence supporting a selective packaging mechanism 
was provided by studies on naturally occurring defective-interfering (DI) vRNAs and by 
characterization of cis-acting packaging signals within vRNA sequences [302,303,304]. DI 
RNAs are internally deleted vRNAs, which lack part of the coding sequence but retain the 
terminal regions and compete with the corresponding full-length segments for incorporation 
into virus particles. 
A more detailed model on packaging signals and genome organization was obtained only 
during the last ten years by contributions from a variety of approaches, including cryo-
electron tomography, fluorescence in situ hybridization (FISH) and reverse genetics. Striking 
evidence for selective and highly organized packaging of vRNPs was provided by high-
resolution structural data from intact and budding virus particles, demonstrating that most 
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virus particles contain a highly organized set of eight (presumably different) vRNPs (Fig. 1) 
[8,31,35,53,305,306]. Segment-specific detection of vRNAs by multicolor single-molecule 
FISH further confirmed that the majority of virus particles contain one copy of each vRNA 
segment and thus incorporate a complete set of the viral genome [56]. The regular 
arrangement of vRNPs indicates a well-defined mechanism of assembly and a well-ordered 
process of genome incorporation. However, also marked morphological and ultrastructural 
differences between particles were reported, and existence of distinct morphogenetic 
pathways was suggested [307]. 
Reverse genetics studies allowed characterizing the packaging signals within RNA sequences 
of all eight vRNA segments (reviewed in [100,305,308]). Even though specific nucleotides 
contributing to the packaging motifs are poorly defined in most cases, the packaging signals 
share common features. They can be described as discontinuous cis-acting RNA sequences 
spanning the 3′ and 5′ terminal regions of vRNAs, comprising both coding and non-coding 
sequences. Minimal sequences for efficient packaging were reported to include between nine 
and 80 nucleotides of the coding sequence at either end [308]. Theoretical considerations on 
nucleotide variability in the viral genome (due to redundancy in the genetic code) confirmed 
evolutionary pressure on codon conservation in the terminal regions of vRNAs independent 
from amino acid conservation [309].  
A hierarchical network of interactions among vRNPs was further suggested based on 
observations that defective packaging of one segment can affect also packaging of other 
segments in trans [310,311,312,313,314]. Not all segments appear to be equally important 
though. In particular, segments 1, 3, 5 and 7 seem to play an important role for genome 
assembly, while segments 2, 4, 6 and 8 appear to be less critical for incorporation of other 
segments, which might facilitate exchange of antigenic determinants among strains [315]. The 
characteristic “7+1” arrangement of vRNPs within virus particles (Fig. 1) similarly seems to 
suggest that the central vRNP segment in genomic complexes might be more important for 
assembly than the surrounding segments. Fournier et al. however reported that segment 4, 
encoding HA, is a likely candidate to occupy the position of the central segment in the 
genome of H3N2 virus A/Moscow/10/99 [306].  
Even though the existence of packaging signals is well established by now, the molecular 
mechanism of selective packaging is still not fully understood. First evidence was obtained 
though. A single interaction network was demonstrated to be formed between vRNAs in vitro, 
involving all eight vRNAs by at least one interaction, supporting that supramolecular 
complexes can be formed by nucleotide base pairing and thus by direct interaction of vRNAs. 
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The relevance of the observed interactions was verified by deletions of known packaging 
signals which strongly affected vRNA-vRNA interactions in vitro [305]. Furthermore, 
nucleotides mediating interaction in vitro could be identified and were tested for their function 
in genome packaging in infected cells, using reverse genetics [316]. The results strongly 
suggested that these nucleotides mediate interaction between vRNPs during virus assembly 
and that multisegmental genomic complexes are formd by base pairing between vRNA 
segments. This hypothesis is furthermore in agreement with the architecture of vRNP 
complexes as described by Baudin et al., indicating that nucleotide bases of NP-bound vRNA 
are exposed to the solvent and that NP increases the accessibility of vRNA bases, presumably 
by unfolding RNA secondary structure [87]. Nevertheless, it was pointed out by Fournier et 
al. that it is still not fully clear whether vRNA is (or is not) able to form secondary structure 
within vRNP complexes [305,306]. It addition to the vRNA nucleotide sequence, it was 
reported that also specific highly conserved amino acids in NP, clustering around the RNA-
binding groove, seem to play an important role in incorporation of multisegmental vRNP 
complexes [317]. 
Strain-specific differences between vRNA interaction networks in vitro were demonstrated by 
comparison of vRNA segments from H3N2 and H5N2 virus strains [318]. Also analysis of 
codon conservation indicated strain-specific differences in certain packaging signals, which 
might have implications for genetic reassortment [309]. In case of H5N2 virus 
(A/Finch/England/205/91), several sequences involved in vRNA-vRNA interactions in vitro 
were unexpectedly found to locate in the central region of vRNA segments. These were 
previously not identified as part of the packaging signals [318]. Similarly, analysis of codon 
conservation revealed low variability of some codons in the central part of vRNA segments, 
suggesting unrecognized functions of these genomic sequences [309].  
Together, data obtained on Influenza virus genome packaging strongly support a selective 
packaging mechanism; they indicate however also a certain flexibility in genome packaging, 
allowing incorporation of seven or nine vRNP segments instead of eight and tolerating 
mutations to varying degrees [309,311,312,313,319,320,321,322]. Also incorporation of 
reporter genes without specific packaging signals [98,314,323] and selection of efficient 
packaging signals from randomized sequences without a clear consensus motif for packaging 
support this flexibility and variability of packaging signals [324,325]. Hutchinson et al. stated 
that “although the evidence for a specific packaging method is overwhelming, the mechanism 
is clearly not perfect” [100]. They further speculate that an imperfect packaging strategy 
might be beneficial to virus fitness. Evolution of Influenza viruses either by reassortment or 
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by accumulation of mutations in the protein coding sequences or promoter regions might 
benfit from a certain flexibility or imprecision of packaging signals.  
The structural organization of multisegmental vRNP complexes within virus particles – as 
revealed by electron tomography – seems to be in accordance with studies on vRNP 
packaging signals and the reported vRNA-vRNA interactions. A “transition zone” underneath 
the viral membrane was described where the bundle of parallel oriented vRNPs forms a 
tightly interconnected platform and establishes close contact with the viral matrix layer and 
the viral envelope. This zone was reported to be long enough (13.3 to 17.5 nm) to comprise an 
average of 206–271 nucleotides from both ends of vRNA, which is consistent with terminal 
packaging signals that closely interact by nucleotide base pairing [306]. Observations are 
inconsistent though regarding the question whether vRNPs are connected along their entire 
length. While, on the one hand, it was stated that no close contacts between vRNPs outside 
the transition zone could be observed [306], another study reported frequent direct contacts 
between vRNPs throughout the virus by short string-like structures resembling RNA [35]. It 
cannot be excluded that different observations might result from analysis of distinct viral 
strains.  
At which stage of the replication cycle higher-order assembly of vRNPs into genomic 
complexes takes place is unknown. Colocalization analysis of vRNA segments in infected 
cells, using FISH with single molecule sensitivity, strongly suggested that vRNPs are 
exported individually from the nucleus, localizing separately first, and assemble during 
cytoplasmic transport with Rab11-positive vesicles, colocalizing at high frequency on 
recycling endosomes before their arrival at the plasma membrane. Rab11 was further shown 
to be required for efficient colocalization of vRNA segments in the cytoplasm, indicating that 
recycling endosomes might serve as platform to gather vRNPs before they reach the plasma 
membrane [134]. Momose et al. proposed that interaction between Rab11 and the viral 
polymerase might help to orient and align vRNPs on the vesicular membrane and thus 
facilitate interaction of the terminal packaging signals adjacent to the polymerase-binding site 
[298]. The work further suggests that before reaching the MTOC vRNPs do not colocalize in 
the cytoplasm early during infection, but can be found separately adjacent to microtubules. As 
opposed to this, another study came to the conclusion that subcomplexes of vRNP segments 
might preassemble already within the nucleus [326]. However, colocalization of vRNPs prior 
to nuclear export is difficult to assess due to the high local density of vRNPs in the nucleus. 
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vRNP complexes are finally transferred from recycling endosomes to the budding site, most 
likely as complete sets of 8 vRNPs. The targeting mechanism and the physical interaction 
responsible for local association with the viral envelope have not been identified yet. As 
aforementioned, the presence of M1 and interaction of M1 with viral envelope proteins were 
shown to be important for efficient incorporation of the viral genome, even though tight 
interaction between vRNPs and the M1 layer within virions is generally not observed by 
electron tomography (1.4.4.2). vRNPs might be delivered to the plasma membrane together 
with viral protein M2 on Rab11-positive endosomes, even though cotransport and targeting 
mechanism of M2 remain to be demonstrated (1.4.4.1). Evidence suggests that M2 promotes 
membrane scission, eventually leading to release of virus particles, which is further supported 
by enzymatic activity of NA [10,18,30,246]. 
1.5 The Influenza A virus nucleoprotein (NP) 
NP is a 498-aa protein, encoded by segment 5 vRNA [327], which is highly conserved among 
Influenza A virus strains [309,328,329,330]. Analysis of 617 NP sequences from Influenza A 
viruses demonstrated 85 % amino acid identity in more than 95 % of the sequences [309]. 
Comparison of 2500 NP sequences further revealed that only 30 % of residues in NP are 
polymorphic [331]. Significant similarities were also reported among Influenza A, B and C 
virus NP [332]. Structural similarities can be observed also with nucleoproteins from other 
negative-sense RNA viruses [333].  
NP consists of two domains, a head and a body domain, and further a tail loop (aa 402428) 
which is connected to head and body domain by two flexible linkers (Fig. 5). X-ray crystal 
structures were obtained from NP homotrimers, revealing that the tail loop enters the 
neighbouring NP subunit and drives homooligomerization by electrostatic, hydrophobic and 
beta-sheet interaction [93,333]. The flexibility of the linkers is assumed to allow formation of 
various oligomeric structures of NP. Purified NP (free from RNA) was shown to form trimers, 
tetramers, pentamers, hexamers, rings of 7 to 11 NP subunits and even helical and double-
helical RNP-like structures [334]. Oligomerization in vitro was found to be strongly 
dependent on the ionic strength [335].  
The secondary structure of NP is mostly α-helical. Head and body domain of NP are tightly 
interconnected by three polypeptide regions. They are formed by discontiguous sequences of 
the polypeptide chain which repeatedly goes back and forth between both domains. This 
specific organization of NP tertiary structure might explain why it was formerly difficult to 
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assign functions like RNA-binding, homooligomerization or interaction with M1 to specific 
regions of the NP primary sequence like the protein N- or C-terminal domains. 
 
 
Fig. 5: Crystal structure of NP from Influenza A/WSN/1933, depicting one NP subunit of an NP homotrimer 
(PDB 2IQH). Illustrations are adapted from [93]. (A) Representation of secondary structure elements, including 
denotations of the 19 α-helices and 8 β-strands. Assignment of flexible basic loop and protruding element are 
based on [333]. (B) Electrostatic surface potential representation of NP, indicating a potential RNA-binding site 
rich in conserved arginine residues. Positive electrostatic potentials are shown in blue, negative potentials in 
red. Both representations A and B show a side view of NP. 
 
NP is a ssRNA-binding protein, which encapsidates both cRNA and vRNA in infection. It has 
a net positive charge at neutral pH and is rich in arginine residues. A net charge of +14 was 
reported for Influenza A/PR/8/34 NP at pH 6.5 [327]. A positively charged groove between 
head and body domain was shown to be implicated in RNA-binding and is thus termed 
“RNA-binding groove” (Fig. 5B) [93,333]. It contains numerous highly conserved arginine 
residues, which are spread throughout the primary sequence, consistent with the finding that 
NP-RNA contact is mediated throughout the entire polypeptide [336]. Two structural features 
were further identified in close proximity to the RNA-binding groove: a flexible basic loop 
(aa 7391) and a protruding element (aa 167186), both containing numerous positively 
charged residues. Mutational analysis confirmed that residues R74, R75, R174 and R175 in 
flexible loop and protruding element as well as the close-by residue R221 together are 
essential for RNA-binding; also residues along the binding groove (R150, R152, R156 and 
R162) were shown to be implicaed in RNA-binding. Since deletion of the flexible loop 
significantly reduced the affinity for RNA, a model was postulated according to which the 
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flexible loop might capture RNA and deliver it into the binding groove where the protruding 
element might clamp the RNA into the groove [333]. Molecular dynamics studies support that 
the flexibility of the basic loop (aa 7391) and further flexibility of the loop spanning residues 
200214 are required for RNA-binding and most likely for conformational changes, which 
are induced by RNA-binding [337]. 
Structural data and mutational analysis are in accordance with results that were obtained in 
earlier studies. Already in 1970, it was postulated that NP binds vRNA electrostatically via its 
phosphate backbone [338]. In 1994, chemical modification experiments confirmed NP-
binding to the RNA phosphate backbone, while showing that the nucleotide bases of NP-
bound RNA are exposed to the solvent. Consistently, NP associates with ssRNA with high 
affinity, but without sequence specificity [87,91]. Accessibility of RNA on the outside of the 
NP protein scaffold is furthermore in accordance with the reported sensitivity of vRNPs to 
RNAse digestion. In 1999, Elton et al. suggested – based on chemical modification 
experiments and intrinsic protein fluorescence measurements – that arginines and 
tryptophanes are involved in RNA-binding, but not lysines [336]. Independent studies 
reported dissociation constants of NP and ssRNA of about 20 nM [87,187,333,339]. A binding 
stoichiometry of 2024 nucleotides per NP subunit was estimated [52,93,96]. RNA fragments 
of 18 nt were furthermore shown to be protected within RNP complexes from RNAse 
digestion [95].  
Evidence suggests that RNA-binding and NP oligomerization are coordinated and cooperative 
processes. NP was reported to self-associate with lower affinity in the absence of RNA than in 
its presence [92], and binding of NP to ssRNA was shown to be highly cooperative in vitro 
[91]. Mutations of RNA-binding sites were moreover found to affect NP oligomerization and 
vice versa, suggesting that both functions are linked via protein conformation: While, on the 
one hand, tail loop mutant R416A, yielding obligate monomeric NP, was found to display 
strongly reduced RNA-binding affinity [335,336,340], RNA-binding mutants R361A and 
R204A-R208A were shown to display an oligomerization defect [337].  
Structure determination revealed that the overall structure of monomeric NP-R416A is mostly 
identical to the structure of wild-type (wt) NP, except for C-terminal residues 386498. The 
C-terminus of the mutant was shown to be rearranged on the NP surface and reaches into the 
RNA binding groove, thus lowering the positive charge of this groove [176]. NP-R416A was 
further found to be unable to support transcription in a minireplicon assay, suggesting also a 
failure of NP-R416A to interact with the viral polymerase [317]. Notably, mutations R361A 
and R204A-R208A were postulated to affect RNA-binding and NP oligomerization by a 
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completely different molecular mechanism, namely by decreasing the flexibility of two 
flexible loops involved in RNA-binding and oligomerization [337].  
Even though NP reportedly forms oligomers in vitro [334,335] and in cells [44], it was 
indicated that only monomeric NP can efficiently polymerize onto RNA, forming larger 
structures [176]. Longtime, it has been unclear how NP oligomerization and RNA-binding 
might be controlled in infected cells until more recently phosphorylation of residue S165 was 
found to stabilize the monomeric state of NP and to reduce its RNA-binding affinity 
[176,261]. This residue is highly conserved among Influenza A and B viruses, and it was 
found to be phosphorylated during infection. It locates in a region reported to be involved in 
intermolecular NP-NP interaction (aa 160167) and adjacent to the protruding element 
involved in RNA-binding (aa 167186) [331]. Phosphorylation thus might be a tool to control 
polymerization and RNA-binding of NP in infected cells, even though its regulation in the 
context of viral infection and replication might be more complex. 
Apart from viral RNA, NP interacts also with another constituent of viral RNPs, namely the 
viral polymerase. Direct interaction between NP and polymerase subunits PB1 and PB2 was 
demonstrated [182,341,342]. NP residues R204, W207 and R208 were further identified to 
interact with the polymerase complex and to be essential for both viral replication and 
transcription [188]. Independent from its RNA-binding activity, NP was shown to interact 
with the viral polymerase and stimulate replication of short model RNA templates in vitro 
why NP was suggested to function as polymerase cofactor [343]. In vitro analysis further 
revealed that NP facilitates promoter escape of the viral polymerase, thus acting as elongation 
factor of the viral polymerase [177].  
The recruitment of NP onto nascent full-length RNPs was found to be driven by NP 
oligomerization rather than RNA-binding, suggesting that RNA-binding might occur 
subsequent to NP oligomerization during RNP assembly. New NP subunits were shown to be 
added in a “tail loop-first” orientation [90]. Nevertheless, RNA-binding activity of NP is 
critically required for stabilization of full-length viral replication intermediates in cells and for 
successful viral replication [90,177,187]. The cellular RNA helicase and NP-binding protein 
UAP56 was further shown to promote encapsidation of viral RNA species by NP, presumably 
acting as chaperone during this process [177].  
A broadly accepted model on viral RNA encapsidation suggests that specific encapsidation of 
viral RNA species is initiated by the viral polymerase, which selectively binds to the 5′ 
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terminal promoter sequences of nascent viral RNAs. It thus forms a nucleation point for 
recruitment of NP, followed by NP homooligomerization [54,175]. Consistently, data seem to 
indicate that NP by itself is not sufficient to stabilize viral replication intermediates in cells, 
but requires the presence of the viral polymerase complex [181].  
A molecular mechanism was postulated by which the viral polymerase might facilitate NP 
oligomerization and RNA-binding: The flexibility of loop 200214 was proposed to be 
important for RNA-binding [337], and it harbours further conserved residues R204, W207 
and R208 for polymerase-binding, leading to the suggestion that interaction between NP and 
the viral polymerase might induce conformational changes in NP, thereby increasing its RNA-
binding affinity and promoting cooperative binding of other NP molecules to the “primed NP-
RNA site” [176]. As indicated above, also regulatory factors like dephosphorylation of 
monomeric NP or involvement of RNA helicase UAP56 might play a role in this process.  
It should be furthermore considered that interaction between NP and viral polymerase could 
possibly involve different interfaces on NP depending on whether NP is part of the RNP 
template structure or part of nascent RNP complexes. Potential interaction sites for 
polymerase-binding apart from R204, W207 and R208 have not been identified though, albeit 
residues selectively affecting different polymerase functions were reported [183,317]. Host-
specific adaption of residue 627 in PB2 was furthermore postulated to affect NP-PB2 
interaction in a host factor-dependent way [344]. This was, however, later on questioned by 
the work of Cauldwell et al. [345].  
Apart from tail loop-mediated linear polymerization of NP, NP establishes also intrastrand 
contacts within the double-helical structure of viral RNPs. An NP-NP dimer interface was 
consistently identified, which allows NP subunits to bind to each other in an antiparallel 
constellation [92]. In those NP dimers, the RNA-binding groove was shown to be fully 
accessible and the RNA-binding affinity is indistinguishable from that of wt NP. The 
dimerization interface involves two polypeptide regions, comprising residues 149167 and 
482498. Disruption of the dimer interface by mutation D491A was shown to prevent 
dimerization but did not affect tail loop-mediated oligomerization. However, failure to 
dimerize severely affected the ability of NP to support replication and transcription. The 
dimerization interface is considered to be essential to organize RNP strands into functional 
double-helical structures [92].  
Close physical contact between the two antiparallel NP strands of double-helical vRNP 
structures was consistently observed also within three-dimensional cryo-electron microscopy 
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(EM) reconstructions of purified native vRNPs [88,89]. However, docking of the NP crystal 
structure into cryo-EM reconstructions led to deviating results in independent studies. While 
one study suggested NP protomers of antiparallel strands to interact via their N-terminal 
domains, the body domains facing each other (Fig. 3) [88], another study concluded that 
interaction between RNP strands involves a region nearby the NP head domain [89]. The 
identified dimer interface might help to define the position of NP (and thus of viral RNA) 
within RNP strands more precisely and contribute to understand the functioning of the viral 
replication machinery on the molecular level. 
Apart from the structural role of NP and its function in viral replication and transcription, NP 
plays an important role also as adaptor to the host cell. It is involved in multiple interactions 
with host cell proteins and has been implicated in Influenza virus-induced signaling.  
NP was shown to induce apoptosis in airway epithelial cells, presumably by direct interaction 
with the anti-apoptotic cellular factor clusterin [346], and it counteracts the protein kinase R 
(PKR)-mediated cellular innate immune response by association with heat shock protein 40 
(Hsp40) and subsequent release of PKR inhibitor p58IPK [347]. These mechanisms enable 
NP to interfere with the host interferon response and to contribute to virus-induced apoptosis, 
which reportedly promotes efficient viral replication late in infection [348].  
NP further interacts with the antiviral cellular protein RUVBL2, which disrupts NP 
oligomerization and inhibits viral polymerase activity [349]. On the other hand, NP interacts 
with cellular factors which promote viral replication like the RNA helicase UAP56, which 
acts as a chaperone of NP for RNA encapsidation [177,350], and further with HMGB1, which 
was shown to increase viral polymerase activity, requiring therefore DNA-binding activity 
[351]. Furthermore, NP and also vRNP complexes bind to histone tails [352]. The function of 
this interaction is still unclear though. More detailed analysis revealed that NP specifically 
interacts with histone modifications characteristic for transcriptionally inactive chromatin, 
suggesting potential functions in chromatin remodeling, host cell shut-off or subnuclear 
targeting of vRNPs [353].   
Cell fractionation experiments furthermore suggest association of NP with cytoskeleton 
elements in infected and transfected cells [339,354]. F-actin was identified as interaction 
partner of purified NP in vitro [339], and β-actin, vimentin and several tubulin isoforms were 
co-immunoprecipitated with reconstituted vRNPs from cells [103]. An NP interaction site for 
actin was proposed (aa 327345), which – according to structure determination – is however 
buried within the NP molecule [93]. NP was found to colocalize with actin stress fibres in 
transfected cells, and disruption of F-actin-binding was shown to be accompanied by nuclear 
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accumulation of NP [339]. More recent studies, however, support a presumably indirect 
interplay between NP and actin filaments during infection. Upon disruption of cortical actin in 
infected cells, NP (most likely in form of vRNPs) was shown to reorganize underneath the 
plasma membrane together with actin, HA and M1 [243]. Interaction and colocalization was 
further demonstrated between NP and the actin-binding protein α-actinin-4, which crosslinks 
and bundles F-actin, forms stress fibers and anchors actin to membranes. Knock-down of α-
actinin-4 was shown to greatly impair viral replication, reducing transcription, replication and 
nuclear localization of NP [355].  
Another important host-dependent function of NP is further the nuclear-cytoplasmic transport 
of NP and genomic vRNPs. Functional interaction between NP and a number of nuclear 
import receptors, namely importin-α1, -α3, -α5 and -α7, was demonstrated 
[119,121,340,356,357,358]. Since efficient nuclear import of both NP and the viral genome is 
absolutely essential for viral replication, it is not surprising that specificity of NP for different 
importin isoforms is a critical determinant of host range. Adaption of avian Influenza viruses 
to mammalian hosts was shown to be accompanied by emergence of importin-α7 specificity 
of NP, while NP from avian strains displays specificity for importin-α3 [356]. Adaptive 
mutations in NP were further shown to enhance affinity between NP and importin-α1, thereby 
promoting viral transcription and replication in mammalian hosts [359].  
NP accumulates in the cell nucleus due to nuclear localization sequences (NLSs), which are 
recognized by nuclear import receptors. NP contains at least two highly conserved NLSs: an 
unconventional N-terminal NLS (NLS1, aa 313) [121] and a classical bipartite NLS (NLS2, 
aa 198216) [122]. A third functional NLS was identified, which is strain-specific though (aa 
90121) [360]. Evidence from several independent studies strongly suggests that NLS1 acts 
as major nuclear import signal of NP, driving nuclear import of NP and vRNP complexes, 
while only minor contributions by NLS2 were reported (see also 1.4.2) [118,120,123,361]. 
Consistently, structural information proved that NLS2 is unlikely to function as bipartite NLS 
in NP since the distance between the bipartite binding sites is too short within the NP 
molecule [93]. Instead, a nucleolar targeting signal was identified within NLS2, spanning 
residues 213216 [123]. This sequence is not only responsible for accumulation of NP in 
nucleoli, but was furthermore shown to be essential for transcriptional activity of vRNPs. 
Various other (above-mentioned) functions have been assigned to the putative bipartite NLS2 
as well: residues 200214 represent a loop in the NP structure whose flexibility has been 
implicated in RNA-binding [337]; residues R204, W207 and R208 were reported to interact 
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with the viral polymerase and to be essential for polymerase activity in viral transcription and 
replication [188], and finally, residues 214 and 217 were reported to play a role in filamentous 
virion formation, presumably through interplay with M1 [14]. 
In addition to nuclear import signals, NP possesses also signals for nuclear export. In early 
studies on NP expression, it was already demonstrated that NP is a shuttling protein between 
nucleus and cytoplasm [124]. Even though NP with 56 kDa is not freely diffusible across the 
nuclear membrane, several studies reported relocalization of NP to the cytoplasm after initial 
accumulation in the nucleus. This shift to cytoplasmic localization was reported to be 
promoted by high cell densities [339], high NP expression levels and phosphorylation 
[362,363]. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, was further 
shown to prevent relocalization of NP to the cytoplasm, indicating the presence of a CRM1-
dependent nuclear export signal (NES) in NP [265]. Only recently, three functional NESs 
were identified in NP: NES1 (aa 2449), NES2 (aa 183197) and NES3 (aa 248274) [274]. 
While NES1 and NES2 mediate CRM1-independent nuclear export, the function of NES3 
was shown to be CRM1-dependent. Notably, NP oligomerization was found to be essential for 
nuclear export of NP [274]. (By contrast, upon interaction with import receptor importin-α5, 
NP was shown to be maintained in a monomeric state instead [340].)  
Since oligomerized NP is the major protein component of vRNPs, a role of NP in nuclear 
export of vRNP complexes was consequently suggested. Experimental results, however, lack 
conclusive evidence that NP NESs might be involved in vRNP nuclear export, but indicate 
instead nuclear export complex formation with viral proteins M1 and NEP and CRM1-
dependent nuclear export involving NEP NESs [66,67,101,116,264,267,280]. Whether the 
different NESs can be integrated in one coherent model for vRNP nuclear export remains to 
be determined. 
NP is furthermore a phosphoprotein [364,365,366]. Only recently, seven sites in NP were 
identified which are phosphorylated during infection and/or within purified virions [261]. 
They are exposed on the NP surface, and five of them are highly conserved (S9/Y10, S165, 
Y296/S297, S402/S403, S457). Another phosphorylation site at conserved residue S3/T3 was 
previously demonstrated [367,368]. The overall phosphorylation pattern of NP was shown to 
be strain-specific and dependent on the host cell [369]. It further changes during the infection 
cycle [368]. In case of S165 and S402/S403, phosphomimetic mutations S165D and S402D 
suggested that constitutive phosphorylation is more detrimental to virus growth than lack of 
phosphorylation by alanine mutation S165A or S402A [261].  
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Phosphorylation sites were found to be located within well-characterized functional regions of 
NP: S402/S403 locates within the NP tail loop, driving NP oligomerization, S3 and S9/Y10 
reside within the unconventional N-terminal NLS, and S165 is part of the RNA-binding 
groove, affecting RNA-binding and oligomerization. Regulatory functions of NP 
phosphorylation were hence proposed in nuclear-cytoplasmic transport and vRNP assembly 
[176,261,370]. General stimulation or inhibition of cellular phosphorylation was consistently 
found to affect nuclear accumulation of NP [363]. Alternative functions of NP 
phosphorylation were suggested also in virus entry, vRNP trafficking, virus assembly or 
immune response. [261]. 
1.6 Biological membranes and lipid rafts 
Biological membranes are an essential prerequisite of life. They enclose all types of cells from 
bacteria to mammalian cells, forming a selective permeable barrier against the environment. 
They allow enrichment of nutrients and storage of energy and information in form of 
chemical gradients. Membranes further compartmentalize eukaryotic cells and enable 
formation of functionally specialized reaction spaces. 
Membranes are formed by amphiphilic lipids, which self-assemble into lipid bilayers (Fig. 
6A). The hydrophobic effect causes the hydrophobic (”water-fearing”) moieties of lipids to 
assemble as hydrophobic core of the membrane, while the polar lipid headgroups face the 
aequeous environment and provide solubility to the lipid bilayer within aequeous 
surroundings [371,372]. The hydrophobic core excludes polar substances and thus constitutes 
a barrier for hydrophilic (“water-loving”) molecules. The so-formed lipid bilayers can embed 
varying amounts of diverse peripheral and transmembrane proteins. This general design is 
conserved and common to all biological membranes; yet, the specific lipid and protein 
composition can vary widely and defines specific functions and properties of biological 
membranes [373,374].  
The three most abundant lipid classes in eukaryotic membranes are the glycerophospholipids, 
the sphingolipids and the sterols (Fig. 7).  
In glycerophospholipids, a glycerol backbone is ester-linked to two acyl chains in positions 1 
and 2 and contains a phosphate ester at position 3 (Fig. 7A). The simplest 
glycerophospholipid is phosphatidic acid (PA) with only one phosphate group. This phosphate 
can establish a diester-bond to various headgroups like choline, ethanolamine, serine and 
inositol, yielding phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
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phosphatidylserine (PS) and phosphatidylinositol (PtdIns), respectively. Inositol can be 
phosphorylated to varying degrees, yielding seven different types of phosphoinositides. They 
represent a minor group of membrane lipids, but play an important role in signal transduction 
processes and membrane trafficking [375]. Apart from their headgroups, 
glycerophospholipids differ also by the lengths and the saturation of their fatty acid chains. 
These can be saturated or mono- or polyunsaturated.  
The backbone of sphingolipids is formed by sphingosine. Sphingosine can be amide-linked to 
a fatty acid chain, forming ceramide, which by further addition of a phosphocholine or 
carbohydrate headgroup becomes sphingomyelin (SM) or a glycosphingolipid, respectively 
 
Fig. 6: Biological membrane organization. (A) Structure of a phospholipid bilayer. The acyl chains of 
phospholipids form the hydrophobic core, while the hydrophilic lipid headgroups constitute the bilayer surface 
that is in contact with the aqueous environment. (B) Fluid mosaic model of biological membranes  according to 
Singer and Nicolson [376]. (C) Model of a biological membrane with lateral raft-based heterogeneity. Rafts are 
enriched in cholesterol and SM and display higher membrane thickness. GSLs and SM are enriched in the 
external membrane leaflet, while GPLs constitute the majority of the cytoplasmic leaflet. Proteins display 
preferential association with raft or non-raft domains, biased by intrinsic properties or protein modifications. 
Membrane domains can be stabilized by cortical actin. Illustration adapted from [373]. GL: glycerophospholipid, 
GSL: glycosphingolipid, SM: sphingomyelin, TM: transmembrane. 
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(Fig. 7B). Sphingolipids are enriched in the plasma membrane of mammalian cells; SM 
represents a major component of nerve cell membranes. The acyl chains of sphingolipids are 
commonly saturated.  
Sterols are an important component of biological membranes despite their inability to form 
lipid bilayers by themselves. They have a less amphiphilic character than glycerophospho- 
and sphingolipids. The sterol found in mammalian cells is cholesterol (Fig. 7C). It has a 
planar four-ring structure with a small hydroxyl headgroup. It incorporates into the 
hydrophobic core of lipid bilayers where it intercalates between the fatty acid chains and is 
shielded by the large headgroups of sphingo- and glycerolipids. The ability of lipid bilayers to 
solubilize cholesterol by shielding it from contact with water has been described as “umbrella 
model” [377,378]. 
In 1972, Singer and Nicolson proposed the “fluid mosaic model” of biological membranes 
(Fig. 6B) [376]. In this model, lipid bilayers were regarded as two-dimensional liquids, in 
which lipids and proteins can freely diffuse. The role of lipids was considered to be rather 
passive, serving as solvent of the embedded proteins and constituting a barrier for cell 
compartmentalization.  
This model of biological membranes has dramatically evolved since 1972. A huge variety of 
several hundred lipid species has been discovered in eukaryotic cells, indicating considerable 
complexity in membrane organization [379,380,381,382]. Furthermore, biological membranes 
were found to be packed with substantial amounts of proteins [383,384] and to be tightly 
interconnected with the cellular cytoskeleton [238,385]. About 2030 % of genes in most 
organisms, including humans, were predicted to encode membrane proteins, which 
corresponds to several thousand genes of the human genome [386,387].  
Both lipids and proteins were shown to be heterogeneously distributed within and across 
cellular membranes and to display a high degree of spatial organization, which has to be 
actively maintained (Fig. 6C). Asymmetric distribution of lipids and proteins between 
membrane leaflets was reported [388,389]. While glycerophospholipids PS, PE and PI were 
shown to localize predominantly on the inner plasma membrane leaflet, PC, SM and 
glycosylated lipids localize preferentially on the outer leaflet. The loss of membrane 
asymmetry and exposure of PS on the extracellular leaflet of plasma membranes is recognized 
as signal of apoptosis by a variety of organisms [390].  
Cholesterol, an uncharged lipid, can move rapidly between the two membrane leaflets. It was 
assumed to be more abundant in the exoplasmic membrane leaflet due to its affinity for 
sphingolipids, yet, experimental findings suggest enrichment of cholesterol in the 
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Fig. 7: Molecular lipid structures. Lipid species from the three most abundant lipid classes in eukaryotic 
membranes are presented. (A) Glycerophospholipids. (B) Sphingolipids. (C) Sterols. The lipid headgroups 
attached to either (A) the glycerophosphate backbone or (B) the sphingosine backbone are highlighted in red. 
The acyl chain in position 2 of the glycerol backbone is commonly unsaturated (A). 
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cytoplasmic leaflet [391]. How 40 mol% of cholesterol are distributed within the plasma 
membrane is still not finally clarified.  
It has furthermore been established that dynamic behavior and organization of the two 
membrane leaflets in model and cellular membranes is interconnected by a phenomenon 
known as “transbilayer coupling” [391,392,393,394]. Whether transbilayer coupling is 
mediated by transmembrane proteins, spanning both leaflets, or rather by lipid-lipid 
interaction and interdigitation of acyl chains is still subject to ongoing research [395,396].  
Apart from transverse membrane asymmetry, also lateral heterogeneity and formation of 
membrane domains were reported in both artificial lipid bilayers and biological membranes. 
The formation of large-scale membrane domains due to lipid-lipid interaction has been 
extensively studied in model membrane systems, demonstrating that specific lipids like 
sphingolipids, cholesterol and saturated phospholipids preferentially associate and form 
liquid-ordered membrane domains within liquid-disordered membranes. These domains, 
formed by phase separation, can be visualized microscopically, using fluorescent probes 
which preferentially partition into one or the other phase [397]. In biological membranes, the 
existence of lateral sorting mechanisms was first implied by observation of different lipid and 
protein compositions in the apical and basolateral plasma membrane of polarized epithelial 
cells [224]. Distinct compositions are maintained despite extensive membrane trafficking 
among the different intracellular compartments and the plasma membrane, which led to 
postulation of the so-called “raft hypothesis”, suggesting lipid and protein sorting based on 
the formation of sphingolipid- and cholesterol-rich platforms, termed rafts, which are formed 
in the Golgi apparatus (where sphingolipids are synthesized) and which preferentially 
incorporate specific proteins and lipids in transit to the apical plasma membrane [226]. 
Initially, rafts were thus considered as sorting platforms for lipids and proteins which 
concentrate specific proteins and thus allow compartmentalization of membrane-bound 
processes. Due to their small size, however, lipid rafts in biological membranes cannot be 
visualized by standard optical microscopy. While raft domains were initially defined 
biochemically as membrane fraction which is resistant to cold detergent extraction 
[398,399,400,401], more advanced techniques with high spatial and temporal resolution later 
confirmed the existence of cholesterol-dependent nanoscale domains within membranes of 
living cells [402,403,404]. While the existence of nanoscale assemblies in biological 
membranes is generally accepted, their exact nature remains still elusive. Properties like 
stability, size, dynamics, composition and the players involved in modulation and formation 
of membrane domains are still controversially discussed [405,406].  
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Sphingolipid- and cholesterol-rich membrane domains were shown to display characteristic 
features like tight packing and high order of their acyl chains [407], low diffusional mobility 
of their components [408] and increased membrane thickness [409]. As compared to liquid-
disordered domains, the high degree of order and increased membrane thickness are caused 
by the presence of saturated fatty acid chains in all-trans configuration and intercalation of 
cholesterol, which stabilizes the stretched conformation of the acyl chains [410]. Atomic force 
measurements in living cells demonstrated greater stiffness of membrane domains harboring 
typical raft marker proteins than of the surrounding non-raft membrane [411]. The large 
fraction of raft lipids in polarized epithelial cells is thought to contribute considerably to the 
robustness of the cell membrane [412] and also to environmental stability of enveloped 
viruses such as Influenza viruses [413].  
Physical properties of raft domains are considered to be important for formation and 
functionality of rafts in biological membranes. Membrane thickness is a critical determinant 
for partitioning of transmembrane proteins into raft domains, driven by the energetic cost of 
hydrophobic mismatch. Proteins residing in ER and Golgi apparatus reportedly feature shorter 
transmembrane domains than proteins of the plasma membrane [247,414], which is consistent 
with increasing cholesterol and sphingolipid concentrations along the exocytic pathway [415]. 
The length of transmembrane domains is thought to facilitate protein sorting and to be one 
determinant of subcellular targeting and protein localization [416]. It is not fully clear though 
whether proteins associate with preformed lipid raft domains, or whether it is rather the 
proteins determining membrane thickness [417] and inducing assembly of raft domains by 
protein-lipid interaction [418,419].  
Line tension that arises at the phase boundary between liquid-ordered and liquid-disordered 
phases due to hydrophobic mismatch was shown to drive coalescence and formation of large-
scale domains in model membranes [420,421]. The small size of rafts in biological 
membranes was proposed to be stabilized by the actin cytoskeleton, which causes 
confinement of molecules and prevents merger of raft domains into large-scale domains 
[406]. Micrometer-sized domains are reversibly formed upon cooling in plasma membrane-
derived vesicles (“blebs”) where the membrane is detached from the underlying cytoskeleton 
[422]. Lipid diversity in cell membranes and lipid species acting as interfacially active agents 
(linactants) were further suggested to contribute to lowering line tension in biological 
membranes and enable regulation of lateral heterogeneity [423,424,425]. Nevertheless, there 
is a large body of evidence that actin plays an important role in the organization of membrane 
domains [235,238,426]. Actin was shown to be critically involved in raft-based cell signaling 
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and in the formation and stabilization of large-scale raft-based membrane domains (signaling 
platforms) in response to external stimuli [239,427,428]. Functionalized large-scale domains 
can be observed for instance upon T-cell activation during formation of antigen receptor 
signaling foci (known as “immunological synapses”) [429,430].  
The physical properties of membrane domains like bilayer thickness, curvature and lateral 
pressure can furthermore also directly affect protein function [431]. Bilayer thickness was 
reported to regulate ion channel activity, presumably by altering protein conformation [432], 
and also the functions of curvature-sensing proteins are usually tightly regulated by direct 
interplay with the membrane [433].  
Lipid raft domains are thought to concentrate specific proteins due to protein motifs that 
promote their association with lipid raft phases. Apart from the length of protein 
transmembrane domains, also acylation with saturated fatty acids or modification with a 
glycosylphosphatidylinositol (GPI) anchor are strong indications for preferential partitioning 
of proteins into lipid rafts. Yet, also the presence of specific lipid binding sites, specific 
protein-protein interactions or “multi key recognition” of several distinct interaction partners 
determine protein targeting. 
Raft association of Influenza virus membrane proteins has been well characterized. It is a 
prerequisite for lipid raft-based virus budding. Also other enveloped viruses were shown to 
use lipid rafts as platform for virus assembly and budding, e.g. HIV-1, Ebola and Measles 
virus [21,232,233]. They exploit the fact that rafts can merge into larger platforms and be 
functionalized by viral proteins to establish the viral budding site. 
In case of Influenza viruses, lipid raft- and actin-dependent clustering of Influenza virus 
membrane proteins HA and M2 was demonstrated [245,249]. HA by itself was further shown 
to form nanometer- to micrometer-sized elongated domains in the plasma membrane [220] 
which correlate with actin-rich plasma membrane regions [240]. In infected cells, not only 
clustering of HA but also actin-dependent organization of Influenza virus core proteins NP 
and M1 was observed within large-scale plasma membrane domains together with HA [243]. 
Lipid raft association of HA was reported to be essential for efficient viral replication [434]. 
Assembly of virus particles in raft domains was furthermore suggested to facilitate virus 
budding, based on the inherent property of lipid raft domains in model membranes to promote 
membrane curvature and domain-induced budding. These effects are driven by the tendency 
to minimize energy costs of interfacial line tension [435,436]. Moreover, also a role for lipid 
rafts in virus-mediated membrane fusion during cell entry was postulated [437].  
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The initial concept of membrane rafts was shaped by the description of relatively stable, 
large-scale liquid-ordered domains in model membranes, which are observed at 
thermodynamic equilibrium. A more current definition of biological rafts, dating from 2006 
and taking into account data from a variety of different approaches with high spatial and 
temporal resolution, emphasizes the small size, the heterogeneity and the dynamic nature of 
rafts. It describes rafts as “small (10–200 nm), heterogeneous, highly dynamic, sterol- and 
sphingolipid-enriched domains that compartmentalize cellular processes. Small rafts can 
sometimes be stabilized to form larger platforms through protein-protein or protein-lipid 
interactions” [438]. More recent experimental evidence suggests also the existence of long-
lived, yet mobile, nanoscale rafts [405]. The functionality of raft domains (e.g. in cell 
signaling) relies on dynamic regulation of raft platforms though.  
Most recent advances in understanding the complex phase behavior of lipid membranes and 
in unifying the diverse raft-associated phenomena have been made by including fluctuations 
into the description of phase behavior [439,440]. This can explain how macroscopic phase 
separation can be related to nanoscale rafts behaving as microemulsions, and how direct 
transitions between coexisting phases and microemulsions can be effectuated by thermal 
fluctuations [441]. In biological membranes, the membrane composition is thought to be 
tuned close to a critical point where the different phases coexist as interconverting 
fluctuations, which allows rapid and marked changes of membrane organization at low energy 
costs in response to small compositional or environmental changes [442,443]. It is thus 
conceivable that membrane organization can be easily manipulated by activity of lipid 
modifying enzymes, protein binding or the presence of viral proteins.  
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2 Aim of this study 
The formation of infectious progeny Influenza A virions requires targeting and transport of the 
eight genomic vRNPs from the site of viral replication in the nucleus to the site of virus 
budding at the plasma membrane. These late events of the viral replication cycle, and 
specifically the mechanisms governing vRNP targeting and transport, are still very poorly 
understood.  
A widely accepted hypothesis that M1 might contribute to target vRNPs to vesicular transport 
and/or to the viral budding site has evolved from in vitro membrane binding studies in 
conjunction with in-cell studies, showing that M1 is a membrane binding protein and that M1 
also interacts with vRNPs and mediates vRNP nuclear export during infection. Yet, no 
evidence has so far been provided for the ability of M1 to simultaneously interact with vRNPs 
and membranes. Findings from microscopy studies on this issue are controversial. Previous 
studies further indicate the possibility that NP as major vRNP constituent might be equipped 
with an intrinsic targeting signal to the apical plasma membrane.  
In this study, therefore, the capacity of vRNPs to associate with lipid membranes in the 
presence and absence of M1 should be explored using model membranes. Intrinsic subcellular 
targeting of NP should further be examined in the context of living cells. Fluorescent NP 
constructs and photoactivatable fluorophores were considered as ideal tools in this context to 
reveal information not only on NP localization, but also on site-specific NP dynamics and 
affinities in living cells. 
In addition to analysis of the molecular mechanisms involved in vRNP transport, this study 
furthermore aimed at a more general approach to study the complex process of virus 
assembly. Numerous aspects still remain to be elucidated to fully understand how the virus 
hijacks the cellular machinery for efficient delivery of viral genomes to the site of virus 
formation. It remains to be determined how and where vRNP nuclear export complexes are 
assembled and if they are disassembled in the cytoplasm, how vRNPs are targeted to 
recycling endosomes and how they are transferred from recycling endosomes to the budding 
site, whether and at which stage individual vRNPs form stable multisegment complexes, and 
which factors finally initiate virus budding. The poor availability of data on these aspects of 
viral replication might be due to the difficulties to detect progeny vRNPs during infection and 
to study vRNPs further in the absence of infection. A major part of this work was therefore 
motivated by the objective to develop an experimental approach that allows studying targeting 
and transport of vRNPs in living infected cells in order to enable a comprehensive picture of 
Influenza genome transport during virus assembly and to approach the above-listed questions.  
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3 Material and Methods 
3.1 Material 
3.1.1 Biological material 
3.1.1.1 Eukaryotic cells lines  
CHO-K1 Chinese hamster ovary cells (epithelial-like) ATCC CCL-61 
HeLa  Human cervical cells (epithelial)   ATCC CCL-2 
MDCK II Madin-Darby canine kidney cells (epithelial) ATCC CCL-34 
293T  Human embryonic kidney cells (epithelial)  ATCC CCL-1573 
3.1.1.2 Bacteria 
E.coli DH5α chemically competent, provided by Christine Klaus (Humboldt- 
Universität)  
genotype:  F
–
 endA1 recA1 hsdR17(rk
–
 mk
+
) supE44 λ– thi-1  
                                    gyrA(Na1) relA1 Φ80 lacZΔM15Δ (lacZY A-argF) 
3.1.1.3 Viruses 
Influenza A/X-31 (H3N2) virus and Influenza A/FPV/Rostock/1934 (H7N1) virus 
(abbreviated as FPV) were grown in 10-day-old embryonated chicken eggs and purified as 
described previously [444]. Allantoic fluid or concentrated virus were stored at –80°C. 
Influenza A/WSN/1933 (H1N1) (abbreviated as WSN) was generated as recombinant virus in 
293T cells and propagated on MDCK II cells. 
3.1.1.4 Recombinant proteins 
Recombinant proteins M1 (recM1) and NP were provided by Nadine Jungnick (Humboldt-
Universität, Berlin). The protein sequences from Influenza A/FPV virus were expressed in 
E.coli and purified by His-tag affinity chromatography. His-tags with the amino acid sequence 
MGSSHHHHHHSSGLVPRGSH were fused N-terminally to the protein sequences. For 
further information see [445]. 
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3.1.1.5 Cell culture media and reagents 
The following media and reagents were purchased from PAA Laboratories GmbH, Pasching, 
Austria, if not stated otherwise. 
 Agarose (SeaPlaque) for plaque assay [Lonza, Verviers, Belgium] 
 Bovine serum albumin (BSA, 35 % in DPBS) [Sigma-Aldrich, Taufkirchen, Germany] 
 DMSO for cell culture [Sigma-Aldrich, Taufkirchen, Germany] 
 Dulbecco’s Modified Eagle’s Medium (DMEM) with phenol red, high glucose (for virus 
propagation only) 
 DMEM without phenol red, high glucose (standard) 
 DPBS with Ca2+ and Mg2+ 
 DPBS without Ca2+ and Mg2+ 
 EMEM (2×) [Lonza, Verviers, Belgium] 
 Fetal bovine serum (FBS) 
 L-glutamine (200 mM)  
 LipofectamineTM 2000 Transfection Reagent [Invitrogen, Karlsruhe, Germany] 
 Neomycin solution (10 mg/ml), sterile filtered [Sigma-Aldrich, Taufkirchen, Germany] 
 Neutral red (3.3 g/l) [Sigma-Aldrich, Taufkirchen, Germany] 
 Penicillin/streptomycin (100×: 10,000 U/ml / 10 mg/ml) 
 Trypsin, TPCK-treated [Sigma-Aldrich, Taufkirchen, Germany] 
 Trypsin/EDTA  
 TurboFectTM Transfection Reagent [Fermentas, St. Leon-Rot, Germany] 
 
3.1.1.6 Antibodies 
Dilutions for immunofluorescence (IF) and Western blotting (WB) are indicated. 
Primary antibodies 
 anti-β-actin antibody, clone AC-74, monoclonal (mouse IgG2a),  WB 1:5000 
[Sigma-Aldrich, Taufkirchen, Germany, #A2228] 
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 anti-coilin antibody, clone IH10, monoclonal (mouse IgG2b) , IF 1:1000 
[Abcam, Cambridge, UK, #ab87913] 
 anti-GFP antibody, polyclonal (rabbit IgG), 1:3000 
[Invitrogen, Karlsruhe, Germany, # A11122] 
 anti-Influenza A Hemagglutinin H7 (anti-HA), clone 9A9, monoclonal (mouse IgG2a) 
[HyTest, Turku, Finland], IF 1:6000 
 anti-Influenza A nucleoprotein antibody (anti-NP), clone A1, monoclonal (mouse IgG2a) 
[Chemicon, Schwalbach, Germany, #MAB8257], IF 1:1000, WB 1:5000 
 anti-Influenza A nucleoprotein antibody FITC-conjugated (anti-NP-FITC), clone A1, 
monoclonal (mouse IgG2a) [Chemicon, Schwalbach, Germany, #MAB8257F], IF 1:1000 
 anti-Influenza A virus H3N2 antibody, polyclonal (goat IgG), WB 1:5000  
[Virostat, Portland, ME, USA, #1311] 
 anti-Influenza A virus M1 antibody, polyclonal (goat IgG), IF 1:1000, WB 1:3000 
[Abcam, Cambridge, UK, #ab34848], for IF applications and WB if not otherwise indicated  
 anti-Influenza A virus M1 antibody, polyclonal (goat IgG), WB 1:3000  
[Virostat, Portland, ME, USA, #1321], used for WB where indicated (section 4.1) 
 anti-membrin antibody, clone 4HAD6, monoclonal (mouse IgG1), IF 1:1000 
[Abcam, Cambridge, UK, #ab13511] 
 anti-PML protein antibody, clone H238, monoclonal (rabbit IgG), IF 1:1000 
[Santa-Cruz Biotechnology, Heidelberg, Germany, #SC-5621] 
 anti-SC35 antibody, monoclonal (mouse IgG1), 1:1000 
[BD Bioscience, Heidelberg, Germany, #556363] 
Secondary antibodies 
 AlexaFluor® 568 goat-anti-mouse IgG, IF 1:1000  
[Invitrogen, Karlsruhe, Germany, #11004] 
 AlexaFluor® 594 goat-anti-rabbit IgG, IF 1:1000 
[Invitrogen, Karlsruhe, Germany, #11012] 
 Atto 647N goat-anti-mouse IgG, IF 1:1000 
[Sigma-Aldrich, Taufkirchen, Germany, #50185] 
 Cy3 rabbit-anti-goat IgG, IF 1:1000 
[Sigma-Aldrich, Taufkirchen, Germany, #C2821] 
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 donkey-anti-goat IgG horseradish peroxidase conjugate (DAGPO), WB 1:5000 
[Santa-Cruz Biotechnology, Heidelberg, Germany, #L1605] 
 goat-anti-mouse IgG horseradish peroxidase conjugate (GAMPO), WB 1:5000 
[Bio-Rad, München, Germany, #170-6516] 
 goat-anti-rabbit IgG horseradish peroxidase conjugate (GARPO), WB 1:5000 
[Bio-Rad, München, Germany, #170-6615] 
 IRDye-680 donkey-anti-goat IgG, WB 1:10.000 
[LI-COR Bioscience, Bad Homburg, Germany, #926-32224]  
 IRDye-680 goat-anti-mouse IgG, WB 1:10.000 
[LI-COR Bioscience, Bad Homburg, Germany,  #926-32220] 
3.1.1.7 Enzymes, molecular biology reagents and kits 
 Agarose [Biozym Scientific, Hessisch Oldendorf, Germany] 
 DNA Loading Dye (6×) [Fermentas, St. Leon-Rot, Germany] 
 dNTP-Mix, 10 mM each [Fermentas, St. Leon-Rot, Germany] 
 GeneRulerTM 1kb DNA Ladder [Fermentas, St. Leon-Rot, Germany] 
 Ligase: T4-DNA-Ligase [New England Biolabs, Frankfurt/Main, Germany] 
 Phosphatase: Calf Intestinal Alkaline Phosphatase (CIP) [New England Biolabs, 
Frankfurt/Main, Germany] 
 Polymerases: 
peqGOLD Taq-DNA-Polymerase for colony PCR with 10× buffer Y [PEQLAB, Erlangen, 
Germany] 
Phusion™ High-Fidelity DNA Polymerase [Finnzymes, Espoo, Finland] 
 Restriction enzymes:  
AflII, AgeI, BamHI, BsaI HF, BsrGI, SacII, XhoI [New England Biolabs, Frankfurt/Main, 
Germany]; Esp3I [Fermentas, St. Leon-Rot, Germany] 
 Rotiphorese® 10× TBE buffer, running buffer for agarose gel electrophoresis [Carl Roth, 
Karlsruhe Germany] 
 SYBR® Safe DNA Gel Stain (1000×) [Invitrogen, Karlsruhe, Germany] 
Kits for DNA and RNA preparation 
 QIAquick Gel Extraction Kit [Qiagen, Hilden, Germany] 
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 QIAprep Spin Miniprep Kit [Qiagen, Hilden, Germany] 
 QIAGEN Plasmid Maxi Kit [Qiagen, Hilden, Germany] 
 RNeasy Mini Kit [Qiagen, Hilden, Germany] 
3.1.1.8 Oligonucleotides and plasmids 
Three basic cloning vectors (pEYFP-C1, pEYFP-N1 and pDendra2-N (Clontech, Saint-
Germain-en-Laye, France)) were used to generate vectors for expression of fluorescent and 
non-fluorescent Influenza NP constructs as listed in Tab. 2. They all encode a fluorescent 
protein under control of a constitutive cytomegalovirus (CMV) immediate early promoter for 
expression in mammalian cells and feature a multiple cloning site either upstream or 
downstream of the fluorescent protein open reading frame for insertion of the sequence of 
interest. To prevent dimerization of EYFP as described in [446], pEYFP-C1 and pEYFP-N1 
plasmids carrying a single codon change in the EYFP sequence (A206K) were used. These 
plasmids termed pmEYFP-C1 and pmEYFP-N1 encode the monomeric form of EYFP 
(mEYFP) and were kindly provided by Silvia Scolari [447]. 
Cloning and expression vectors encoding other fluorescent proteins were constructed based 
on the plasmids described above. For the generation of pDendra2-C, the open reading frame 
(ORF) of Dendra2 was amplified by polymerase chain reaction (PCR) from the template 
plasmid pDendra2-N and was then digested with AgeI and XhoI. The mEYFP encoding 
sequence was removed from pmEYFP-C1 by digestion with AgeI and XhoI and was replaced 
by the Dendra2 ORF. The primers designed for PCR and including the appropriate restriction 
sites are listed in Tab. 3 ({6}, {7}). pmCherry-C1 was obtained by cutting the mCherry ORF 
from plasmid pmCherry-gp41 (provided by Roland Schwarzer, HU Berlin, Germany) using 
AgeI and BsrGI and subsequent ligation into pmEYFP-C1 which had been digested with the 
same enzymes thereby replacing the mEYFP ORF by an mCherry ORF.  
The plasmid pHH21-NP ([448], kindly provided by Michael Veit, Freie Universität Berlin, 
Germany) contains the cDNA of Influenza A/FPV/Rostock/1934 segment 5 vRNA, and 
served as template for amplification of the NP ORF from Influenza A/FPV/Rostock/1934, 
which was subsequently inserted at the multiple cloning sites of the fluorescent protein 
expression vectors that were described above. The sequence was thereafter further mutated if 
required. NP expressing plasmids generated in this work are specified in Tab. 2, the 
corresponding primer pairs are listed in Tab. 3. Plasmids for the expression of M1 from 
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Influenza A/FPV/Rostock/1934 were kindly provided by Bastian Thaa (Freie Universität 
Berlin, Germany): pCFP-M1-NES [257,449]. 
pRab11-RFP was obtained from Maik Lehmann (Humboldt-Universität, Berlin) [450]. 
Tab. 2: Plasmids generated for the expression of Influenza A/FPV/Rostock/1934 NP. The vector, the insert with 
restriction sites (in brackets) and the primer pairs that were used for construction of each designated plasmid 
are listed. All NP inserts were amplified from pHH21-NP. Mutations were introduced by PCR-based QuikChange 
mutagenesis using the indicated primer pairs. (Tags that were introduced code for the following amino acid 
sequences: nuclear export signal (NES): LQLPPLERLTL; tetracysteine (TC)-tag: CCPGCC) 
 
 
 
name vector insert/mutation primers 
pmCherry-C1 pmEYFP-C1 
mCherry (AgeI, BsrGI) cut from 
plasmid pmCherry-gp41 
 
pDendra2-C1 pmEYFP-C1 Dendra2 (AgeI, XhoI) {6}, {7} 
    
pNP pmEYFP-NP-N1 
NP (AflII, XhoI) cut from   
pmEYFP-NP-C1 
 
pmCherry-NP pmCherry-C1 NP (XhoI, BamHI) {3}, {2} 
pDendra2-NP pDendra2-C1 NP (XhoI, BamHI) {1}, {2} 
pNP-Dendra2 pDendra2-N NP (XhoI, SacII) {3}, {4} 
pmEYFP-NP pmEYFP-C1 NP (XhoI, BamHI) {1}, {2} 
pNP-mEYFP pmEYFP-N1 NP (XhoI, SacII) {3}, {4} 
    
pNP-E339A-Dendra2 pNP-Dendra2 NP mutation E339A {8}, {9} 
pNP-R416A-Dendra2 pNP-Dendra2 NP mutation R416A {10}, {11} 
    
pNP-NES pDendra2-N NP-NES(-Stop) (XhoI, BamHI) {1}, {5} 
pDendra2-NP-NES pDendra2-C1 NP-NES (XhoI, BamHI) {1}, {5} 
pmEYFP-NP-NES pmEYFP-C1 NP-NES (XhoI, BamHI) {1}, {5} 
    
pNP-TC100 pNP  
TC-tag insertion  
QuikChange mutagenesis 
{12}, {13} 
pNP-TC125 pNP  
TC-tag insertion  
QuikChange mutagenesis 
{14}, {15} 
pNP-TC247 pNP  
TC-tag insertion  
QuikChange mutagenesis 
{16}, {17} 
pNP-TC288 pNP  
TC-tag insertion  
QuikChange  mutagenesis 
{18}, {19} 
pNP-TC372 pNP  
TC-tag insertion  
QuikChange mutagenesis 
{20}, {21} 
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Tab. 3: DNA oligonucleotides used for PCR amplification and mutagenesis of Influenza A/FPV/Rostock/1934 
NP. Restriction sites are underlined. Bold letters indicate mutation sites or sequence insertions. 
Oligonucleotides were synthesized by Invitrogen, Karlsruhe, Germany. 
 
 
No. name sequence (5′ → 3′) purpose 
    
{1} 
fw_NP_pEYFP-C1 
(XhoI) 
ACG TTA CTC GAG AAA TGG CGT CTC AAG GC  cloning/PCR 
{2} 
rev_NP_pEYFP-C1 
(BamHI) 
AGC TGC GGA TCC TTA  ATT GTC ATA CTC CTC TGC cloning/PCR 
{3} 
fw_NP_pEYFP-N1 
(XhoI) 
ACG TTA CTC GAG ATG GCG TCT CAA GGC cloning/PCR 
{4} 
rev_NP_pEYFP-N1 
(SacII) 
ACA GTA CCG CGG ATT GTC ATA CTC CTC TGC cloning/PCR 
{5} 
rev_NP_NES 
(BamHI) 
TCG GAT CCT TAA AGA GTA AGT CTC TCA AGC GGT 
GGT AGC TGA AGA TTG TCA TAC TCC TCT GC 
cloning/PCR 
{6} fw_Dendra-C (AgeI) ACT TAC CGG TCG CCA CCA TGA ACA CCC C cloning/PCR 
{7} 
rev_Dendra-C 
(XhoI) 
ACT TCT CGA GAT CTG AGT CCG GAC CAC ACC TGG CTG 
GGC  
cloning/PCR 
{8} NP_E339A_1 CCA TTC TGC AGC ATT TGC AGA CCT GAG AGT GTC AAG C mutagenesis 
{9} NP_E339A_2 GCT TGA CAC TCT CAG GTC TGC AAA TGC TGC AGA ATG G mutagenesis 
{10} NP_R416A_1 
CCC ACT TTC TCT GTA CAG GCA AAT CTC CCT TTC GAG 
AGA GCG 
mutagenesis 
{11} NP_R416A_2 
CGC TCT CTC GAA AGG GAG ATT TGC CTG TAC AGA GAA 
AGT GGG 
mutagenesis 
{12} 
fw_TC-insert_100-
101_FPV 
CCA ATC TAT AGA CGG AGA TGC TGC CCA GGA TGC 
TGC GAT GGA AAA TGG G  
mutagenesis 
{13} 
rev_TC-insert_100-
101_FPV 
CCC ATT TTC CAT CGC AGC ATC CTG GGC AGC ATC 
TCC GTC TAT AGA TTG G 
mutagenesis 
{14} 
fw_TC-insert_125-
126_FPV 
GCC AAG CGA ACA ATT GCT GCC CAG GAT GCT GCG 
GAG AGG ACG CAA C 
mutagenesis 
{15} 
rev_TC-insert_125-
126_FPV 
GTT GCG TCC TCT CCGC AGC ATC CTG GGC AGC AA 
TTG TTC GCT TGG C 
mutagenesis 
{16} 
fw_TC-insert_247-
248_FPV 
GGG AAA GCC GGA ATT GCT GCC CAG GAT GCT GCC 
CTG GGA ATG CTG 
mutagenesis 
{17} 
rev_TC-insert_247-
248_FPV 
CAG CAT TCC CAG GGC AGC ATC CTG GGC AGC AAT 
TCC GGC TTT CCC 
mutagenesis 
{18} 
fw_TC-insert_288-
289_FPV 
GCT GTG GCC AGT GGG TGC TGC CCA GGA TGC TGC 
TAC GAC TTT GAG AG 
mutagenesis 
{19} 
rev_TC-insert_288-
289_FPV 
CTC TCA AAG TCG TAGC AGC ATC CTG GGC AGC AC 
CCA CTG GCC ACA GC 
mutagenesis 
{20} 
fw_TC-insert_372-
373_FPV 
CAA ATG AGA ACA TGG AGT GCT GCC CAG GAT GCT 
GCA CAA TGG ATT CCA GC 
mutagenesis 
{21} 
rev_TC-insert_372-
373_FPV 
GCT GGA ATC CAT TGT GC AGC ATC CTG GGC AGC 
ACTC CAT GTT CTC ATT TG 
mutagenesis 
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Generation of recombinant Influenza A/WSN/1933 virus by reverse genetics was performed 
using plasmids pHW181-PB2, pHW182-PB1, pHW183-PA, pHW184-HA, pHW185-NP, 
pHW186-NA, pHW187-M, pHW188-NS [451]. For insertion of the sequence encoding the 
tetracysteine (TC)-tag into segment 5 vRNA at various positions, two-stage PCR-based 
mutagenesis of plasmid pHW185-NP was carried out (3.2.1.5). An overview of all generated 
mutant pHW185-NP plasmids is given in Tab. 5 with the corresponding mutagenesis primer 
pairs in Tab. 6.  
In the particular case of TC-tag insertion at the 3′ end of the NP ORF of segment 5 vRNA, 
duplication of 60 3′ nucleotides of the NP ORF was required to preserve the segment 5 
packaging signal for genome incorporation into progeny virus particles. Therefore, sequences 
encoding modified segment 5 vRNA were inserted into the cloning vector pHW2000 at the 
BsmBI/Esp3I restriction site yielding pHW185-NP60mut-nTC-NP and pHW185-NP60mut-
FLN-TC-NP. This will be described in more detail in section 4.2.3. Details on primer pairs 
and inserts are given in Tab. 5 and Tab. 6. pHW2000 was a generous gift by Robert Webster 
(St. Jude Children’s Research Hospital, Memphis, TN, USA). 
The sequences of all constructs generated in this work were verified by sequencing of the 
ORFs. Sequencing and sequencing primer synthesis were performed by Invitek GmbH, 
(Berlin, Germany). Tab. 4 displays the oligonucleotides that were used for sequence analysis 
or for the amplification of control fragments by colony PCR to verify successful sequence 
insertion. 
Tab. 4: DNA oligonucleotides used for sequencing and colony PCR. Oligonucleotides were synthesized by 
Invitrogen, Karlsruhe, Germany, or Invitek, Berlin, Germany.  
No. name sequence purpose 
    
{39} control_fw_NP GGC TGA TCC AGA ACA GCA TAA C colony PCR 
{40} control_rev_NP GCC ACA GCA AGT CCA TAT ACA C colony PCR 
{41} control_fw_EYFP CGA CGT AAA CGG CCA CAA G colony PCR 
{42} control_rev_EYFP CAG CAG GAC CAT GTG ATC G colony PCR 
{43} fw_TC-tag_control TGC TGC CCA GGA TGC TGC colony PCR 
{44} CMV for CGC AAA TGG GCG GTA GGC GTG sequencing 
{45} XFP_fw GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC sequencing 
{46} fw_NP_1 CCC ATT TGA TGA TCT GGC ATT CC sequencing (FPV) 
{47} fw_NP_2 GAC AAC TAT CCA CCA GAG GAG TC sequencing (FPV) 
{48} fw_WSN-NP_A TGC TGC AGT CAA  AGG AGT TGG sequencing (WSN) 
{49} fw_WSN-NP_B AAG CAG ATA CTG GGC CAT AAG G sequencing (WSN) 
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Tab. 5: pHW185-NP derived plasmids generated for reverse genetics with Influenza A/WSN/1933. Mutations 
were introduced by PCR-based QuikChange mutagenesis using the primer pairs listed. For cloning, the inserts 
were amplified from the vectors using the specified primers and were digested with the indicated restriction 
enzymes. Ligation of the two insert fragments with plasmid pHW2000 was performed simultaneously to insert 
both fragments consecutively at the BsmBI/Esp3I site of pHW2000. (Amino acid sequences of the tags that 
were fused to the NP open reading frame, TC: CCPGCC; nTC: MAGG-CCPGCC; FLN-TC: M-FLN-CCPGCC-MEP) 
 
 
  
name vector mutation/insert primer 
    
pHW185-NP-TC125 pHW185-NP  
TC-tag insertion  
QuikChange mutagenesis 
{22}, {23} 
pHW185-NP-TC288  pHW185-NP 
TC-tag insertion  
QuikChange mutagenesis 
{24}, {25} 
pHW185-NP-TC292 pHW185-NP 
TC-tag insertion  
QuikChange mutagenesis 
{26}, {27} 
pHW185-NP-TC372 pHW185-NP 
TC-tag insertion  
QuikChange mutagenesis 
{28}, {29} 
    
pHW185-NP-2ATG pHW185-NP 
ATG → ATC codon mutations:  
38 G → C and 49 G → C (NP ORF) 
{30}, {31} 
pHW185-NP-3ATG 
pHW185-NP-
ATCmut 
ATG → GCG codon mutation:   
(1,2) AT → GC (NP ORF) 
{32}, {33} 
    
pHW185-NP60mut-nTC-
NP 
pHW2000 
insert 1: vRNA-NP60mut-Kozak 
(Esp3I, BsaI) amplified from  
pHW185-NP-3ATG 
{34}, {35} 
insert 2:Kozak-nTC-NP-vRNA (BsaI, 
Esp3I) amplified from  pHW185-NP 
{36}, {37} 
pHW185-NP60mut-FLN-
TC-NP 
pHW2000 
insert 1: vRNA-NP60mut-Kozak 
(Esp3I, BsaI) amplified from  
pHW185-NP-3ATG 
{34}, {35} 
insert 2: Kozak-FLN-TC-MEP-NP-
vRNA (BsaI, Esp3I) amplified from  
pHW185-NP 
{38}, {37} 
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Tab. 6: DNA oligonucleotides used for PCR amplification and mutagenesis of Influenza A/WSN/1933. 
Restriction sites are underlined. Bold letters indicate mutation sites or sequence insertion. Oligonucleotides 
were synthesized by Invitrogen, Karlsruhe, Germany, or BioTez, Berlin, Germany. 
 
 
No. name sequence (5’ → 3’) purpose 
    
{22} 
fw_TC-insert_125-
126_WSN 
GCC AAG CTA ATA ATT GCT GCC CAG GAT GCT GCG 
GTG ACG ATG CAA C 
mutagenesis 
{23} 
rev_TC-insert_125-
126_WSN 
GTT GCA TCG TCA CCG CAG CAT CCT GGG CAG CAA 
TTA TTA GCT TGG C 
mutagenesis 
{24} 
fw_TC-insert_288-
289_WSN 
GCC GTA GCC AGT GGA TGC TGC CCA GGA TGC TGC 
TAC GAC TTT GAA AG 
mutagenesis 
{25} 
rev_TC-insert_288-
289_WSN 
CTT TCA AAG TCG TAG CAG CAT CCT GGG CAG CAT 
CCA CTG GCT ACG GC 
mutagenesis 
{26} 
fw_TC-insert_292-
293_WSN 
GGA TAC GAC TTT GAA TGC TGC CCA GGA TGC TGC 
AGA GAG GGA TAC TC 
mutagenesis 
{27} 
rev_TC-insert_292-
293_WSN 
GAG TAT CCC TCT CTG CAG CAT CCT GGG CAG CAT 
TCA AAG TCG TAT CC 
mutagenesis 
{28} 
fw_TC-insert_372-
373_WSN 
CCA ATG AAA ACA TGG AGT GCT GCC CAG GAT GCT 
GCA CTA TGG AAT CAA GTA CC 
mutagenesis 
{29} 
rev_TC-insert_372-
373_WSN 
GGT ACT TGA TTC CAT AGT GCA GCA TCC TGG GCA 
GCA CTC CAT GTT TTC ATT GG 
mutagenesis 
{30} ATC_fw 
CGA TCT TAC GAA CAG ATC GAG ACT GAT CGA GAA CGC 
CAG AAT GC 
mutagenesis  
ATG→ATC 
{31} ATC_rev 
GCA TTC TGG CGT TCT CGA TCA GTC TCG ATC TGT TCG 
TAA GAT CG 
mutagenesis  
ATG→ATC 
{32} ATG-GCG_fw GAC ATC GAA ATC GCG GCG ACC AAA GGC 
mutagenesis   
ATG→GCG 
{33} ATG-GCG_rev GCC TTT GGT CGC CGC GAT TTC GAT GTC 
mutagenesis   
ATG→GCG 
{34} 
NP60mut_fw 
(Esp3I) 
ATC ATC GTC TCG GGG AGC AAA AGC AGG 
cloning/PCR; 
vRNA-
NP60ATGmut 
{35} 
NP60mut_rev 
(BsaI) 
ATT TGG TCT CGG CGG CCT GGC GTT CTC GAT C 
cloning/PCR; 
vRNA-
NP60ATGmut 
{36} nTC-NP(BsaI)_fw 
ATC TGG TCT CTC CGC CAT GGC TGG TGG CTG CTG 
CCC AGG ATG CTG CAT GGC GAC CAA AGG C 
cloning/PCR; 
TC-NP-vRNA  
{37} nTC-NP(Esp3I)_rev CTA TCG TCT CTT ATT AGT AGA AAC AAG G 
cloning/PCR;  
TC-NP-vRNA  
{38} 
nFLNTCMEP-
NP(BsaI)_fw 
ATC TGG TCT CTC CGC CAT GTT CCT GAA CTG CTG 
CCC AGG ATG CTG CAT GG AGC CCA TGG CGA CCA 
AAG GC 
cloning/PCR; 
FLN-TC-MEP-
NP-vRNA  
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3.1.2 Chemicals  
Chemicals that are not included in the following list were purchased either from Sigma-
Aldrich (Taufkirchen, Germany) or Carl Roth (Karlsruhe, Germany) in analytical standard 
quality. Phospholipids and fluorescent phospholipid analogues were obtained from Avanti 
Polar Lipids (Alabaster, AL, USA). 
 Acetic acid, 100% [Carl Roth, Karlsruhe, Germany] 
 Acrylamide/bisacrylamide (37.5:1) 30 %, “Rotiphorese® Gel 30” [Carl Roth, Karlsruhe, 
Germany]  
 Aminotriazole (3-amino-1,2,4-triazole) [Sigma-Aldrich, Taufkirchen, Germany] 
 Ammonium persulfate (APS) [Sigma-Aldrich, Taufkirchen, Germany] 
 BactoTM agar, BactoTM  tryptone, BactoTM yeast extract [BD Biosciences, Heidelberg, 
Germany] 
 BAL, British Anti-Lewisite (2,3-dimercapto-1-propanol) [Sigma-Aldrich, Taufkirchen, 
Germany] 
 BAL wash buffer (In-Cell Tetracysteine Tag Detection Kit) [Invitrogen, Karlsruhe, Germany] 
 BCA Protein Assay Kit Pierce, #23225 [Thermo Fisher Scientific, Bonn, Germany]  
 Chloroform Uvasol® for spectroscopy [Merck, Darmstadt, Germany] 
 Cholesterol [Sigma-Aldrich, Taufkirchen, Germany] 
 Coomassie Brilliant Blue R-250 [Carl Roth, Karlsruhe, Germany] 
 Cytochalasin D [Sigma-Aldrich, Taufkirchen, Germany] 
 DAB (3,3′-diaminobenzidine tetrahydrochloride) [Sigma-Aldrich, Taufkirchen, Germany] 
 DAPI nucleic acid stain [Invitrogen, Karlsruhe, Germany]  
 DiD lipophilic carbocyanine dye [Invitrogen, Karlsruhe, Germany] 
 ER-Tracker™ Red (BODIPY® TR Glibenclamide) [Invitrogen, Karlsruhe, Germany] 
 Ethanol for spectroscopy, >99.5 % Ph. Eur. [Carl Roth, Karlsruhe, Germany] 
 Ethylenediaminetetraacetic acid (EDTA) [SERVA, Heidelberg, Germany] 
 FlAsH-EDT2 labeling reagent (TC-FlAsH™ II In-Cell Tetracysteine Tag Detection Kit) 
[Invitrogen, Karlsruhe, Germany] 
 Formaldehyde 37 % (w/v) [Fluka/Sigma-Aldrich, Taufkirchen, Germany], for silver staining 
 Formalin solution, 10 %, neutral buffered [Sigma-Aldrich, Taufkirchen, Germany], for cell 
fixation 
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 Glutaraldehyde solution, Grade I, 50% in H2O, for use as fixative for electron microscopy 
[Sigma-Aldrich, Taufkirchen, Germany] 
 Glycine [Sigma-Aldrich, Taufkirchen, Germany] 
 Lysophosphatidylcholine (Lyso-PC) from egg yolk  [Sigma-Aldrich, Taufkirchen, Germany] 
 Methanol Uvasol® for spectroscopy [Merck, Darmstadt, Germany] 
 Mowiol® 4-88 reagent [Calbiochem/Merck, Darmstadt, Germany] 
 Octyl β-D-glucopyranoside [Sigma-Aldrich, Taufkirchen, Germany] 
 Potassium cyanide (KCN) [Sigma-Aldrich, Taufkirchen, Germany] 
 ReAsH-EDT2 labeling reagent (TC-ReAsH™ II In-Cell Tetracysteine Tag Detection Kit) 
[Invitrogen, Karlsruhe, Germany] 
 Rhodamine phalloidin [Tebu-bio, Offenbach, Germany] 
 Sodium dodecyl sulfate (SDS) [Carl Roth, Karlsruhe, Germany] 
 Sucrose [AppliChem, Darmstadt, Germany]  
 TEMED (N,N,N’,N’-Tetramethyl-ethane-1,2-diamine) ) [Sigma-Aldrich, Taufkirchen, 
Germany] 
 
3.1.3 Buffers and solutions  
 Cell culture media 
Complete medium:  DMEM with 10 % (v/v) FBS, 2 mM L-glutamine and  
penicillin/streptomycin (100 U/ml, 100 µg/ml)  
Freezing medium: 70 % (v/v) DMEM, 20 % (v/v) FBS, 10 % (v/v) DMSO  
Infection medium:  DMEM with 0.2 % (w/v) BSA (for cell culture), 0.1 % (v/v) FBS, 2 mM 
L-glutamine, 1 µg/ml trypsin TPCK-treated, penicillin/streptomycin (100 U/ml, 100 µg/ml) 
Overlay medium (plaque assay): EMEM (2×) with 0.4 % (w/v) BSA, 0.2 % FBS, 4 mM L-
glutamine, 2 µg/ml trypsin (TPCK-treated) and penicillin/streptomycin (200 U/ml, 200 µg/ml) 
mixed with equal volume of 1.8 % (w/v) SeaPlaque agarose (autoclaved)  
Live-cell imaging medium: DMEM with 20 mM HEPES, pH 7.4 
 Coomassie staining solutions 
Coomassie staining solution: 45 %  (v/v) ethanol, 10 % (v/v) acetic acid, 2.5 g/l Coomassie 
Brilliant Blue R-250 
Coomassie destaining solution: 40 % (v/v) ethanol, 7.5 % (v/v) acetic acid 
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 Flotation assay and LUV preparation 
Flotation buffer: 10 mM NaPO4, 120 mM KCl, pH 7.0 
Sucrose step gradient: 25 % and 75 % (w/v) sucrose in flotation buffer 
 Immunofluorescence solutions 
Fixative: 4 % formalin in DPBS with Ca2+ and Mg2+ (made from a 10 % formalin stock 
solution, Sigma-Aldrich, Taufkirchen, Germany) 
Blocking buffer: 3 % (w/v) BSA in DPBS for cell culture 
Permeabilization buffer: 0.5 % (v/v) Triton X-100 in DPBS 
 Isolation of vRNPs 
All buffers were prepared with ultrapure RNAse-free water from a Millipore Milli-Q® system 
and using RNAse-free pipet tips. 
Lysis buffer: 100 mM KPO4, 100 mM KCl, 5 mM MgCl2, 5 % (w/v) glycerol, 1.5 mM dithio-
threitol, 50 mM Octyl β-D-glucopyranoside, 10 mg/ml lysophophatidylcholine from egg yolk, 
pH 8.1 
Gradient buffer: 100 mM KPO4, 150 mM NaCl, pH 7.8 with 33 %, 40 %, 50 % or 70 % (w/v) 
glycerol 
Resuspension buffer: 10 mM KPO4, 120 mM KCl, pH 8.0 
 Media for propagation of E.coli 
LB medium: 10 g/l BactoTM tryptone, 5 g/l BactoTM yeast extract, 5 g/l NaCl 
with 50 µg/ml kanamycin or 100 µg/ml ampicillin 
LB agar: LB medium with 15 g/l agar, 50 µg/ml kanamycin or 100 µg/ml  
ampicillin 
Antibiotic stocks: 50 mg/ml ampicillin; 100 mg/ml kanamycin (in ddH2O, sterile   
filtered)   
 PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2 
 PIP strip buffers 
TBS: 10 mM Tris-HCl, 150 mM KCl, pH 8.0 
TBS-T: TBS with 0.1 % (v/v) Tween®-20 
Blocking buffer: TBS with 3 % BSA (w/v) 
 ReAsH photoconversion for electron microscopy 
Cacodylate buffer: 0.2 M cacodylate, pH 7.4 
Fixation buffer:  cacodylate buffer with 2 % (w/w) glutaraldehyde 
Photoconversion blocking buffer: 20 mM glycine, 10 mM KCN, 10 mM aminotriazole in 
cacodylate buffer 
DAB solution: 0.5 mg/ml DAB in cacodylate buffer (freshly oxygenated) 
MATERIAL AND METHODS 
64 
 
 SDS-PAGE buffers 
Stacking gel (5 %): 5 % (w/v) acrylamide/bisacrylamide (37.5:1; 30 % stock solution 
“Rotiphorese® Gel 30”, Carl Roth, Karlsruhe, Germany), 125 mM Tris-HCl pH 6.8, 
0.1 % (w/v) SDS, 0.1 % (w/v) APS, 0.1 % (v/v) TEMED 
Resolving gel (10 %): 10 % (w/v) acrylamide/bisacrylamide, 375 mM Tris-HCl pH 8.8, 
0.1 % (w/v) SDS, 0.1 % (w/v)  APS, 0.04 % (v/v) TEMED 
Resolving gel (12 %): 12 % (w/v) acrylamide/bisacrylamide, 375 mM Tris-HCl pH 8.8, 
0.1 % (w/v) SDS, 0.1 % (w/v) APS, 0.04 % (v/v) TEMED 
SDS sample buffer, non reducing (4×): 5 % (w/v) SDS, 0.5 g/l bromophenol blue, 25 % (v/v) 
glycerol, 500 mM Tris-HCl pH 6.8 
SDS sample buffer,  reducing (4×): 5 % (w/v) SDS, 0.5 g/l bromophenol blue, 25 % (v/v) β-
mercaptoethanol, 25 % (v/v) glycerol, 500 mM Tris-HCl pH 6.8 
Protein standards: Precision Plus Protein All Blue Standards [Bio-Rad, München, Germany]; 
PageRuler™ Prestained Protein Ladder [Fermentas, St. Leon-Rot, Germany] 
Running buffer: 3 g/l Tris-HCl, 1 g/l SDS, 14.4 g/l glycine; pH 8.3 
 Silver staining solutions  
Fixative: 30 % (v/v) ethanol, 10 % (v/v) acetic acid 
Sensitizer: 30 % (v/v) ethanol, 0.5 % (w/v) glutaraldehyde, 0.5 M sodium acetate, 0.2 % (w/v) 
sodium thiosulfate  
Staining solution: 0.1 % (w/v) silver nitrate, 0.74 % (w/v) formaldehyde 
Developer: 2.5 % (w/v) sodium carbonate, 0.37 % (w/v) formaldehyde 
Stop solution: 0.05 M EDTA 
 Virus purification 
TNE buffer : 10 mM Tris-HCl; 100 mM NaCl, 1 mM EDTA, pH 7.4  
TNE sucrose gradient: linear gradient formed from 20 % and 60 % (w/v) sucrose in TNE 
buffer 
 Western blotting solutions 
Transfer buffer: 40 % (v/v) running buffer, 20 % (v/v) methanol, 0.06 % (w/v) SDS 
Blocking and washing buffer (for horseradish peroxidase chemiluminescence detection): PBS 
with 0.5 % (v/v) Tween®-20 and 5 % (w/v) skimmed milk powder 
Blocking buffer (for IR-dye coupled secondary antibodies and fluorescence detection): 
Odyssey® Blocking Buffer 1:2 in PBS 
Washing buffer (for IR-dye coupled secondary antibodies and fluorescence detection): 
PBS with 0.1 % (v/v) Tween®-20 (PBS-T) 
Amersham ECL™ Advance Western Blotting Detection Kit [GE Healthcare, München, 
MATERIAL AND METHODS  
65 
 
Germany] 
Fixer and Developer solutions T-Matic for film development [ADEFO-CHEMIE, 
Dietzenbach, Germany] 
3.1.4 Consumables 
Basic laboratory consumables are not included in this list. 
 Amicon Ultra-15 Centrifugal Filter Units with molecular weight cut-off 10 kDa or  50 kDa  
[Millipore, Schwalbach, Germany] 
 Beckman Microfuge Tube, 1.5 ml, polyallomer  [Beckman Coulter, Krefeld, Germany] 
 Cell culture flasks T25, T75, T175 [Nunc, Langenselbold, Germany] 
 Cell culture plates 6-well and 12-well [Nunc, Langenselbold, Germany] 
 Cuvettes, acrylic, and semi-micro cuvettes, polystyrene [Sarstedt, Nümbrecht, Germany] 
 Extruder filter support 610014 [Avanti Polar Lipids, Alabaster, AL, USA] 
 Extruder Nuclepore track-etched membrane 100 nm pore size, 13 mm diameter [Whatman, 
Dassel, Germany] 
 Microscopy glass bottom culture dishes, 35 mm, uncoated  
[MatTek, Ashland, U.S.A, # P35G-1,5-14C] 
 Microscopy glass bottom culture dishes, gridded  
[MatTek, Ashland, U.S.A, #P35G-2-14-CGRD] 
 Microscopy glass cover slips, glass thickness no.1 (24×60 mm; Ø12 mm)  
[Carl Roth, Karlsruhe, Germany]  
 PIP Strips™, P-6001 [Echelon Biosciences, Salt Lake City, UT, U.S.A] 
 RNAse-free filtered pipette tips [STARLAB, Hamburg, Germany] 
 Transwell plates, Corning Transwell® polycarbonate membrane permeable support, pore size 
0.4 µm, Ø 24 mm [VWR, Darmstadt, Germany] 
 Western blotting: Amersham Hyperfilm ECL [GE Healthcare, Freiburg, Germany] 
 Western blotting: Amersham nitrocellulose membrane Hybond ECL [GE Healthcare, 
Freiburg, Germany] 
 Western blotting: Extra thick blot paper [Bio-Rad, München, Germany] 
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3.1.5 Equipment and instruments 
Basic laboratory equipment is not included in this list. 
 Biophotometer plus [Eppendorf, Hamburg, Germany] 
 Centrifuge Avanti J-20XP (Rotor JLA10.500) [Beckman Coulter, Krefeld, Germany] 
 Centrifuge Heraeus Biofuge Stratos [Thermo Scientific, Langenselbold, Germany] 
 DEASAGA Digital documentation system CabUVIS [Sarstedt, Nümbrecht, Germany] with 
CCD camera HV-C20A (Hitachi)  
 Density gradient fractionators “Auto Densi-Flow” [Labcono, Kansas City, MO, USA]  
 Electrophoresis equipment (agarose gel electrophoresis): Mini-Sub Cell GT Systems [Bio-
Rad, München, Germany] 
 Electrophoresis equipment (SDS-PAGE): Mini-PROTEAN 3 electrophoresis system with 
accessories [Bio-Rad, München, Germany]  
 Extruder, Mini [Avanti Polar Lipids, Alabaster, AL, USA] 
 Gradient Master ip [Biocomp Instruments, Fredericton, Canada] 
 Incubators Heraeus [Thermo Scientific, Langenselbold, Germany] 
 Laminar hood Heraeus [Thermo Scientific, Langenselbold, Germany] 
 Microscope: Confocal laser scanning microscope FluoViewTM  FV1000; 60× (N.A. 1.2) water 
immersion objective UplanSApo; 60× (N.A. 1.35) oil immersion objective UplanSApo 
[Olympus, Hamburg, Germany] 
 Microscope: IX-81 inverted epifluorescence microscope [Olympus, Hamburg, Germany] 
 Microscope (single particle tracking): Nikon TE2000 inverted epifluorescence microscope 
[Nikon, Düsseldorf, Deutschland] with back-illuminated Andor iXon3 897 single photon 
detection EMCCD camera, 512×512 pixels, 16×16 µm pixel size [Andor Technologies, 
Belfast, UK]; equipped with Sapphire Laser 488 nm, 30 mW and Compass Laser 561 nm, 
25 mW [Coherent, Göttingen, Germany]; objective Plan Apo VC 60× Oil (N.A. 1.4) [Nikon, 
Düsseldorf, Germany] 
 Microscope (cell culture): Telaval 31, phase contrast inverted microscope, [Zeiss, Göttingen, 
Germany] 
 Milli-Q ultra pure water purification system [Millipore, Schwalbach, Germany] 
 Odyssey® Infrared imaging system [LI-COR Bioscience, Bad Homburg, Germany] 
 Phosphorimager: Fluorescent image analyzer FLA-3000 [Fujifilm, Düsseldorf, Germany]  
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 Power supply for electrophoresis and Western blotting: PowerPac 1000 [Bio-Rad, München, 
Germany] and Amersham EPS 601 [GE Healthcare, Freiburg, Germany] 
 Rotary evaporator Rotavapor R-200 [Büchi Labortechnik, Essen, Germany]  
 Shaker: Mini-rocker MR-1 [Bioscan, Paris, France]; rocking shaker [GFL, Burgwedel, 
Germany] 
 Spectrofluorometer AMINCO-BowmanTM Series 2 [Thermo Electron Corporation, Germany] 
 Thermal Cycler MyCyclerTM [Bio-Rad, München, Germany] 
 Thermomixer comfort [Eppendorf, Hamburg, Germany] 
 Ultracentrifuge TL-100, tabletop, rotor TLA 100.3 [Beckman Coulter, Krefeld, Germany] 
 Ultracentrifuge XL-70 and Optima L-100K [Beckman Coulter, Krefeld, Germany] 
 UV transilluminator [Vilber Lourmat, Eberhardzell, Germany] 
 UV-Vis spectrophotometer UV1 [Thermo Electron Corporation, Germany] 
 Western blot: Trans-Blot® SD semi-dry electrophoretic transfer cell [Bio-Rad, München, 
Germany] 
3.1.6 Software 
 Andor iQ [Andor Technologies, Belfast, UK]: device control and image viewing software for 
EMCCD camera Andor iXon3 897 
 Clone Manager [Sci-Ed, Cary, NC, USA]: cloning simulation; DNA sequence viewing, 
alignment, editing and ORF analysis 
 FV 10-ASW FluoView1000 [Olympus, Hamburg, Germany]: device control, image viewing 
and data analysis software for confocal microscope FV1000 
 ImageJ Version 1.46e (http://imagej.nih.gov/ij/) [Wayne Rasband, National Institute of 
Health, Bethesda, MD, USA] [452]: signal quantification, particle tracking, image processing 
 ImageJ plugin MtrackJ (http://www.imagescience.org/meijering/software/mtrackj/) [Erik 
Meijering, Biomedical Imaging Group, Erasmus MC, Rotterdam, Netherlands] [453] 
 ImageJ plugin Spot Tracker (http://bigwww.epfl.ch/sage/soft/spottracker/) [Daniel Sage, 
Biomedical Imaging Group, Ecole Polytechnique Fédérale de Lausanne, Switzerland] [454] 
 EMBOSS (http://www.ebi.ac.uk/Tools/emboss/) [European Bioinformatics Institute, 
Cambridge, UK]: DNA translation, sequence alignment 
 The PyMOL Molecular Graphics System, Version 1.1eval Schrödinger, LLC. [DeLano 
Scientific, SanFrancisco, CA, USA]: molecular visualization of protein structures 
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3.2 Methods 
3.2.1 Molecular biology 
Plasmid constructs were generated by application of standard molecular biology techniques. 
The specific DNA sequences to be encoded in a plasmid for protein expression were 
generated by polymerase chain reaction (PCR) (3.2.1.1) and inserted into the plasmid by 
restriction digest and ligation (3.2.1.3). Point mutations were introduced by site-directed 
mutagenesis (3.2.1.4). The plasmids for generation of recombinant viruses were processed in 
the same way. Plasmids were amplified in E.coli (3.2.1.6 and 3.2.1.7), and the open reading 
frame (ORF) of each newly generated plasmid was checked for correctness by sequencing 
(Invitek GmbH, Berlin, Germany). Sequencing primers are listed in Tab. 4. 
3.2.1.1 Polymerase chain reaction (PCR) 
DNA fragments to be inserted into a plasmid were specifically amplified from a template 
DNA by PCR. For each PCR, two oligonucleotide primers defining the beginning and the end 
of the fragment were designed (Tab. 3 and Tab. 6). They were complementary to the first 10–
15 nucleobases of the fragment (forward primer, fw) and reverse complementary to 10–15 of 
the terminal nucleobases (reverse primer, rev), respectively. Adjacent to these sequences, 
restriction sites were added matching the restriction sites of the plasmid into which the PCR 
product was to be inserted. Furthermore, terminal tags like the nuclear export signal (NES) 
and the TC-tag were encoded by the PCR primers and thereby fused to the gene of interest. 
For PCR, template DNA (2 ng), forward and reverse primers (0.5 µM), a nucleotide mix 
(dNTPs, 200 µM each), HF buffer (as supplied with the polymerase) and the heat-stable 
Phusion high-fidelity DNA polymerase (0.02 U/µl) were mixed in a final volume of 50 µl and 
subjected to repeated temperature changes in a thermal cycler. The double-stranded template 
DNA was initially denatured at 98 °C for 30 s followed by the reaction cycle of DNA 
denaturation at 98 °C for 10 s, annealing of the primers with template DNA at 54 °C for 30 s 
and elongation of the primers by synthesis of template-complementary DNA at 72 °C. The 
duration of the elongation step was 20 s per 1000 nucleotides of DNA fragment to be 
synthesized. The reaction cycle was repeated 35 times and the PCR was completed by 10 min 
at 72 °C. The PCR product was detected and purified by agarose gel electrophoresis (3.2.1.2).  
Another application of PCR, the colony PCR, was performed to verify successful insertion of 
DNA into a plasmid or the uptake of a certain plasmid by E.coli. The same PCR protocol was 
followed as described before, but the initial denaturation time was extended to 10 min. Instead 
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of the template DNA, part of an E.coli colony was picked and resuspended in the reaction 
mixture. The colony PCR primers (Tab. 4) did not contain restriction sites and were chosen 
for amplification of an arbitrary fragment of the target gene. 
3.2.1.2 Agarose gel electrophoresis 
Agarose gels were produced with 1 % (w/v) agarose in TBE buffer supplemented with the 
DNA stain SYBR Safe. Electrophoresis was run at 70 mA to separate negatively charged 
DNA fragments according to their size. For further applications, DNA bands were cut from 
the gel and the DNA was extracted using the QIAquick Gel Extraction Kit.  
3.2.1.3 Restriction digestion and ligation 
A DNA insert, generated by PCR and flanked by two restriction sites, and about 1 µg of the 
target plasmid were separately digested with the same two restriction endonucleases for 2 h at 
37 °C. The buffer composition was chosen according to the requirements of the enzymes as 
given by the manufacturer’s instructions. The reactions produced overhanging ends of 
unpaired nucleotides (“sticky ends”) at both ends of the DNA molecules. To prevent self-
ligation of the plasmid in the following ligation reaction, the reaction mixture for digestion of 
the plasmid was supplemented with calf intestinal alkaline phosphatase to remove the reactive 
5′ phosphate. The reaction products were analyzed and purified by agarose gel electrophoresis 
(3.2.1.2), and DNA fragments were extracted with the QIAquick Gel Extraction kit for 
subsequent ligation. As insert and plasmid possessed complementary sticky ends, they could 
be linked by formation of a phosphodiester bond between the 3′ hydroxy and 5’ phosphate 
groups catalyzed by the T4-DNA-ligase. For this reaction, the linearized plasmid was 
incubated with an excess of DNA insert and the T4-DNA-ligase in T4-DNA-ligase buffer at 
16 °C for at least 1 h. The solution was stored at 4 °C until transformation of E.coli (3.2.1.6). 
Prior to transformation the ligase was heat-inactivated at 65 °C for 10 min. 
3.2.1.4 Site-directed mutagenesis 
Point mutations were introduced into plasmid DNA by PCR-based site-directed mutagenesis 
based on the QuikChange protocol by Stratagene. A complementary primer pair was designed 
that anneals to the target sequence on the plasmid where the mutations were supposed to be 
introduced. These primers carry the desired point mutation(s) flanked by 10–15 nucleotides of 
the matching sequences on both sides, terminated by two or more G and/or C bases (Tab. 3; 
Tab. 6) (Primer Design Guidelines, QuikChange
®
 site-directed mutagenesis kit, #200518, 
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Stratagene). PCR was carried out by mixing 25 µM of each primer, 200 mM dNTPs, 50 ng of 
template DNA, 1× HF buffer and 0.02 U/µl Phusion HF DNA polymerase in a final volume of 
50 µl and the DNA was amplified by thermal cycling. An initial denaturation step (3 min, 
98 °C) was followed by 20 cycles of 98°C for 10 s, 70 °C for 30 s and 72 °C for 3 min. The 
duration of the DNA elongation step at 72 °C was chosen long enough that the full length of 
the plasmid could be synthesized. The reaction was completed by final extension at 72 °C for 
10 min. The reaction yielded unmethylated linear copies of the plasmid. The methylated 
template DNA was thereafter digested with the restriction endonuclease DpnI (0.2 U/µl) for 
1 h at 37 °C leaving the unmethylated PCR products. E.coli DH5α were transformed for 
amplification (see 3.2.1.6), subsequent purification (3.2.1.7) and sequencing (Invitek, Berlin, 
Germany) of the mutated plasmids. 
3.2.1.5 Two-stage PCR mutagenesis for insertion of large segments 
For insertion of long nucleotide sequences like the tetracysteine (TC)-tag encoded by 18 
bases, a modified QuikChange protocol was applied. The procedure was essentially the same 
as described in section 3.2.1.4 adapted according to the two-stage PCR protocol for site-
directed mutagenesis described by Wang and Malcolm [455]. Mutagenesis primers were 
designed as described above carrying the new insert sequence flanked by complementary 
sequences of the plasmid (Tab. 3; Tab. 6). Unlike the standard QuikChange protocol for point 
mutations, the thermal cycling reaction for plasmid amplification was preceded by a primer 
extension step. Therefore, two separate PCR reaction mixtures were prepared with the same 
composition as in 3.2.1.4, but only containing either the forward or the reverse primer. The 
two reaction mixtures were subjected to initial denaturation at 98 °C for 30 s and three cycles 
of 98 °C for 10 s and 72 °C for 3 min. Subsequently, 25 µl of both reaction mixtures were 
combined, now containing elongated mutagenesis primers with higher affinity for the plasmid 
than for each other, and the standard PCR protocol for site-directed mutagenesis comprising 
amplification and DpnI digestion was resumed (see 3.2.1.4). 
3.2.1.6 Transformation of E.coli 
To amplify plasmids obtained by insert ligation or mutagenesis, they were introduced into 
chemically competent E.coli DH5α by transformation. 100 µl aliquots of bacteria were 
carefully thawed on ice and mixed with a few nanograms of plasmid. The suspension was 
incubated on ice for 10 min, treated by heat-shock at 42 °C for 45 s and placed back on ice for 
5 min. Bacteria were pelleted by centrifugation at 6,000 × g for 5 min and resuspended in 
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50 µl LB medium before plating them on agar plates containing the appropriate antibiotic for 
selection of bacteria carrying the plasmid. Plates were incubated overnight at 37 °C and single 
colonies were picked for colony PCR (3.2.1.1) or plasmid purification (3.2.1.7). Clones were 
stored in 30 % glycerol-LB medium at –80 °C. 
3.2.1.7 Plasmid purification 
For plasmid purification, single colonies were picked from agar plates for inoculation of LB-
medium with selection antibiotic and propagation at 37 °C for 16 h in a shaking incubator. 
Bacteria were then pelleted, and plasmids were isolated using the QIAprep Spin Miniprep Kit 
(for 5 ml culture) or QIAGEN Plasmid Maxi Kit (for 100 ml culture) according to manual. 
DNA concentrations were determined photometrically by measuring the absorbance at 
260 nm (Biophotometer plus), and the plasmids were used for sequencing, transfection of 
eukaryotic cells or molecular biology. 
3.2.2 Cell biology 
3.2.2.1 Cell culture 
Adherent CHO-K1, HeLa, MDCK II and 293T cells were maintained in complete medium 
(DMEM supplemented with 10 % FBS, 2 mM L-glutamine and penicillin/streptomycin) 
under cell culture conditions (humidified atmosphere with 5 % CO2, 37 °C). They were 
routinely passaged in 75-cm
2
 cell culture flasks (T75) every 3–4 days when reaching 
confluency. For passaging, cells were washed twice with DPBS and incubated with 2 ml 
trypsin/EDTA at 37 °C until detachment. Then, the cells were mixed with 10 ml complete 
medium. They were seeded into appropriate dishes or used for continued culture (typically 
1/12). Treatment of cells was under sterile conditions (laminar flow bench). Cell culture was 
routinely maintained in DMEM without phenol red to avoid interference of the dye with 
fluorescence methods. 
For long term storage, cells were detached from the T75 flask, diluted in DMEM, pelleted for 
3 min at 300× g and transferred into 1.5 ml freezing medium. After cooling down to -80 °C 
overnight, cell stocks were stored in liquid nitrogen at –196 °C. For unfreezing, the cells were 
rapidly thawed in a 37 °C water bath, diluted with 10 volumes of complete medium and 
pelleted for 3 min at 300× g. The cell pellet was gently resuspended in pre-warmed culture 
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medium and transferred into a cell culture flask. Cells were then grown under cell culture 
conditions as described before.  
3.2.2.2 Transfection 
Transfection of plasmid DNA into eukaryotic cells (CHO-K1, HeLa, MDCK II) was 
performed using the cationic lipid-based Lipofectamine 2000 transfection reagent according 
to the manufacturer’s instructions. A total of 4 µg DNA was used for transfection of cells 
grown to 90 % confluency in 35-mm dishes. The DNA was mixed with DMEM to a final 
volume of 250 µl, while 10 µl of Lipofectamine 2000 were added to 240 µl of DMEM. 
Solutions were incubated for 5 min at room temperature (RT), combined and thoroughly 
mixed. After another 20 min at RT, the transfection mixture was added dropwise to the cells 
that had been washed with DPBS (containing Ca
2+
 and Mg
2+
) and been covered with 1.5 ml of 
DMEM. The dishes were then gently swirled and incubated at 37 °C. The transfection 
medium was replaced by DMEM after 4 h. Subsequent processing for live-cell imaging, 
immunofluorescence or analysis of cell lysates was done as described in the respective 
sections.  
For production of recombinant Influenza viruses in 293T cells (3.2.4.3), the transfection 
reagent TurboFect, a cationic polymer solution, was used. 1 µg DNA of each of the eight 
required plasmids was thoroughly mixed with 800 µl DMEM plus 12 µl of TurboFect. The 
mixture was incubated 15 min at RT and then added dropwise to 293T cells grown to about 
60 % confluency on 60-mm dishes. Before addition, the cells had been washed and covered 
with 4 ml of fresh DMEM. The medium was removed after 4–6 hours and 5 ml of infection 
medium were added. 
3.2.2.3 Cell polarization 
Epithelial cells can form polarized layers of tightly associated cells with structurally and 
functionally distinct apical and basolateral domains. For polarization, MDCK II cells were 
grown in Transwells (permeable polycarbonate supports with pores of 0.4 µm that allow 
uptake of nutrients and exchange of substances across the basal cell membrane). The cells 
were seeded into the Transwells and supplied with complete growth medium from both sides. 
Transfection with Lipofectamine 2000 was performed one day after seeding when the cells 
were about 80 % confluent. At 4 h post-transfection (p.t.), the transfection medium was 
replaced by complete medium and was thereafter changed every day, now supplemented with 
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250 µg/ml Neomycin. Neomycin exerts a positive selection pressure on cells that have been 
transfected with a plasmid carrying a neomycin resistance gene. 13 days after transfection, 
cells were washed with DPBS (with Ca
2+
 and Mg
2+
) and either imaged as living cells or fixed 
for 45 min in 4 % formalin solution and further subjected to immunofluorescence staining. 
For imaging, the membrane was cut into large pieces and placed upside down on a 
microscope slide for observation with an inverted microscope. Apical localization of the 
control protein HAmYFP was used to verify the polarization state of the cells. 
3.2.2.4 Fluorescence labeling of fixed and living cells 
For fluorescence imaging, cells were grown in 35-mm glass-bottom dishes or on glass cover 
slips in 12-well cell culture plates. To avoid photobleaching of fluorophores, samples were 
protected from light during processing. 
3.2.2.4.1 Immunofluorescence (IF) 
For the detection of specific (transfected, viral or endogenous) proteins by IF, the cells were 
transfected or infected as required and fixed with 4 % formalin at RT for 30 min. Cells were 
then washed twice with DPBS, permeabilized for 8 to 10 min with 0.5 % (v/v) Triton-X100 
and washed twice. Unspecific binding sites were then blocked with 3 % (w/v) BSA in DPBS 
for 1 h. Use of BSA-containing solutions was omitted in case of FlAsH-labeled cells 
(3.2.2.4.3) due to unspecific binding of FlAsH to BSA. DPBS was used instead. Primary and 
secondary antibodies were generally diluted 1:1000 in blocking buffer (anti-HA, 1:6000). 
Cells were incubated with the primary antibody for 1–1.5 h, washed three times with blocking 
buffer and subsequently incubated for another hour with the secondary fluorescently labeled 
antibody. When anti-NP-FITC was used, a secondary antibody was not required. For co-
staining of different target proteins, a mixture of antibodies was applied. Finally, the cells 
were washed three times in blocking buffer and twice in DPBS. Cells in glass-bottom dishes 
were covered with DPBS and stored at 4 °C. Glass cover slips were mounted on microscope 
slides with 20 µl of Mowiol
 
4-88 Reagent. The samples were analyzed by fluorescence 
microscopy within two days. 
3.2.2.4.2 Labeling of subcellular structures 
For visualization of DNA, nucleoli or actin filaments, fixed and permeabilized cells were 
stained with DAPI, propidium iodide (PI) or rhodamine phalloidin, respectively. This was 
generally done following immunostaining.  
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Counterstaining of the cell nuclei was performed by incubation of the cells with 100 nM 
DAPI in DPBS at RT for 3 min. Nucleic acids and in particular nucleoli as prominent 
structures were labeled with 500 nM PI in PBS for 5 min [456]. For staining of F-actin, 
permeabilized cells were incubated with rhodamine phalloidin (100 nM) for 30 min. Staining 
procedures were followed by three washing steps with DPBS before mounting the cover slips 
on microscope slides with Mowiol
 
4-88 Reagent or covering the cells with DPBS. 
The endoplasmic reticulum (ER) was labeled with the cell-permeant, live-cell stain ER-
Tracker RED, a BODIPY TR labeled glibenclamide that binds to a receptor which is 
prominent on the ER.  The dye was diluted to 1 µM in pre-warmed DPBS with Ca
2+
 and 
Mg
2+
, and the cells were rinsed with DPBS before incubation with the staining solution for 
25 min at 37 °C. Subsequently, the cells were washed and fixed in 4 % formalin solution for 
30 min or directly analyzed by live-cell fluorescence microscopy. 
3.2.2.4.3 Labeling of tetracysteine-tags with biarsenical dyes 
Labeling of the tetracysteine (TC) tag of proteins expressed in transfected or infected cells 
was performed with the green-fluorescent Fluorescein Arsenical Hairpin Binder (FlAsH) or 
the red-fluorescent Resofurin Arsenical Hairpin Binder (ReAsH) in living cells [457]. The 
labeling reagents FlAsH-EDT2 and ReAsH-EDT2 precomplexed with 1,2-ethanedithiol (EDT) 
were freshly diluted to 1 µM in DMEM at RT. The dyes are membrane permeable and upon 
formation of four covalent bonds between the two arsenic atoms of the dye and the four thiol 
groups of the peptide tag, the fluorescence intensity of the fluorophores increases 
considerably. Cells in 35-mm dishes were rinsed with DMEM and incubated with 500 µl of 
the dye solution for 1 h at RT.  Washing buffer was prepared diluting 100× BAL washing 
buffer (2,3-dimercapto-1-propanol) in DMEM to a final concentration of 250 µM. The 
staining solution was removed from the cells which were then rinsed with DMEM and 
washed twice with 1 ml BAL washing buffer for 10 min at RT to reduce the background 
signal. Finally, the cells were rinsed with DMEM and either analyzed by live-cell 
fluorescence microscopy or fixed in 4 % formalin solution for subsequent immunostaining. 
The labeling was stable for some days consistent with the dissociation rate constant 
determined for FlAsH with various model peptides in vitro to be in the range of 10
-6
/s. 
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3.2.3 Microscopy  
For live-cell imaging, cells were grown in 35-mm glass-bottom dishes and were maintained in 
imaging medium (DMEM supplemented with 20 mM HEPES, pH 7.4). Fixed cells were kept 
in DPBS or mounted on microscope slides with Mowiol 4-88 Reagent. 
3.2.3.1 Confocal fluorescence microscopy (CLSM) 
Images of living or fixed fluorescently labeled cells were acquired by confocal laser scanning 
microscopy (CLSM) using an Olympus FV1000 inverted microscope. In CLSM, the samples 
are scanned by point illumination with a laser beam and the fluorescence signal of each point 
is detected by a photomultiplier tube (PMT) after spatial filtering through a pinhole that 
eliminates out-of-focus light thereby improving the image quality. The primary photon signal 
generates an electronic output from the PMT that is converted into digital pixel values from 
which the images are reconstructed. The microscope was equipped with a 405-nm diode laser, 
a 559-nm diode laser, a 635-nm diode laser and a multi-line Argon laser (458-nm, 488-nm, 
515-nm). Images were acquired with a 60× (N.A.1.35) oil immersion objective or a 60× (N.A. 
1.2) water immersion objective (UplanSApo, Olympus). Image acquisition with different 
fluorophores was performed in a sequential mode of excitation to avoid spectral crosstalk of 
the detecting PMT channels. Fluorophores were excited at 405 nm (DAPI), 458 nm (CFP), 
488 nm (FITC), 488 or 515 nm (mEYFP), 559 nm (AlexaFluor568, AlexaFluor594, mCherry, 
RFP, PI, rhodamine) or 633 nm (Atto 647N).  
Fluorescence emission was recorded for DAPI between 425 and 475 nm, for CFP between 
475 to 500 nm, for FITC from 500 to 545 nm, for mEYFP between 500 and 545 nm or 525 
and 550 nm, for Atto 647N between 655 and 755 nm and for AlexaFluor568, AlexaFluor594, 
mCherry, RFP, PI and rhodamine from 570 to 670 nm. When specific combinations of dyes 
were used, the emission ranges had to be narrowed to avoid spectral overlap, e.g. 
AlexaFluor594 was detected between 570 and 603 nm when in combination with Atto 647N. 
The settings were adjusted by appropriate negative control samples. 
3.2.3.2 Fluorescence photoactivation 
The dynamic behaviour of NP in living cells was measured by fluorescence photoactivation of 
Dendra2 fusion proteins. Dendra2 is a photoactivatable fluorophore that can be switched 
irreversibly from a green- to a red-fluorescent state by irradiation at around 400 nm. This 
causes a break of the polypeptide backbone adjacent to the chromophore. The formation of an 
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additional double bond leads to an extended π-electron system and causes a shift of excitation 
and emission spectra to longer wavelengths [458] . 
Photoactivation measurements of Dendra2 constructs in living cells were performed at RT. 
The green state of the fluorophore was excited at 488 nm and recorded from 500 to 545 nm. 
An image of the initial distribution of total Dendra2-tagged protein (green state) was taken, 
and the region of interest (ROI) for photoactivation was chosen with a diameter of 10–25 
pixels (between 3 and 21 µm
2
). Irradiation of the ROI at 405 nm was performed in the fast 
Tornado scanning mode (50 mW diode laser, output 5 %, 20 µs/pixel, three repeats). 
Irradiation time and intensity were kept constant for all measurements. Images of the 
activated red state were scanned at 2 µs/pixel by excitation at 559 nm and detection from 570 
to 670 nm. A time series of images consisting of 20 pre-activation and 230 post-activation 
frames was acquired at intervals of 428 ms. Illumination conditions for imaging of the red 
state were chosen so that fluorescence bleaching was negligible. The intensity of the red-
fluorescent state in the photoactivated area was analyzed using the microscopy software 
FluoView FV10-ASW (Olympus). 
As bleaching controls, cells expressing free Dendra2 were photoactivated within a large area 
of the cell in order to photoconvert a significant fraction of the fluorophore. After 4 min when 
the fluorophore had evenly spread throughout the cell to a steady-state distribution, a time 
series of the activated red state was acquired and the conditions of illumination (laser 
intensity, illumination time per pixel and scanning frequency) were checked for bleaching 
effects. 
3.2.3.3 Single particle tracking (SPT) 
For single particle tracking of NP constructs in living cells, time-lapse imaging was performed 
at 37 °C using either the inverted epifluorescence microscope Nikon TE2000 equipped with a 
highly sensitive back-illuminated EMCCD camera or the confocal laser scanning microscope 
Olympus FV1000. Using the epifluorescence microscope with EMCCD camera, images 
(512×512 pixels) were acquired at intervals of 0.5 s, while confocal laser scanning microscopy 
allowed a frame rate of one image per 1.1 s or 1.6 s, depending on the scanning speed of 
2 µs/pixel or 4 µs/pixel, respectively. Confocal imaging was preferentially performed to study 
single particle movements at the nuclear surface or underneath the plasma membrane, while 
fast epifluorescence imaging was used to analyze trajectories and velocities of cytoplasmic 
particle movements in general.  
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Imaging was performed in two dimensions monitoring single cross-sections of cells over 
time. Pixel size corresponded to 0.178 µm in case of epifluorescence imaging and to 
0.103 µm in case of confocal imaging. For fast dual color imaging of cotransport of mEYFP-
NP and Rab11-RFP, images were recorded alternately by excitation at 488 nm or 561 nm, 
respectively, with exposure times of 30 ms/image.  
Image processing and particle tracking analysis were performed using the software ImageJ. 
The procedure was as follows: The median projection of an image sequence was formed and 
subsequently subtracted from each image of the stack. This helped to reduce signals of static 
fluorescent structures like the cell nucleus which is highly enriched with fluorescent NP 
constructs, while signals from mobile particles were retained. Subsequently, the Spot 
Enhancing Filter of the Spot Tracker plugin was applied [454], which is based on a Mexican hat 
filter (Laplacian of a Gaussian operator) to detect edges (intensity changes) and enhance the 
contours of Gaussian-like spots for improved detection of single particle fluorescent signals. 
Tracking of punctate fluorescent signals was then performed using the Spot Tracker tracking 
algorithm. Movements of particles to be traced were selected manually by specification of the 
starting point, followed by a semi-automated tracking procedure implementing a cost function, 
which could be adjusted by introducing user-defined constraints like an intensity factor or a 
movement constraint. A fully automated tracking approach was not feasible due to high particle 
densities. When numerous bright and (often static) signals in close proximity to the moving 
particle complicated automated tracking and led to confusion of particles identities and false 
results, additional node points could be added to further constrain the path of the particle and 
correct the trajectory. Instant velocities were calculated from the signal coordinates between 
consecutive frames. Using an in-house generated python script (Dr. Martin Seeger), the data was 
transferred to the MTrackJ plugin [453] for graphic representation of trajectories in the original 
fluorescence image stacks.  
3.2.3.4 Correlated fluorescence and electron microscopy of tetracysteine-tagged 
proteins 
Correlated electron microscopy with tetracysteine (TC)-tagged proteins is based on the fact 
that the TC-binding dye ReAsH is not only a fluorophore, but can also mediate efficient 
photoconversion of 3,3’-diaminobenzidine (DAB) into an osmiophilic precipitate that can be 
visualized by electron microscopy [459,460]. Upon intense illumination, excited ReAsH 
catalyzes the formation of singlet oxygen that causes the localized oxidative polymerization 
of DAB. This method allows combining the specific detection of a genetically encoded tag 
with high resolution imaging by electron microscopy.  
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The protocol was performed according to [460]. MDCK II cells were grown on glass-bottom 
dishes with a photo-etched grid structure (600 × 600 µm squares; MatTek) to facilitate 
preparation and identification of photoconverted cells in electron microscopy. The cells were 
infected with Influenza A/WSN/33 virus mutants carrying TC-tagged NP. 20 h p.i. cells were 
washed and labeled for 1 h at RT with 1 µM ReAsH in DMEM (see 3.2.2.4.3). Subsequently, 
the cells were incubated for 5 min in pre-warmed cacodylate buffer with 2 % (w/w) 
glutaraldehyde for rapid fixation. The samples were cooled down to 4 °C and fixation was 
continued for another 30 min. The solution was removed and cells were washed four times 
with ice-cold cacodylate buffer. They were briefly imaged by confocal microscopy to choose 
an area of infected cells for photoconversion and were then covered with photoconversion 
blocking buffer (20 mM glycine, 10 mM KCN, 10 mM aminotriazole, 0.2 M cacodylate, pH 
7.4) for 30 min at 4 °C.  In the meantime, 0.5 mg/ml DAB was freshly prepared in ice-cold 
cacodylate buffer diluted from a 10 mg/ml stock solution stored at –80 °C. The DAB solution 
was oxygenated for 5 min by constant bubbling with pure oxygen. Following the 
photoconversion blocking step, cells were rinsed once with cacodylate buffer and incubated 
with the oxygenated DAB solution. Illumination for photoconversion and imaging were 
performed using the inverted epifluorescence IX-81 microscope with a U-MWG2 filter unit 
(Olympus) and maximum intensity illumination from a mercury lamp. Differential 
interference contrast (DIC) and fluorescence images were taken with the 40× (N.A. 0.75) 
objective UplanFL prior to constant illumination for photoconversion. Irradiation was 
performed for about 15 min on a 4°C temperature controlled stage insert. The DAB solution 
was refreshed every 3 min until brown precipitates were observed by transmitted light. This 
procedure was repeated for two or three areas on the same dish followed by five final washing 
steps with cacodylate buffer on ice, each for the duration of 3 min. The following processing 
of the samples for transmission electron microscopy (TEM) and image acquisition were 
performed by Maik Lehmann and Gabriele Drescher (Humboldt-Universität, Molekulare 
Parasitologie). This included post-fixation with 1 % (v/v) osmium tetroxide for 1 h, en bloc 
staining with 0.5 % (v/v) uranyl acetate for 1 h, stepwise dehydration with ethanol, 
embedding with EMBed 812 (Electron Microscopy Science) and sectioning. After infiltration 
of the sample with embedding medium, a small cylindrical block of polymerized resin (used 
like a stamp) was placed on the region of the gridded cover slip where photoconversion had 
been performed. After polymerization at 70 °C for 48 h and cooling down, the glass cover slip 
was briefly placed on a hot plate and removed from the base of the cylinder. The cells and the 
imprint of the grid were thereby transferred to the block surface and the block was trimmed 
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leaving only the brown area of photoconversion. Cells were cut en face into 70–90 nm 
sections and sections were counterstained with 4% (w/v) uranyl acetate followed by lead 
citrate. Images were acquired using a transmission electron microscope equipped with a wide-
angle CCD camera (Zeiss EM 900, TRS Systems).  
3.2.4 Virological methods 
3.2.4.1 Infection and virus propagation 
For infection of eukaryotic cells with Influenza A virus, cells were washed with DPBS (with 
Mg
2+
 and Ca
2+
) and covered with the virus suspension, diluted appropriately in DMEM, for 
1 h under cell culture conditions while gently agitating every 15 min. Thereafter, the virus 
supernatant was removed, cells were washed twice in DPBS and the medium for cell 
maintenance was chosen according to the experimental objective. For microscopy of infected 
cells, cells were supplied with DMEM without further additions. For virus propagation, cells 
were maintained in infection medium that was freshly supplemented with TPCK-trypsin for 
cleavage of HA on newly formed virus particles to allow multiple infection cycles.  
For preparation of virus stock solutions, MDCK II cells of 80 % confluency were infected 
with a multiplicity of infection (MOI) of 0.01 (MOI 0.1 for virus mutants). The supernatant 
containing newly released virus particles was harvested 1–3 days after infection upon 
observation of a cytopathic effect (CPE) and was cleared from cell debris by centrifugation 
for 5 min at 2000× g. Aliquots were stored at –80 °C. 
3.2.4.2 Virus purification and labeling 
For purification and labeling of Influenza A virus, MDCK II cells were infected (MOI 0.1) 
and harvested from three T175 flasks as described in 3.2.4.1. The virus-containing supernatant 
that had been cleared from cell debris was subsequently centrifuged for 2 h at 100,000× g. 
The virus pellet was resuspended in 200–500 µl TNE buffer and mixed with 2 µM FlAsH-
EDT2 or ReAsH-EDT2. The labeling solution was incubated at RT for 1.5 h or at 4 °C 
overnight and was then layered on top of a linear sucrose gradient (20–60 % (w/v) in TNE 
buffer) that was centrifuged for 4 h at 100,000× g. The virus appearing as a turbid layer was 
collected, diluted with 10 ml DPBS and pelleted at 100,000× g for 2 h. The virus pellet was 
finally resuspended in 200 µl DPBS or TNE buffer and was analyzed by SDS-PAGE or 
confocal microscopy, or it was stored at –80 °C. 
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3.2.4.3 Reverse genetics 
Recombinant Influenza A/WSN/1933 virus was generated by reverse genetics using the eight 
plasmid system described by Hoffmann et al. [451]. Each plasmid contains the cDNA of one 
of the viral RNA segments flanked by the promoter sequences of human RNA polymerase I 
and II (Pol I and Pol II) and by termination and polyadenylation signals for the production of 
full-length RNA or capped and polyadenylated mRNA, respectively. For the generation of 
genetically modified viruses, the desired modification (e.g. TC-tag insertion) was introduced 
into the respective plasmid cDNA by molecular biology techniques (see 3.2.1.4). The eight 
plasmids were transfected into 293T cells as described in section 3.2.2.2. Subsequently, the 
cells were maintained in infection medium and those that were successfully co-transfected 
with all eight plasmids formed virus particles which could infect other cells and replicate. 2 d 
p.t. the supernatant was collected and cell debris was removed by centrifugation (5 min, 
2000× g). For virus propagation, subconfluent MDCK II cells in a T25 flask were infected 
with 1 ml of the supernatant for 1 h. 4 ml of infection medium were added and finally the 
supernatant was harvested upon observation of a CPE, but not later than three days after 
infection. The recovered supernatant was purified from debris as before and stored at –80 °C. 
Successful generation of recombinant virus was verified by plaque assay (3.2.4.4) and by 
immunofluorescence (3.2.2.4.1) of NP in infected cells. The modifications introduced in to 
the viral genome by mutagenesis of segment 5 cDNA were verified by sequencing of purified 
viral RNA. Therefore, virus was propagated and harvested from three 175-cm² flasks as 
described in 3.2.4.1. It was pelleted by centrifugation for 2 h at 100,000× g. Total viral RNA 
was extracted using the Rneasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions. cDNA synthesis of segment 5 vRNA and sequencing was performed by Meixner 
GmbH (Berlin, Germany).  
3.2.4.4 Plaque assay 
Plaque assays were performed to determine the viral titer (the concentration of infectious viral 
particles in a suspension). To this end, MDCK II cells were grown to confluency in 6-well 
plates. A ten-fold serial dilution of the virus stock solution was prepared in DMEM. The cells 
were washed with DPBS (with Mg
2+
 and Ca
2+
) and infected with 500 µl of virus dilutions for 
1 h. Then, the virus suspension was removed by aspiration followed by two washing steps 
with DPBS (with Mg
2+
 and Ca
2+
) and addition of 2 ml of overlay medium per well  which 
was freshly prepared from pre-warmed solutions at 37 °C. The overlay was allowed to 
solidify at RT before incubating the plates for three days under cell culture conditions. As 
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viruses that are released from infected cells cannot diffuse freely in the gel matrix of the 
overlay medium and infect only the neighbouring cells, locally restricted plaques are formed. 
After three days, cells were stained with Neutral Red for 3 h to visualize the plaques as cell-
free areas within the cell layer. Plaques were counted for every dilution that displayed an 
appropriate, low density of discernible plaques, each of which under these conditions most 
likely represents a single infection event with one infectious unit (virus particle). The titer of 
the stock solution in plaque-forming units (PFU) per millilitre was determined from the 
number of plaques and the corresponding dilution factor normalized to the applied volume. 
3.2.4.5 Determination of viral titer by immunofluorescence 
If recombinant Influenza A WSN virus mutants were unable to form clear plaques, the titer 
was determined by immunofluorescence detection of NP expression. Three dilutions of the 
virus stock solution were prepared and MDCK II cells were infected as described in 3.2.4.4. 
After infection, cells were maintained in DMEM and fixed at 20 h p.i. Immunofluorescence 
staining with anti-NP-FITC antibody and nuclear DAPI staining were carried out as in 
3.2.2.4, and the fraction of infected cells (nuclei positive for NP) was determined by 
fluorescence microscopy of at least 400 cells. The multiplicity of infection (MOI) was 
calculated, which is defined as the number of infectious particles per number of target cells. 
The calculation is based on the Poisson distribution P(n) = (MOI)
n
 × e
–MOI
 / (n!), which  
describes the probability that one cell is infected by n virus particles at a given MOI. The 
fraction of uninfected cells (p0) (as a measure for the probability of infection with n = 0) 
allowed the calculation of the MOI: MOI = −ln(p0). Hence, the titer of the virus could be 
derived from the number of infected cells, the dilution factor of the virus and the applied 
volume of the virus stock.  
3.2.4.6 Growth curve 
Growth curves were recorded to describe the replication rate of Influenza virus strains. 
MDCK II cells in 12 dishes, about 80 % confluent, were simultaneously infected at an MOI of 
0.01 (0.1 in case of WSN nTC virus) as described in section 3.2.4.1 and were subsequently 
maintained in 1 ml of infection medium. The MOI of the WSN nTC virus was based on the 
titer value determined by immunofluorescence analysis (3.2.4.5). Samples were prepared in 
duplicate for each time point. Supernatant was collected at 0, 8, 16, 24 and 48 h p.i. and 
briefly centrifuged at 2000× g for 5 min. Samples were stored at –80 °C and the virus titer of 
each sample was determined by plaque assay (see 3.2.4.4).  
MATERIAL AND METHODS 
82 
 
3.2.5 Biochemical methods 
3.2.5.1 Protein determination 
The protein content of virus preparations and purified vRNPs was quantified using the BCA 
Protein Assay Kit (Pierce) according to the manufacturer’s instructions. The assay is based on 
the reduction of Cu
2+
 by proteins in alkaline solution combined with the colorimetric 
detection of resulting Cu
+
 ions by chelation with bicinchoninic acid (BCA). The enhanced 
protocol with a reaction temperature of 60 °C was used allowing the detection of protein in 
the range of 5–250 µg/ml. The absorbance of Cu+/BCA was measured at 562 nm using the 
UV-Vis spectrophotometer UV1, and the sample concentration was determined within the 
range of the standard curve obtained from BSA standards. As the addition of 2 % SDS to the 
virus preparations did not affect the results, an interfering effect of lipids was excluded [461]. 
This allowed the comparison of protein contents of different virus mutants even though they 
can potentially differ in protein-lipid ratio.  
3.2.5.2 Purification of vRNPs 
vRNPs were purified for in vitro studies from Influenza A/X-31 virus according to the 
protocol described by Babcock et al. [117]. Concentrated virus (2 mg protein, about 1 ml) was 
diluted with 5 ml PBS and pelleted for 40 min at 41,100 rpm and 4 °C (rotor 70.1 Ti, 
Beckman Coulter). The pellet was thoroughly resuspended in 2 ml pre-warmed lysis buffer 
and incubated for 35 min at 31 °C. Glycerol gradients were formed with 7 ml 70 %, 0.75 ml 
50 %, 0.375 ml 40 % and 1.8 ml 33 % (w/v) glycerol in gradient buffer. Detergent-disrupted 
virus was loaded onto the gradient and centrifuged for 4 h (190,000× g, 4 °C). Thereafter, 
300-µl fractions were collected and aliquots (4 µl) were analyzed by SDS-PAGE with 
subsequent silver staining or Western blotting. The vRNP containing fractions were identified 
by the presence of NP and pooled. They were diluted with 5 ml resuspension buffer and 
centrifuged at 190,000× g and 4 °C for 2 h. Then, the supernatant was carefully removed and 
the pellet was resuspended in 100 µl resuspension buffer and stored at –20 °C.  
For removal of contaminating M1 protein prior to flotation assay (3.2.5.5), the vRNP 
preparation was filtrated with a molecular weight cut-off of 50 kDa using Amicon Ultra-15 
centrifugational filters. To retain M1, the filtration molecular weight cut-off was 10 kDa. 
Filtration was performed by diluting the sample four times in 10 ml resuspension buffer and 
centrifugation at 4000× g to a final volume of 200 µl. Finally, the sample was analyzed by 
SDS-PAGE (3.2.5.6) and stored at –20 °C. 
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3.2.5.3 Spectrofluorometric analysis of vRNPs by nucleic acids stains 
The presence of RNA in purified vRNPs  was probed with two different nucleic acid stains, 
the intercalating propidium iodide (PI) and the electrostatically interacting acridine orange 
(AO). Measurements were performed in 200 µl flotation buffer using a quartz microcuvette 
and an AMINCO-Bowman Series 2 spectrofluorometer. PI emission and excitation spectra 
were recorded by excitation at 535 nm and fluorescence detection at 607 nm, respectively. 
Pure buffer spectra were measured before addition of 1.5 µM PI and recording of the PI 
spectrum in buffer. Finally, 5 µl of purified vRNPs (1/20 of a preparation from 2 mg virus 
protein) (3.2.5.2) were added and the spectra were again recorded with the same settings. 
Difference spectra were computed.  AO was used at 20 nM and excited at 460 nm. The 
excitation maximum of RNA-bound AO is at 460 nm, but it is also an appropriate wavelength 
for excitation of free or intercalated AO.  The fluorescence emission spectrum was recorded 
between 500 and 700 nm and was checked for an emission peak at 650 nm which is 
characteristic RNA-bound AO. AO was measured in solution and after successive addition of 
6 and 3 µl of vRNP preparation. 
3.2.5.4 Preparation of large unilamellar vesicles (LUVs) 
LUVs were prepared with different lipid compositions. Lipid stock solutions in chloroform, 
stored at –20 °C, were mixed at the desired molar ratios to a total amount of 2 µmol. Further, 
0.5 or 1 mol% of the fluorescent lipid analogue N-NBD-DPPE (1,2-dipalmitoyl-sn-glycero-3-
phosphoethanol-amine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) was added and the solvent was 
evaporated under a stream of nitrogen while rotating the round-bottom glass tube to obtain a 
thin lipid film. Lipids were then pre-dissolved in 5 µl of ethanol and subsequently hydrated 
with 1 ml of flotation buffer yielding a 2 mM lipid suspension. Vigorous vortexing was 
applied for 3 min to accomplish the formation of multilamellar vesicles, followed by five 
freeze-thaw cycles. Finally, to obtain unilamellar vesicles of the desired mean size  [462], the 
suspension was extruded 10 times through a polycarbonate membrane filter with a pore size 
of 100 nm using a mini extruder with compressed nitrogen to apply the required pressure. The 
temperature was kept above the phase separation temperature of the lipid mixture which was 
commonly at RT, but raised to 55 °C when cholesterol (Chol) and sphingomyelin (SM) were 
contained. LUVs were stored at 4 °C and used within one week. 
Assuming that the different lipids were equally solubilized, the fluorescence intensity of N-
NBD-DPPE in each liposome preparation was determined by fluorescence spectroscopy and 
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used as a measure of lipid concentration to apply comparable amounts of lipids in the 
flotation assay. NBD was excited at 468 nm and emission was detected at 536 nm 
(FluoroMax-4, Horiba Yobin Yvon).   
3.2.5.5 Flotation assay 
The flotation assay allows characterizing the membrane-binding ability of proteins in vitro 
[463]. The assay is based on the separation of liposomes and soluble proteins according to 
their densities. Liposome-bound proteins partition into lower density fractions of a density 
gradient than proteins alone. The proteins or protein complexes of interest (e.g. vRNPs, M1, 
NP or the control protein PDC-109) were mixed with 100 µl of liposomes  in a total volume 
of 150 µl. Liposomes were prepared with an initial concentration of 2 mM lipid (see 3.2.5.4). 
For each experiment comparing different liposome preparations, the lipid concentrations of 
the samples were adjusted as described in 3.2.5.4.  Protein concentrations were applied as 
follows: 12 µM PDC-109, 1.5 µM recombinant NP, 1.5 µM recombinant M1 or 0.5 µM 
recombinant M1, if mixed with vRNPs. For vRNPs, 1/8 of a vRNP preparation made from 
2 mg/ml virus was used for each flotation (about 2.5 µg protein). Incubation times of proteins 
and LUVs prior to flotation were as follows: recombinant M1 and NP for 5 min on ice, vRNP 
and vRNP/M1 for 30 min on ice and in case of a two-step incubation, recombinant M1 or 
vRNPs with LUVs for 15 min on ice prior to addition of vRNPs or M1, respectively. For 
PDC-109, an incubation period with liposomes was not necessary. The protein-liposome 
mixture was then adjusted to 30 % (w/v) sucrose by addition of 100 µl of a 75 % (w/v) 
sucrose solution in flotation buffer. The gradient was formed by layering 200 µl of 25 % (w/v) 
sucrose solution and 50 µl of flotation buffer on top of the high-density fraction. 
Centrifugation was performed for 1 h at 4 °C in a TL-100 tabletop ultracentrifuge at 
240,000× g. Subsequently, fractions of 80 µl, 200 µl and 200 µl were collected manually from 
the top to the bottom. Collection of fractions was done under UV light to visualize the 
fluorescently labeled liposomes. To test for protein adsorption to the centrifugation tube, the 
tube was rinsed with 50 µl of prewarmed SDS sample buffer which was collected for further 
analysis. 20 µl of each fraction (named ‘0 %’, ’25 %’, ’30 %’ and ‘T’ for tube) were analyzed 
by SDS-PAGE. 
3.2.5.6 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
By SDS-PAGE, proteins were separated according to their electrophoretic mobility which is, 
due to the stoichiometric binding of anionic sodium dodecyl sulfate (SDS), principally based 
MATERIAL AND METHODS  
85 
 
on the molecular weight (MW) of the proteins [464]. Discontinuous polyacrylamide gels  
[465] were prepared using the equipment of the Mini-PROTEAN 3 system (Bio-Rad). 
Composition of buffers and gels are specified in section 3.1.3. Resolving gels of 10 or 12 % 
acrylamide/bisacrylamide at pH 8.8 were casted and overlaid with a 5 % stacking gel of 
pH 6.8. Samples were incubated with SDS sample buffer at 98 °C for 5 min and loaded onto 
the gel. To analyze tetracysteine-tagged proteins labeled with FlAsH or ReAsH, non-reducing 
sample buffer was used and incubation temperature was reduced to 70 °C. Electrophoresis 
was run at constant voltage of 120 V (stacking gel) and then raised to 180 V in the resolving 
gel. For detection of the proteins after electrophoresis, the gel was processed by silver 
staining, Coomassie staining or Western blotting (see 3.2.5.8, 3.2.5.7 and 3.2.5.9). 
Fluorescently labeled proteins were directly detected with the Fluorescent Image Analyzer 
FLA-3000 (FujiFilm) by scanning the gel at 473 nm and 532 nm for excitation of FlAsH and 
ReAsH, respectively. This was usually followed by Western blotting or Coomassie staining.  
3.2.5.7 Coomassie staining 
For the detection of total protein in an SDS polyacrylamide gel, the gel was incubated for at 
least 2 h in Coomassie staining solution followed by incubation with destaining solution until 
the background was sufficiently removed. The detection limit is about 0.1 µg of protein per 
spot. The result was recorded at 700 nm with the Odyssey Infrared Imaging System (LI-
COR). 
3.2.5.8 Silver staining 
Silver staining is one of the most sensitive techniques for the visualization of total protein in a 
polyacrylamide gel with a detection limit of a few nanogrammes per band. All solutions were 
freshly prepared and incubation steps were carried out under constant agitation at RT. After 
electrophoresis the gel was fixed for at least 30 min in 30 % (v/v) ethanol and 10 % (v/v) 
acetic acid followed by incubation with sensitizer solution for 30 min and three extensive 
10 min washing steps with ultrapure water. Subsequently, the staining solution with 0.1 % 
(w/v) silver nitrate was added for 30 min allowing the Ag
+ 
ions to form non-stoichiometric 
complexes with the proteins. Excess Ag
+
 ions were removed by washing with water for 30 s, 
and the Ag
+
 ions that were complexed by proteins were then reduced to elemental silver by 
the developer solution, which was incubated with the gel until the protein bands became 
clearly visible. The reaction was terminated by addition of the stop solution (0.05 M EDTA).   
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3.2.5.9 Western blotting 
Western blotting was performed after electrophoretic separation of proteins (0) to identify 
specific protein bands by antibody recognition. To this end, the proteins were transferred 
(‘blotted’) from the gel onto a nitrocellulose membrane. Subsequent to SDS-PAGE, the gel 
was placed onto the membrane which was soaked in transfer buffer and together they were 
squeezed between two thick blotting papers also soaked in transfer buffer. An electric field 
was applied perpendicular to the stack with 20 V for 30 min using a Trans-Blot Semi-Dry 
Transfer Cell (Bio-Rad). The efficiency of the transfer was verified by use of a prestained 
molecular weight marker that had previously been loaded onto the gel for SDS-PAGE. Since 
the membrane unspecifically binds all proteins, it was blocked after the transfer to prevent 
unspecific binding of antibodies. Blocking was done by incubating the membrane for 1 h with 
milk solution or Odyssey Blocking Buffer (LI-COR) depending on the detection method. For 
chemiluminescence detection with horseradish peroxidase (HRP)-linked antibodies, milk was 
used as blocking reagent, whereas the Odyssey Blocking Buffer was used with near infrared 
dye (IRDye)-labeled antibodies. The membrane was gently agitated during all incubation 
steps. Antibodies were diluted in the respective blocking buffer with up to 0.5 % (v/v) Tween-
20. Primary antibodies were typically used 1:3,000 and secondary antibodies 1:10,000. The 
primary antibody which is specific for the protein of interested was incubated with the blot for 
1 h at RT or at 4°C overnight, followed by three times washing for 10 min with PBS-T and 
incubation with the secondary antibody for 1 h. Finally, the membrane was washed as before 
and rinsed twice with PBS. If the secondary antibody was linked to a HRP for 
chemiluminescence detection, the blot was treated with the ECL Detection Kit (Amersham) 
and the light signal produced by a HRP-mediated reaction was captured on a photographic 
film. Secondary antibodies labeled with an IRDye were detected with the LI-COR Odyssey 
scanner by excitation at 700 nm. 
3.2.5.10 PIP strip lipid-binding specificity assay 
Lipid-binding capacity and specificity of purified Influenza virus RNPs and M1 in vitro was 
tested on PIP Strips (Echelon). PIP Strips
 
are hydrophobic membranes spotted with eight 
different phosphoinositides and seven other biologically relevant lipids. The membrane was 
blocked with 3 % (w/v) fatty acid free BSA in TBS for 1 h at RT and was subsequently 
incubated with vRNP-M1 preparations purified from virus particles (0) and diluted in 4 ml 
blocking buffer. After 1 h at RT the membrane was washed three times with TBS-T for 10 min 
and incubated with primary anti-M1 (Virostat) or anti-NP antibodies (1:1000 in blocking 
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buffer) for 1 h at RT. The membrane was washed as before followed by incubation with 
secondary HRP-linked antibodies (1:5000 in blocking buffer) for another hour. Finally, the 
membrane was washed three times for 10 min in TBS-T and treated with the ECL detection 
reagent (Amersham) for 5 min. The chemiluminescence signal of the HRP-mediated reaction 
was detected on a photographic film. 
To reduce unspecific background of NP immunodetection with anti-NP and GAMPO 
antibodies, the same protocol was also carried out replacing BSA blocking buffer by 1 % milk 
in TBS. Results were not affected by the change of blocking reagent. 
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4 Results 
4.1 In vitro studies of Influenza A virus ribonucleoprotein 
interactions with lipid membranes  
Association of Influenza A viral ribonucleoproteins (vRNPs) with the viral envelope is crucial 
for the formation of progeny virus particles. In the first part of this study, the intrinsic ability 
of vRNPs to interact with lipid membranes was analyzed, and the capacity of the matrix 
protein M1 to mediate membrane association of vRNPs was investigated using an in vitro 
approach with model membranes, purified M1 and vRNPs. 
4.1.1 Purification of Influenza A/X-31 vRNPs 
For in vitro analysis, intact vRNP complexes had to be purified from virus particles. 
Detergent-disrupted Influenza A/X-31 virus was fractionated by density gradient 
centrifugation according to Babcock et al. [117], and the protein content of each fraction was 
analyzed by SDS-PAGE and silver staining (Fig. 8). The major protein bands visualized by 
silver staining were also detectable by anti-Influenza A virus H3N2 polyclonal antibody in 
Western blot analysis (data not shown). In addition to the viral proteins, small amounts of the 
cellular protein β-actin were identified by Western blotting and shown to be present 
exclusively in the low-density membrane fractions of the gradient (Fig. 8A). β-actin was 
further found in virus that had been purified by sucrose gradient Fig. 8G) indicating that the 
presence of membrane-bound β-actin is not an external contamination of the virus 
preparation. 
The vRNP complexes were expected to partition into high-density fractions and to be 
detectable by the presence of NP as the major protein component of vRNPs. Two protein 
bands were observed in fractions of higher density, typically in fractions 12 to 19 (Fig. 8A); 
these could be identified as NP (56 kDa) and as matrix protein M1 (27 kDa) by Western blot 
analysis (Fig. 8B, D, E). Additionally, a faint protein band of about 80 kDa indicates the 
presence of the viral polymerase subunits as part of intact vRNP complexes in these fractions 
(PA 82.6 kDa; PB1 86.6 kDa; PB2 86.1 kDa). The presence of the matrix protein M1 in the 
same fractions was however unexpected based on the protocol described by Babcock et al. 
[117]. Western blot analysis showed that M1 could be found in all fractions (Fig. 8B). To 
obtain purified vRNPs in the presence of M1, fractions which were clearly devoid of other 
proteins (typically fractions 14 to 17) were pooled and concentrated. The protein content was 
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then again verified by SDS-PAGE (Fig. 8C) and immunodetection of NP and M1 (Fig. 8D, E). 
If the resolution of  protein bands in the gel was high, NP was resolved as a double band (Fig. 
8C, F) which is known to be due to the differential phosphorylation states of NP [364].  
For the following experiments, vRNPs were prepared in the presence or in the absence of M1. 
Therefore, isolated vRNPs were filtrated with a molecular weight cut-off of 10 kDa to 
maintain M1 (in the following referred to as “vRNP/M1”) and with a cut-off of 50 kDa to 
remove M1 (Fig. 8F). A small fraction of residual M1 was usually retained in the sample after 
filtration with 50 kDa cut-off, even when the number of washing steps was increased 
indicating an association of M1 with larger vRNP complexes or oligomerisation of M1. 
Acidification of the complexes for dissociation of M1 was avoided to prevent conformational 
changes. Such changes usually prime vRNPs during cell entry by endocytosis [29,279,466], 
but might also mark them as incoming vRNPs and affect properties required for transport and 
assembly. A difference between newly formed progeny vRNPs and acidified incoming vRNPs 
has not been reported yet, but cannot be excluded.  
To verify that the purified proteins were indeed part of intact RNA-containing RNP 
complexes, the samples were further analyzed by electron microscopy (performed by Kai 
Ludwig, Freie Universität Berlin) and by fluorescence spectroscopy with RNA-binding dyes. 
Electron micrographs of isolated vRNP/M1 preparations (Fig. 9) showed elongated and 
flexibly curved structures in the range of 100 nm in length strongly resembling vRNP 
structures that had been previously reported [52,82]. The textured, heterogeneous background 
of the images might have been caused by the presence of the M1 protein, but this remains 
unproved. Clustering of vRNP segments was not observed. As it had been reported that NP 
can form large polymeric structures resembling vRNPs even in the absence of RNA [334], 
and as RNP-bound vRNA is sensitive to RNAse [94,95], the presence of RNA in purified 
complexes was additionally verified by propidium iodide (PI) and acridine orange (AO) 
fluorescence spectroscopy (Fig. 10). PI is an intercalating nucleic acid dye that undergoes 
substantial spectral changes upon binding to single-stranded (ss) or double-stranded (ds) 
nucleic acids [467,468,469]. This allows specific detection of RNA and DNA. Compared to 
free PI in buffer, nucleic acid-bound PI exhibits a bathochromic shift of the excitation 
spectrum to longer wavelengths and a hypsochromic shift of the fluorescence emission to 
shorter wavelengths. To analyze the RNA content of vRNP preparations, excitation and 
emission spectra were measured for 1.5 µM PI in the presence and absence of 5 µl of a 
vRNP/M1 preparation (1/20 of one preparation, corresponding to about 1 µg protein). 
Difference spectra were calculated (Fig. 10A). The pure buffer spectra were subtracted from 
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the PI spectra in buffer to obtain those spectral components that are caused by free PI in an 
aqueous buffered environment (PI-buffer spectra). Further, the spectra of PI in buffer were 
subtracted from PI spectra in the presence of vRNP/M1 giving those spectral components that 
result from the interaction of PI with the vRNP/M1 sample (PI-vRNP spectra). The vRNP/M1 
sample itself was non-fluorescent in the analyzed range. A clear shift of PI excitation and
 
Fig. 8: Purification of Influenza vRNPs. Detergent-disrupted Influenza A/X-31 virus was fractionated by density 
gradient centrifugation in a glycerol gradient. (A) Fractions were analyzed by SDS-PAGE and subsequent silver 
staining. Membrane proteins can predominantly be found in low density fractions 3 to 11. A protein around 
40 kDa of non-viral origin could be identified as β-actin by Western blotting and was exclusively present in low 
density membrane fractions. Fractions 12 to 19 typically contained NP (56 kDa) and the matrix protein M1 
(27 kDa). (B) M1 was identified by Western blotting in all fractions throughout the gradient. (C–E) Higher 
density fractions supposed to contain vRNPs and showing exclusively NP and M1 signals were pooled, washed 
and analyzed by SDS-PAGE. The two proteins were detected by silver staining (C) and specifically probed by 
Western blotting with anti-NP (D) and anti-M1 (Virostat) (E) antibodies and HRP-coupled detection. (F) Pooled 
vRNP fractions were filtrated with a molecular weight cut-off of 10 or 50 kDa and proteins were detected by 
SDS-PAGE and silver staining showing removal of most of M1 (arrow) by cut-off 50. (G) Intact virions purified by 
sucrose gradient were analyzed for the presence of β-actin by Western blotting. 
RESULTS 
92 
 
emission spectra upon addition of the vRNP/M1 preparation was observed which is 
characteristic for the binding of PI to nucleic acids and which demonstrates the presence of 
nucleic acids within the vRNP/M1 isolates from Influenza A virus. The excitation maximum 
of PI in buffer was about 480 nm compared to 530 nm in the presence of the vRNP/M1 
preparation. The maximum of fluorescence emission shifted from about 632 nm to 615 nm 
upon interaction with the vRNP/M1 sample and the fluorescence intensity increased. To 
further confirm that the nucleic acid that had been detected by PI fluorescence was single-
stranded and complexed by proteins, a second nucleic acid dye was used. AO in contrast to PI 
intercalates only into ds DNA or RNA and binds to ss nucleic acids by electrostatic interaction 
with the phosphate backbone [470,471]. These binding modes can be differentiated by their 
characteristic orthochromatic and metachromatic fluorescence spectra. When intercalated into 
DNA, AO emits green fluorescence at 525 nm. In a complex with RNA, red fluorescence is 
detectable with an emission maximum at 650 nm. The fluorescence spectra of AO were 
measured before and after addition of purified vRNP/M1 (Fig. 10B). An increase of 
fluorescence emission at 650 nm, which is characteristic for electrostatic complex formation 
of AO with ss RNA, was not detectable, although the amount of added vRNP/M1 preparation 
was comparable to the amount used to monitor PI spectral changes. An increase of 
fluorescence intensity at 525 nm indicating intercalation of AO into ds DNA was not observed 
either. Instead, fluorescence intensity at 525 nm decreased due to dilution. Obviously, the 
nucleic acids that could be detected by PI were undetectable by AO. These results allow the 
interpretation that the shifts of PI spectra were caused by PI intercalation into ss nucleic acids, 
a binding mode that is not suitable for detection by AO, and that the phosphate backbone of 
the ss nucleic acids is inaccessible for electrostatic interactions with AO. This is consistent 
with our knowledge about the vRNP structure where ss vRNA is bound to the NP scaffold by 
electrostatic interactions via the RNA phosphate backbone [87,93].  
In summary, the results of SDS-PAGE analysis, electron microscopy and fluorescence 
spectroscopy confirm that intact vRNPs of appropriate size consisting of NP, vRNA and 
polymerases were successfully purified from Influenza A/X-31 virus particles. 
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Fig. 9: Negative stain electron micrographs of Influenza vRNPs purified from detergent-disrupted Influenza 
A/X-31 virus. Uranyl acetate was used as contrast agent. Sample processing for transmission electron 
microscopy (TEM) and image acquisition were performed by Kai Ludwig (Freie Universität, Berlin). 
 
 
Fig. 10: Spectrofluorometric analysis of purified vRNP/M1 with nucleic acid dyes propidium iodide (PI) and 
acridine orange (AO). (A) Difference spectra of PI. Fluorescence emission and excitation spectra of 1.5 µM PI in 
buffer were recorded. Difference spectra were formed by subtracting pure buffer spectra from PI spectra in 
buffer (blue, black). The same measurement was repeated after addition of 5 µl purified vRNPs/M1 and 
difference spectra were calculated by subtraction of PI spectra in buffer (light red, dark red). Additional spectral 
components of PI in the presence of vRNP/M1 result from interactions of PI with the vRNP sample. The 
vRNP/M1 sample itself is non-fluorescent (not shown). Arrows indicate the red shift and the blue shift of 
excitation and emission spectra, respectively, upon interaction of PI with the vRNP/M1 sample. (B) Fluorescence 
spectra of 20 nM AO were recorded in buffer and after addition of purified vRNPs. The fluorescence signal 
decreased (due to dilution). An additional emission peak at 650 nm, which is characteristic for electrostatic 
interaction of AO with RNA, was not observed.  
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4.1.2 Analysis of vRNP binding to membranes by flotation assay with 
liposomes 
To study the ability of the vRNP segments to associate with pure lipid bilayers, the purified 
viral complexes from Influenza A/X-31 virus were analyzed by flotation assay with large 
unilamellar vesicles (LUVs) of various lipid compositions. Instead of pelletizing the 
liposomes, flotation was chosen as experimental approach to obtain a clear separation of 
membrane-bound floating protein complexes from protein aggregates and proteins that 
adsorbed to the test tube. Protein adsorption to the tube was found to be a major problem in 
preliminary tests, particularly in the presence of M1 (see also Fig. 12C, D). LUVs were 
prepared according to a well-established method by extrusion through polycarbonate filters of 
100 nm pore size [462]. To mimic typical features of cellular membranes and analyze 
potential requirements for vRNP interaction with membranes, LUVs of various lipid 
compositions were produced and tested for the association of purified proteins. Due to 
variable loss of lipid during LUV generation caused by incomplete dissolution or adsorption 
to the filter membrane, the lipid concentration of different LUV preparations had to be 
adjusted for comparability after extrusion. Therefore, the fluorescence signal (being 
proportional to the concentration) of the lipid analogue N-NBD-DPPE in each preparation 
was determined and served as a measure to apply equal amounts of each liposome species for 
flotation. Differences among the preparations were typically less than 10 % and never larger 
than 20 %. For the binding assay, lipids were applied in molar excess of protein to exclude 
that protein binding is limited by the amount of available lipid. The protein to lipid ratio was 
typically chosen in the order of 1 to 1000. A schematic overview of the experimental 
procedure is given in Fig. 11A. Proteins and LUVs were mixed and separated by density 
gradient centrifugation. Liposomes (and associated proteins) partitioned to the top of the 
gradient, which could be visualized by UV-light detection of N-NBD-DPPE fluorescence. 
Collected fractions were analyzed by SDS-PAGE which conveniently allowed detection of the 
NBD-labeled lipid in the gel by fluorescence detection in parallel to the standard protein 
detection by silver staining.  
For evaluation of the method, a positive control experiment (Fig. 11B) was performed using 
PDC-109, a seminal plasma protein that is known to specifically bind to choline lipid 
headgroups [472,473]. LUVs made from pure 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) were mixed with PDC-109 at molar protein/lipid ratios from 1/10 to 1/80. PDC-109 
purified from the seminal plasma of Holstein bulls as described in [474] was kindly provided 
by Peter Müller (Humboldt-Universität, Berlin). In the absence of liposomes, flotation of 
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PDC-109 was not observed. An increasing amount of floating, membrane-bound PDC-109 
could be detected with increasing lipid concentration (Fig. 11B). At a protein/lipid ratio of 
1/40, the entire protein was found in the two liposome-containing top fractions (0 % and 25 % 
sucrose), whereas at a ratio of 1/20, part of the protein remained in the pellet fraction (30 % 
sucrose). Considering that only half of the lipid is exposed on the outer leaflet of the 
liposomal bilayer, the results are consistent with a binding stoichiometry of 10–20 lipids per 
protein that had been described before [475].  
 
Fig. 11: Membrane-binding analysis by liposome flotation assay. (A) Schematic representation of the flotation 
assay procedure. The presence of large unilamellar vesicles (LUVs) containing a fluorescent NBD-lipid is 
represented by yellow color. (B–D) Sucrose gradient fractions from flotation assay were analyzed - after 
ultracentrifugation - by SDS-PAGE and subsequent silver staining. The fluorescent NBD-lipid was detected in the 
SDS-gel by Fluorescence Image Analyzer. Lipids were predominantly present in the low-density fractions (0 % 
(w/v) sucrose). Collected fractions are designated according to their sucrose concentration, 0 %, 25 %, 30 % 
(w/v) sucrose (B) Positive control for flotation with the seminal plasma protein PDC-109. PDC-109 binds 
specifically to the choline lipid headgroup and was analyzed with DOPC LUVs at various molar protein to lipid 
ratios. (C) Flotation of vRNPs purified from Influenza A/X-31 virus and separated from M1 by filtration (cut-off 
50 kDa). vRNPs were incubated with LUVs of different compositions for 30 min on ice prior to flotation. LUVs 
were prepared from DOPC, DOPC/DOPS/DOPE (8/1/1), DOPC/DOPS (8/2), DOPC/Chol/SM (5/2.5/2.5) or total 
brain lipid extract. Flotation of DOPC/DOPS was performed in the presence of 1 mM CaCl2. (D) Flotation of 
recombinant NP with LUVs made from DOPC, DOPC/DOPS (8/2), DOPC/Chol/SM (5/2.5/2.5) and brain lipid. NP 
was incubated with LUVs for 5 min prior to flotation. His-tag purified recombinant NP from Influenza A/FPV was 
kindly provided by Nadine Jungnick (Humboldt-Universität, Berlin). 
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The same experiment was performed with purified vRNPs (devoid of M1 protein) from 
Influenza A/X-31 virus (Fig. 11C). LUVs were incubated with vRNP complexes for 30 min 
before flotation. A variety of different lipid compositions was analyzed. First, liposomes made 
of pure DOPC were chosen because unsaturated phosphatidylcholines represent a major 
constitutent of cellular membranes [412]. Further, DOPC was mixed with dioleoyl-
phosphatidylserine (DOPS) and dioleoyl-phosphatidylethanolamine (DOPE) (8/1/1), which 
both represent phospholipids that characteristically locate on the inner leaflet of cellular 
plasma membranes [389], the site of Influenza virus assembly. As Influenza vRNPs are 
negatively charged complexes, a beneficial role of divalent Ca
2+
 ions for association with 
negatively charged DOPC/DOPS (8/2) LUVs was also tested. Taking into consideration that 
the Influenza viral envelope is specifically enriched in raft lipids like sphingomyelin (SM) 
and cholesterol (Chol) [16,234] and that membrane rafts have for a long time been assumed to 
be locations of virus assembly, a lipid raft mixture consisting of DOPC/SM/Chol (5/2.5/2.5) 
was prepared for analysis. Finally, vRNP binding was investigated with LUVs prepared from 
total brain lipid extract. This endogenous lipid mixture allowed to cover a broad range of 
natural lipid diversity and to include also specialized, minor lipid species like 
phosphoinositides. Representative results of vRNP flotation with the different types of LUVs 
are shown in Fig. 11C. Association of vRNPs with liposomes could not be detected for any of 
the lipid compositions. NP as representative component of vRNPs was entirely found in the 
pellet fractions (30 %). Recovery of the liposomes in the two floating fractions (0 % and 
25 %) was verified by the NBD-lipid fluorescence signal in the SDS-gel.  
In addition to the results from flotation analysis, it was not possible to observe purified 
vRNPs bound to lipid membranes of giant unilamellar vesicles (GUVs) using fluorescence 
microscopy (data not shown). 
As reports have indicated accumulation of NP at the apical membrane of polarized cells in the 
absence of other viral components [299], membrane-binding was also investigated for NP 
alone. His-tag purified recombinant Influenza A/FPV virus NP was kindly provided by Carina 
Glöckner and Nadine Jungnick (Humboldt-Universität, Berlin). Results are shown in Fig. 
11D. NP did not associate with pure DOPC LUVs. Although apical accumulation of NP in 
transfected cells had previously been suggested to be lipid raft-dependent [299], direct 
binding of NP to a classical lipid raft mixture could not be observed either. However, a 
fraction of NP was found to associate with DOPC/DOPS LUVs and with liposomes made 
from total brain lipid extract. Both types of LUVs shared the presence of negatively charged 
lipids. DOPC/DOPS LUVs contained 20 % DOPS. The total brain lipid extract comprised 
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11 % DOPS, but also other negatively charged lipids like phosphatidic acid and 
phosphtidylinositol. As NP is known to be a basic protein with a net positive charge of +14 at 
pH 6.5 [327], binding to negatively charged liposomes was expected. Such association was 
not observed for NP being part of the vRNP complexes (Fig. 11C), when NP is 
electrostatically bound to vRNA and its basic residues are thus neutralized. This indicates that 
NP binding to DOPC/DOPS and brain lipid LUVs competes with RNA binding and is 
presumably of electrostatic nature. As the observed membrane association of NP is apparently 
not functionally relevant for vRNP complexes, the NP interaction with negatively charged 
liposomes was not further investigated. Nevertheless, this finding might reflect a property of 
NP that can potentially contribute to the subcellular targeting of NP when expressed alone. 
Negative surface charges of cellular membranes have been reported to contribute to the 
subcellular localization of proteins with polybasic clusters directing strongly cationic proteins 
like NP to the plasma membrane [286]. Even though this does not fully explain a lipid-raft 
dependent targeting of NP to the apical plasma membrane as suggested by Carrasco et al. 
[299], co-segregation of negatively charged PS with sphingolipid and cholesterol-enriched 
liquid-ordered membrane domains as described by Fairn et al. [476] might offer an 
explanation for lipid raft-dependent behavior of NP. 
After intrinsic membrane binding of vRNPs and NP could not be demonstrated in vitro, the 
capacity of M1 to mediate membrane association of vRNPs was examined. A key role of M1 
for assembly and simultaneous cross-linking of the different viral components has been 
suggested for a long time [20,34,41,50], but a direct role in mediating association between 
vRNPs and membranes has not been demonstrated yet. Preparations of purified vRNP/M1 
were analyzed by flotation with liposomes made of DOPC, DOPC/DOPS/DOPE, raft lipids 
(DOPC/SM/Chol) or total brain lipid extract (Fig. 12). In the absence of LUVs, vRNPs 
(detected by NP) and M1 remained entirely in the pellet fraction, whereas upon flotation with 
negatively charged LUVs, a small but distinct fraction of M1 together with vRNPs partitioned 
into the liposome-containing low-density fraction (Fig. 12A; DOPC/DOPS/DOPE and brain 
lipid). In case of uncharged liposomes made of DOPC or raft lipids, trace amounts of NP 
close to background levels were sometimes detected in the floating fractions, which was 
presumably caused by contamination during fractionation. The requirement for highly 
sensitive protein detection due to low protein recovery is a drawback of this experimental 
approach and will be discussed below together with an alternative approach for improved 
detection of membrane binding. M1 had previously been reported to bind to negatively 
charged membranes [42,43,45]. For vRNPs, it has been demonstrated above (Fig. 11C) that 
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they do not possess intrinsic membrane binding properties under the selected conditions. The 
results of the combined flotation of vRNPs and M1 therefore indicate that the presence of M1 
can promote association of vRNPs with negatively charged liposomes, even though the extent 
of membrane association was rather poor (Fig. 12A). The majority of M1 and NP remained 
unbound in the pellet fractions thereby questioning the significance of the observed 
interaction of M1 and vRNPs with membranes. Inefficient binding of M1 to an excess of 
negatively charged liposomes was unexpected in comparison to efficient flotation of M1 alone 
(Fig. 12B, bottom). This indicates that M1 might cluster with the negatively charged vRNPs 
and might thereby be partially prevented from membrane binding. Indeed, in vitro clustering 
of vRNP-M1 complexes was previously visualized by electron microscopy [42] and was 
further reported for purified vRNP/M1 by Kemler et al. [85]. 
To provide more free M1 protein and to obtain a larger fraction of membrane-associated 
proteins, purified vRNP/M1 complexes were combined with additional, recombinantly 
generated M1 protein for flotation analysis. In a parallel control experiment, flotation was 
performed with recombinant M1 alone (Fig. 12B). The His-tag purified recombinant M1 was 
kindly provided by Nadine Jungnick (Humboldt-Universität, Berlin) [445]. M1 alone 
(1.5 µM) bound very efficiently to negatively charged liposomes consisting of 
DOPC/DOPS/DOPE or total brain lipid extract (Fig. 12B, bottom), i.e. the protein was 
exclusively detected in the liposome-containing floating fractions. Surprisingly, in the absence 
of liposomes and in case of M1 flotation with DOPC or raft lipid LUVs, only very faint 
signals of M1 could be detected at all. This observation suggested that, in the absence of 
negatively charged M1-binding surfaces, M1 precipitated and adsorbed to the test tube. This 
was confirmed by experiments in which protein adsorption to the test tube was analyzed by 
recovering the adsorbed protein in SDS sample buffer. The protein recovered from the test 
tube is referred to as fraction “T” in Fig. 12. It was found that M1 adsorbed almost completely 
to the test tube in the absence of liposomes and that a considerable fraction of M1 could be 
prevented from precipitation by addition of negatively charged liposomes (Fig. 12C). The 
negatively charged liposomes apparently competed with the test tube surface for M1 binding 
explaining reduced recovery of soluble protein in the absence of membrane binding. 
Incubation of M1 with vRNPs (15 min on ice) prior to flotation led to precipitation and 
adsorption of the entire protein even in the presence of negatively charged liposomes and 
inhibited M1 binding to the liposomes (Fig. 12C). This observation suggests strong 
interactions, possibly aggregation, among M1 and vRNPs and is consistent with the above- 
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Fig. 12: Membrane-binding studies of purified vRNPs in the presence of M1 (Flotation assay). Liposomes were 
prepared with the following lipid compositions: pure DOPC, DOPC/DOPS/DOPE (7/2/1), DOPC/DOPS (8/2), 
DOPC/Chol/SM (5/2.5/2.5) or total brain lipid extract. Each mixture was labeled with 0.5 mol% N-NBD-DPPE. 
Flotation was performed by sucrose density gradient centrifugation. The gradient (0 %, 25 % and 30 % (w/v) 
sucrose) was fractionated and the protein content was analyzed by SDS-PAGE and silver staining. The 
fluorescent marker lipid NBD-DPPE was detected in the SDS-gel by fluorescence imaging showing that LUVs 
were predominantly present in the low density fractions (0 % sucrose). (A) Flotation of vRNP/M1 purified from 
Influenza A/X-31 virus particles (filtration cut-off 10 kDa). (B) top: Flotation of vRNP/M1 with LUVs that were 
incubated with recombinant M1 (recM1) for 15 min prior to flotation. bottom: Flotation of recombinant M1 
alone. (C) Flotation of recombinant M1 with brain lipid LUVs in the presence and absence of vRNPs. Protein 
adsorption to the centrifugation tube was analyzed by recovering the adsorbed protein in SDS sample buffer 
(fraction “T”). M1 adsorbed almost completely to the tube in the absence of liposomes, which could be 
reduced by addition of LUVs causing partial flotation of recM1. The incubation of M1 with vRNPs for 15 min 
prior to flotation led to precipitation of all protein and prevented M1 from binding to the liposomes. (D) vRNPs 
separated from M1 by filtration (cut-off 50 kDa) were subjected to flotation with DOPC and DOPC/DOPS LUVs in 
the presence and the absence of recombinant M1. Recombinant M1 increased vRNP adsorption to the reaction 
tube, but also mediated liposome binding of a minor fraction of vRNPs to DOPC/DOPS LUVs. Experiments (B) 
and (C) were performed in collaboration with N. Jungnick (Humboldt-Universität, Berlin), who kindly provided 
the recombinant His-tagged Influenza A/FPV M1.  
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described inefficient binding of purified vRNP/M1 complexes to negatively charged 
membranes. 
Therefore, another experimental procedure was tested for combined flotation of vRNP/M1 
with recombinant M1: liposomes were provided first, mixed with recombinant M1 and 
incubated for 15 min on ice (coating). Subsequently, vRNPs were added and incubation was 
continued for another 15 min on ice. It was found that incubation of M1 with liposomes prior 
to addition of vRNPs was favorable for membrane binding of M1 and vRNPs (Fig. 12D). This 
procedure was therefore chosen for flotation analysis of vRNP/M1 in combination with 
recombinant M1. Representative results are shown in Fig. 12B (upper panel). This experiment 
clearly reproduced the results obtained by flotation of purified vRNP/M1 (Fig. 12A) 
indicating M1-mediated association of vRNPs to negatively charged liposomes. However, a 
substantial improvement of protein detection and membrane association was not achieved. On 
the contrary, the total amount of detectable protein appeared to be reduced. Notably, the more 
recombinant M1 was added, the less protein was detectable suggesting protein precipitation. 
Best results were obtained with 0.5 µM recombinant M1 as presented in Fig. 12B. For 
negatively charged liposomes made of DOPC/DOPS/DOPE or brain lipid extract, the viral 
M1 as well as the slightly larger His-tagged recombinant M1 associated with the liposome-
containing fractions, whereas in the absence of liposomes or in the presence of uncharged 
liposomes, M1 remained in the bottom fraction. In the latter case, the detection of M1 was 
weak. For NP, the signals showed a clear correlation with the behaviour of M1. A prominent 
fraction of vRNPs associated with the liposome fractions of the negatively charged LUV 
species together with M1, and like for M1, membrane association was not observed upon 
flotation with DOPC or raft lipid LUVs. Unbound vRNPs were instead detected in the pellet 
fraction of these samples. 
Taken together, the above-described results are reproducible and consistent with previous 
reports on M1-binding to negatively charged lipid membranes [45], but they provide beyond 
that evidence for the capacity of M1 to mediate association of vRNPs with pure lipid 
membranes. The effect of M1 on vRNP membrane-binding independently from other viral or 
cellular factors could be demonstrated in this in vitro assay. However, the presence of vRNPs, 
on the other hand, seemed to interfere with M1 membrane-binding and enhance precipitation. 
Extensive precipitation appears to be the major limitation of this in vitro method for studying 
vRNP and M1 membrane binding. Due to this experimental artifact, low signal detection 
should therefore not be interpreted as insignificance or inefficiency of the observed 
interaction, but as a methodological restriction. However, high affinity binding of vRNP-M1 
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complexes to negatively charged membranes cannot be concluded either. A quantitative 
evaluation is not possible. Nevertheless, the data suggests that M1 can simultaneously bind to 
lipid membranes and vRNP complexes and that vRNPs can acquire membrane association due 
to the presence of M1.  
4.1.3 Probing lipid binding specificity of purified Influenza virus vRNPs and 
M1 protein with phosphoinositides  
Major lipid constituents of cellular membranes were included in the membrane binding 
studies of vRNPs and M1 by flotation assay (section 4.1.2) for probing characteristic features 
of membranes that can serve for protein recognition, e.g. electrostatic properties, fluidity, lipid 
packing and lipid headgroups. Cellular membranes consist, however, of hundreds of different 
lipid species, some of which are only marginally present and serve as regulatory factors in cell 
physiology and in signaling pathways. An important group herein are the phosphoinositides, 
reversibly phosphorylated forms of phosphatidylinositol (PtdIns) carrying phosphate groups 
at position 3, 4 and/or 5 of the inositol ring. Besides functions in signaling processes, they act 
as constitutive signals for regulation of membrane trafficking, cytoskeleton remodeling, 
membrane permeability and definition of organelle identity [477], which makes them an 
attractive target for viral proteins to exploit or interfere with cellular machinery.  
Commercially available PIP-strips, lipid-spotted membranes, offer the possibility to test 
specific recognition of phosphoinositides by purified vRNP/M1 preparations from Influenza 
A/X-31 virus. Besides the seven phosphoinositide species also other lipid species are 
presented for comparison (Fig. 13B). 
vRNP/M1 were purified as described in (4.1.1), and the protein content of the sample was 
verified by SDS-PAGE (Fig. 13A). The preparation was then incubated with the PIP-strip 
membrane and analyzed by immunodetection with anti-M1 and anti-NP antibodies (Fig. 13B 
and D). The results were reproduced in two independent experiments.  
For M1, the strongest binding and most prominent signal was detected with PtdIns(4)P. This 
interaction seems to represent a highly specific recognition as M1 displayed a clear preference 
for PtdIns(4)P compared to the very closely related PtdIns(3)P and PtdIns(5)P. In this context, 
electrostatic interactions seem to play a minor role considering that the more negatively 
charged bis- and trisphosphates could not recruit M1 more efficiently than PtdIns(4)P. M1 was 
found to associate to a minor degree with the other six phosphoinositides and phosphatidic 
acid. A very faint signal was further detected for PS. In a control experiment, it was ruled out 
that the signals were caused by unspecific antibody binding (Fig. 13C).  
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This result obtained for purified M1 from Influenza A/X-31 virus in the presence of vRNPs is 
very similar although not identical with PIP-strip analysis of M1 that was recombinantly 
generated and contained an N-terminal His-tag as described in [445]. However, both results 
agree in the central finding that M1 specifically and most strongly bound to PtdIns(4)P. 
When turning to the other lipid species presented on the PIP-strip which displayed lower or 
no M1 signal, it was remarkable that a pronounced association of M1 with PS could not be 
observed (Fig. 13B), even though the presence of PS clearly induced binding of M1 to 
liposomes in flotation analyses (Fig. 12B). This might be due to differential organization and 
exposure of the lipids in both systems. In liposomes, the lipid molecules form bilayers with a 
certain fluidity, whereas the organization of lipids on the PIP-strip is unknown except for the 
fact that the molecules have to be stably anchored to the support membrane. It is possible that 
either the PS headgroups are not properly exposed on the PIP-strip for M1 association or that 
the hydrophobic part of the lipid bilayer with flexible fatty acid chains plays an essential role 
for M1 association with PS-containing liposomes. The latter assumption is  supported by early 
work on M1 membrane association suggesting that M1 partially inserts into liposomal 
bilayers [43,46,47,48] or into cellular membranes [50], and by later studies showing a major 
electrostatic component of M1 membrane interactions, but not excluding a possible initial 
binding by electrostatic interactions that proceeds to a tighter association which is no longer 
purely electrostatic [45]. A contributory role of the hydrophobic lipid moiety for M1 binding 
is further supported by another observation. On the PIP-strip membrane, M1 was clearly 
detected to associate with phosphatidic acid but not with lysophosphatidic acid, although the 
two lipids differ only by the presence of one fatty acid. The headgroup and the charge of the 
molecules are the same. Differential behavior of M1 might be caused either by distinct 
exposure of the headgroups or by differences in overall structural organization including the 
fatty acid moiety. However, it has to be pointed out that the role of the hydrophobic part of a 
biological membrane for protein binding can hardly be characterized in the context of lipids 
that were spotted onto a nitrocellulose membrane. Nevertheless, differential M1 binding to 
phosphatidic acid and lysophosphatidic acid or to PS on PIP strips and to PS in liposomes 
indicates that - besides specific molecular recognition of the headgroup and simple 
electrostatic attraction - specific aspects of the lipid bilayer structure (orientation, packing, 
accessibility of fatty acids) might be crucial for M1 binding.  
In the present study, not only M1 but in particular vRNP binding to lipids was addressed. 
Therefore, simultaneous binding of vRNPs and M1 to PIP-strips was studied by NP 
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immunodetection (Fig. 13D). vRNPs were however not detected to associate with any of the 
lipid species presented on the PIP-strip. This result suggests that vRNPs do not specifically 
recognize phosphoinositide headgroups, neither can they be recruited to these lipid species by 
M1 mediated binding. The latter is in clear contrast to M1-mediated association of vRNPs to 
negatively charged liposomes that was observed by flotation analysis (Fig. 11 & Fig. 12). 
Differences might be due to the different experimental systems that are compared, but also to 
the different lipid species that are compared. Based on investigations by circular dichroism 
measurements that were performed in the group of Prof. A. Herrmann [445], M1 undergoes 
differential conformational changes upon binding to DOPS- or PtdIns(4)P-containing LUVs. 
These conformational states of M1 might differ by their ability to interact with vRNPs. 
Differential modes of membrane binding by M1 might correlate with different functions of 
M1 in the viral replication cycle. For vRNPs, it can be concluded that even though they can 
be recruited to membranes by the presence of M1, they do not inevitably associate with M1 
when the latter is bound to lipids.  
To characterize the often discussed multifunctionality of M1 and its consequences, vRNP/M1 
should be analyzed with PtdIns(4)P liposomes by flotation assay for comparison with DOPS 
liposome flotation. However, within this study, assembly is studied with focus on vRNPs and 
their fate during assembly and budding, leaving this aspect open future work. 
 
Fig. 13: Analysis of lipid specificity of vRNPs and M1 by PIP-strip immunodetection. (A) vRNP/M1 preparation 
from detergent-disrupted virus was filtrated with a molecular weight cut-off of 10 kDa and analyzed by SDS-
PAGE and silver staining. The same sample was applied in (B) and (D) for lipid binding analysis on a PIP-strip 
membrane, onto which the indicated lipids are spotted. Incubation of vRNP/M1 with the lipid-spotted 
membrane was followed by immunodetection with (B) anti-M1 (Virostat) or (D) anti-NP antibodies. (C) In a 
negative control experiment, vRNP/M1 incubation was omitted, while immunodetection was performed as in 
(B). PtdIns(3)P: phosphatidylinositol(3)phosphate; PtdIns(4)P: phosphatidylinositol(4)phosphate; PtdIns(5)P: 
phos-phatidylinositol(5)phosphate; PtdIns(3,4)P2: phosphatidylinositol-(3,4)bisphosphate; PtdIns(3,5)P2: phos-
phatidylinositol(3,5)bisphosphate; PtdIns(4,5)P2: phosphatidylinositol(4,5)bisphosphate; PtdIns(3,4,5)P3: phos-
phatidylinositol(3,4,5)tris-phosphate; PC: phosphatidylcholine; PE: phosphatidylethanolamine. 
RESULTS 
104 
 
4.2 Generation of tetracysteine-tagged recombinant Influenza 
viruses for (live-cell) studies of genomic vRNP segments 
during viral replication  
For studying Influenza virus RNPs during viral infection, an experimental system is required 
that allows live-cell imaging combined with high resolution analysis of newly formed vRNPs 
during viral assembly. As the processes of viral entry are experimentally more easily 
accessible (in vitro and in cells), they have been studied for many years and in more detail 
than the mechanisms of virus assembly. Only very recently, the transport pathway of vRNPs 
from the nucleus to the budding site was identified [280,297,298]. But still, essential aspects 
remain to be addressed for a comprehensive picture of the processes involving vRNPs during 
assembly, e.g. the location where the eight segments are assembled into a multisegmental 
complex, the question if the incorporation of vRNPs into virus particles is a rate-limiting step 
and if and how vRNPs specifically target the budzone of the preforming viral envelope. 
The following part of this work therefore deals with the development of a tool that can permit 
experimental access to these processes. Recombinant viruses were generated containing a 
genetically encoded tetracysteine (TC)-tag in the NP sequence to allow fluorescent labeling of 
vRNPs for live-cell imaging combined with high resolution analysis by correlated electron 
microscopy. Working with recombinant viruses ensures that the vRNPs assembled during 
infection are functional and replication competent complexes. Furthermore, there are no 
interfering effects due to transfection and exogenous viral protein expression. Additionally, 
specific labeling of the viral genome also in intact virus particles opens up new options for 
studying vRNPs during viral entry, e.g. fusion-dependent genome release from the 
endosomes, uptake into the nucleus and targeting of specific subnuclear sites. NP as the major 
protein component of vRNP complexes was chosen for attachment of the tag, promising 
efficient labeling and a good signal-to-noise ratio. Furthermore, NP staining of cytosolic 
progeny vRNPs in infection can be readily distinguished by their granular appearance from 
free homogenously distributed cytosolic NP. 
4.2.1 Construction of Influenza A virus NP with tetracysteine (TC)-tag insertion  
The TC-tag is a small, genetically encoded six amino acid sequence (CCPGCC) which can be 
fused to a protein of interest for site-specific labeling with biarsenical fluorescent ligands in 
living cells [459]. Biarsenical dyes such as FlAsH or ReAsH are specifically designed to 
match the spacing between the two pairs of cysteines of the peptide motif to enable the 
formation of a metal chelate complex with high affinity [457,478]. The in vitro dissociation 
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constants of TC peptides with biarsenical dyes were shown to be in the picomolar range 
[457]. The formation of four covalent bonds between the two arsenic atoms of the dye and the 
thiol groups of the peptide leads to a substantial increase of fluorescence intensity of the dye 
allowing site-specific labeling and reduced background detection [478]. 
Due to its small size (0.6 kDa), the TC-tag can not only be fused to the protein termini like the 
considerably larger, intrinsically fluorescent proteins (~27 kDa), but it can more flexibly be 
inserted within the protein sequence, for instance in loop regions [479]. This makes it a 
suitable tool to overcome limitations of Influenza reverse genetics that are imposed by the 
specific architecture of the viral genome. The TC-tag was previously successfully inserted 
into the NS1 sequence of recombinant Influenza virus [480]. The Influenza virus genome is 
characterized by terminal packaging sequences in each of the genomic segments that have to 
be maintained for efficient replication and genome incorporation [100,306]. These packaging 
signals comprise the non-coding regions as well as parts of the open reading frames at the 3′ 
and 5′ terminal ends of the vRNA (Fig. 14A). Modifications within these regions, like the 
insertion of terminal protein tags, can interfere with viral replication at the genomic level and 
affect genome incorporation even though the protein functions might not be impaired.   
Segment 5 vRNA (encoding NP) has recently been reported to play an important role for the 
genome packaging process [315] and it was further shown that 105 nucleotides (nt) of the 3′ 
end and 143 nt of the 5′ end of segment 5 vRNA are sufficient for incorporation of a reporter 
gene into virions [123]. Therefore, for insertion of the TC-tag into the NP sequence, these 
terminal vRNA regions were left unaltered and only the middle part of the NP open reading 
frame (corresponding to amino acids 61 to 458) was considered for the introduction of the tag 
(Fig. 14A).  
Various criteria further guided the choice of the positions for TC-tag insertion: Based on the 
crystal structure of NP (Fig. 14B) [93], surface loops were selected to avoid disruption of 
secondary structure elements by the helix-breaking residues proline and glycine in the tag 
sequence and to facilitate the accessibility of the tag for the dye. In the next step, surface 
loops were excluded to which specific functions had been assigned, like the flexible linker 
mediating NP oligomerization (aa 429–436), polymerase interacting residues (aa 204, 207 and 
208) or the nuclear localization signal (aa 198–216). The selection was further based on the 
mutational analysis of highly conserved residues performed by Li and coworkers [317]. 
Conserved amino acid changes in recombinant viruses classified as ‘nonviable’, ‘attenuated’ 
and ‘little attenuated’ were plotted into the NP structure (Fig. 14B; red, yellow and white  
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Fig. 14: Design of NP mutants with TC-tag insertion based on structure and sequence information. (A) 
Schematic representation of Influenza A virus segment 5 vRNA. The non-coding (dark blue) and parts of the 
coding regions (light blue) at the 3′ and 5′ ends of Influenza vRNA constitute signals that are critical for genome 
packaging into progeny virions. The size of the packaging signals is mapped according to Ozawa et al. [123]. TC-
tag insertions were introduced into the middle region of the open reading frame as indicated. (B) Crystal 
structure of an NP trimer from Influenza A/WSN virus (PDB 2IQH, [93]). The structure was edited with PyMOL. 
Conserved residues that were characterized by mutational analysis and reverse genetics [317] are highlighted 
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labels); such loops containing residues that critically affect replication were hence excluded 
for TC-tag insertion. Furthermore alignment of more than 2500 NP sequences [331] has 
revealed the presence of a few hypervariable residues in NP. Some of these hypervariable 
residues (residues 100, 101, 371, 373 and 375) are located in two NP surface loops which are 
in close proximity in the tertiary structure. Five surface loops were finally chosen for 
modification by TC-tag insertion, one of them located in the head domain of the NP structure, 
the other four in the body domain (Fig. 14B; as indicated by TC-tag positions in purple).  
To assess the effect of TC-tag insertion on NP expression and subcellular localization, 
preliminary expression experiments were performed, and efficient biarsenical labeling of each 
TC-tagged construct was tested before proceeding to recombinant virus generation. 
The TC-tag was therefore first introduced into Influenza A/FPV NP at amino acid positions 
100/101, 125/126, 247/248, 288/289 or 372/373. Insertion of the six amino acid sequence was 
performed by two-stage PCR-based mutagenesis of the NP expressing plasmid pNP (Tab. 2) 
as described in section 3.2.1.5. Resulting NP mutant constructs were designated NP-TC100, 
NP-TC125, NP-TC247, NP-TC288 and NP-TC372. An overview of all NP constructs with 
TC-tag insertion is given in Fig. 14C. 
Each construct was expressed in MDCK II cells, followed by labeling with the biarsenical dye 
FlAsH (Fig. 15A). All constructs showed distinct fluorescence signals indicating efficient 
expression and labeling of the inserted TC-tags. In contrast, control cells expressing wt NP 
showed only a background FlAsH signals confirming the specificity of FlAsH for the TC-tag. 
Control cells were further immunostained for NP to verify successful transfection and wt NP 
expression. Three of the TC-tagged constructs, namely NP-TC125, NP-TC288 and NP-
TC372, showed a predominantly nuclear localization of the FlAsH signal and a coarsely 
structured nuclear distribution similar to typical NP wt expression (compare with 
immunofluorescence of NP wt). NP-TC100, in contrast, showed a clearly distinct, granular 
and exclusively cytoplasmic staining indicating misfolding or incorrect targeting of the
(red, yellow, white). Surface loops with hypervariable residues (R100, D101, V371, A373, D375; [71]) were 
chosen for TC-tag insertion. The sites finally selected for introduction of the TC-tag (purple) are indicated by the 
positions of the two flanking amino acids. (C) Overview of the NP mutant constructs with TC-tag insertion 
generated within this study. (Left) TC-tag insertion into Influenza A /FPV virus NP was performed by two-stage 
PCR-based site-directed mutagenesis of pNP expression vector. (Right) TC-tag insertion into Influenza A /WSN 
virus NP was performed by two-stage PCR-based site-directed mutagenesis of plasmid pHW185-NP for reverse 
genetics. The designation of each construct indicates the amino acid position after which the TC-tag was 
inserted. 
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 construct. For NP-TC247, the subcellular localization was less clear. Therefore, NP-TC247- 
expressing cells were further subjected to immunofluorescence (IF) staining (Fig. 15B), 
which revealed diverse phenotypes of NP-TC247 expression that clearly differed from NP wt 
expression. Due to the (partial) failure to localize to the nucleus, both mutants NP-TC100 and 
NP-TC247 were considered as unsuitable for the generation of recombinant viruses and were 
hence discarded.  
 
Fig. 15: Expression and FlAsH labeling of TC-tagged NP mutants from Influenza A/FPV virus in MDCK II cells. 
(A) Cells were transfected with NP mutant constructs NP-TC100, NP-TC125, NP-TC247, NP-TC288 or NP-TC372. 
For comparison, cells were also transfected with NP wt. FlAsH labeling (green) was performed at 24 h p.t. The 
cells were then fixed and studied by confocal fluorescence microscopy. NP wt transfected cells were further 
immunostained with anti-NP and Alexa568-anti-mouse antibodies (red). FlAsH did not unspecifically label NP 
wt. Representative pictures are displayed. Constructs NP-TC125, NP-TC288 and NP-TC372 displayed the 
expected characteristic nuclear accumulation like NP wt. Due to diffuse and non-uniform FlAsH signal of NP-
TC247, this construct was additionally analyzed by IF (B). (B) NP-TC247 was expressed and the cells were fixed 
at 24 h p.t. Immunostaining was performed using anti-NP and Alexa568-anti-mouse antibodies. NP-TC247 
displayed various types of subcellular distribution. Scale bar, 10 µm. 
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For the generation of recombinant Influenza virus (strain A/WSN/1933), TC-tag insertions 
were then introduced into plasmid pHW185-NP (Tab. 5), which comprises segment 5 cDNA 
and is part of the eight plasmid system for reverse genetics of Influenza A/WSN virus 
(3.2.4.3). The tag was introduced between residues 125/126, 288/289 or 372/373 of the NP 
sequence analogously to the above-described constructs, and additionally at position 292/293, 
yielding plasmids pHW185-NP-TC125, pHW185-NP-TC288, pHW185-NP-TC292 and 
pHW185-NP-TC372. Insertion was again performed by two-stage PCR-based mutagenesis 
(3.2.1.5).  
Protein expression of the TC-tagged constructs was then analyzed in MDCK II cells by 
transfection followed by immunofluorescence for NP (Fig. 16). As before for FPV NP, the 
three constructs NP-TC125, NP-TC288 and NP-TC372 of the WSN virus strain localized 
predominantly to the cell nucleus similarly to NP wt. The strongest tendency for cytoplasmic 
accumulation was detected for NP-TC292, which sometimes displayed equal distribution 
between nucleus and cytoplasm. The NP signals indicated protein stability and expression 
close to NP wt levels. 
All four TC-tagged NP variants were chosen for reverse genetics experiments for the 
generation of recombinant virus mutants.  
 
 
Fig. 16: Expression of TC-tagged NP mutants (Influenza A/WSN virus) in MDCK II cells. Cells were transfected 
with pHW185-NP-based plasmids expressing WSN NP-TC125, NP-TC288, NP-TC292, NP-TC372 or NP wt. At 
23 h p.t. cells were immunostained with anti-NP and Alexa568-anti-mouse antibodies and analyzed by confocal 
fluorescence microscopy. All constructs displayed nuclear localization. NP-TC288 and NP-TC292 had a stronger 
tendency to localize in the cytoplasm than the other constructs. Scale bar, 10 µm. 
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4.2.2 Generation of recombinant Influenza A/WSN virus mutants carrying 
segment 5 vRNA with TC-tag insertion 
Generation of recombinant Influenza A/WSN virus was performed as described in 3.2.4.3. 
First, 293T cells were transfected with the eight-plasmid system for reverse genetics [451]. 
Upon successful transfection of a cell with all eight plasmids, viral proteins and the eight 
vRNA segments are synthesized, and infectious virus particles can be assembled and released 
(Fig. 17). For the generation of recombinant mutant virus with TC-tag insertion in segment 5 
vRNA, plasmid pHW185-NP (wild-type) was replaced by the modified plasmids pHW185-
NP-TC125, pHW185-NP-TC288, pHW185-NP-TC292 or pHW185-NP-TC372 (Tab. 5). 
These plasmids are described in 4.2.1 and were tested for efficient NP expression (Fig. 16).  
Recombinant virus mutants encoding NP-TC125, NP-TC292 or NP-TC372 failed 
formation 
When pHW185-NP (encoding the wild-type sequence of segment 5) was used, production of 
recombinant WSN wt virus was succesfull in five different control experiments. These virus 
preparations showed a considerable cytopathic effect (CPE) on MDCK II cells and were 
clearly quantifiable in plaque assays. They further showed typical NP expression in 
immunofluorescence analysis of infected MDCK II cells at 8, 17, 21 and 41 h p.i. (data not 
shown). 
 
Fig. 17: Reverese genetics. Schematic presentation of the generation of recombinant Influenza A/WSN virus. 
293T cells were transfected with eight plasmids encoding viral mRNA and full-length viral RNA under control of 
human Pol II and Pol I promoters. For generation of mutant viruses with TC-tagged NP, the wt plasmid pHW185-
NP was replaced by a plasmid carrying the modified NP gene segment. Production of all eight viral proteins and 
vRNAs in transfected cells led to formation of virus particles. 
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In contrast, recombinant virus could not be recovered when using pHW185-NP-TC125, 
pHW185-NP-TC292 or pHW185-NP-TC372 in four independent experiments that were 
conducted in parallel to WSN wt virus generation. When infecting MDCK II cells with the 
initial supernatant from transfected 293T cells for virus propagation, a CPE was not observed, 
not even after 4 days. The failure to produce mutant virus with NP-TC125, NP-TC292 or NP-
TC372 was confirmed by plaque assay and immunofluorescence analysis. Neither plaques nor 
NP expression (at 17 or 41 h p.i.) were detectable upon infection of MDCK II cells with the 
supernatant from the first passage. Notably, the result for generation of recombinant virus 
using plasmid pHW185-NP-TC288 was different (see Fig. 18). 
Abortive replication of WSN TC288 virus 
A schematic overview of the characterization of WSN TC288 virus is shown in Fig. 18. A 
considerable CPE of recombinant WSN TC288 virus was observed during the first passage on 
MDCK II cells. However, infectious virus particles could not be detected in the supernatant of 
the first passage, neither by plaque assay nor by immunofluorescence analysis of infected 
MDCK II cells at 24 or 41 h p.i. This finding was consistent with the fact that a CPE was not 
observable anymore during the second passage on MDCK II cells. As the supernatant initially 
generated from transfected 293T cells had caused a CPE on MDCK II cells, the same 
suspension was analyzed by infection of MDCK II cells and subsequent immunostaining for 
NP. Indeed, NP-TC288 expression clearly demonstrated successful infection of the cells and 
viral protein synthesis by newly generated recombinant virus particles (Fig. 18, top right 
image). However, the same virus preparation was not able to form plaques (Fig. 18, top left) 
indicating failed multicycle replication as plaques require several rounds of replication to 
form.  
These findings indicate that virus particles were efficiently produced from plasmid DNA in 
transfected cells, but that the virus was not able to undergo a complete round of replication 
upon infection of cells. Therefore, the TC-tag apparently affected processes of viral 
replication that were bypassed in transfected cells, i.e. the RNA synthesis. The failure to 
replicate the viral genome might explain the complete abrogation of infectious particle 
production in the first round of replication. 
Comparison of MDCK II cells infected with WSN wt and WSN TC288 virus by 
immunofluorescence analysis at 24, 48 and 72 h p.i. (Fig. 19) showed that NP wt accumulated 
as punctate signals in the cytoplasm around 24 h p.i., whereas NP-TC288 did not appear as 
granular cytoplasmic signal at any of the observed time points, but remained in the nucleus 
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instead (Fig. 19e, f). Appearance of punctate cytoplasmic NP late in infection reflects the 
nuclear export of newly formed progeny vRNPs [297]; therefore, the results suggest that 
WSN TC288 virus is defective in vRNP formation or in vRNP nuclear export. As vRNP 
nuclear export must have occured during initial formation of WSN TC288 virus, this result 
supports that the replication defect has to be on the level vRNP formation. 
As judged by the immunofluorescence signal of NP (Fig. 19), infection kinetics of the WSN 
TC288 virus appeared to be slower than the kinetics of the wt virus. WSN wt virus showed 
highest NP expression levels at 24 h p.i. and a considerable CPE with a decreasing number of 
infected cells 48 h p.i., whereas WSN TC288 virus showed strongest NP expression only at 
48 h p.i. and a decreasing number of infected cells and expression levels at 72 h p.i. In 
conclusion, this experiment shows that the time points chosen for harvesting and for 
characterization of WSN TC288 virus during this study were appropriate to obtain significant 
data.  
 
Fig. 18: Analysis of recombinantly generated Influenza A/WSN mutant virus TC288. The virus was generated 
by reverese genetics, i.e. transfection of 293T cells with eight plasmids encoding the viral proteins and vRNAs. 
The virus released into the supernatant was used for infection of MDCK II cells (1
st
 passage) causing a clear 
cytopathic effect (CPE). This is consistent with IF analysis of infected MDCK II cells at 24 h p.i. with anti-NP-FITC 
antibody showing a positive NP expression signal in the nuclei of infected cells. The 2
nd
 passage on MDCK II 
cells, however, did produce neither CPE nor a positive signal for NP expression by IF indicating that infectious 
virus was not produced during the 1
st
 passage. Consistently, WSN TC288 mutant virus was not able to form 
plaques (within 4 days). Scale bar (IF images), 50 µm. 
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Fig. 19: Comparison of Influenza A/WSN wt and TC288 mutant virus infection in MDCK II cells. Infection was 
performed with newly generated recombinant WSN TC288 mutant virus (293T cell supernatant, 330 µl) and 
WSN wt virus (MOI 1). Cells were fixed at (a, b) 24 h, (c, d) 48 h and (e, f) 72 h p.i., immunostained with anti-NP-
FITC and analyzed by confocal fluorescence microscopy. The NP expression level and the CPE increased more 
rapidly in WSN wt virus infection than in mutant virus infection. The highest number of infected cells and the 
highest NP expression levels were detected at 24 h p.i. for WSN wt virus infection and at 48 h p.i. for WSN 
TC288 virus infection. (g, h) At 24 h p.i., granular cytoplasmic NP signals were observed in WSN wt virus 
infection (indicating newly formed vRNPs which underwent nuclear export) (g). Punctate cytoplasmic NP signals 
were not observed at any time in WSN TC288 mutant virus-infected cells. Scale bar, 10 µm. 
Rescue of virus mutants with TC-tag insertion by supplementation with wt NP 
In a second approach to rescue a recombinant mutant virus encoding NP-TC125, NP-TC288, 
NP-TC292 or NP-TC372, a mixture of WSN wt and WSN mutant virus was produced to 
support viral replication of the TC-tagged virus by the presence of wt NP. Therefore, when 
generating recombinant virus by transfection of 293T cells, the mutated plasmids pHW185-
NP-TC125, pHW185-NP-TC288, pHW185-NP-TC292 or pHW185-NP-TC372 were mixed 
with plasmid pHW185-NP encoding the wt segment 5 sequence (ratio 2:1). These 
recombinant, mixed virus productions were propagated on MDCK II cells and produced a 
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considerable CPE during the first passage. The CPE of WSN TC288/wt virus was consistently 
lower than the CPE of the other virus preparations suggesting an inhibitory effect of NP-
TC288 on viral replication. Virus preparations were then analyzed by infection of MDCK II 
cells (Fig. 20). Infection of 100 % of the cells ensured multiple infections of most cells and 
coexpression of wt and TC-tagged NP. At 21 h p.i., the cells were stained with FlAsH 
followed by immunostaining of NP for comparative analysis of both signals. 
All four different virus preparations supposed to contain mutant virus and wt virus genomes 
successfully infected MDCK II cells and apparently induced expression of both wt and TC-
tagged NP: NP expression could be detected by immunofluorescence as well as TC-tag-
specific FlAsH signal (Fig. 20 b–e). WSN wt virus-infected control cells displayed only NP 
immunofluorescence, but lacked the FlAsH signal confirming the specificity of the TC-tag for 
FlAsH labeling (Fig. 20a). Hence, recombinant WSN virus was successfully generated 
carrying modified segment 5 vRNA with TC-tag insertion that allowed TC-tagged NP 
expression in infected cells. 
However, a remarkable disparity of NP localization was observed when comparing NP 
immunodetection and TC-tag-specific FlAsH labeling, suggesting differential behavior of wt 
and TC-tagged NP in infected cells of each sample. In WSN TC372/wt infected cells (Fig. 
20e), a considerable fraction of NP accumulated as punctate structures in the cytoplasm as 
shown by immunofluorescence, whereas FlAsH-labeled NP remained almost exclusively in 
the cell nucleus. This observation suggests that NP-TC372 failed to be exported from the 
nucleus as part of intact vRNP complexes and that cytoplasmic vRNPs were constituted 
primarily of wt NP. In WSN TC288/wt virus-infected cells (Fig. 20c) FlAsH and 
immunofluorescence signals were mostly overlapping, but in this case cytoplasmic NP was 
hardly detected. This indicates an impairment of vRNP formation or vRNP nuclear export by 
the presence of NP-TC288 similarly as in cells infected with WSN TC288 (Fig. 19). In both 
WSN TC292/wt and WSN TC125/wt virus-infected cells, unusual broad patches of FlAsH 
signal were detected in the cytoplasm that were typically not observed for wt NP in infection 
(Fig. 20b, d). In addition, characteristic punctate NP signals resembling cytoplasmic vRNPs in 
infection were observed; they were however largely devoid of FlAsH staining. 
Even though all four modified segment 5 vRNAs with TC-tag insertion could be efficiently 
replicated in the presence of wt NP and TC-tagged NP was expressed in infected cells, FlAsH 
labeling of cytoplasmic NP structures to study transport and assembly of newly formed 
vRNPs was not achieved. NP-TC125, NP-TC292 and NP-TC372 might be unable to compete 
with wt NP for incorporation into vRNP complexes and/or may interfere with vRNP 
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formation or transport when once incorporated. NP-TC288 instead might generally interfere 
with vRNP formation, as indicated above.  
        
Fig. 20: Rescue of recombinant Influenza A/WSN mutant viruses carrying NP gene segments with TC-tag 
insertion by mixed formation with WSN wt virus. Comparison of FlAsH signals with NP immunofluorescence. 
Recombinant viruses with mutated segment 5 vRNA with TC-tag insertion (NP-TC125, NP-TC288, NP-TC292, NP-
TC372) were generated by reverse genetics by cotransfection of pHW185-NP wt and pHW185-NP-TC mutant 
plasmids (ratio 1:2). After the 1
st
 passage, the virus mixture was analyzed by infection of MDCK II cells with 
subsequent FlAsH labeling and IF staining (anti-NP/Alexa568-anti-mouse) at 21 h p.i. Representative confocal 
fluorescence microscopy images of the cells are presented. (a) WSN wt virus-infected cells did not show 
unspecific FlAsH staining, and NP was detected predominantly cytoplasmic. (b–e) All samples with mixed 
infections of the indicated TC-tagged mutant virus with wt virus were positive for TC-tagged NP expression as 
shown by FlAsH signals. Granular, cytosolic IF signals of NP did not correlate with the FlAsH signal. WSN 
TC288/wt virus infections displayed very little cytosolic NP signal compared to other mixed or wt virus 
infections (c). Particularly low FlAsH signals were observed for WSN TC292/wt infected cells (d). Scale bar, 
10 µm. 
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4.2.3 Generation of recombinant Influenza A/WSN virus mutants encoding N-
terminally TC-tagged NP  
As TC-tag insertion into the highly conserved NP sequence failed to produce infectious 
recombinant viruses (4.2.2), a segment 5 vRNA was constructed encoding NP with an N-
terminal TC-tag.  
To circumvent the disruption of the segment 5 packaging signal by an N-terminal insertion, 
the 3′ terminal packaging sequence was restored by duplicating part of the packaging signal 
according to Ozawa et al. [123] (Fig. 21). As the first 60 nucleotides of the NP ORF have 
been shown to be sufficient for incorporation of the segment into progeny virus particles, the 
corresponding vRNA nucleotides 46–105 were duplicated and the three ATG codons within 
the first duplicate were removed by point mutations. The TC-tag sequence, preceded by an 
ATG start codon, was introduced right before the unmodified complete NP ORF. Thereby, the 
terminal packaging sequence was left largely unaltered, except for four point mutations, and 
the functional ORF now including the N-terminal TC-tag insertion was shifted behind the 
vRNA packaging signal. 
Technically, the vRNA encoding plasmid pHW185-NP for reverse genetics was sequentially 
mutated by site-directed PCR-based mutagenesis (3.2.1.4) using primer pairs {30, 31} and 
{32, 33} (Tab. 6) for elimination of the first three ATG codons of the vRNA 3′ end yielding 
pHW185-NP-3ATG (Tab. 5). Subsequently, two PCR products were generated (3.2.1.1) for 
insertion into pHW2000, which is the basic cloning vector of the eight-plasmid system for 
reverse genetics [451]. One PCR insert was amplified from the modified plasmid pHW185-
NP-3ATG encompassing the non-coding 3′ end of the vRNA, the first 60 nt of the NP ORF 
lacking all ATG codons and part of an additional Kozak consensus sequence (using primers 
{34}, {35}; Tab. 6). The other PCR fragment was amplified from the unmodified plasmid 
pHW185-NP and comprised the other half of the Kozak consensus sequence and the TC-tag 
sequence followed by the complete NP ORF and the non-coding 5′ end of the vRNA. 
Depending on the TC-tag sequence that was introduced, this PCR product was termed 
“Kozak-nTC-NP-vRNA” or “Kozak-FLN-TC-MEP-NP-vRNA” (generated with primer pairs 
{36, 37} or {38, 37}, respectively; Tab. 6). The two PCR fragments were then ligated with 
each other and with plasmid pHW2000 using restriction sites Esp3I and BsaI (3.2.1.3) finally 
yielding the plasmids pHW185-NP60mut-nTC-NP or pHW185-NP60mut-FLN-TC-NP for 
reverse genetics (Tab. 5). The two plasmid differ only by the specific sequence of the TC-tag 
depending on the use of “Kozak-nTC-NP-vRNA” or “Kozak-FLN-TC-MEP-NP-vRNA” for 
ligation.  
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Two different N-terminal TC-tag sequences were used: The first TC-tag termed “nTC”-tag 
(amino acid sequence MAGGCCPGCC) consisted of the essential TC sequence (CCPGCC) 
and another four amino acids that were added for stabilization of the N-terminus. The other 
TC-tag termed “FLN” (amino acid sequence MFLNCCPGCCMEP) comprised the essential 
six amino acid TC-tag (underlined) flanked by three amino acids on both sides for improved 
fluorescence signals. Higher affinity and increased fluorescence quantum yield has been 
reported for the FLN sequence [481].  
Generation of recombinant Influenza A /WSN mutant virus encoding N-terminally TC-tagged 
NP was performed as described in 3.2.4.3. pHW185-NP encoding wt vRNA was therefore 
replaced by pHW185-NP60mut-nTC-NP or pHW185-NP60mut-FLN-TC-NP for the 
production of WSN nTC and WSN FLN mutant virus, respectively. During the first passage 
on MDCK II cells, a clear CPE was observed for both mutants. Viruses were further 
propagated for sequencing of segment 5 vRNA (3.2.4.3). The sequencing results confirmed 
successful generation of WSN nTC and WSN FLN mutant viruses encoding the correct vRNA  
 
Fig. 21: Generation of segment 5 vRNA encoding N-terminally TC-tagged NP for reverse genetics. Illustration 
adapted from Ozawa et al. [123]. The 3′ terminal packaging signal of segments 5 vRNA (46–105) consists of the 
non-coding sequence (grey) and part of the coding sequence (mid blue). The first 60 bases of the coding 
sequence were duplicated (green) and three ATG start codons were replaced by point mutations [123]. The TC-
tag was introduced in front of the NP coding sequence, starting with an ATG codon and indicating the beginning 
of the functional ORF. Two types of TC-tag were designed: the “nTC” terminal tag consisting of four N-terminal 
stabilizing amino acids (MAGG) followed by the six amino acids of the TC-tag (CCPGCC), and the “FLN” terminal 
tag containing the TC sequence (CCPGCC) flanked by the amino acid sequences (MFLN) and (MEP) for improved 
fluorescence signals. 
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sequences as designed. Modifications of segment 5 were apparently maintained during several 
replication cycles and neither NP function nor vRNA packaging was fundamentally affected.  
For following experiments, WSN nTC and WSN FLN virus were preferentially utilized from 
the first passage, as viral titers tended to decrease over several passages, in particular for 
WSN FLN virus (see also 4.2.5). When WSN FLN virus was subjected to successive 
passaging by infecting cells always with the same fraction of the supernatant from the 
preceding passage, the titer rapidly decreased, and after the fourth passage virus could not be 
detected anymore by NP immunofluorescence analysis (data not shown).  
4.2.4 Qualitative and quantitative analysis of biarsenical labeling of N-
terminally TC-tagged NP in virus infection 
The recombinantly generated viruses WSN nTC and WSN FLN (4.2.3) were first analyzed for 
the labeling efficiency and specificity of the TC-tagged NP variants during infection.  
4.2.4.1 Specificity of biarsenical labeling for nTC-NP and FLN-NP in infection 
MDCK II cells were infected with either WSN nTC, WSN FLN or WSN wt virus and stained 
with the green or red fluorescent biarsenical dyes FlAsH or ReAsH at 20 h p.i. For 
comparison with NP-specific signals, the cells were subsequently fixed and immunostained 
for NP with anti-NP-FITC or anti-NP and Alexa568-anti-mouse antibodies, respectively. 
WSN nTC and WSN FLN virus-infected cells clearly showed efficient expression of TC-
tagged NP and efficient labeling with both FlAsH and ReAsH (Fig. 22A, B). In contrast, 
WSN wt virus-infected cells lacked any NP-specific FlAsH or ReAsH signal, demonstrating 
that wt NP was not unspecifically labeled by the biarsenical dyes (Fig. 22C); instead FlAsH 
and ReAsH specifically stained NP with nTC-tag or FLN-tag. Immunofluorescence signals of 
NP showed that there were no pools of NP in cells infected with WSN nTC or WSN FLN 
virus that were not stained with the biarsenical dyes (Fig. 22A, B). However, in some of the 
cells occasional NP-independent nucleolar staining was observed, which was further analyzed 
and will be set out below in more detail (Fig. 23; not obvious in selection of Fig. 22).  
An unspecific, diffuse background signal of the biarsenical dyes was generally detected in 
infected and uninfected MDCK II cells. The signal-to-noise ratio was better in ReAsH- than 
in FlAsH-labeled cells. It was noted though that the background staining was higher in 
samples of wt virus infection (Fig. 22C) than in viral infections with TC-tag expression (Fig. 
22A, B). This is likely due to a higher free concentration of the dye in wt virus-infected cells, 
where the dye does not become partially bound by the TC-tag. The reduction of the free dye  
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Fig. 22: Specificity of FlAsH and ReAsH labeling for TC-tagged NP in Influenza A/WSN mutant virus-infected 
cells. MDCK II cells were infected with (A) WSN nTC, (B) WSN FLN or (C) WSN wt virus (MOI 0.5), labeled with 
ReAsH or FlAsH at 20 h p.i. as indicated and subsequently immunostained with anti-NP-FITC or anti-
NP/Alexa568-anti-mouse antibodies, respectively. Cells were visualized by confocal fluorescence microscopy. 
Representative images are shown. Scale bar, 10 µm. 
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concentration within TC-tag-expressing cells due to complexation by the tag cannot be 
determined though since the concentration of the TC-tag and the exchange rates of the dye 
with the cell culture supernatant (the main reservoir of the dye) are unknown. In general, the 
cellular background of biarsenical labeling was found to be strongly dependent on the dye 
concentration. Under the conditions of labeling applied here (see 3.2.2.4.3), the diffuse 
background was however low compared to the specific TC-tag signals, and a prominent 
unspecific labeling of cellular structures was not systematically observed. Intriguingly, 
however, some cells occasionally displayed as already mentioned a distinct nucleolar FlAsH 
or ReAsH fluorescence signal.  
It was therefore examined if infection with WSN virus might induce unspecific biarsenical 
labeling of cellular structures. MDCK II cells were thus infected with WSN wt virus at 
different multiplicities of infection (MOI 0.05 and MOI 5). The results of the ReAsH labeling 
at 20 h p.i. in comparison with NP immunostaining as a marker for infection demonstrated 
that WSN wt virus infection did in fact cause unspecific, TC-tag-independent labeling of 
subnuclear structures (Fig. 23A). By comparison with the DIC images, it was inferred that 
these structures are nucleoli. The number of cells with nucleolar staining was considerably 
increased with the number of infected cells, which becomes obvious when comparing 
infections at MOI 0.05 and MOI 5 (bottom and top in Fig. 23A, respectively). All infected and 
uninfected cells displayed a diffuse ReAsH background, but only a fraction of the infected 
cells showed additional bright nucleolar signals. This was also seen for FlAsH labeling of 
WSN wt virus-infected cells (Fig. 23B).  
Unspecific nucleolar labeling with FlAsH and ReAsH was also examined upon infection with 
the two mutant virus strains WSN nTC and WSN FLN. Infected cells were labeled with 
FlAsH or ReAsH and subsequently immunostained for NP to distinguish between unspecific 
and NP-specific FlAsH or ReAsH signals. In WSN nTC infection, several infected cells 
displayed a nucleolar FlAsH or ReAsH staining, which did not colocalize with the 
immunofluorescence signal of NP, suggesting an unspecific nucleolar labeling with the 
biarsenical dyes just like in wt virus infection (Fig. 23B). Occasionally, morphological 
changes of the nucleolar structure were seen in WSN wt and nTC virus-infected cells by DIC 
imaging (Fig. 23B, enlarged sections). They were typically accompanied by prominent 
unspecific biarsenical. In contrast, unspecific nucleolar staining with FlAsH or ReAsH was 
not observed in cells infected with WSN FLN virus, nor were there any prominent 
morphological changes of nucleoli. 
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Fig. 23: Analysis of unspecific FlAsH and ReAsH labeling induced by Influenza A/WSN virus infection. (A) 
MDCK II cells were infected with WSN wt virus at two different MOI (top: MOI 5; bottom: MOI 0.05). At 
20 h p.i., cells were labeled with ReAsH followed by immunostaining with anti-NP-FITC. Confocal fluorescence 
images were acquired with constant settings. In a fraction of the infected cells, unspecific labeling of nucleoli by 
ReAsH was observed. (B) Examples of WSN wt and WSN nTC infected cells showing nucleolar FlAsH and ReAsH 
labeling. Infection was identified by positive anti-NP immunostaining. The nucleolar FlAsH and ReAsH signals of 
WSN nTC infected cells did not correlate with immunodetection of TC-tagged NP demonstrating unspecific 
staining. Morphological changes of nucleoli frequently observed in infected cells are shown in enlarged sections 
of the DIC images on the right. Scale bar, 10 µm. 
In conclusion, N-terminal TC-tagging of NP with duplication of the vRNA packaging signal 
in the recombinant viruses WSN nTC and FLN allows for efficient and specific labeling of 
TC-tagged NP with FlAsH and ReAsH, while care must be taken with respect to staining of 
nucleoli, which can be induced unspecifically by Influenza A/WSN virus infection. Thus, in 
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following experiments, nucleoli were excluded from analysis of biarsenical labeling in 
infected cells. 
4.2.4.2 Comparative analysis of labeling efficiencies of nTC-NP and FLN-NP with 
FlAsH and ReAsH  
For the determination of optimal conditions for fluorescence imaging of TC-tagged NP, the 
two different tag sequences nTC and FLN and the two biarsenical dyes FlAsH and ReAsH 
were tested in all possible combinations (Fig. 24). The signals were quantified relative to each 
other and relative to a common reference, and they were set into context with the fluorescence 
background signals.  
For this purpose, MDCK II cells were infected with WSN nTC or WSN FLN virus and then 
labeled competitively with FlAsH and ReAsH at 20 h p.i. as described in 3.2.2.4.3. The cells 
were fixed and imaged by confocal fluorescence microscopy with constant settings (Fig. 
24A). The images show that the two tags were efficiently labeled with both FlAsH and 
ReAsH. For quantification, the nuclei (which present the major signal in the cells) were 
manually selected and the mean intensity was measured with ImageJ. The FlAsH-to-ReAsH 
signal ratio was calculated and compared (Fig. 24A). The result clearly shows that the two 
tags have a differential preference for the two dyes, the nTC-tag displaying a higher FlAsH-
to-ReAsH signal ratio than the FLN-tag. This difference might be due to either distinct 
affinities or to a distinct fluorescence brightness of these tag-dye combinations. To determine 
more precisely which tag-dye combination is preferable, FlAsH and ReAsH signals were 
compared to a reference signal, in this case the immunofluorescence (IF) signal of NP, in 
order to normalize the signals to the NP concentration. To this end, MDCK II cells were 
infected with WSN nTC, FLN or wt virus. They were then labeled with either FlAsH or 
ReAsH at 20 h p.i. and subsequently immunostained with anti-NP/Alexa568-anti-mouse or 
anti-NP-FITC antibodies, respectively. It is assumed here that the affinity of the monoclonal 
anti-NP antibody is unaffected by the presence of the tags. Image acquisition and 
quantification were performed as before, and the FlAsH-to-IF and ReAsH-to-IF signal ratios 
were calculated (Fig. 24B, C). Consistent with results from the competitive labeling assay 
(Fig. 24A), nTC-NP was more efficiently labeled with FlAsH than FLN-NP, whereas FLN-NP 
showed a considerably higher ReAsH signal than nTC-NP. Consequently, FlAsH appears to 
be better suitable to label nTC-NP, whereas ReAsH was apparently better for FLN-NP 
staining. A general improvement of the TC-tag by the flanking sequences in the FLN-tag  
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Fig. 24: Quantitative analysis of FlAsH and ReAsH labeling of WSN nTC and WSN FLN virus-infected cells. 
MDCK II cells were infected and labeled at 20 h p.i. The fluorescence signals were detected by confocal 
fluorescence microscopy and the mean signal intensities of the cell nuclei were determined using ImageJ. FlAsH 
and ReAsH nuclear signals were quantified (A) relative to each other, or (B, C) relative to immunofluorescence 
signals of NP. The signal ratios strictly depend on the acquisition parameters, which were kept constant during 
the experiments, using standard settings if not stated otherwise. (A) Competitive labeling of WSN FLN virus 
(top) and WSN nTC virus (bottom) with FlAsH and ReAsH. Fluorescence images show efficient labeling of the TC-
tagged NP constructs with both dyes (Scale bar, 10 µm). The FlAsH-to-ReAsH signal ratio was determined for 27 
nuclei of WSN nTC and 41 nuclei of WSN FLN virus-infected cells, mean vaues ± SD are displayed on the right-
hand side. (B) FlAsH signals and (C) ReAsH signals of WSN FLN, WSN nTC and WSN wt virus-infected cell nuclei 
were quantified relative to the NP immunofluoresence signal for normalization to the amount of NP (B: anti-
NP/Alexa568-anti-mouse; C: anti-NP-FITC). The dye-to-IF ratio for WSN wt was set to 1. The ratios of unspecific 
FlAsH and ReAsH labeling in wt virus infection relative to IF signals of NP depend on the NP expression level and 
present an average value of background signal relative to NP expression in the detected range, for comparison 
with the normalized FlAsH and ReAsH signals of nTC-NP and FLN-NP. Two independent experiments (Exp.1, 
Exp.2) are shown in (C) differing by the duration of ReAsH labeling (Exp.1: 1 h; Exp.2: 1.5 h) and the FITC 
detection range (exceptionally, Exp.1: 500–540 nm; Exp.2: 500–530 nm). At least 13 cells of each sample were 
analyzed. The results are given as mean signal ratio ± SD.   
[481] could not be confirmed by comparison to labeling results of the nTC-tag. To assess 
unspecific background signals, signals of both dyes in the nuclei of wt virus-infected cells 
were quantified relative to the IF signal of NP. This ratio, unlike the ratios of nTC- and FLN-
NP labeling, is dependent on the NP expression level, but it presents an average value of 
background signal relative to NP expression in the detected range and can therefore be used 
RESULTS 
124 
 
for comparison with the relative nTC- and FLN-tag-specific signals. Comparison indicates 
that the signal-to-noise ratio was considerably better for ReAsH labeling than for FlAsH 
labeling under the applied conditions. The relative ReAsH signals of nTC-NP and FLN-NP 
were several-fold above the average unspecific relative background signal of ReAsH in wt 
virus infection, whereas the relative FlAsH signals of nTC-NP and FLN-NP were only less 
than two fold higher than the average FlAsH background ratio. This difference becomes 
important especially for detection of low-expressing cells. In particular, the combination of 
FlAsH with the FLN-tag was shown to be unfavorable producing signals close the average 
background staining. 
4.2.4.3 Analysis of cytoplasmic nTC-NP and FLN-NP in infection with biarsenical 
labeling 
Late in Influenza virus infection, NP characteristically appears as granular cytoplasmic 
structures representing progeny vRNPs which are in transit to the plasma membrane using the 
recycling endosomal transport pathway as reported in [297]. For studying transport and 
assembly of newly generated vRNPs in infection using the tetracysteine labeling technique, 
the labeling efficiency and specificity were tested in particular for the cytoplasmic NP 
structures in WSN nTC and WSN FLN virus-infected cells. 
To qualitatively examine the presence and the local distribution of cytoplasmic NP signals, 
WSN nTC, FLN and wt virus-infected cells were labeled with ReAsH at 20 h p.i. and were 
subsequently immunostained with anti-NP-FITC antibody. Unexpectedly, cells infected with 
WSN FLN virus did not show the characteristic prominent accumulation of punctate NP in the 
cytoplasm. WSN FLN virus was therefore excluded from this analysis. In WSN nTC virus 
infection, however, the characteristic patterns of NP distribution were observed like in WSN 
wt virus infection (Fig. 25). Unlike wt virus-infected cells, only few WSN nTC virus-infected 
cells displayed cytoplasmic NP though (see also Fig. 28D and 4.2.5). Both nTC-NP and wt 
NP were frequently found to accumulate as punctate signals in a single focus of the 
juxtanuclear region, and from this site, NP spots were spread throughout the cytoplasm (Fig. 
25a, b). This juxtanuclear site of prominent NP accumulation is probably the microtubule 
organizing center (MTOC) as identified before [280]. In other cases, the punctate NP signals 
were dispersed throughout the cytoplasm and near the plasma membrane being laterally 
restricted to one side of the cell nucleus, resulting in a laterally polarized distribution (Fig. 
25c, d). These phenotypic distributions of NP have been described previously [297]. 
Immunofluorescence and ReAsH signals in the cytoplasm of WSN nTC virus-infected cells 
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Fig. 25: Comparison of cytoplasmic NP distribution in WSN nTC and WSN wt infected cells. (A) MDCK II cells 
infected with WSN nTC or WSN wt virus were labeled with ReAsH at 20 h p.i., subsequently fixed and 
immunostained with anti-NP-FITC antibody. ReAsH fluorescence (red) and NP immunofluorescence (green) are 
presented as overlay. (B) WSN nTC virus-infected cells were fixed at 20 h p.i. and immunostained with anti-NP-
FITC antibody. Confocal fluorescence images of infected cells with representative cytoplasmic NP distribution 
patterns are shown. Scale bar, 10 µm. 
perfectly colocalized, confirming the specificity of ReAsH for nTC-NP (Fig. 25A, left-hand 
panel). Furthermore, it was noticed that punctate NP signals in ReAsH-labeled wt virus-
infected cells were finer and smaller than in cells infected with nTC mutant virus (Fig. 25A, 
compare left-hand and right-hand panel). When the cells were fixed and immunostained 
without preceding ReAsH labeling, cytoplasmic nTC-NP was finely dispersed similar to wt 
NP in infection (Fig. 25B). This might indicate TC-tag-dependent aggregation of NP due to 
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Fig. 26: Differential staining of cytoplasmic nTC-NP in infection using FlAsH and ReAsH. MDCK II cells were 
infected with WSN nTC virus and labeled with (a, c) FlAsH or (b, d) ReAsH at 20 h p.i. Subsequently, 
immunofluorescence was performed (a, c: anti-NP/Alexa568-anti-mouse; b, d: anti-NP-FITC). Cells with very 
bright and with low cytoplasmic IF signals are presented. (a) Labeling of cytoplasmic NP with FlAsH was less 
efficient than the immunostaining (relative to the nuclear signals). (c) Cytoplasmic NP with faint IF signals was 
not detectable by FlAsH labeling. (b, d) ReAsH and IF staining identified the same cytoplasmic NP structures. 
Relative to the nuclear signals, the ReAsH staining of cytoplasmic NP was stronger than the immunostaining. 
Scale bar, 10 µm.                   
biarsenical labeling. 
When comparing ReAsH and FlAsH labeling of cytoplasmic nTC-NP in infection, a 
preference of the nTC-NP for ReAsH was observed (Fig. 26). For this analysis, FlAsH and 
ReAsH labeling were performed in cells infected with WSN nTC virus at 20 h p.i. as before, 
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and the signals were compared to the IF signal of NP as internal reference. Notably, the signal 
intensities of the biarsenical labeling and the immunostaining did not correlate uniformly 
within one cell. The intensity of the cytoplasmic signal relative to that of the nuclear signal 
was clearly higher for ReAsH than for IF detection (Fig. 26b). On the contrary, for FlAsH, 
this ratio was reversed. The signal in the cytoplasm relative to the nuclear signal was 
significantly weaker for FlAsH compared to the IF signal (Fig. 26a). As the same monoclonal 
primary antibody was used for IF staining of FlAsH and ReAsH-labeled cells, the 
compartment-specific differences between FlAsH and ReAsH labeling relative to the 
immunostaining were most likely due to different properties of the biarsenical dyes. FlAsH 
and ReAsH might differ by their affinity or by their fluorescence brightness when bound to 
nTC-NP, and these differences seem to occur in a compartment-specific way. The FlAsH 
labeling of cytosolic nTC-NP was very low compared to the IF signal, but it was also 
remarkably low compared to the nuclear FlAsH labeling and to the unspecific cellular FlAsH 
background (Fig. 26a). Moreover, when considering specifically very fine cytoplasmic nTC-
NP structures, which were detected by a relatively low IF signal, these structures were 
distinctly detectable with ReAsH labeling (Fig. 26d), but remained undetectable with FlAsH 
labeling (Fig. 26c). The disparity of the two NP populations in the nucleus and in the 
cytoplasm might possibly result from the specific state of NP as preferentially uncomplexed 
or vRNP-bound protein. In addition, cytoplasmic vRNPs are very likely associated with M1, 
and NP might be N-terminally phosphorylated. The constraints of NP in cytoplasmic vRNP 
complexes may impose conformational restrictions or obstruct the accessibility of the nTC-
tag. The slightly larger molecular size of FlAsH (664.5 Da) compared to ReAsH (545.4 Da) 
might hence explain the impairment of FlAsH labeling of cytoplasmic vRNPs, whereas 
ReAsH can efficiently stain the TC-tag in cytoplasmic nTC-NP. Differences of the 
environment-dependent fluorescence brightness of FlAsH and ReAsH can however not be 
excluded.  
In conclusion, FlAsH was found to be unfavorable for labeling cytoplasmic nTC-NP in 
infection, whereas ReAsH performed comparably well and yielded excellent cytoplasmic 
nTC-NP-specific signals. The nTC-tag with the ReAsH ligand is hence the favorable tag-dye 
combination for detection of cytoplasmic vRNPs in infection with recombinant virus. 
ReAsH has been reported to have a phenotypic effect on labeled cells causing a transient 
rounding and disruption of the cell shape [482]. ReAsH thus appears to transiently disrupt the 
cytoskeleton. A similar effect was observed with MDCK II cells in the present study; 
rounding of the cells briefly after labeling ceased after about 30 minutes. Therefore, the effect 
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of ReAsH and FlAsH labeling on nuclear export and the presence of cytoplasmic vRNPs in 
infection was analyzed (Tab. 7). MDCK II cells were infected with equal amounts of WSN 
nTC virus (MOI~0.8). At 19 h p.i., they were then labeled with FlAsH or ReAsH. Control 
cells were treated without dye. The signals of the subsequent immunostaining of NP were 
analyzed for the fraction of infected cells with characteristic cytoplasmic vRNP signals (Tab. 
7). The results demonstrate that neither FlAsH- nor ReAsH-labeled cells displayed 
significantly altered fractions of cells with cytoplasmic vRNP signals compared to non-
labeled cells. Being aware of the variations of the fractions of infected cells among the 
samples (due to a very heterogeneous distribution of infected cells), the fractions of cells with 
cytoplasmic signal were determined relative to the number of infected cells of each of the 
sections which was randomly chosen for analysis. It was shown before that the cytoplasmic 
distribution of nTC-NP after ReAsH labeling was qualitatively comparable to the 
characteristic wt NP distribution in infection (Fig. 25). Solely the formation of enlarged NP 
spots was observed specifically for nTC-NP, but not for wt NP after ReAsH labeling, 
suggesting that this was an effect due to the nTC-tag itself and not to the interference of 
ReAsH with the cytoskeleton. Accordingly, an effect of ReAsH on the presence and the 
distribution of cytoplasmic vRNPs could not be observed.  
 
Tab. 7: Effect of FlAsH and ReAsH labeling on the presence of cytoplasmic NP in WSN nTC virus infection. The 
fraction of infected MDCK II cells displaying cytosolic NP signals were determined for ReAsH- and FlAsH-labeled 
cells at 19 h p.i. in comparison to non-labeled cells. The fractions of infected cells and of infected cells with a 
cytosolic NP signal were determined by immunofluorescence detection of NP. IF detection in ReAsH-labeled 
cells was performed with anti-NP-FITC; IF detection in FlAsH-labeled cells was performed with anti-
NP/Alexa568-anti-mouse. At least seven frames per sample were evaluated. The results are given as mean value 
with SD.  
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Additionally, the effect of biarsenical labeling on virus formation was analyzed independently 
of the TC-tag (Fig. 27). To this end, MDCK II cells were infected with WSN wt virus and the 
supernatant was collected at 19 h p.i. Infected cells were then labeled with FlAsH or ReAsH 
according to 3.2.2.4.3. Control cells were treated without dye. The labeling solution was then 
replaced by normal medium and the supernatant was again collected after 3 h or 5 h. The viral 
titers of the samples collected before and after labeling were analyzed by 
immunofluorescence analysis (as described in 3.2.4.5). The results show that labeling of the 
cells with either FlAsH or ReAsH had no particular effect on the virus titer compared to the 
titer of virus released from unlabeled control cells (Fig. 27). This implies that the formation of 
infectious virus particles is not affected by the biarsenical dyes and that the cytoskeleton 
remains functional for transport and budding processes. 
 
 
Fig. 27: Comparison of Influenza A/WSN wt virus production in the presence and absence of biarsenical dyes. 
In three independent experiments, MDCK II cells were infected with WSN wt virus (Exp.1: MOI 0.4; Exp.2: 
MOI 0.3; Exp.3: MOI 0.3). The supernatant was collected at 19 h p.i. and the cells were subsequently labeled 
with 1 µM FlAsH or ReAsH for 1 h at RT according to the standard labeling procedure (3.2.2.4.3). Control cells 
(w/o dye) were incubated with pure DMEM instead. The supernatant was again collected at 23 or 25 h p.i. The 
virus titer of labeled and non-labeled samples was determined by IF analysis (3.2.4.5).  
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4.2.5 Characterization of viral replication of recombinant Influenza A/WSN nTC 
and A/WSN FLN virus 
The recombinant Influenza mutant viruses with TC-tagged NP were analyzed regarding viral 
replication kinetics and the effect of biarsenical labeling on replication. 
At first, plaque assay (3.2.4.4) was employed to determine the titer of the recombinant WSN 
viruses. WSN wt virus formed distinct, round plaques after three days as shown in Fig. 28B, 
and the number of plaque forming units (PFU) could be determined. In contrast, no distinct 
plaques were formed by WSN FLN virus indicating that this virus mutant was not able to 
undergo multiple replication cycles. For WSN nTC virus, plaques could sometimes be 
observed, but they appeared vague and blurry (Fig. 28B). Not all of the small, faint and semi-
translucent patches could unambiguously be identified as plaques. When looking closely at 
the cell layer using an inverted microscope, the rounded, translucent areas with a more or less 
strong CPE still enclosed living cells, suggesting a low pathogenic effect on the cells. 
Unusually, when cells were infected with a ten times higher virus concentration than the 
concentration at which plaques were observed, the formation of ten times more plaques did 
not occur. Instead, a homogenously distributed CPE was observed and the confluent cell layer 
completely disintegrated (macroscopically observed by a semi-translucent cell layer in Fig. 
28B). This effect is shown for WSN nTC virus which was harvested from the first passage on 
MDCK II cells and was analyzed at dilutions 10
-1
 and 10
-2
. The nonlinear effect suggests an 
underestimation of the correct number of infected cells by plaque detection, and it indicates a 
large fraction of infected cells which are unable to form plaques. Incomplete packaging of the 
viral genome might be able to explain these data. Hence, the determination of mutant virus 
titers by plaque assay was not feasible.  
Therefore, the titer of WSN mutant viruses was determined by immunofluorescence analysis 
of infected cells (see 3.2.4.5) where infected cells are detected based on viral protein 
expression. In this case, titer determination does not depend on the ability of the virus to 
perform multiple cycles of replication, which is of particular importance for viruses with 
replication or packaging defects. Based on the Poisson-distribution 
P(n) = (MOI)
n
 × e
-MOI
 / (n!), which describes the probability that a cell at a given MOI is 
infected with n virus particles, the MOI and thereby the titer of a virus suspension was 
calculated from the fraction of uninfected cells (p0): MOI = −ln(p0), with p0 determined by 
immunofluorescence detection of NP expression. The titer values thus obtained differed 
clearly from those obtained by plaque assay: The first passage of newly generated WSN nTC 
virus typically yielded an apparent titer of about 10
3
 PFU/ml when analyzed by plaque assay,  
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Fig. 28: Characterization of viral infection and growth kinetics of recombinant Influenza A/WSN viruses. (A) 
Growth curve of WSN wt virus. The titer of virus collected from infected cells (MOI 0.01) at different time points 
post infection was determined by plaque assay (duplicate, mean ± SEM). (B) Plaque formation of WSN wt, WSN 
nTC and WSN FLN virus. (C) WSN nTC virus collected from infected cells (MOI 0.1) at different time points post-
infection was analyzed by plaque assay. Plaques could not be observed, but a varying degree of CPE was seen 
(and confirmed by microscopy). The most pronounced CPE was caused by virus collected at 21 h p.i. (D) Time 
course of infection with WSN wt, WSN nTC and WSN FLN virus analyzed by IF and confocal microscopy. MDCK II 
cells were infected (MOI 1), fixed at different time points post-infection and immunostained with anti-NP-FITC 
antibody and DAPI. Scale bar, 10 µm. 
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whereas the titer of the same preparations determined by immunofluorescence analysis of NP 
expression revealed titers of about 10
6 
infectious particles/ml. WSN wt virus in comparison 
usually yielded titers of about 10
8
 PFU/ml, but about 10
9 
infectious particles/ml determined 
by immunofluorescence analysis. For WSN FLN virus, the titer of newly generated virus after 
the first passage determined by immunofluorescence analysis was in the range of 10
6 
infectious particles/ml.  
To characterize the replication kinetics of WSN wt and mutant virus, MDCK II cells were 
infected and the supernatants were harvested and analyzed for the amount of newly generated 
virus at various time points post-infection (see 3.2.4.6). The growth curve for WSN wt virus 
as determined by plaque assay is presented in Fig. 28A. In case of WSN nTC virus, the 
analyzed samples did not produce distinct plaques as outlined above. Therefore, quantitative 
titer determination was precluded, but it was possible to evaluate the extent of CPE that was 
induced by the pure supernatant harvested at different time points post-infection. No CPE was 
observed for the virus produced until 8 h p.i.; the highest degree of CPE showing all cells 
dead was found for the viral supernatant harvested at 21 h p.i. and a successively decreasing 
CPE was observed for the supernatants at 29 and 54 h p.i (Fig. 28C). Qualitatively, the degree 
of cell damage reflecting the number of infectious virus particles increased and decreased in a 
time-dependent manner comparably to the growth curve of WSN wt virus (Fig. 28A). 
Alternative immunofluorescence-based titer determination (3.2.4.5) providing quantitative 
data for the WSN nTC virus growth curve was however not pursued, because a strong 
dependence of the replication kinetics on the initial MOI was expected after realizing the non-
linear relation between number of infections and the production of replication-competent 
progeny virus particles. A conclusive and sufficient characterization of the virus by this data 
could therefore not be expected. 
As the inability of TC-tagged mutant viruses to form plaques might reflect a vRNP packaging 
defect, the role of genome packaging was explored (Tab. 8). Cells were infected with two 
dilutions of WSN wt, nTC and FLN virus, respectively, and the apparent titer (MOI) of each 
sample was determined by immunofluorescence analysis (see 3.2.4.5). Using standard setting 
for detection of NP expression in infected cells, very low levels of NP were not detected. The 
MOI ratio of the two dilutions was then compared with the actual dilution factor (see Tab. 8, 
bold figures). For all viral strains, the decrease of the MOI by dilution of the virus as detected 
by immunofluorescence was higher than the actual dilution of the virus concentration. 
However, it was only 2.6 times higher for wt virus infections, while it was 22 times higher in 
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case of WSN nTC virus infections. For FLN virus, infected cells were not observed anymore 
upon infection with a fivefold diluted virus suspension. The MOI and MOI ratio could 
therefore not be determined. Nevertheless, the MOI ratio for FLN virus infections appeared to 
be considerably higher than fivefold. According to calculations, 5.1 % of the 644 counted 
cells would have been expected to be infected.  
 
Tab. 8: Comparison of the relative amount of virus applied for infection with the actually observed amount of 
infectious virus as determined by MOI calculation. MDCK II cells were infected with two dilutions of Influenza 
A/WSN wt, nTC and FLN virus, respectively. The fraction of infected cells was determined by 
immunofluorescence with anti-NP-FITC antibody and DAPI staining at 20 h p.i. by analyzing at least five different 
frames and 480 cells of each sample (2
nd
 column). The results are given as mean value with SEM (3
rd
 column). 
The multiplicity of infection (MOI) (4
th
 column) was calculated by MOI = –ln(P0). P0, the fraction of non-infected 
cells. The ratio of the MOI of the two virus dilutions (4
th
 column) was calculated for comparison with the actual 
dilution factor (1
st
 column).  
Thus, the effective titer of infectious virus particles in the virus preparations decreased more 
than expected upon dilution of the virus suspensions. The data suggests that by reduction of 
the number of virus particles the probability of infection per virus particle was decreased. This 
was in particular true for the mutant virus strains WSN nTC and WSN FLN. Conversely, the 
probability of infection per virus particle obviously increased with a higher virus 
concentration, when also the probability increases that one cell is infected by more than one 
virus particle. Individual defects can then be compensated. This correlation suggests that a 
fraction of the virus particles might be deficient of critical components for infection and might 
form infectious units only in combination with other defective virions. As the probability of 
infection with a specific number of virus particles at a given MOI is Poisson-distributed, the 
probability of infection with a combination of different virus particles generally increases 
with a higher MOI. In case of infectious units that consist of more than one virus particle, a 
higher MOI would therefore result in detection of a higher effective number of infectious 
units, which non-linearly increases with the virus concentration. The experimental data (Tab. 
8) is hence consistent with the existence of infectious units that comprise more than one virus 
particle. This analysis supports the assumption of a packaging defect in WSN nTC and WSN 
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FLN virus particles, albeit it does not stringently prove such a defect. Other explanations for 
this non-linear relation between virus dilution and the detectable virus titer (based on the 
number of infected cells) might be possible, e.g. infection of cells with some of the newly 
released virus particles (despite the lack of HA cleavage for activation) or the influence of 
cellular responses to differing multiplicities of infection. However, these effects would be 
expected to be similar for WSN wt virus. Considering the structural role of NP in the genomic 
complexes and modification of the packaging signal in the NP segment, it is reasonable to 
assume a packaging defect in the first place. For sufficient evidence, though, further 
experiments are required, e.g. cryo-electron tomography, quantitative RT-PCR or a reporter 
gene assay. 
As the replication kinetics of the WSN nTC and WSN FLN virus as a multi-cycle process 
could not be compared to those of WSN wt virus by standard growth curve, the course of 
infection of WSN wt, nTC and FLN virus (at MOI 1) was comparatively analyzed by NP-
specific immunofluorescence at various time points post-infection (Fig. 28D). As judged by 
the intensity of the NP signal, expression of NP progressed equally for all three strains. This 
finding indicates that expression rates were apparently not affected by the TC-tag. One 
significant difference between WSN wt and WSN mutant viruses was the larger fraction of 
cells displaying cytoplasmic NP found in wt virus infection at 20 h and in particular at 
24 h p.i. Besides, also the amount of cytoplasmic NP was higher in wt virus infections. These 
data indicate an attenuated formation and/or transport of vRNPs in nTC and FLN mutant virus 
infections. The above-postulated packaging defect of vRNPs in mutant virus particles might 
also have contributed to this result. When assuming infections with an incomplete set of 
genomic segments, the lack of segments encoding proteins like M1 and NEP would result in 
impaired nuclear export of vRNPs, which might partially explain the reduced number of cells 
with cytoplasmic NP signal.  
Incomplete genome packaging might furthermore be the reason for another observation 
presented in Fig. 28D. At 28 h p.i., the CPE of mutant virus-infected cells was more 
pronounced than in the wt case. Most cells in WSN nTC and FLN virus infections had died 
and detached at that time point, even the apparently uninfected (NP-negative) cells, whereas 
in wt virus infection, many infected and uninfected cells were still intact, suggesting that in 
mutant virus infections the number of infected cells was actually higher than the number 
detected by NP-specific immunofluorescence. A lack of NP expression in some of the infected 
cells might explain this observation, supporting the hypothesized packaging defect of the viral 
genome in the mutant viruses. Sequence analysis of segment 5 vRNA did not reveal any 
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sequence variations in WSN nTC or FLN virus which might explain a partial expression 
defect. Due to underestimation of the virus titer by immunofluorescence detection, the actual 
MOI applied for WSN nTC and WSN FLN virus infection might have been higher than the 
MOI of wt virus infection. Nevertheless, in the following, the virus titer was determined by 
immunofluoresence analysis of infected cells, as it provides a defined measure that has been 
shown to be reasonably comparable to wt virus infection in the applied range (Fig. 28D). 
4.2.6 Studying fluorescently labeled vRNPs during virus entry  
4.2.6.1 Analysis of FlAsH and ReAsH labeling of vRNPs in intact virus particles 
For application of the recombinantly generated WSN nTC and WSN FLN virus particles in 
cell entry studies, the labeling of vRNPs with FlAsH or ReAsH in intact virus particles was 
examined first. SDS-PAGE followed by fluorescence analysis of the size-separated viral 
proteins was performed to verify covalent binding of the biarsenical dye molecules to the TC-
tagged NP. Therefore, WSN wt, nTC and FLN virus particles were propagated, labeled and 
purified as described in 3.2.4.2. After labeling with 2 µM FlAsH or ReAsH, the virus was 
purified by sucrose gradient centrifugation and the protein concentration of each sample was 
determined. Equal amounts of each sample were applied to SDS-PAGE, and the fluorescence 
of FlAsH or ReAsH within the gel was detected with the Fluorescent Image Analyzer 
followed by Coomassie staining or Western blotting (Fig. 29). As the instrument settings did 
not allow optimal detection of FlAsH and ReAsH fluorescence, the absolute signal intensities 
should not be interpreted in comparison to Coomassie staining and Western blotting signals. 
The Coomassie-stained gels displayed the characteristic bands of the Influenza virus proteins 
(Fig. 29A, B). The relative amounts of NP (56 kDa) and M1 protein (27 kDa) varied among 
different preparations. A constantly lower incorporation of NP and M1 into mutant virus 
particles compared to wt virus preparations cannot be reported, but it was frequently observed 
(compare Fig. 29A & Fig. 29B). The results show that ReAsH and FlAsH bound specifically 
to TC-tagged NP of nTC and FLN virus, but not to wt NP. This was confirmed by comparison 
of FlAsH fluorescence with NP-specific immunodetection in Western blot analysis (Fig. 29C). 
Unexpectedly, though, the protein M1 was unspecifically (i.e. TC-tag independently) labeled 
with FlAsH and ReAsH (Fig. 29A, B). Western blotting and M1 immunodetection in 
comparison to the FlAsH-signal identified M1 as fluorescently labeled protein (Fig. 29C). 
Unspecific fluorescent protein bands after biarsenical labeling and SDS-PAGE have been 
reported previously [483,484]. It is possible that the signal is an artifact of the denaturated 
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Fig. 29: Analysis of purified FlAsH- and ReAsH-labeled virus by SDS-PAGE and fluorescence detection. 
Influenza A/WSN wt virus and WSN nTC and FLN mutant viruses were labeled with FlAsH or ReAsH, purified by 
sucrose gradient centrifugation and analyzed by SDS-PAGE (non-reducing conditions). The same amount of 
protein of each virus preparation was applied. The gels were scanned for (A) FlAsH or (B) ReAsH fluorescence 
and the total protein was visualized by Coomassie staining. (A) SDS-PAGE with ReAsH-labeled virus (200 µg 
protein of each preparation). (B) SDS-PAGE with FlAsH-labeled virus (104 µg of each sample). (C) Western 
blotting analysis of FlAsH-labeled virus (50 µg). FlAsH fluorescence in the gel was detected, followed by blotting 
and immunodetection of NP or M1. MM: molecular weight marker. 
state of M1 in SDS-PAGE and of the flexible accessibility of its cysteine residues. However, 
to exclude any contribution of M1 to the FlAsH or ReAsH signals in infected cells, the 
fluorescence of FlAsH and ReAsH in infected and non-infected cells was quantified in WSN 
wt virus-infected samples that were labeled with FlAsH and ReAsH simultaneously (Fig. 30). 
Typically, M1 is abundantly expressed at 20 h p.i. and is distributed throughout the infected 
cells. M1-specific staining should therefore result in an overall increase in fluorescence signal 
in infection. Infected cells were identified by immunostaining with anti-NP and Atto647N-
anti-mouse antibodies, and the signals of infected and non-infected cells (Fig. 30A, top) were 
quantified and compared (Fig. 30B). Obviously, native M1 in infection did not affect the 
cellular fluorescence background signals of FlAsH and ReAsH (nor did any viral protein) 
suggesting that M1 in its native state and under physiological conditions is not labeled with 
biarsenical dyes.  
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Fig. 30: Quantitative analysis of unspecific cellular FlAsH or ReAsH labeling induced by Influenza A/WSN virus 
infection. WSN wt virus-infected and mock-infected MDCK II cells were labeled with both FlAsH and ReAsH at 
20 h p.i. followed by immunostaining with anti-NP and Atto 647N-anti-mouse antibodies. (A) Confocal 
fluorescence images were acquired with constant settings. Scale bar, 10 µm. (B) FlAsH and ReAsH signals from 
24 infected and 48 non-infected cells of the WSN wt virus-infected sample were quantified using ImageJ. 
Infected cells were identified by positive anti-NP immunofluorescence signal. An increase of unspecific FlAsH or 
ReAsH background labeling was not induced by Influenza A/WSN virus infection. Results are given as mean 
intensity of the cell nuclei ± SD.  
4.2.6.2 Virus entry and infection with labeled WSN nTC and WSN FLN virus 
Purified and labeled virus was then applied to study virus entry in MDCK II cells. This 
experiment was performed in collaboration with Christian Sieben (Humboldt-Universität, 
Berlin) (Fig. 31). The TC-tagged viruses were labeled with 0.4 µM FlAsH overnight followed 
by staining of the viral envelope with the lipophilic marker DiD for another 2 h. The virus 
was filtrated with 200 µm pore size and was added to the cells for 10 min on ice. The uptake 
was then traced by confocal microscopy for more than 60 min, and z-stacks of images were 
acquired about every 10 min. The time points 5 min and 40 min p.i. are presented in Fig. 31 
for WSN FLN virus. Signals of FlAsH and DiD clearly colocalized in small dots within 
infected cells and were often found in the periphery of the cell nuclei as expected for virus 
particles after uptake. However, FlAsH and DiD signals did not separate within the 
observation period indicating that a separation of the viral envelope and the viral genome did  
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Fig. 31: Visualization of virus entry into MDCK II cells using FlAsH-labeled WSN FLN virus. This experimental 
data was kindly provided by Christian Sieben (Humboldt-Universität, Berlin). MDCK II cells were infected with 
Influenza A/WSN FLN virus labeled with FlAsH and the lipophilic dye DiD. The cells were incubated with virus on 
ice for 10 min and unbound virus was subsequently removed by washing. The cells were then stained with 
Hoechst dye (blue, DNA) and the uptake was observed for over 60 min. Infected cells (z-stack) at (a) 5 min and 
(b) 40 min after virus incubation show colocalization of FlAsH and DiD signals. The signals did not separate 
within the observation period and FlAsH was not found to accumulate in the cell nuclei. Scale bar, 10 µm.  
not occur. Consistently, an accumulation of the FlAsH signal in the cell nuclei was not 
observed, even though the viral genome would have been expected to reach the cell nuclei 
within the first hour [115]. The decrease of the DiD signal relative to the FlAsH signal 
observed over time might have been due to fusion of the viral membrane with the endosomal 
membrane; evidence for successful fusion was however not obtained in this assay. The same 
results were obtained when performing the experiment with WSN nTC virus (not shown). 
As the data indicate a failure of the TC-tagged and FlAsH-labeled viral genome to enter the 
nucleus, the assumed impairment of infection was tested by detection of viral NP expression 
several hours after infection with labeled virus particles (Fig. 32). As before, WSN nTC and 
WSN FLN virus, but also WSN wt virus were labeled with FlAsH or ReAsH for 1.5 h at RT 
and were then purified by sucrose gradient centrifugation. The protein content was determined 
and the same amount of virus protein of each strain (typically, 10 to 18 µg) was used to infect 
about 10
6
 cells. Similar amounts had also been used for imaging of virus entry (Fig. 31), 
although for imaging, the virus had been additionally filtrated to eliminate virus aggregates. 
Cells were incubated with the virus for 10 min on ice and the unbound virus was then 
removed. Infection was allowed to proceed for 17 h, followed by immunostaining of NP and  
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Fig. 32: Infection of MDCK II cells with FlAsH- or ReAsH-labeled virus. WSN wt, nTC and FLN virus preparations 
were labeled with 2 µM FlAsH or ReAsH for 1.5 h and purified by sucrose gradient (3.2.4.2). MDCK II cells 
(~1x10
6
 per dish) were then infected with equal amounts of the labeled virus according to protein 
determination (A: 10 µg; B: (a) 18 µg, (b) 15 µg, (c) 10 µg). At 17 h p.i., cells were fixed and immunostained with 
anti-NP-FITC antibody. DNA counterstaining was performed with DAPI. Images were acquired with constant 
settings and quantitatively analyzed for the fraction of infected (NP-positive) cells. (A) Infection with ReAsH-
labeled virus at 17 h p.i. Confocal fluorescence images show varying NP expression levels between wt, nTC and 
FLN virus-infected cells and a varying degree of the cytopathic effect. Scale bar, 10 µm. (B) Results of three 
independent experiments are represented in graphs a, b and c. Data in (a) are exceptionally referring to 
infection at 20 h p.i. At least seven frames were analyzed per sample and not less than 150 cells. Results are 
given as mean value ± SEM. The total fraction of infected cells (dark green/red) was determined as the number 
of NP expressing cells per number of cell nuclei (DAPI signals). The fraction of cells with high NP expression 
(light green/red) was evaluated by the number of NP nuclear signals reaching the maximally detectable pixel 
intensity (an arbitrary threshold that is met by all wt virus-infected cells) per total number of cell nuclei.  
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analysis by confocal fluorescence microscopy (Fig. 32A). According to NP expression and the 
CPE, the infectivity of FlAsH- and ReAsH-labeled WSN nTC virus was significantly reduced 
compared to WSN wt virus. One hundred percent of wt virus-treated cells were infected and 
expressed NP, whereas only a fraction of nTC virus-treated cells were infected according to 
NP detection. Consistently, the CPE was considerably reduced in WSN nTC virus infection 
compared to WSN wt virus infection, and the NP expression levels in nTC mutant virus-
infected cells were found to be far below those of wt virus-infected cells. Albeit, it was the 
WSN FLN virus-infected sample which was most attenuated compared to wt virus infection. 
The labeled WSN FLN virus was, with few exceptions, not able to infect the cells. A CPE was 
not detectable, and NP expression levels were very low compared to nTC and wt virus 
infections.  
For a quantitative comparison, the total fraction of infected (i.e. NP-expressing) cells was 
determined in three independent experiments (Fig. 32B). For both mutant virus strains, which 
were labeled with either FlAsH or ReAsH, the fraction of infected cells was found to be 
significantly lower than the fraction of infected cells in wt virus infection. These data suggest 
that even though numerous mutant virus particles were added and were probably endocytosed 
by the cells (compare Fig. 31) (possibly similar numbers as in wt virus infection where the 
same amount of protein was applied), only a small number of cells actually became infected. 
This is consistent with the finding that numerous FlAsH- and DiD-labeled virus particles were 
observed in virus-treated cells, but release of the genome and transport into the nucleus as a 
prerequisite for infection were not observed (Fig. 31). The small fraction of viral genomes of 
WSN nTC virus that entered the nucleus for successful infection (Fig. 32A, B), might have 
been missed when studying virus entry at the single particle level due to the large majority of 
non-infecting virus particles. It is also possible that a delayed release of the labeled genomes 
from the endosomes might have occurred only after the observation period (which was within 
the first hour after infection).  
Overall, the results of reduced infectivity are consistent with the finding that the viral 
genomes of the mutant viruses were largely unable to enter the cell nucleus. In conclusion, the 
use of fluorescently labeled WSN FLN virus to study virus entry is apparently not feasible. 
The use of labeled WSN nTC virus, though, might allow the acquisition of data regarding 
genome release and nuclear import. However, it remains doubtable if such data is 
representative for wt virus infection, e.g. for measuring the pH dependence of vRNP release 
or the kinetics of vRNP nuclear import. 
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As the signal intensities of NP expression (Fig. 32A) differed markedly among the three 
strains, not only the total fraction of infected cells, but also the fraction of infected cells with 
high NP expression was determined for each sample (Fig. 32B, pale green/red). To this end, 
an arbitrary fluorescence intensity threshold was chosen that included all wt virus-infected 
cells and that was supposed to exclude all cells with low NP signals which may result from 
incoming NP rather than newly expressed NP or from infection with strongly attenuated virus. 
It was found that cells with strongly attenuated NP expression represented a large fraction of 
the cells infected with labeled mutant viruses (Fig. 32B).  
4.2.7 Live-cell imaging of the fluorescently labeled viral genome in WSN nTC 
virus-infected cells 
Recombinant WSN nTC mutant virus was finally used to study fluorescently labeled viral 
genomes during transport and assembly in the cytoplasm of living infected cells.  
To this end, MDCK II cells were infected with WSN nTC virus (MOI 1). WSN wt virus-
infected cells served as control cells to assess unspecific background labeling. Since 
preliminary experiments had shown that ReAsH was better suitable to label cytoplasmic NP 
than FlAsH (4.2.4.3) and since the signal-to-noise ratio was generally better for ReAsH than 
for FlAsH labeling, biarsenical labeling of the infected cells was performed with ReAsH. At 
first, standard labeling was performed at 7 h p.i. with 1 µM ReAsH for 1 h at RT (3.2.2.4.3). 
Images were then acquired with an inverted epifluorescence microscope equipped with a 
highly sensitive CCD camera. For tracking the infected cells over time, images were recorded 
at an interval of 500 ms over a period of 10 min. Measurements were performed at 37 °C. 
ReAsH efficiently labeled nTC-NP, yielding characteristic nuclear and cytoplasmic NP 
signals as described above (4.2.4), and even though the cytoplasmic punctate signals were 
prominent, they were completely immobile. Any fast or slow movement could not be 
recorded within the acquisition period. Consequently, labeling conditions were altered 
attempting to preserve the cellular dynamics. The incubation temperature during labeling was 
shifted to 37 °C. Longer and shorter incubation times were tested as well as higher and lower 
dye concentrations. Time series were acquired between 7 h and 9 h p.i. or between 16 and 
19 h p.i. Specific labeling conditions were as follows: 2 µM ReAsH for 15 min; 0.1 µM 
ReAsH for either 15 min, 3 h or 4 h; 0.01 µM ReAsH for either 15 min, 1.5 h or 17 h, and 
finally 0.001 µM ReAsH for 17 h. The labeling results differed markedly regarding absolute 
signal intensity and bleaching sensitivity, but also with respect to the emergence of unspecific 
background (including punctate cytoplasmic signals). Labeling with 0.01 µM ReAsH for 
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1.5 h was found to yield the best results. However, all differently treated samples shared the 
fact that ReAsH-labeled fluorescent structures did not show any dynamic behavior with a 
very few exceptions. Small dot-like particles with very low signal intensities were observed 
occasionally to perform fast directional movements. There were however not more than four 
mobile particles in 30 samples and a multitude of measurements.  
Even though preliminary experiments had shown that ReAsH does not impair replication of 
WSN wt virus and did not affect the presence of cytoplasmic nTC-NP in infection (4.2.4.3), 
thereby implying that the cellular cytoskeleton was not critically affected by ReAsH labeling, 
these results suggest the interference of ReAsH labeling with cytoplasmic transport. For 
comparison, labeling was additionally performed with FlAsH, for which phenotypic effects on 
cells have not been reported. However, FlAsH labeling (1 µM, 1 h, 37 °C) yielded the same 
results as ReAsH labeling: Characteristic nuclear and cytoplasmic nTC-NP staining was 
detectable, but mobility of the fluorescently labeled structures was repeatedly not observed. 
Accordingly, it has to be concluded that WSN nTC virus cannot serve to analyze the dynamic 
behavior of fluorescently labeled vRNP complexes by single particle tracking. 
4.2.8 Correlated fluorescence and electron microscopy of infected MDCK II 
cells  
Even though TC-tagged mutant virus was not suitable to study the dynamic behavior of 
fluorescently labeled vRNPs during infection (4.2.7), ReAsH-labeled nTC-NP was 
furthermore tested for its usability in correlative fluorescence and electron microscopy for 
high resolution analysis of vRNP complexes in infection. Correlated electron microscopy is 
based on the formation of singlet oxygen by excited fluorophores like ReAsH, leading to 
oxidative polymerization of diaminobenzidine (DAB) which can then be visualized by 
electron microscopy [460]. Intrinsically fluorescent proteins, which form a β-barrel structure 
encompassing the fluorophore, are typically unable to mediate photoconversion of DAB. 
Therefore, the genetically encoded TC-tag binding to ReAsH provides the requirements to 
couple genetically encoded labeling with high resolution electron microscopy imaging. 
To test the applicability of ReAsH-labeled nTC-NP for correlated electron microscopy, 
samples were prepared as follows: MDCK II cells were infected with WSN wt virus or with a 
mixture of WSN nTC and WSN wt virus. The mixture of WSN nTC with WSN wt virus was 
used to dilute nTC-NP with wt NP in order to reduce possible intermolecular cross-linking of 
the TC-tag by ReAsH labeling. At 20 h p.i., the cells were labeled with ReAsH according to 
the standard protocol (3.2.2.4.3). Subsequent processing of the samples was based on the 
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Fig. 33: Transmission electron micrographs of infected MDCK II cells (20 h p.i.). (a) MDCK II cell, untreated. (b, 
c, d) Cells were infected with Influenza A/WSN wt virus. Representative images were selected with a focus on 
the cell nuclei. In (c, d), the cells were additionally stained with ReAsH and subjected to photoconversion 
treatment. (d) Enlargement from (c). (e) Mixed infection with Influenza A/WSN wt and nTC mutant virus 
followed by ReAsH staining and photoconversion. Nucleoli are marked by asterisk. Nu: nucleus, C: cytoplasm. 
Scale bar, (a, c) 2500 nm and (b, d, e) 1000 nm. 
protocol published by Gaietta et al. [460] and is described in detail in section 3.2.3.4. ReAsH-
labeled were recorded by fluorescence microscopy. To be able to retrieve the same cells for 
photoconversion treatment and for electron microscopy, the cells were grown on a gridded 
cover-slip. Photoconversion was then performed by intense illumination of the cells in the 
presence an oxygenated solution of DAB until the illuminated area displayed the brown color 
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of the DAB precipitate. Control samples with uninfected and wt virus-infected cells were 
neither labeled with ReAsH nor subjected to photoconversion treatment. Processing of the 
samples for transmission electron microscopy (TEM) was then performed by Maik Lehmann 
and Gabriele Drescher (Humboldt-Universität, Berlin). The cells which had previously been 
recorded by fluorescence microscopy and subjected to photoconversion could be precisely 
retrieved by the distinct, dark DAB precipitates. Cells were post-fixed with osmium tetroxide, 
stained with uranyl acetate and dehydrated, then embedded, trimmed and finally sectioned 
(3.2.3.4). TEM images of 70–90 nm sections were acquired and eventually compared to 
fluorescence images. Representative cells and patterns are shown in Fig. 33 and Fig. 34. 
An example of an uninfected and non-labeled control cell is given in Fig. 33a. It displays the 
typical morphology of MDCK II cells with a round-shaped nucleus and distinct, rounded  
nucleoli. For comparison, a nucleus from the WSN wt virus-infected cells is displayed in Fig. 
33b. Infected cells typically display a fragmented nuclear structure and irregular, coarse-
grained nucleoli. When WSN wt virus-infected cells were additionally labeled with ReAsH 
and treated with DAB for photoconversion (Fig. 33c, d), the contrast of the coarse-grained 
nucleolar structures was enhanced and they appeared as dark, electron-dense structures. 
Additionally, elongated and fine structures were observed throughout the nucleus. 
Furthermore, small, often spindle-shaped structures appeared as electron-dense accumulations 
in certain regions of the cytoplasm close to the nucleus. This can be seen in the bottom part of 
Fig. 33c and in the enlarged section in Fig. 33d. Upon magnification, cytoplasmic inclusions 
were found to be surrounded by dot-like structures resembling ribosomes (not shown). It 
should be emphasized that these cells did not express TC-tagged NP suggesting that the 
electron-dense structures were induced by infection with wt virus and photoconversion 
independently of the TC-tag. 
Equivalent electron-dense structures were found in cells infected with a mixture of WSN wt 
and WSN nTC virus: the coarse-grained, irregular nucleoli, the fine, elongated nuclear 
structures and the spindle-shaped cytoplasmic accumulations. It seems very tempting to 
speculate that the fine elongated structures in the nucleus might represent ReAsH-labeled TC-
tagged vRNPs. However, the correlation of ReAsH fluorescence signals with the occurrence 
of elongated nuclear structures in TEM images demonstrated that the fine, elongated 
structures occurred independently from the ReAsH signal in the nucleus (Fig. 34). Thus, these 
structures do not represent specifically ReAsH-labeled vRNPs. Phase contrast and ReAsH 
fluorescence images of infected and ReAsH-labeled cells acquired with an inverted 
epifluorescence microscope are shown in Fig. 34 a–c, respectively. This section of the sample  
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was selected and further analyzed by TEM (Fig. 34e). The corresponding cells in electron 
micrographs were identified by comparison of the cell shape, the cell cluster and distinctive 
features like the electron-dense spot in one of the cell denoted as cell no. 2.  Cell shapes did 
not perfectly match when comparing phase contrast with TEM images, as the TEM image 
shows only a 70–90 nm section of the cells, whereas the phase contrast image shows a 
projection of the whole cells by transmitted light, including also overlapping growth of the 
cells. Three cells designated “1”, “2” and “3” are shown at higher magnification in Fig. 34g. 
Cell 1 displayed a relatively smooth appearance of the cytoplasm and the nucleus without any 
particular electron-dense structures. The nucleus comprised three oval-shaped, intact nucleoli 
with the characteristic bright fibrillar centers surrounded by the dense fibrillar component 
(compare [485]). Enlarged sections of the nucleus are shown in Fig. 34h and i. According to 
characteristic changes which were observed upon infection of the cells with WSN wt virus 
(Fig. 33), cell 1 was presumably neither infected with WSN wt virus nor with WSN nTC virus 
which can be inferred from the absence of nuclear ReAsH staining (compare Fig. 34b). In 
contrast, cell 2 displayed ReAsH labeling of the nucleus indicating infection with WSN nTC 
virus. Whether a double infection with WSN wt virus had occurred cannot be assessed. The 
appearance of characteristic electron-dense structures as described before was less 
pronounced than in other cells, but clearly detectable. The presence of nucleoli could however 
not be observed. Some electron-dense structures were found in the cytoplasm and fine, 
elongated electron-dense structures were detected in the nucleus. Enlargements of these 
elongated nuclear structures are shown in Fig. 34j and k. They often appeared to be either 
branched or be an accumulation of tangled elements. However, these structures were not 
specific to nuclei with ReAsH-labeled nTC-NP. The same structures were found in cell 3 (Fig. 
34 l–o), which was devoid of any ReAsH signal. This cell featured numerous cytoplasmic 
spindle-shaped structures, irregular nucleoli and elongated and branched nuclear structures 
(Fig. 34n, o) suggesting that this cell had been infected with WSN wt virus. nTC-NP 
expression could be excluded by the absence of ReAsH labeling. 
In summary, the treatment of infected cells by ReAsH labeling and the photoconversion 
procedure apparently enhanced detection of subcellular electron-dense structures that were 
induced by WSN wt virus infection. Detection of structures specific to WSN nTC virus 
infection, i.e. detection of TC-tagged vRNPs, was however not achieved. Whether this was a 
technical problem or a systematic failure remains to be determined. Correlated electron 
microscopy using ReAsH photoconversion in Influenza virus-infected cells does not seem to 
provide a satisfactory specificity due to the large number of various electron-dense structures 
RESULTS 
146 
 
 
RESULTS 
147 
 
 
Fig. 34: Correlated fluorescence and transmission electron microscopy. MDCK II cells were infected with a 
mixture of Influenza A/WSN wt and nTC mutant virus and stained with ReAsH at 20 h p.i. (a, b) ReAsH 
fluorescence was recorded before photoconversion. (b, c, d) Phase contrast images showing dark, precipitated 
DAB were acquired after 15 min of photoconversion. (e–o) Transmission electron microscopy (TEM) of the 
photoconverted cells was performed. (e, f) The cluster of cells that had been detected by light microscopy was 
identified by cell shape and the electron-dense spot as landmark. (b, d, f) Three cells that were analyzed in 
more detail are numbered (“1”, “2”, “3”) and marked by outline. Only cell no. 2 displayed a bright nuclear 
ReAsH signal. (g) Overview of the cells from (f) with higher resolution. Cells no. 2 and 3 contained small, 
electron-dense, elongated or tangled nuclear structures and dark cytoplasmic spots, whereas cell no. 1 was 
lacking these structures and displayed round, intact nucleoli. Enlarged sections of the three cells are shown in 
(h–o): (h, i) Nuclear sections of cell no. 1. The nucleoplasm was relatively smooth with a few small spots. (j, k) 
Regions of the cell nucleus no. 2 with electron-dense, irregular structures. (l, m) The same type of electron-
dense nuclear structures were enlarged from cell nucleus no. 3. (n, o) Sections of cell no. 3, rich in nuclear and 
cytoplasmic dark structures and with irregular nucleoli. Nu: nucleus, C: cytoplasm, asterisk: nucleolus. Scale bar, 
(a–f) 5000 nm, (g) 2500 nm, (h, j, k) 500 nm and (i, l–o) 1000 nm. 
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in infected cells. Therefore, ReAsH photoconversion for detection and high-resolution 
imaging of TC-tagged viral proteins during infection was not further pursued and is not 
recommended.  
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4.3 Analysis of intrinsic subcellular targeting of NP using 
fluorescent NP fusion proteins  
In the third part of this work, the intrinsic properties of NP were studied in a cellular context 
in the absence of virus infection, using fluorescent NP fusion proteins. The subcellular 
distribution, sites of preferential targeting and site-specific mobility of NP in living cells were 
analyzed. Initially, expression of NP constructs was studied in preparation for the use of these 
fluorescent NP fusion proteins in the context of viral infection (section 4.4). Repeated 
observation of a non-homogeneous nuclear distribution, however, prompted a detailed 
analysis of the subnuclear targeting of NP. While NP is known to localize to the cell nucleus, 
its prominent subnuclear distribution has not been characterized yet. Expression of NP and 
fluorescent NP constructs has been investigated in previous studies 
[121,123,124,260,299,360,363], but their focus was the nuclear-cytoplasmic transport of NP 
and the role of NP in transport processes during infection. Since proteomic and yeast-two-
hybrid screens have identified numerous cellular interaction partners of NP in recent years 
[103,358], these findings indicate a role of NP in host cell interactions apart from transport 
processes, such as the inhibition of the host’s antiviral response [347,350]. In the present 
study, the site-specific aspect of NP interactions with the host cell, in particular with the cell 
nucleus, was addressed based on the concept of functional compartmentalization of the 
nucleus, which was introduced by Schul and coworkers in 1998 [486] and was consolidated 
during the past years [487,488,489,490]. This concept suggests that the spatial correlation of 
subnuclear structures is not random and has functional implications. Genomes of other 
nuclear replicating viruses have previously been reported to be targeted to specific subnuclear 
sites by viral proteins involved in viral transcription and replication [491,492].  
Does NP also target specific subnuclear domains either to recruit cellular machinery for viral 
replication or to interfere with host cell processes? The subnuclear localization of 
exogenously expressed NP was hence investigated in more detail than in previous studies. To 
this end, fluorescent and photoactivatable protein tags were used to study the dynamic 
behavior of NP and sites of preferential association. Furthermore, special NP constructs with a 
nuclear export signal (NES) were generated to lower the local nuclear NP concentration and 
to reveal sites of high affinity for NP.  
In the first part of this chapter, expression and detection of various NP constructs will be 
characterized. In the second part, the application of these constructs to analyze subnuclear 
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targeting of NP will be described, while in the third part cytoplasmic localization of NP will 
be addressed.  
4.3.1 Expression and analysis of fluorescent NP fusion proteins 
4.3.1.1 Expression of NP constructs  
A variety of fusion constructs of Influenza A/FPV/Rostock/34 NP with fluorescent proteins 
was generated using standard molecular biology techniques (3.2.1). An overview of all 
constructs and technical specifications are given in Tab. 2 (3.1.1.8).  
First, fusion proteins of NP with monomeric enhanced yellow fluorescent protein (mEYFP) 
were expressed in MDCK II (Fig. 35) and CHO-K1 (Fig. 36) cells. C-terminal (a–c) and N-
terminal (d–f) mEYFP-tags yielded comparable results in both cell types. As expected from 
previous studies [121,123], NP constructs accumulated predominantly in the cell nucleus. 
Characteristic patterns of heterogeneous subnuclear distribution were observed. A selection of 
frequently detected expression patterns is shown in Fig. 35 and Fig. 36: NP fusion proteins 
showed varying degrees of local enrichment in the nucleoplasm. They distributed either 
uniformly with a granular appearance (a, d), or they were found to be locally enriched in 
speckles or bright irregular structures (b, e). Larger accumulations appearing more compact 
and highly enriched with fluorescent NP fusion proteins and filling major parts of the nuclear 
volume were also frequently observed (c, f). Additionally, a small fraction of mEYFP-tagged 
NP always localized to nucleoli (indicated by arrowheads). But only in a subset of cells, 
nucleoli appeared as prominent bright structures in which the fluorescent construct was 
enriched relative to the surrounding nucleoplasm (a, d). Nucleoli were identified by high 
contrast in DIC images. A nucleolar targeting signal of NP was reported previously [123].  
Upon expression of mEYFP alone, the free fluorescent protein distributed rather 
homogeneously throughout the cells with a slight bias to accumulate in the cell nucleus (Fig. 
35g), demonstrating that the intrinsic properties of mEYFP were not responsible for the 
above-described subcellular distribution of the mEYFP-tagged NP constructs. 
The same patterns of subcellular distribution that were detected for NP constructs at 24 h p.t. 
were also found at earlier and later times post-transfection (Fig. 37): Granular and uniformly 
distributed nuclear NP-mEYFP as well as irregular subnuclear structures highly enriched with 
NP-mEYFP were detected at 4 h, 7 h and 48 h p.t. The tendency to form large, localized 
accumulations was however strongest around 24 h p.t. when expression levels were high, 
whereas a more uniform distribution with a granular appearance and small speckles was more 
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frequently found at 4 and 48 h p.t., indicating a correlation with expression levels of NP 
fusion proteins. A slight increase of the cytoplasmic mEYFP signal over time was possibly 
caused by free fluorophore molecules which formed as a byproduct in NP-mEYFP expressing 
cells as demonstrated by immunoblotting (Fig. 40A (c)). A shift of NP localization over time 
due to intrinsic properties of NP cannot be excluded though. 
 
Fig. 35: Expression of mEYFP fusion proteins of NP in MDCK II cells (24 h p.t.).  The cells were transfected with 
(a–c) NP-mEYFP, (d–f) mEYFP-NP or (g) mEYFP and fixed at 24 h p.t. The mEYFP fluorescence signal and 
corresponding transmitted light DIC images were recorded by confocal fluorescence microscopy. Both NP 
constructs showed predominantly nuclear accumulation and similar patterns of local enrichment in the cell 
nucleus. A selection of representative images is shown. Arrowheads point to nucleoli. Scale bar, 10 µm. 
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Fig. 36: Expression of mEYFP fusion proteins of NP in CHO-K1 cells (24 h p.t.). (a–c) NP-mEYFP and (d–f) 
mEYFP-NP were expressed in CHO-K1 cells, and EYFP fluorescence was analyzed in living cells by confocal 
fluorescence microscopy. Both constructs displayed nuclear accumulation and similar patterns of local 
enrichment in the cell nucleus with a varying degree of heterogeneity. Representative images are shown. 
Arrowheads point to nucleoli. Scale bar, 10 µm. 
It was speculated that the observed non-homogeneous distribution of NP constructs in the 
nucleus might result from preferential association of NP with specific subnuclear domains. To 
test this assumption and to further exclude the possibility that self-polymerization as an 
intrinsic feature of NP caused the formation of unspecific precipitates, a fusion protein of NP 
with the photoactivatable fluorophore Dendra2 was generated to monitor protein dynamics, 
and mutations known to prevent NP oligomerization were subsequently introduced into these 
NP probes.  
Upon expression in MDCK II cells, the fusion protein NP-Dendra2 displayed a predominantly 
nuclear localization and formed local subnuclear accumulations comparable to those formed 
by mEYFP-tagged NP (Fig. 38 a–c). The free fluorophore Dendra2, on the contrary, 
distributed evenly throughout control cells, but was largely absent from nucleoli (Fig. 38d). 
By introducing the amino acid substitutions E339A or R416A into the NP sequence of NP-
Dendra2, yielding NP-E339A-Dendra2 and NP-R416A-Dendra2 (Tab. 2), two different 
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Fig. 37: Expression of NP-mEYFP in CHO-K1 cells at different time points. The EYFP fluorescence signal of NP-
mEYFP expression was analyzed by confocal fluorescence microscopy in living CHO-K1 cells at 4 h p.t. (a, b), 7 h 
p.t. (c, d) and 48 h p.t. (e, f). At each time point, the signal was detected predominantly in the cell nuclei. 
Representative examples of transfected cells with a uniform, granular distribution of the construct (a, c, e) or 
with irregularly structured, heterogeneous local accumulations (b, d, f) in the cell nucleus are presented. Scale 
bar, 10 µm.  
monomeric mutants of NP were generated. It was previously shown by electron microscopy 
[93] and static light scattering [493] that both mutations prevent oligomerization of NP. 
Remarkably, the two monomeric constructs displayed the same patterns of non-homogeneous 
subnuclear distribution upon expression in MDCK II cells as the wild-type construct, ranging 
from a uniformly granular appearance to a speckled appearance or even the formation of large 
irregular structures highly enriched with the respective protein (Fig. 39). Small, speckled 
structures were however more frequently observed for the monomeric constructs than in case 
of wild-type NP-Dendra2, while larger accumulations were less frequently found. These 
results thus clearly demonstrate that the local accumulations of NP constructs within the 
nucleus are not the result of NP polymerization, although the formation of larger 
accumulations was apparently promoted by the ability of NP to self-assemble.  
The application of Dendra2 constructs to monitor local protein dynamics as a measure for 
site-specific affinities will be described in section 4.3.2.  
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Fig. 38: Expression of NP-Dendra2 fusion protein in MDCK II cells. (a–c) MDCK II cells were transfected with 
NP-Dendra2 and fixed at 16 h p.t. Dendra2 fluorescence was analyzed by confocal fluorescence microscopy. The 
construct accumulated in the cell nucleus with a variable degree of heterogeneous local enrichment. 
Representative images are shown. (d) Control cells expressing free Dendra2 at 16 h p.t. Scale bar, 10 µm.  
Expression of the full-length proteins mEYFP-NP, NP-mEYFP, NP-Dendra2, NP-E339A-
Dendra2 and NP-R416A-Dendra2 was verified by Western blot analysis of transfected cells 
by immunodetection of either the mEYFP-tag (Fig. 40A) or the NP moiety (Fig. 40B). An 
antibody for detection of Dendra2 was not available. In case of NP-specific detection, only 
protein bands of the size of the full-length proteins (~83 kDa) were detected. Upon detection 
of the mEYFP-tag however, additional bands demonstrated the presence of truncated mEYFP-
tagged proteins in case of NP-mEYFP expression (Fig. 40A, c); the major band aside from the 
full-length protein corresponded in size to the free fluorescent protein (27 kDa). The failure to 
detect the truncated forms of NP-mEYFP by monoclonal anti-NP antibody (Fig. 40B) was 
presumably due to the absence of the antibody-specific epitope from the remaining protein 
fragments. Neither truncated proteins nor free fluorescent protein were observed by 
immunodetection of mEYFP in samples expressing the N-terminally tagged mEYFP-NP (Fig. 
40A, b). This leads to the conclusion that mEYFP fluorescence signals obtained by 
fluorescence imaging can unambiguously be assigned to the full-length fusion protein in case 
of NP expression with an N-terminal mEYFP-tag (mEYFP-NP), whereas expression of the C-
terminally tagged NP (NP-mEYFP) was apparently tainted with the formation of free mEYFP 
and truncated mEYFP-tagged proteins. When NP-mEYFP and mEYFP-NP expression were 
compared by fluorescence microscopy, contributions of free mEYFP to the NP-mEYFP signal 
were not obvious though (Fig. 35, Fig. 36). Both constructs apparently displayed qualitatively
RESULTS 
155 
 
 
Fig. 39: Expression of NP monomeric mutant constructs NP-R416A-Dendra2 and NP-E339A-Dendra2 in 
MDCK II cells (16 h p.t). Cells were transfected with (a–d) NP-R416A-Dendra2 and (e–f) NP-E339A-Dendra2. 
Dendra2 fluorescence was analyzed in living cells by confocal fluorescence microscopy. Representative images 
are shown. Similar to wt NP constructs, the monomeric NP mutants localized predominantly to the cell nucleus 
and formed patterns of local accumulations with varying extents of local enrichment. In (h), the Dendra2 signal 
was detected with considerable detector overload to visualize also fluorescence of lower intensity in nucleoli. 
Scale bar, 10 µm.  
the same subcellular behavior. This was presumably due to the relatively small fraction of free 
mEYFP in NP-mEYFP expressing cells and its homogenous distribution within the cells. 
Truncated forms of NP-mEYFP larger than free mEYFP represented a minor fraction of the 
expressed protein and did apparently not show a noticeable effect on the overall distribution 
either. This was confirmed by coexpression of C-terminally tagged NP-mEYFP with an N-
terminally tagged red-fluorescent NP construct (mCherry-NP, Tab. 2) (data not shown). 
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Fig. 40: Western blot analysis of NP fusion protein expression in MDCK II cells. (A) Cell lysates of transfected 
cells expressing (a) mEYFP-NP-NES, (b) mEYFP-NP and (c) NP-mEYFP were prepared at 24 h p.t. by addition of 
reducing sample buffer. They were analyzed by SDS-PAGE and Western blotting. Immunodetection of mEYFP 
was performed with polyclonal anti-GFP antibody and demonstrates efficient expression of the three mEYFP-
tagged constructs. The major detected bands correspond to the full-length proteins (~83 kDa). In case of NP-
mEYFP (c), additional bands demonstrate the presence of truncated forms of the construct, the main band 
corresponds in size to the free fluorescent protein (27 kDa). (B) Transfected cells were processed as in (A). 
Immunodetection of NP constructs was performed with monoclonal anti-NP antibody. Full-length constructs 
were detected as single bands: (a) mEYFP-NP-NES, (b) mEYFP-NP, (c) NP-mEYFP, (d) NP, (e) NP-NES, (f) NP-
Dendra2, (g) NP-R416A-Dendra2, (h) NP-E339A-Dendra2, and (i) Dendra2-NP-NES.  
The presence of truncated fluorescent proteins had to be considered more carefully, however, 
in case of dynamics measurements with Dendra2 constructs (section 4.3.2). It is postulated 
here that the results for mEYFP-tagged NP constructs can be extrapolated to other fluorescent 
protein tags which are fused to NP in the same way, e.g. Dendra2. Since the presence of free 
Dendra2 could not be detected by Western blotting due to the lack of Dendra2-specific 
antibody, it was therefore assumed that expression of C-terminally tagged NP-Dendra2 (Fig. 
38) was – just like in case of NP-mEYFP – accompanied by the formation of free fluorescent 
protein and truncated forms of the construct. Consequently, an NP fusion protein with N-
terminal Dendra2-tag was furthermore generated, which was – by analogy with mEYFP-NP – 
expected to be untainted by the formation of free Dendra2 or truncated fluorescent proteins, 
thus suitable to monitor Dendra2-NP mobility as performed in 4.3.2. 
Finally, the subcellular distribution of the fluorescent NP constructs was verified to be 
representative for the expression of untagged wild-type NP. MDCK II cells expressing NP 
were therefore fixed at 24 h p.t., and the subcellular distribution of NP was visualized by 
immunofluorescence staining of NP (Fig. 41). NP accumulated in the cell nuclei and showed 
different types of subnuclear distribution with patterns of local enrichment analogous to 
fluorescent NP fusion proteins: In some of the cells, NP was enriched in nucleoli (Fig. 41a), 
while in other cases NP accumulated predominantly in the nucleoplasm and adopted a 
granular appearance (Fig. 41b). Larger structures, compact and highly enriched with NP as in 
case of fluorescent NP fusion proteins (Fig. 35b, e), were however not observed for wild-type 
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NP. Nevertheless, a different type of large, irregular local accumulations was observed by 
immunodetection of NP. These appeared elongated and curved, surrounding areas depleted of 
NP (Fig. 41c). It was suspected that these structures were equivalent to the compact, larger 
structures observed for fluorescent NP fusion proteins, but that only the periphery of these 
structures was efficiently labeled by immunostaining (implying a very dense packing).  
 
Fig. 41: Immunofluorescence detection of NP expression in MDCK II cells (24 h p.t.). (a–c) MDCK II cells were 
transfected with NP (from Influenza A/FPV). (d) Control cells were mock-transfected. The cells were fixed at 
24 h p.t., immunostained with anti-NP and Alexa568-anti-mouse antibodies and analyzed by confocal 
fluorescence microscopy. NP localized to the cell nuclei and displayed different patterns of subnuclear 
distribution. Representative images are shown. Scale bar, 10 µm. 
4.3.1.2 Comparative analysis of immunofluorescence and intrinsic protein 
fluorescence signals 
Even though wild-type NP displayed a non-homogeneous subnuclear distribution just like 
fluorescent NP fusion constructs, slight differences in the appearance of immunofluorescence 
signals and signals of fluorescent protein tags (compare Fig. 35 and Fig. 38 with Fig. 41) 
prompted a comparative analysis of the two detection methods. For this analysis, mEYFP-NP-
NES was used, an mEYFP-tagged NP construct with a C-terminal nuclear export signal 
(NES). This construct provided reduced amounts of NP fusion protein in the nucleus and was 
thereby used later on in this study to unravel sites of preferential association (see 4.3.2). 
mEYFP-NP-NES was expressed in MDCK II cells which were additionally immunostained 
for NP. The signal of intrinsically fluorescent mEYFP was then compared to the signal 
introduced by labeling with NP-specific antibodies (Fig. 42). Expression of the full-length 
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Fig. 42: Comparison of NP immunofluorescence (IF) and EYFP signals in mEYFP-NP-NES-expressing cells. 
MDCK II cells were transfected with mEYFP-NP-NES and immunostained with anti-NP and Alexa568-anti-mouse 
antibodies at 24 h p.t. mEYFP and IF (Alexa568) fluorescence signals were sequentially recorded by confocal 
fluorescence microscopy. Images (a–d) illustrate the discrepancies between IF and instrinsic mEYFP 
fluorescence. The nuclear export signal (NES) of mYFP-NP-NES caused cytoplasmic accumulation of the 
construct in a subset of cells, an example of which is shown in (d). Arrowheads point to nucleoli. Scale bar, 
10 µm. 
protein mEYFP-NP-NES and the absence of truncated fluorescent proteins was verified by 
Western blotting (Fig. 40, a). Intrinsic mEYFP fluorescence is therefore assumed to accurately 
report both localization and relative amounts of the full-length NP construct. Nevertheless, 
striking differences between the NP-specific immunofluorescence signal and the mEYFP 
signal were observed within cells. In comparison to mEYFP fluorescence, antibodies 
preferentially labeled cytoplasmic NP rather than nuclear NP (Fig. 42 a–d), leading to the 
detection of different nuclear-cytoplasmic ratios by immunofluorescence and mEYFP 
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fluorescence imaging. Presumably, this was the result of a better accessibility of the 
cytoplasmic compartment for immunostaining. Due to uneven permeation of the antibody 
through the cells or variable exposure of the NP epitope, immunofluorescence labeling with 
NP-specific antibodies might be generally more prone to the detection of artifacts than the 
detection of NP by mEYFP-tag. Prominent differences between immunofluorescence and 
mEYFP signals were also observed within the nucleus: While mEYFP-NP-NES was spread 
evenly throughout the entire nuclear volume according to mEYFP fluorescence, 
immunostaining indicated a preferential accumulation in the periphery of the cell nucleus 
(Fig. 42 a–c). Preferential peripheral staining might have been caused by a limited perfusion 
of the inner nuclear compartment with anti-NP antibodies and thus by formation of an 
antibody concentration gradient. However, other explanations are possible, e.g. a site-specific 
selective exposure of the NP epitope recognized by the monoclonal anti-NP antibody. 
Immunofluorescence signals in some cases even implied a polarized distribution of mEYFP-
NP-NES in the nucleus (Fig. 42b). Here, the most pronounced immunofluorescence signals 
typically pointed away from neighboring transfected cells, whereas mEYFP fluorescence 
signals displayed a non-polarized distribution in the same cells, suggesting again irregularities 
of the immunostaining, for instance variations of the antibody concentration within the 
sample due to local depletion or the above-mentioned differential accessibility of the NP 
epitope.  
Another major difference observed refers to the detection of mEYFP-NP-NES in nucleoli. 
Direct comparison of mEYFP and immunofluorescence signals revealed that the relative 
amount of mEYFP-NP-NES in nucleoli was typically underestimated by immunofluorescence 
detection (Fig. 42 c–d). Unlike the mEYFP signal, which frequently indicated similar levels of 
mEYFP-NP-NES in the nucleoplasm and in nucleoli, the immunofluorescence signal implied 
that nucleoli were depleted of mEYFP-NP-NES relative to the surrounding nucleoplasm (Fig. 
42c). The same failure to detect nucleolar mEYFP-NP-NES by immunostaining was also 
observed in those cell nuclei that were largely devoid of the NP construct due to the function 
of the nuclear export signal (Fig. 42d). A predominantly cytoplasmic localization of mEYFP-
NP-NES was observed in 42 ± 9 % of the transfected cells (mean ± SD, determined from four 
independent experiments including a total of 322 cells). In these cells, the remaining nuclear 
mEYFP-NP-NES associated with nucleoli and speckled structures and was clearly detectable 
by the mEYFP fluorescence signal, whereas it was only poorly detectable by the 
immunofluorescence signal. About the reasons for this lack of nucleolar and subnuclear 
labeling can be speculated as before. Nucleoli were previously shown to be freely accessible 
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for proteins up to 150 kDa, but the available free volume for penetrating proteins was shown 
to be reduced compared to the surrounding nucleoplasm, causing a local decrease of freely 
diffusing proteins like EGFP in nucleoli [494,495]. This might explain the here encountered 
reduced labeling efficiency of nucleolar proteins by immunostaining with antibodies of 
150 kDa. Poor antibody penetration into nucleoli was reported before [496]. 
The quality of nuclear signals obtained by mEYFP fluorescence was generally better 
compared to signals obtained by immunofluorescence detection (due to higher and more 
distinct signals). Intrinsic protein fluorescence was therefore considered promising to gain 
information on NP subnuclear organization which might have remained unnoticed in previous 
immunofluorescence studies (see 4.3.2). Moreover, the use of intrinsically fluorescent fusion 
proteins allows studies in living cells.  
The influence of self-quenching of the fluorophores or fluorescence energy transfer between 
mEYFP and the antibody-coupled fluorophore Alexa568 were considered negligible in this 
analysis since both Alexa568 and mEYFP have a low tendency of self-quenching [497], and 
energy transfer from mEYFP to Alexa568 (which requires a close spatial proximity, i.e. high 
local concentrations or direct interaction) was not consistent with obtained results: Even 
though site-specific energy transfer can potentially account for higher Alexa568 signals in the 
cytoplasm or the nuclear periphery, the concentrations of mEYFP-NP-NES were generally 
lowest in the cytoplasm and thus cannot explain elevated local energy transfer from mEYFP 
to Alexa568. Furthermore, mEYFP-NP-NES was found to be evenly distributed throughout 
the nucleus also in the absence of immunostaining, not displaying any enrichment in the 
nuclear periphery (data not shown). Detection of peripheral enrichment of mEYFP-NP-NES 
was thus unique to immunofluorescence detection.  
Finally, it should be mentioned that the cell-to-cell variability was rather high and not every 
transfected cell displayed the differences between immunofluorescence and mEYFP signals 
that were described here. The peripheral nuclear accumulation detected by 
immunofluorescence seemed to be more pronounced in cells with high expression levels, and 
differences in detection of nucleolar NP seemed to be affected by a yet unknown factor. 
However, this comparative analysis clearly showed the general susceptibility of 
immunofluorescence detection to depict artifacts which do not reflect the actual local protein 
concentrations.  
According to these results, the use of intrinsically fluorescent protein tags is favorable for 
qualitative and quantitative analysis of NP subcellular distribution in comparison to 
immunofluorescence detection. Especially the limited accessibility of nuclear NP for 
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immunostaining strongly suggested the preferential use of intrinsically fluorescent constructs 
for analysis of the subnuclear localization of NP in following experiments.  
4.3.1.3 Comparison of NP expression in infection and transfection  
The results obtained for expression of NP constructs in the absence of other viral components 
were further compared to NP expression in infection (Fig. 43). In infected cells, nuclear 
accumulation of NP was observed already at 3 h p.i., but in contrast to transfected cells, the 
distribution of NP shifted to a predominantly cytoplasmic localization later during infection. 
Cytoplasmic NP appeared here as punctate signals with a laterally polarized distribution, and 
it frequently accumulated prominently at the plasma membrane (Fig. 43 c–h). Comparable 
punctate cytoplasmic signals were identified as vRNP complexes by colocalization with
 
Fig. 43: Immunofluorescence detection of NP in a time series of Influenza A/FPV virus infection. MDCK II cells 
were infected (MOI 30) and subsequently fixed at (a, b) 3 h p.i., (c, d) 5 h p.i., (e, f) 7 h p.i. or (g, h) 9 h p.i. 
Immunostaining was performed with anti-NP and Cy2-anti-mouse antibodies. Confocal fluorescence images of 
the infected cell layer are shown in the top row (a, c, e, g). Individual cells at higher magnification are presented 
as fluorescence and transmitted light images in (b), (d), (f) and (h). NP localization changed from predominantly 
nuclear at 3 h p.i. to a more cytosolic localization over time. Scale bar, 10 µm. 
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vRNA in previous studies [297]. Consistently, such punctate cytoplasmic signals were 
completely absent from transfected cells expressing only NP or fluorescent NP fusion proteins 
(Fig. 41, Fig. 35).  
In the nucleus of infected cells, viral NP appeared either granular (Fig. 43b) or largely 
homogenous (Fig. 43f), but prominent local accumulations highly enriched with NP as seen in 
expression of NP alone were never observed in infected cells (compare Fig. 35, Fig. 36 and 
Fig. 38 with Fig. 41). According to these results, a heterogeneous organization of nuclear NP 
with a granular or speckled appearance is a common feature that is found for NP in infection 
as well as for NP when expressed alone. However, larger nuclear accumulations highly 
enriched with NP do not seem to represent structures relevant to infection. They might rather 
be artifacts of NP expression in the absence of infection. 
4.3.1.4 NP localizes to the interchromatin space in infection and in transfection 
Counterstaining of infected and transfected cells with DAPI revealed that viral NP in 
infection, and also mEYFP-tagged NP when expressed alone, accumulated preferentially in 
the interchromatin space (Fig. 44): In infection, viral NP adopted a granular organization and 
distributed throughout the nucleus preferably into those spaces which were largely devoid of 
DNA, except for nucleoli (Fig. 44e). The chromatin in infected cells appeared unaltered 
compared to the chromatin of untreated cells (Fig. 44a), forming a dense network throughout 
the nucleus and accumulating in tight contact around the nucleoli. In transfected cells, NP-
mEYFP also localized preferentially to interchromatin spaces, and this apparently resulted in 
the characteristic heterogeneous distribution of NP-mEYFP in the nucleus (Fig. 44b). This 
finding implies that the interchromatin space might represent the underlying template of NP 
nuclear organization, defining the sites of local NP-mEYFP accumulation. It should be noted 
at this point that the chromatin in general does not exclude proteins smaller than 100 kDa 
[495,498]. Instead, a high degree of penetration of such proteins into the chromatin network 
was reported, the intranuclear space being freely accessible, which is consistent with the 
homogeneous distribution observed for mEYFP and Dendra2 in the nucleus (Fig. 35g, Fig. 
38d). It was further reported that the mobility of such small proteins does not correlate with 
chromatin density and that the chromatin does not obstruct their diffusion, suggesting that 
preferential association of NP-mEYFP with the interchromatin space as observed here must 
be caused by other factors, e.g. specific interactions with components of the nucleoplasm.  
In cases of small, punctate and speckled accumulations of NP-mEYFP, the chromatin 
structure was not evidently changed (Fig. 44b). It was remarkable, however, that the 
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Fig. 44: NP preferentially accumulates in the interchromatin space and can induce rearrangement of 
chromatin. MDCK II cells (a) untreated, (b, c, d) transfected with NP-mEYFP (11 h p.t.) and (e) infected with 
Influenza A/FPV virus (MOI 100, 10.5 h p.i.) were fixed, permeablilized and counterstained with DAPI. Infected 
cells were additionally immunostained with anti-NP and Alexa568-anti-mouse antibodies. mEYFP fluorescence 
and immunofluorescence signals were detected by confocal fluorescence microscopy. Representative images of 
nuclei in NP-mEYFP expressing cells (b–d) illustrate the displacement of chromatin by different degrees of NP-
mEYFP accumulation in the nucleus. Scale bar, 10 µm. 
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chromatin seemed to be displaced by NP-mEYFP with increasing accumulation of NP-
mEYFP into larger structures, (Fig. 44c, d). In cases of extensive nuclear accumulation of the 
construct, even major rearrangements of the chromatin were observed (Fig. 44d). The 
chromatin was then found confined within tubular structures across the nucleoplasm or along 
the rim of the nucleus, while densely packed NP-mEYFP filled the largely DNA-free nuclear 
volume. As neither the formation of compact structures highly enriched with NP nor 
rearrangement of chromatin was observed in infected cells, these effects seemed to be 
artifacts of NP (over)expression in the absence of infection. However, general aspects of the 
interplay between NP and chromatin are implied, and despite of the considerable impact of 
NP-mEYFP on cellular chromatin, a cytopathic effect of the expression of NP constructs was 
not observed within the first 48 h p.t. (compare Fig. 37).  
4.3.2 Analysis of subnuclear targeting of NP                                                 
Upon expression in mammalian cells, NP constructs accumulate predominantly in the cell 
nucleus and distribute non-homogeneously in the interchromatin space as described in the 
previous section (4.3.1). Exclusion from the chromatin network and local enrichment of NP 
constructs specifically in the nucleoplasm indicate sites of preferential association for NP. 
This is supported by the formation of local nuclear accumulations even by monomeric NP 
constructs. In the here following part, the hypothesis of specific subnuclear targeting of NP 
was therefore further investigated.  
4.3.2.1 Analysis of subnuclear targeting of NP using nuclear export constructs of 
NP 
First, to exclude that local accumulations of NP constructs were caused by precipitation of 
overexpressed protein, the NP concentration in the nucleus was decreased by fusion of NP 
constructs to a C-terminal nuclear export signal (NES) (amino acid sequence: 
LQLPPLERLTL) [499]. It was shown previously that the NES does not prevent transport of 
proteins into the nucleus, but causes rapid nuclear export via a CRM1-dependent pathway 
[257]. One of these constructs, mEYFP-NP-NES, comprising NP C-terminally fused to the 
NES and N-terminally linked to mEYFP, was introduced already in section 4.3.1 and was 
shown to be expressed as full-length protein by Western blot analysis (Fig. 40). Upon 
transfection of MDCK II cells (Fig. 45), HeLa cells (Fig. 48) or CHO-K1 cells (not shown), 
some of the cells displayed an almost exclusive cytoplasmic localization of mEYFP-NP-NES, 
leaving the cell nuclei largely devoid of the protein. However, a fraction of mEYFP-NP-NES 
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Fig. 45: Expression of NP and M1 constructs comprising a C-terminal nuclear export signal (NES). MDCK II cells 
were transfected with (a, b) mEYFP-NP-NES or (c) NP-NES together with CFP-M1-NES, and they were fixed at 
20 h p.t. DNA counterstaining was performed with DAPI (a). Nucleoli were highlighted with propidium iodide 
(PI) staining (b), and immunostaining for NP was performed with anti-NP and Alexa568-anti-mouse antibodies 
(c). Images were acquired by confocal fluorescence microscopy. Representative images of cells are shown that 
display nuclei largely depleted of NP and M1 constructs. Scale bar, 10 µm. 
was found to remain associated with two distinct types of subnuclear structures, indicating 
subnuclear domains of high affinity for the construct. The first structure could easily be 
identified as nucleoli by colocalization with propidium iodide staining [500] (Fig. 45b). This 
was consistent with the previously reported association of NP with nucleoli in infected and in 
transfected cells [123,361]. The second structure resistant to nuclear export appeared as small, 
bright dots that located in the interchromatin space (Fig. 45a). Cells displaying these 
structures typically contained 1–8 of these dots. In most cases, only two or three of them were 
observed. Their sizes varied from 1.2 µm down to the resolution limit of standard optical 
microscopy. The formation of larger patches was observed in a few cases (Fig. 48b). It is 
possible that in infection and during (over)expression of wild-type NP such punctate nuclear 
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accumulations are usually obscured by excess amounts of NP in the nucleus and have 
therefore not been described before, making this nuclear export construct of NP an interesting 
tool to study subnuclear structures with high affinity for NP.  
In order to account for the possibility that the fluorescent protein moiety or the NES-tag might 
be responsible for unspecific accumulation or aggregation of the construct, a control 
experiment was performed expressing NP-NES (lacking the mEYFP-tag) and CFP-M1-NES, 
another nuclear protein from Influenza A/FPV/Rostock/34 that was N-terminally fused to the 
cyan fluorescent protein (CFP) and contained an identical C-terminal NES. CFP-M1-NES 
was kindly provided by Bastian Thaa (Freie Universität, Berlin). Immunofluorescence 
detection of NP-NES (Fig. 45c) clearly revealed the same subnuclear patterns as mEYFP-NP-
NES in nuclei that were otherwise depleted of the protein; NP-NES was found to associate 
with nucleoli and small dot-like structures even at very low total nuclear concentrations and in 
the absence of the mEYFP moiety. In contrast, CFP-M1-NES did not show any residual 
nuclear signals (Fig. 45c), demonstrating that the NES did not per se cause accumulation of 
proteins in dot-like structures or in nucleoli as a part of its transport mechanism. Since the 
NES of mEYFP-NP-NES was the same as in CFP-M1-NES, both constructs can be assumed 
to access the same nuclear export machinery. Together, the results for NP-NES and CFP-M1-
NES implied that the NP moiety itself had an affinity for the described subnuclear structures 
and was responsible for the association of mEYFP-NP-NES with subnuclear domains. 
4.3.2.2 Analysis of subnuclear targeting of NP by fluorescence photoactivation 
studies 
As a direct measure for site-specific affinities of NP, fluorescence photoactivation 
measurements were performed in living cells, and the dynamic behavior of NP constructs in 
different subcellular structures was analyzed. Therefore, fusion constructs of NP with the 
photoactivatable protein Dendra2 (introduced in 4.3.1) were applied. Dendra2 can be 
irreversibly photoconverted from a green- to a red-fluorescent state by illumination with UV 
light. By selection of a region of interest within transfected cells and localized irradiation, a 
specific subpopulation of Dendra2 can be activated and subsequently traced (Fig. 46): 
Dendra2 constructs were therefore expressed in MDCK II cells and photoactivation 
measurements were performed at 24 h p.t. (as described in 3.2.3.2). Cells were imaged in their 
pre-activation state, and after the photoactivation pulse in the region of interest, using 405-nm 
light, time-lapse imaging of the activated red-fluorescent state was performed for about 98 s. 
230 frames were taken at intervals of 428 ms.  
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Examples of time-lapse imaging are presented in Fig. 46, where diffusion of free Dendra2 is 
compared to diffusion of Dendra2 fusion proteins with different NP variants. The activated 
free nuclear Dendra2 was found to spread rapidly throughout the entire nucleus within 5 s 
after photoactivation (Fig. 46, top row). This was followed by slower diffusion across the 
nuclear membrane into the cytoplasm. After 98 s of time-lapse imaging, the activated protein 
was still more enriched in the nucleus than in the cytoplasm, but when the same cell was 
checked again at 7 min post-activation, the equilibrium between nucleus and cytosol was 
finally established. For a quantitative description, the fluorescence signal of activated 
Dendra2 within the photoactivated region was plotted over time and compared to the 
simultaneous signal increase at other subcellular locations (Fig. 47A, left). A rapid and 
complete equalization of photoactivated molecules within the nucleus was confirmed 
(compare blue curve and red curve). The increase of the cytoplasmic signal (cyan curve), 
which corresponded to the slow decay of the nuclear fluorescence, further demonstrated slow 
diffusion of activated molecules across the nuclear membrane. 
 
Fig. 46: Photoactivation of Dendra2 constructs and time-lapse imaging of the activated red-fluorescent state. 
Dendra2 constructs (as indicated) were expressed in MDCK II cells and photoactivation measurements were 
performed at 24 h p.t. in living cells. Confocal fluorescence images of the green- and the red-fluorescent states 
of Dendra2 were acquired before activation (left) followed by photoactivation of the region of interest (white 
circles) by irradiation at 405 nm. Subsequently, time-lapse imaging of the activated red-fluorescent state was 
performed for about 98 s (right). 230 images were acquired at intervals of 428 ms, a selection of which is 
presented. Single images were then again recorded at 7 min post-activation to detect long-term changes in the 
distribution of some of the constructs. Photoactivation was performed the either in nucleus (1
st
, 2
nd
, 3
rd
 row) or 
in the cytoplasm (4
th
 row). 
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Fig. 47: Comparison of intracellular dynamics of NP constructs by fluorescence photoactivation. MDCK II cells 
were transfected with (a, b) Dendra2, (c, d) Dendra2-NP, (e, f, i, k) NP-R416A-Dendra2 and (g, h) Dendra2-NP-
NES, and photoactivation measurements were performed in living cells at 24 h p.t. For the detection of total 
Dendra2 in transfected cells, confocal fluorescence images of the Dendra2 green-fluorescent state were 
acquired prior to photoactivation. A region of interest (ROI) was then selected within transfected cells for site-
specific photoactivation by irradiation at 405 nm (white circles). The activated red-fluorescent state was 
monitored in 20 pre-activation frames and 230 post-activation frames at intervals of 428 ms, and the relative 
fluorescence intensity within the ROI was plotted over time as presented in the diagrams (blue curves). (A) 
Photoactivation of free Dendra2 was performed in the nucleus (left) and in the cytoplasm (right), in ROIs as 
indicated by the white outline. The fluorescence signal of the activated state was further measured and plotted 
for other regions (red and cyan) to monitor the spreading of the activated molecules within the cell. The 
increase of signal in these regions reflects the signal decrease that was measured in the activated ROI. (B) 
Photoactivation measurements in nucleoli and in the cytoplasm were compared for three different NP 
constructs. (C) Photoactivation measurements with monomeric NP-R416A-Dendra2 in the nucleus were 
performed for a punctate subnuclear accumulation of the construct (left) and for diffusely distributed 
nucleoplasmic protein (right). (D) A control measurement to evaluate fluorescence photobleaching with the 
here applied settings was performed by photoactivation of a major fraction of cellular Dendra2-NP-NES and 
detection of fluorescence after a time lapse of 4 min when the activated fluorophore had reached a steady-
state distribution within the cell and diffusion of the protein did not affect the signal intensity anymore. 
Photobleaching was not observed within a detection period of 42 s. Repeated photoactivation after 42 s of 
time-lapse imaging demonstrated that the signal decay was due to initial dispersal of the newly activated 
fluorophore. Scale bar, 10 µm. 
Very different kinetics were however observed when Dendra2 was fused either to wild-type 
NP, to monomeric NP-R416A or to NP-NES. These NP constructs (Dendra2-NP, NP-R416A-
Dendra2 and Dendra2-NP-NES) showed an exceptionally low mobility in the nucleus, but 
also in the cytoplasm their mobility was reduced as compared to Dendra2 alone (Fig. 46 & 
Fig. 47). Photoactivation of the wild-type construct Dendra2-NP within compact nuclear 
structures that were highly enriched with Dendra2-NP caused the localized conversion of 
Dendra2 which then remained stably associated with the photoactivated area during time-
lapse imaging (Fig. 46, second row), indicating immobility and precipitation of Dendra2-NP 
within these structures. Yet, also the monomeric mutant NP-R416A-Dendra2, which was 
studied by photoactivation measurement in a more heterogeneous and apparently less densely 
packed region of the nucleus, showed a considerably reduced mobility as compared to free 
Dendra2 (Fig. 46, third row). The photoactivated NP-R416A-Dendra2 remained largely 
confined to the photoactivated area during time-lapse imaging, and only a small fraction of 
the protein appeared to invade the space closely adjacent to the activated region of interest. 
Even at 7 min post-activation, the major part of activated NP-R416A-Dendra2 was still found 
to reside in the initially irradiated area, but spreading of the red-fluorescent state into the 
adjoining nucleoplasm became more evident at this time point, indicating a continued but 
very slow diffusion of nuclear NP-R416A-Dendra2. This experiment involving monomeric 
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NP-R416A-Dendra2 demonstrated that the extraordinarily slow nuclear dynamics of NP 
constructs were not due to the intrinsic ability of NP to polymerize. Instead, extensive 
interactions of NP with nuclear components are implied. 
It should be noted here that when considering free diffusion along a concentration gradient as 
described by the Stokes-Einstein equation and Fick’s first law of diffusion, the difference in 
molecular weight between monomeric Dendra2 (26 kDa) and Dendra2-NP (82 kDa) is merely 
able to explain a 1.47 times lower diffusion coefficient of Dendra2-NP compared to Dendra2 
and thus a 1.47 times lower flux of photoactivated molecules. For application of the Stokes-
Einstein equation a spherical protein shape and a molecular volume proportional to the 
molecular weight have to be assumed. Previously, however, it was shown for EGFP oligomers 
(monomers to tetramers) that their diffusion coefficients do not match the expected values for 
globular proteins [498]. The measured kinetics were found to be better fitted by a model for 
rod-like proteins consistently with their actual 3D structure, nevertheless the nuclear diffusion 
coefficients between a monomeric 27-kDa protein and a trimeric 81-kDa protein differed only 
by a factor of  2.1. Differences of this scale cannot account for the reduced nuclear mobility 
observed for NP-R416A-Dendra2 in comparison to free Dendra2 though (see Fig. 47a, e, i, k).  
In previous studies, it was furthermore shown that the mobility of proteins in the range from 
27 to 108 kDa is not affected by the local chromatin density in the nucleus [495,498], and the 
diffusion coefficients of such average-sized proteins were reported to be only 3.5 times larger 
in nuclei than in aqueous solution [494], confirming a low nucleoplasmic viscosity for 
proteins and small molecules in contrast to a higher mesoscale nuclear viscosity reported for 
particles larger than 100 nm [501]. A considerable steric obstruction of free diffusion of 
monomeric NP constructs in the nucleus (e.g. due to the chromatin network or other 
subnuclear structures) can therefore be excluded. And even though the apparent viscosities of 
the cytoplasm and the nucleoplasm were reported to be identical for proteins between 30 and 
150 kDa [494], the mobility of NP constructs was found to be distinctly higher in the 
cytoplasm than in the nuclear compartment (Fig. 46 & Fig. 47), thus strongly supporting the 
assumption that NP constructs are involved in numerous high-affinity interactions specifically 
in the nucleus.  
For the NES-tagged construct Dendra2-NP-NES, which was generated to visualize sites of 
high affinity in the nucleus, it was shown that the NES-tag did not significantly affect the 
diffusion kinetics of the construct as compared to wild-type Dendra2-NP, neither in the 
cytoplasm nor in nucleoli (Fig. 47B, c–d, g–h). Expression of the full-length protein was 
verified by Western blotting (Fig. 40). Comparable local protein dynamics of the NES-tagged 
RESULTS 
171 
 
construct and the wild-type protein support the validity of the results obtained with Dendra2-
NP-NES to describe subnuclear targeting of NP. Both proteins displayed the same slow signal 
decay after photoactivation in nucleoli, which indicates a very low exchange rate of 
photoactivated molecules for the nucleolar compartment. The same kinetics were furthermore 
observed for the monomeric NP-R416A-Dendra2 (Fig. 47B, left), demonstrating that 
interactions of NP constructs with nucleoli were not affected by the polymerization state of 
NP. Control experiments confirmed that effects of photobleaching were negligible under the 
applied conditions (Fig. 47D). Accordingly, the signal decay observed in photoactivation 
measurements was solely due to protein diffusion, and NP constructs in association with 
nucleoli were hence not immobilized, but displayed an extraordinarily slow mobility 
compared to NP constructs in the cytoplasm (Fig. 47B) or in the nucleoplasm (Fig. 47k). 
Photoactivation measurements thus confirmed that low exchange rates are responsible for 
persistent association of Dendra2-NP-NES with nucleoli, even under conditions of ongoing 
nuclear export. 
Localized punctate accumulations in the nucleoplasm were the second type of Dendra2-NP-
NES accumulation in the nucleus that was found to resist nuclear export. These punctate 
structures were studied by the use of monomeric NP-R416A-Dendra2 to exclude effects of 
polymerization on protein dynamics and to be able to compare protein mobility at different 
locations primarily based on site-specific interactions. Measurements with NP-R416A-
Dendra2 revealed that exchange rates of such punctate nuclear accumulations with the 
surrounding nucleoplasm were similarly low as for nucleoli, both structures featuring a linear 
signal decay after photoactivation (Fig. 47e, i). In contrast, the mobility of photoactivated NP-
R416A-Dendra2 in the surrounding nucleoplasm was clearly higher, causing an exponential 
decay of the photoactivated signal (Fig. 47k). These results support that punctate 
accumulations in the nucleus were not static precipitates of NP constructs, but rather dynamic 
structures that exchanged molecules with the nucleoplasm, implying a certain functionality. 
The results further confirmed that nucleoli as well as punctate accumulations were the two 
cellular structures that displayed the highest affinity for NP constructs as it had been 
hypothesized based on results for NES-tagged NP constructs (Fig. 45). 
It should be noted that free Dendra2 was expected to be expressed as a byproduct and minor 
fraction in NP-R416A-Dendra2 expression as inferred from Western blot analysis (4.3.1, Fig. 
40). However, upon photoactivation of NP-R416A-Dendra2 (Fig. 47B, C), a fast component 
of the signal decay comparable to the signal decay of free Dendra2 was not observed (Fig. 
47A), even though it would be expected to be well-distinct from the particularly slow nuclear 
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and cytoplasmic dynamics observed for NP-R416A-Dendra2. A possible contribution of free 
Dendra2 to fluorescence detection of NP-R416A-Dendra2 was thus apparently negligible.  
To summarize the results of the photoactivation studies, a remarkably slow subcellular 
mobility of NP constructs was observed in comparison to the mobility of the free fluorescent 
protein, indicating that NP is engaged in numerous interactions with cellular components. 
This was reinforced by considerations on the molecule size and by the finding that slow 
diffusion was independent of the ability of NP to polymerize. Retardation of diffusion and 
thus interaction with the host cell were distinctly more pronounced in nuclei than in the 
cytoplasm, suggesting that nuclear accumulation of NP constructs in transfection and 
infection might not only be due to the nuclear localization sequences of NP, but also to 
nuclear retention due to extensive interaction.  
Within nuclei, sites of different affinities for NP constructs could be distinguished. The 
highest mobility was observed in the nucleoplasm for homogenously distributed monomeric 
NP-R416A-Dendra2, whereas the least mobile fractions of NP were detected in nucleoli and 
small punctate nuclear accumulations, which also associated with NP constructs even at low 
concentrations. The kinetic data confirmed that these sites did not accumulate immobilized 
(non-functional) precipitates, but represented sites of high affinity that displayed the lowest 
exchange rates measured in cells.  
Complete absence of mobility was only seen in the case of larger, irregular nuclear 
accumulations which appeared as compact structures and were densely packed with NP 
constructs (Fig. 46, second row). The dynamic behavior thus indicated non-functional 
precipitation within these structures, consistent with the absence of such structures from 
infected cells and their tendency to displace chromatin (Fig. 44). It cannot be excluded though 
that these compact structures initially formed by specific association of NP with structures of 
high affinity, which then continued to grow and possibly aggregated due to high local 
concentration and/or extensive self-polymerization. It is further possible that exchange of 
molecules between these structures and the nucleoplasm occurs only along their boundaries.  
4.3.2.3 Analysis of subnuclear targeting of NP by colocalization studies with 
subnuclear domains 
The next step was the identification of the subnuclear structures with high affinity for NP. 
Targeting of NP to nucleoli by a specific nucleolar localization signal has been described 
before [123] and is consistent with our observations (Fig. 45b). The description of dot-like 
accumulations of NP is however unprecedented, and the assignment of these structures to 
RESULTS 
173 
 
specific, functional nuclear domains is less obvious. However, the recurring observation of 
interchromatin dots of similar size and number in cells expressing mEYFP-NP-NES (Fig. 
45a) strongly implied a non-random nuclear organization similar to that of nuclear bodies 
(NBs) [490,502].  
The cell nucleus is a highly organized compartment and, even though membraneless, the 
interchromatin space is known to be compartmentalized into functionally specialized domains 
[488,489]. To test the assumption that punctate mEYFP-NP-NES accumulations are non-
random foci, they were correlated with known subnuclear structures by immunostaining of 
marker proteins of NBs. It was found that SC35, a component of splicing speckles [503], did 
not colocalize with mEYFP-NP-NES nuclear dots, neither in HeLa cells (Fig. 48c) nor in 
MDCK II cells (data not shown). Spatial correlation could not be inferred from the data due to 
 
Fig. 48: Expression of mEYFP-NP-NES in HeLa cells and colocalization analysis with nuclear body proteins. 
Cells were fixed at 20 h p.t. and immunostained for nuclear body proteins, the PML protein (a, b) and the 
speckle protein SC35 (c, d). A z-projection made from the sum of confocal images of the cell nucleus is 
presented in (a). Single confocal fluorescence images are shown in (b–d). Scale bar, 10 µm.   
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Fig. 49: Colocalization of mEYFP-NP-NES with PML and Cajal bodies in HeLa cells. (a) Untreated cells or (b, c) 
cells transfected with mEYFP-NP-NES were fixed at 23 h p.t. and immunostained for subnuclear domains with 
anti-PML and anti-coilin antibodies (with secondary Alexa594-anti-rabbit and Atto647-anti-mouse, 
respectively). PML is a marker protein of PML bodies and coilin is a protein of Cajal bodies. Z-projections of the 
cells are presented which were obtained by forming the sum of confocal fluorescence images throughout the 
nucleus. White squares indicate enlargement of the outlined sections in subadjacent images. In (b), the contrast 
of mEYFP-signals in the enlarged images was enhanced using Image J. Scale bar, 10 µm (for enlarged sections 
1 µm).  
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Fig. 50: Colocalization of mEYFP-NP with PML and Cajal bodies in HeLa cells. Transfected cells were fixed at 
23 h p.t. and immunostained with anti-PML and anti-coilin antibodies (with secondary Alexa594-anti-rabbit and 
Atto647-anti-mouse, respectively). In (a), fluorescence images represent single confocal planes. In (b) and (c), 
cells are presented as z-projections made from the sum of confocal fluorescence images throughout the 
nucleus. White squares indicate an enlargement of the outlined section in subadjacent images. Scale bar, 10 µm 
(1 µm for enlarged sections).  
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the high number of SC35 speckles and the corresponding high probability to detect mEYFP-
NP-NES dots in close proximity to SC35 signals. The promyleocytic leukemia (PML) protein, 
the defining component of PML bodies, did not show strict colocalization with mEYFP-NP-
NES dots either, but was frequently found adjacent to or partially overlapping with them (Fig. 
48a). The dots were judged as adjacent structures when they were directly associated or in 
close proximity to each other (i.e. at a distance shorter than the average radius of the spots). 
Interestingly, when mEYFP-NP-NES formed larger accumulations, PML bodies typically 
localized within these domains (Fig. 48b), whereas SC35 speckles were generally excluded 
from these domains (Fig. 48d). This indicates a very different interplay of PML bodies and 
splicing speckles with mEYFP-NP-NES-rich domains.  
In the following, punctate nuclear accumulations of NP constructs will also be referred to as 
“NP bodies”. It should be noted that PML and NP bodies frequently occurred as adjacent 
structures, but each type was also found separately, indicating a correlated arrangement of a 
subset of these domains, but not a mutual dependence. 31 cells from three independent 
transfection experiments were analyzed. They displayed residual mEYFP-NP-NES subnuclear 
structures in otherwise depleted nuclei, and 87 % of the cells contained at least one pair of 
closely associated PML and NP bodies. 52 % of the cells even contained the highest possible 
number of adjacent pairs, limited by the number of the less abundant structure. In average, 
69 % of the PML bodies and 54 % of the mEYFP-NP-NES dots per cell were detected in a 
paired arrangement. These results strongly support the assumption that punctate 
accumulations of mEYFP-NP-NES are not randomly distributed in the nucleus, but can be 
found in specific surroundings.  
A similar observation as for mEYFP-NP-NES dots was previously reported for the relation of 
PML with Cajal bodies (CBs), a subnuclear structure which frequently associates with PML 
bodies, but which is not strictly correlated [504,505]. CBs are a subtype of nuclear bodies 
involved in posttranscriptional modification of small nuclear (sn) RNA and biogenesis of 
snRNPs. Coilin is the marker protein of CBs. Costaining of mEYFP-NP-NES-transfected 
cells for PML NBs and CBs was performed using anti-PML and anti-coilin antibodies, and 
indeed, punctate nuclear accumulations of mEYFP-NP-NES were found to associate with 
PML bodies as well as with CBs (Fig. 49b, c). The three domains were frequently found in 
triplet arrangements, but also pairs of two were observed in every possible combination. They 
typically displayed a partial overlap, but complete colocalization of NP bodies with one of 
these nuclear domains was not detected. This result hence supports the hypothesis of specific 
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subnuclear targeting of NP constructs, but the primary target of mEYFP-NP-NES was 
apparently neither PML bodies nor CBs. 
The same immunofluorescence analysis was then performed with mEYFP-NP lacking the 
“artificial” NES. As considerable nuclear accumulation of this construct was suspected to 
obscure targeting of NP to specific subnuclear sites, cells with low expression levels were 
selected for this analysis. At 23 h p.t., most of the transfected cells displayed a strongly 
heterogeneous accumulation of mEYFP-NP in the nucleus, and only very few cells showed 
low expression levels and a more homogeneous distribution with few distinct patches that 
were enriched with mEYFP-NP and appeared bright against the generally high nuclear signal. 
These prominent accumulations were dot-like just as residual nuclear signals of mEYFP-NP-
NES, and, just like these, most of them colocalized with PML and/or CBs (Fig. 50). They 
either formed adjacent structures or partly overlapped with each other. Typically, these were 
the sites with the highest mEYFP-NP concentrations in the entire nucleus. These results are 
consistent with the findings for mEYFP-NP-NES, thus strongly indicating that nuclear sites of 
particularly high mEYFP-NP concentration (Fig. 50) represent the same structures as the 
domains that remain associated with mEYFP-NP-NES in almost depleted nuclei (Fig. 49).  
Even though a considerable fraction of local mEYFP-NP accumulations colocalized with 
PML and CBs, not all of the NP bodies were found adjacent to PML or Cajal bodies, and not 
all of the PML and Cajal bodies were flanked by NP bodies. For a quantitative description, 10 
cells with distinct punctate nuclear accumulations of mEYFP-NP were evaluated. They 
comprised a total of 30 NP bodies, 20 PML bodies and 19 Cajal bodies. It should be noted 
that for mEYFP-NP only the brightest spots were counted, although the cells occasionally also 
showed diffuse accumulations of mEYFP-NP. Similarly, only distinct bright spots were 
considered in case of PML. It is possible that due to the overall presence of PML in the 
nucleus, some PML bodies might have been missed, but even if they were not identified as 
PML bodies, elevated PML levels were often found in regions highly enriched with mEYFP-
NP. Neglecting these cases of weak or diffuse colocalization, still 37 % of NP bodies were 
found to colocalize with both PML and CBs, additional 13 % localized to PML bodies and 
17 % were found adjacent to CBs. Altogether, a large fraction of NP bodies (67 %) was hence 
localized in close proximity to PML and/or Cajal bodies. Accordingly, 33 % of NP bodies 
were found as solitary domains. In cases of PML bodies and CBs, only 15 % and 5 % 
represented solitary structures, respectively, and another 10 % were paired in the absence of 
NP bodies. The largest fractions of PML and CBs (75 % and 84 %, respectively) were 
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Fig. 51: Colocalization analysis of heterogeneously distributed nuclear mEYFP-NP with PML and Cajal bodies 
in HeLa cells. Transfected cells were fixed at 23 h p.t., and immunostaining was performed with anti-PML and 
anti-coilin antibodies (with secondary Alexa594-anti-rabbit and Atto647-anti-mouse). Confocal fluorescence 
images are presented which specifically display nuclei with subnuclear enrichment of mEYFP-NP in form of 
broad, irregular and diffuse patches. A single confocal plane of the nucleus is presented in (a), while a 
projection of confocal fluorescence images of the nucleus is shown in (b). White squares indicate enlargement 
of the outlined sections in the images beneath. Scale bar, (a, b) 10 µm (1 µm for enlarged sections). 
however involved in a close spatial relation with NP bodies. 55 % of PML bodies and 58 % of 
CBs were even part of closely associated CBs, PML and NP bodies forming triplet structures.  
In those cases of mEYFP-NP expression when nuclear mEYFP-NP accumulations were 
larger, more irregular and diffuse, but less punctate than described above (Fig. 50), a spatial 
correlation of mEYFP-NP with PML and CBs was still clearly observed (Fig. 51). Diffuse 
mEYFP-NP accumulations did not resemble nuclear bodies in size or shape, but nevertheless 
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they broadly overlapped with PML and coilin. It is not clear from these data if a varying 
appearance of mEYFP-NP subnuclear distribution possibly correlates with the distribution of 
subnuclear factors or domains other than PML and CBs. 
It should be noted in the context of this analysis that a general problem in spatial correlation 
and neighborhood analysis is the non-assessable effect of nuclear crowding and of limited 
interchromatin space on the actual likelihood of random association [506]. This makes it 
impossible so far to classify the observed distances as non-random or random localization 
according to a theoretical model. Therefore, only those nuclear bodies were considered as 
correlated structures in the present analysis which were either directly associated or at a 
distance shorter than the average radius of the dots, assuming that this is a non-random 
association.  
This appeared to be a reasonable criterion since in case of random association of NP bodies 
with subnuclear domains a close proximity of NP bodies to their own kind should have been 
observed with similar frequencies. Pairs of equal kind were however not detected at all. 
Furthermore, in case of random organization, the probability for NP bodies to localize in a 
short distance to PML and CBs is generally larger than the probability to overlap with one of 
these structures, which is due to the same probability of presence at each location. However, 
NP bodies were rarely observed at a short distance to PML or CBs; instead, the vast majority 
of NP bodies (67 % in case of mEYFP-NP) was closely associated with these subnuclear 
domains. This strongly supports the non-random character of this close association. The 
specific influence of the nuclear architecture is not included into these theoretical 
considerations, but a non-random correlation under actual experimental conditions was 
furthermore supported by the fact that PML and CBs are known interacting domains which 
associate non-randomly [505]. They were observed to associate with NP bodies at a similar 
frequency as to each other, thus supporting the non-randomness of this association. 
Summarizing, the results suggest that punctate nuclear accumulations of NP constructs 
represent subnuclear sites of high affinity for NP which localize preferentially in close 
proximity to PML and CBs. The data furthermore indicate that NP has the intrinsic property to 
specifically target these subnuclear domains, thereby implying an interplay of NP with host 
cell processes, e.g. to support efficient viral replication or as a target for the cellular antiviral 
response. 
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4.3.3 Analysis of cytoplasmic targeting of NP                                                 
Based on previous studies indicating the intrinsic ability of NP to target the apical plasma 
membrane [299], the subcellular distribution of fluorescently tagged and non-tagged NP 
constructs was analyzed in polarized MDCK II cells. For polarization, MDCK II cells 
expressing NP constructs were grown on porous filter membranes for 13 days. Transfection 
with NP constructs was performed one day after seeding and the cells were maintained in 
selective medium during growth as described in 3.2.2.3. The polarization state of the cells was  
 
Fig. 52: Expression of NP and NP fusion proteins in polarized MDCK II cells. MDCK II cells were grown on 
porous filter membranes for polarization. One day after seeding, they were transfected with (a) NP, (b) mEYFP-
NP, (c) NP-mEYFP, (d) NP-NES, (e) mEYFP-NP-NES or (f) HAmYFP. After 13 days, the cells were fixed, 
permeabilized and stained with DAPI (blue) and rhodamine phalloidin (red) to label the cell nuclei and F-actin, 
respectively (a–e). Non-fluorescent proteins NP and NP-NES were additionally immunostained with anti-NP-
FITC (green). Intrinsic fluorescence of mEYFP is also displayed in green. Cells expressing HAmYFP were not 
further processed after fixation (f). Representative confocal fluorescence images of transfected cells are 
displayed. Images of xy-confocal planes are shown accompanied by a lateral view of the cells in xz-dimension 
beneath, which was generated by z-axis reconstructions of confocal image stacks. Scale bar, 10 µm. 
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checked after 13 days in control cells expressing the apically targeted protein HAmYFP as 
positive control. This construct was kindly provided by Silvia Scolari [447] and comprised the 
Influenza A virus HA transmembrane domain, the cytoplasmic tail and an N-terminal 
mEYFP-tag.  
HAmYFP was found exclusively on the apical plasma membrane after 13 days of polarized 
growth and confirmed efficient differentiation of apical and basolateral membranes (Fig. 52f). 
In contrast, none of the NP constructs displayed a bias to localize to the apical side of the cell. 
NP and fluorescent fusion proteins of NP that were N-terminally or C-terminally tagged with 
mEYFP were still found predominantly in the cell nucleus. The small fraction of cytoplasmic 
NP distributed evenly throughout the cytoplasm (Fig. 52a–c). The same non-polarized 
distribution was observed for the NES-tagged constructs NP-NES and mEYFP-NP-NES, 
which were used to increase the total amount of cytoplasmic NP (Fig. 52d, e). Evidence for 
intrinsic apical targeting of NP was not obtained. 
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4.4 Monitoring newly formed vRNPs in living infected cells by 
coexpression of fluorescent NP fusion proteins 
The first approach to establish an experimental system that allows studying newly formed 
vRNPs in living Influenza virus-infected cells was described in section 4.2. Yet, the 
biarsenical labeling technology was shown to be unfeasible for live-cell studies on vRNPs. 
The second approach to monitor vRNPs in living infected cells is reported here, using 
intrinsically fluorescent proteins.  
Fluorescent NP fusion proteins were therefore coexpressed in infection to be incorporated into 
newly forming vRNPs. It is known from the work of Loucaides and coworkers [507] that 
transcription-competent vRNP complexes can be successfully reconstituted using GFP-tagged 
NP in plasmid-based reconstitution, indicating the possibility to label vRNPs by incorporation 
of fluorescent NP fusion proteins also during infection.  
In the absence of infection, expression of NP fusion proteins was extensively characterized 
(see 4.3). NP constructs show a predominantly nuclear localization, and only a small fraction 
is homogeneously spread in the cytoplasm (Fig. 35). This NP expression pattern can be 
clearly distinguished from the punctate cytoplasmic signal that is characteristic for NP late in 
infection, resulting from nuclear export of progeny vRNPs (Fig. 43, immunostaining of NP in 
infected cells). It was therefore assumed that efficient incorporation of fluorescent NP fusion 
proteins into vRNPs and subsequent nuclear export of the complexes would lead to the 
appearance of characteristic punctate cytoplasmic signals of progeny vRNPs, which then can 
be analyzed as intrinsically fluorescent complexes by single particle tracking (SPT) and 
provide information on the dynamics of vRNP transport and virus assembly.  
4.4.1 Optimization of experimental conditions for coexpression of mEYFP-NP 
in infected cells 
The major challenge of this approach was to simultaneously establish infection and 
exogenous NP expression in the same cell. Since Influenza virus infection is known to induce 
host cell shut-off, it is most likely that also exogenous protein expression from plasmid DNA 
is downregulated. On the other hand, NP as a viral protein is likely to have an impact on viral 
replication, causing disturbances if expressed exogenously. A variety of experimental 
conditions thus had to be tested.  
In all experiments, infections were performed with the Influenza A/FPV strain. The NP 
sequence of exogenously expressed NP constructs was derived from the same virus strain. 
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In a first attempt, MDCK II cells were transfected with fluorescent NP constructs several 
hours ahead of infection. Infection at MOI 50 was performed at either 4 h p.t. or 17 h p.t. 
when expression of mEYFP-tagged NP was already detectable. Infection was then allowed to 
proceed for another 6 h. Both N- and C-terminally mEYFP-tagged NP constructs were tested, 
but in none of these experiments superinfection had an impact on the localization of mEYFP-
tagged NP in comparison to non-infected cells. A redistribution of mEYFP-tagged NP to the 
cytoplasm was not observed. The result is shown exemplarily for mEYFP-NP expression in 
superinfected and in mock-infected cells fixed at 10 h p.t. and 6 h p.i. (Fig. 53). In order to
 
Fig. 53: Superinfection of mEYFP-NP expressing cells.  MDCK II cells were first transfected with mEYFP-NP.  At 
4 h p.t., the cells were then superinfected with Influenza A/FPV virus (MOI 50) and incubated for another 6 h. At 
10 h p.t. and 6 h p.i., the cells were fixed and subjected to immunostaining with polyclonal anti-M1 and 
secondary Cy3-anti-rabbit antibody. Confocal fluorescence images were recorded, and the cells were analyzed 
for mEYFP-NP expression and viral M1 expression as an indicator for virus infection. (a) In superinfected 
samples, the mEYFP-NP signal showed a predominantly nuclear localization like in the absence of infection. As 
judged by the viral M1 signal, infection was inhibited or considerably retarded in most transfected cells as 
compared to neighbouring non-transfected cells. (b) In a few cases, the M1 signal in mEYFP-NP expressing cells 
indicated successful superinfection (arrow). mEYFP-NP expression levels were comparably low in these cells. 
Cytoplasmic accumulation of NP constructs was not observed. (c) The M1 immunostaining was found to be 
slightly unspecific in mock-infected control cells. It is therefore not clear if infection is completely inhibited or 
strongly delayed in transfected cells (a). Scale bar, 10 µm. 
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verify successful viral infection, additional immunofluorescence detection of viral M1 was 
performed and revealed that M1 expression was strongly reduced in most mEYFP-NP 
expressing cells, indicating specific impairment of infection in transfected cells with 
exogenous NP expression (Fig. 53a). It is not clear though if infection was completely 
prevented or just considerably retarded since low levels of unspecific immunofluorescence 
staining were also observed in mock-infected cells (Fig. 53c). 
A successful infection of transfected cells was detected in very rare cases and only in cells 
expressing particularly low levels of NP fusion proteins (Fig. 53b, arrow). Relocalization of 
exogenously expressed NP to the cytoplasm was however not observed in these cells.  
The findings from this first of set experiments, performing superinfection of transfected cells, 
indicate that the premature presence of exogenous NP constructs at early stages of infection 
inhibits progression of viral replication very efficiently. Even though transfection in general 
was found to have a negative effect on virus infection, as verified by expression of free 
mEYFP (not shown), the effect was considerably more pronounced when NP constructs were 
expressed. Since viral NP most likely contributes to coordinated progression of viral 
replication (affecting e.g. the switch between viral transcription and replication), prematurely 
expressed NP constructs might critically disturb the sequence of events during infection and 
lead to abortion of viral replication in an early phase.  
In conclusion, transfection and plasmid-based NP expression prior to infection was found to 
be largely detrimental to viral replication and was therefore not further pursued. 
In the next approach, the order of events was reversed, performing first infection followed by 
subsequent transfection. MDCK II cell were therefore infected with Influenza A/FPV 
(MOI 50). Transfection was performed either at 1 h p.i., 2 h p.i. or 3 h p.i. The different 
samples were then analyzed for the efficiency to establish exogenous NP expression in 
infected cells.  
When transfection was performed at 3 h p.i. and the cells were fixed at 7 h p.i. and 4 p.t., the 
number of infected cells was about 100 % (Fig. 54a, c). Infection was obviously efficiently 
established within the first three hours of infection. The transfection efficiency on the other 
hand was very low in these cells. The number of mEYFP-NP expressing cells and mEYFP-NP 
expression levels were highly attenuated in comparison to mock-infected cells (Fig. 54b, d). 
High NP expression levels similar to those in mock-infected cells were exclusively observed 
in cells lacking infection, which occasionally occurred also in infected samples (Fig. 54c, 
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Fig. 54: Supertransfection of virus-infected cells with mEYFP-NP at 3 h p.i. MDCK II cells were first infected 
with Influenza A/FPV (MOI 50). At 3 h p.i., the cells were then transfected with mEYFP-NP. At (A) 7 h p.i and 
4 h p.t. and (B) 8 h p.i and 5 h p.t., the cells were fixed and immunostained with (A) anti-M1 and Cy3-anti-rabbit 
antibodies and (B) anti-HA and Alexa568-anti-mouse antibodies. (a, c) According to M1 and HA 
immunostainings, the cells were about 100 % infected. In comparison to mock-infected cells (b, d), expression 
levels of mEYFP-NP were found to be reduced in infected cells. The highest mEYFP-NP expression levels in 
infected samples were found in occasionally observed uninfected cells (identified by the lack of HA staining) (c, 
arrow), indicating that infection efficiently downregulated mEYFP-NP expression. Scale bar, 10 µm. 
arrow). These findings indicate downregulation of mEYFP-NP expression specifically in 
infected cells, which could be a consequence of the virus-induced host cell shut-off. 
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Fig. 55: Coexpression of mEYFP-NP in virus-infected cells by transfection at 2 h p.i. MDCK II cells were infected 
(MOI 50) with Influenza A/FPV 2 h prior to transfection with mEYFP-NP. At 8 h p.i and 6 h p.t., the cells were 
fixed and analyzed for (A) viral M1 expression or (B) viral HA expression by immunostaining with anti-M1 and 
Cy3-anti-rabbit antibodies or anti-HA and Alexa568-anti-mouse antibodies, respectively. Images were recorded 
by confocal fluorescence microscopy. Overview images of the cell lawn are given in a, b, e and f.  Selected 
individual cells are shown at higher magnification in c, d and g. (a, e) Infected (M1 or HA expressing) cells were 
successfully transfected with mEYFP-NP. Expression levels of mEYFP-NP and the number of transfected cells 
were however lower than in mock-infected samples at 6 h p.t. (compare with b and f). (c, g) A fraction of 
infected cells coexpressing mEYFP-NP displayed a clear cytoplasmic mEYFP-NP signal with a punctate 
appearance and laterally polarized distribution (arrowhead), indicating nuclear export in form of vRNP 
complexes. (d) In the absence of infection or in case of delayed infection, expression levels of mEYFP-NP were 
relatively high, but a punctate cytoplasmic NP signal was missing (arrow, right cell). A direct comparison 
between a simultaneously transfected and infected cell and a transfected non-infected cell is shown. Scale bar, 
10 µm. 
Notably, in infected cells weakly coexpressing mEYFP-NP, mEYFP-NP often relocalized to 
the cytoplasm and formed punctate cytoplasmic signals with a laterally polarized distribution 
(not shown), indicating the formation of mEYFP-tagged vRNP complexes. The fluorescence 
signal bleached very rapidly though due to overall low signal intensities. 
In conclusion, the low yield of infected cells coexpressing mEYFP-NP and barely detectable 
cytoplasmic signals suggested that the conditions for mEYFP-NP expression in infection had 
to be further improved. 
In the then following approach, transfection was performed already at 2 h p.i. (Fig. 55). 
Considerably more transfected cells and higher mEYFP-NP expression levels were attained in 
comparison to samples transfected at 3 h p.i., but also a delay of infection could be more 
frequently observed in form of reduced M1 expression levels (Fig. 55d). Apparently, an 
improvement of exogenous NP expression was achieved at the expense of viral replication. 
While transfection at 3 h p.i. yielded mainly two populations of infected cells (untransfected 
cells and cells weakly coexpressing mEYFP-NP), the transfection performed at 2 h p.i. 
yielded a larger variety of cellular conditions. Different levels of mEYFP-NP expression were 
observed in infected cells (Fig. 55a, e), and infections were delayed to a varying extent (Fig. 
55d). A strict correlation between exogenous NP expression level and delay in infection was 
however not observed.  
As expected, a redistribution of mEYFP-NP to the cytoplasm was exclusively observed in 
infected cells, indicating functional incorporation of mEYFP-NP into vRNPs. Cytoplasmic 
accumulating mEYFP-NP had a punctate appearance and displayed a laterally polarized 
distribution (Fig. 55c, d, g), resembling the cytoplasmic distribution of viral NP in infection. 
On the contrary, when infection was considerably retarded or suppressed, the distribution of 
mEYFP-NP seemed to be unaffected by Influenza virus infection, and mEYFP-NP remained 
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primarily in the cell nucleus. A direct comparison between mEYFP-NP expressing cells in the 
presence and absence of ongoing virus replication is exemplarily shown in Fig. 55d. 
In order to examine if coexpression of mEYFP-NP in infected cells could be even further 
improved, the gap between infection and subsequent transfection was further reduced to 1 h. 
Yet, an improvement of the results was not obtained under these conditions. On the contrary, 
in an increasing number of mEYFP-NP expressing cells, viral replication was efficiently 
suppressed as shown by the lack of viral HA expression (Fig. 56a, asterisks). Infected cells 
coexpressing mEYFP-NP on the other hand displayed relatively low mEYFP-NP expression 
levels. Cytoplasmic signals were close to the fluorescence background (Fig. 56b). 
Among the tested experimental approaches, the best results to establish coexpression of 
fluorescent NP constructs in the context of infection were hence obtained when transfection 
was performed at 2 h p.i. Under these conditions, the highest mEYFP-NP expression levels in 
infected cells and the most prominent cytoplasmic mEYFP-NP signals were attained. No 
significant differences were further observed when C-terminally tagged NP-mEYFP was 
expressed instead of N-terminally tagged mEYFP-NP. The use of C-terminally tagged NP-
mEYFP was abandoned though due to the co-occuring formation of free mEYFP (Fig. 40). 
Satisfying results were further obtained when the MOI was increased from 50 to 100 (see 
4.4.2). 
It has to be pointed out that despite optimization of the experimental conditions, the total yield 
of infected cells coexpressing mEYFP-NP and showing redistribution of mEYFP-NP to the 
cytoplasm was below 1 %. An even smaller fraction, comprising less than 1 ‰ of the cells, 
displayed sufficiently bright cytoplasmic mEYFP-NP signals for application in time-lapse 
imaging for over 10 min and 1200 frames without a critical degree of bleaching.  
The low yield of cells showing prominent cytoplasmic mEYFP-NP signals did not impede 
analyses on the single cell level like subcellular localization studies and single particle 
tracking (SPT). Bulk experiments or biochemical analysis on the other hand were unsuitable 
to characterize the specific subset of cells or the progeny viruses produced from these cells. 
Evidence for successful incorporation of mEYFP-NP into vRNPs during infection and 
formation of mEYFP-tagged viruses were therefore difficult to obtain. 
The high variability among the cells is believed to be due to a fragile equilibrium between 
transfection and infection and to a very tight time window that determines which of these 
processes finally dominates over the other or whether they will coexist. According to the 
findings obtained by modulating the delay between infection and transfection, the critical time
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Fig. 56: Supertransfection of virus-infected cells at 1 h p.i. MDCK II cells were infected with Influenza A/FPV at 
MOI 50, subsequently transfected with mEYFP-NP at 1 h p.i. and finally fixed at 8 h p.i. and 7 h p.t. The cells 
were immunostained for viral HA to visualize infection, and they were monitored by confocal fluorescence 
microscopy. Representative images are shown. (a) High transfection efficiencies were attained in infected 
samples. In particular in mEYFP-NP expressing cells, infection was frequently found to be delayed or inhibited 
(asterisk). Despite MOI 50, effective infection was thus observed in less than 100 % of the cells. (b) Fine, 
punctate mEYFP-NP signals could be detected in the cytoplasm of some infected cells coexpressing mEYFP-NP. 
Cytoplasmic mEYFP-NP signals were however low compared to the nuclear signal and close to fluorescence 
background levels. Scale bar, 10 µm. 
to establish exogenous mEYFP-NP expression in infected cells seems to be between 1 h p.i. 
and 3 h p.i. During this time, mEYFP-NP expression coincides with increasing viral 
transcription and protein synthesis [116,187], whereas host cell shut-off and inhibition of 
exogenous protein expression do not seem to be fully established yet. The critical time for the 
shut-down of exogenous protein expression is apparently between 2 h p.i. and 3 h p.i., since 
after 2 h of infection, the transfection was found to be still very effective (Fig. 55), whereas 
after 3 h p.i. mEYFP-NP expression was almost completely aborted (Fig. 54). A different 
susceptibility of the cells to be either transfected or infected might further contribute to the 
diversity of cellular states. As a consequence, the critical phase to establish coexpression of 
NP in infected cells might vary among the cells, but according to the experimental data it 
apparently ranges between 1 h p.i. and 3 h p.i.  
Based on these considerations, further optimization of the experimental approach is 
considered to be limited by the heterogeneity of the cells. Following experiments were 
therefore focused on single cell analyses.  
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4.4.2 Cytoplasmic mEYFP-NP is cotransported with Rab11-positive recycling 
endosomes in infected cells 
It was an important finding from experiments combining infection and exogenous mEYFP-
NP expression (4.4.1) that infection is in fact able to induce relocalization of mEYFP-NP to 
the cytoplasm in form of small discrete particles, which adopt a laterally polarized distribution 
and tend to accumulate at the plasma membrane (Fig. 55g).  
These observations suggest that a fraction of the fluorescent NP construct is incorporated into 
vRNPs and undergoes export from the nucleus towards the viral budding site at the plasma 
membrane. The granular appearance of mEYFP-NP in the cytoplasm of infected cells gives a 
first hint that mEYFP-NP indeed forms part of larger complexes. The observed distribution is 
further consistent with the characteristic cytoplasmic appearance of vRNPs during infection 
as previously shown by fluorescence in situ hybridization of vRNA and NP immunostainings 
[280,298].  
However, it cannot be entirely excluded that mEYFP-NP by itself is affected by infection and 
redistributes to the cytoplasm. As aforementioned, biochemical analysis of cell lysates to 
provide evidence for incorporation of mEYFP-NP into vRNPs travelling the cytosol are not 
an appropriate tool due to the particularly small fraction of infected cells coexpressing 
mEYFP-NP and displaying further cytoplasmic localization of the construct.  
While the current work was in progress, three other studies were published dealing with the 
mechanism of apical transport of vRNPs during infection. It was shown that vRNPs 
colocalize with Rab11-positive recycling endosomes (RE) [297,298] and associate with 
Rab11 via the PB2 subunit of the viral polymerase [280].  
 
Fig. 57: Coexpression of mEYFP-NP and Rab11-RFP in MDCK II cells (8 h p.t.). MDCK II cells were cotransfected 
with mEYFP-NP and Rab11-RFP. The living cells were imaged with an epifluorescence microscope at 8 h p.t. 
Representative images are shown. mEYFP-NP localized predominantly in the nucleus, while the majority of 
Rab11-RFP could be found in the cytoplasm. Cytoplasmic fractions of both proteins had a relatively 
homogenous appearance, Rab11-RFP displaying the highest local concentration in a distinct juxtanuclear 
region. Scale bar, 10 µm.  
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In order to verify that the here established experimental system to analyze vRNP transport in 
living infected cells is consistent with the Rab11-dependent transport mechanism that was 
described in the above-mentioned studies, mEYFP-NP was cotransfected with the red-
fluorescent Rab11-RFP in the presence or absence of infection. 
Cotransfection experiments with mEYFP-NP and Rab11-RFP in the absence of infection 
demonstrated that mEYFP-NP and Rab11-RFP adopt largely distinct subcellular distributions 
(Fig. 57). Just like when expressed by itself, the vast majority of mEYFP-NP targeted to the 
nucleus, and only a small fraction could be found diffusely spread throughout the cytoplasm. 
Rab11, on the other hand, which is a pericentriolar recycling endosomal marker [508], 
displayed the most prominent local accumulation in a juxtanuclear region likely to be the 
MTOC and was further diffusely distributed throughout the cytoplasm. Coexpression of 
Rab11-RFP did not seem to affect the subcellular localization of mEYFP-NP. 
Upon coexpression of mEYFP-NP and Rab11-RFP in virus-infected cells, the distribution of 
Rab11-RFP changed into a more punctate appearance, and a more prominent perinuclear 
accumulation was observed (Fig. 58). Similar infection-induced changes have been reported 
also for endogenous Rab11 [280,297]. 
In some cells, infection-induced relocalization of mEYFP-NP to the cytoplasm was observed 
as described in 4.4.1; whenever such accumulation of mEYFP-NP in form of punctate 
cytoplasmic structures was detected, an excellent degree of colocalization between mEYFP-
NP and Rab11-RFP was observed (Fig. 58). The two proteins colocalized most prominently in 
the juxtanuclear region likely to be associated with the MTOC and in more dispersed speckled 
 
Fig. 58: Coexpression of mEYFP-NP and Rab11-RFP in Influenza virus-infected cells (9 h p.i., 7 h p.t). MDCK II 
cells were infected with Influenza A/FPV at MOI 100, and transfection with mEYFP-NP and Rab11-RFP was 
performed at 2 h p.i. Confocal fluorescence images were acquired at 9 h p.i. and 7 h p.t. Punctate cytoplasmic 
mEYFP-NP signals colocalized with Rab11-RFP in the perinuclear region and in the cell periphery. (The 
prominent juxtanuclear local accumulations of mEYFP-NP and Rab11-RFP shown here were imaged within the 
focal plane, which was positioned slightly above the nuclear compartment, highly enriched with mEYFP-NP, 
which can be observed as stray light). Scale bar, 10 µm.  
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structures in the peripheral cytoplasm. The majority of cytoplasmic mEYFP-NP apparently 
became associated with the recycling endosomal compartment. 
The findings are consistent with the reported colocalization between vRNPs and Rab11 during 
Influenza virus infection, and they suggest that also mEYFP-NP associates with the recycling 
endosomal compartment in form of vRNP complexes.  
Considering that the interaction between vRNPs and Rab11 was previously shown to be 
mediated by the viral polymerase [280,298], it is most likely that also mEYFP-NP targets to 
Rab11-positive structures in form of vRNPs through interaction with the polymerase subunit. 
This is supported by the finding that mEYFP-NP associates with recycling endosomes in 
infected cells, but not in the absence of infection (Fig. 57 & Fig. 58). 
In conclusion, control experiments support the initial assumption that the fraction of mEYFP-
NP which accumulates as punctate structures in the cytoplasm of infected cells represents 
intact vRNP complexes. Such mEYFP-tagged vRNPs, formed by incorporation of mEYFP-
NP, apparently target the Rab11-dependent vesicular transport system just like vRNPs in 
normal infection.  
Using the established experimental approach, it could not only be demonstrated that mEYFP-
NP colocalized with Rab11 in infected cells, but it was also possible to monitor cotransport of 
mEYFP-NP with Rab11 in living infected cells.  
Living infected cells coexpressing mEYFP-NP and Rab11-RFP were therefore imaged over 
10 min in two dimensions with a frame rate of 2 frames per second. Image processing and 
analysis was performed as described in Material and Methods (3.2.3.3). Cytoplasmic mEYFP-
NP typically localized in double-labeled structures together with Rab11-RFP, sharing the 
same dynamic behavior. Many of these particles remained static for long periods of time or 
even during the entire observation period, while other particles displayed fast saltatory 
movements, which are characteristic for microtubule-based transport. 
For one representative cell, a random selection of 33 particles displaying movements between 
2 and 20 µm was analyzed (Fig. 59). For each particle, mEYFP and RFP signals were 
independently traced. The results are shown in Fig. 59b and Fig. 59c. The overlay of the 
trajectories confirms cotrafficking of mEYFP-NP and Rab11-RFP (Fig. 59d, yellow and blue 
lines, respectively). The congruence of the tracks further demonstrates that the movement of 
particles could be relatively precisely and reliably be described, using the here applied semi-
automated tracking method.  
16 particles were initially selected from RFP fluorescence images, and 17 particles were 
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Fig. 59: Single particle tracking of mEYFP-NP and Rab11-RFP in living infected cells (10 h p.i. and 8 h p.t.). 
MDCK II cells were infected with Influenza A/FPV (MOI 100) and transfected with mEYFP-NP and Rab11-RFP at 
2 h p.i. Two-dimensional time-lapse imaging of living cells was performed at 10 h p.i. and 8 h p.t. by 
epifluorescence microscopy. Image stacks were acquires over 10 min at a frame rate of 2 frames/s. For analysis, 
cells were selected displaying granular cytoplasmic mEYFP-NP signals. Trajectories of single fluorescent particles 
were analyzed using ImageJ and the Spot Tracker plugin. The graphic representation was generated with the 
MTrackJ. For one representative cell (a-d, single optical sections), the movement of 33 particles is indicated, 
which was separately traced for (b) mEYFP and (c) Rab11-RFP signals. Particle movements which could be 
detected for only one of the two fluorophores are represented in red. An overlay of the tracks is shown in (d) 
and demonstrates cotrafficking of mEYFP-NP (yellow lines) with Rab11-RFP (blue lines). Blue lines are concealed 
by yellow lines in case of overlapping trajectories. Trafficking of mEYFP-NP in the absence of colocalization with 
Rab11-RFP was rarlely observed (indicated by an arrow). The indicated track describes a movement from the 
nucleus to the cytoplasm covering a distance of 2.3 µm. Scale bar, 10 µm.  
chosen from mEYFP images. Not all of the particles displayed the corresponding signal in 
mEYFP and RFP fluorescence images, though. In particular, movements of Rab11-RFP were 
frequently observed in the absence of mEYFP-NP (here: 5 out of 16 tracks, depicted as red 
lines in Fig. 59c). 
Trafficking of mEYFP-NP, on the other hand, did typically not occur independent from 
Rab11-RFP transport, consistent with a Rab11-dependent transport mechanism. One 
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exception was observed though: a short trajectory, 5 µm in length and reaching from the 
nuclear rim into the cytoplasm, displayed mEYFP but not RFP fluorescence (Fig. 59b, arrow). 
It is possible that this trajectory describes translocation of an mEYFP-tagged vRNP 
subsequent to nuclear export and before association with the Rab11-dependent recycling 
endosomal machinery. The movement can be described as a directional movement with an 
average velocity (± SEM) of 0.23 ± 0.03 µm/s. This is close to reported values for myosin-
driven actin-based transport [110,509,510] and further consistent with the existence of a 
perinuclear actin network. The particle then remained immobile for the rest of the observation 
time. This movement was not found to be representative though for movements in the 
perinulear region, which tended to be faster and cover longer distances (see below, Fig. 61). 
It is a general limitation that individual mEYFP-NP particles cannot be detected within nuclei 
since the overall nuclear mEYFP-NP concentrations are too high. Therefore, it cannot be 
proven with certainty that a particle emerging at the nuclear surface has just been exported 
from the nucleus. Also particles which move close to the nuclear membrane in the perinuclear 
space might appear in the two-dimensional image plane close to the nuclear surface as though 
they exit from the nucleus.  
Some considerations can help to interpret the data though. Considering the low probability for 
sharp turns of movement in one point, a particle movement perpendicular to the nuclear 
surface is more likely to represent an export event, while a parallel orientation of the track 
would rather indicate a perinuclear movement. It has to be further distinguished between 
imaging of the upper part of the nucleus, typically showing also accumulation of NP and 
Rab11 in the perinuclear region (Fig. 59), and imaging of the middle section of the nuclear 
compartment (Fig. 61).  
In the upper part of the cell, particles moving across the nuclear compartment typically 
displayed a non-intermittent uniform movement and were distinguishable from the nucleus by 
distinct fluorescence intensities, suggesting that these particles moved in the perinuclear space 
above the nuclear compartment. When the middle section of nuclei was monitored instead, it 
was frequently seen that particles suddenly detached from nuclei and rapidly moved into the 
cytoplasm in a directed movement (Fig. 60a). These particles were undetectable in the 
cytoplasm or the nucleoplasm prior to their appearance at the nuclear surface. Yet, some of the 
particles emerged slightly underneath the nuclear outline, indicating that they were in fact 
coming from the inside of the nucleus (Fig. 60b). Also cases of retrograde movement towards 
the nucleus were observed where particles disappeared at the nuclear surface or slightly 
underneath as though being imported into the nucleus. 
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Fig. 60: Live-cell imaging of NP nuclear-cytoplasmic transport in infected cells (8.5 h p.i., 6.5 h p.t.). MDCK II 
cells were infected with Influenza A/FPV (MOI 100) and transfected with (a) mEYFP-NP or (b) mCherry-NP at 
2 h p.i. Time-lapse imaging was performed at 8.5 h p.i. and 6.5 h p.t. (a) by epifluorescence microscopy at 
intervals of 0.5 s or (b) by confocal laser scanning microscopy at intervals of 1.6 s. Original fluorescence images 
(single optical sections of different time points) are shown in (a1, b1). Image stacks were then processed by 
forming of the median projection of the time stack, which was subtracted from each image of the stack, and 
finally the Spot Enhancement Filter from the ImageJ Spot Tracker plugin was applied. The results of image 
processing are shown in (a2, b2), represented as pseudo color images using the ImageJ lookup table “fire”. 
Yellow indicates high signal intensity, while blue represents low signal. The nuclear outline was derived from the 
median projection as the line between the NP-rich nucleoplasm and the NP-depleted cytoplasm and is 
indicated as a dashed line in (a2, b2). Arrows indicate moving particles emerging at the nuclear boundary and 
traveling into the cytoplasm. Scale bar, 1 µm.  
Particle movements from the nucleus into the cytoplasm were observed in most infected cells 
coexpressing fluorescent NP constructs. An example is shown in Fig. 61 where coexpression 
of the red-fluorescent mCherry-NP replaced expression of mEYFP-NP. mCherry-NP is an 
analogous construct which behaves like mEYFP-NP in experiments, but it has a considerably 
higher photostability. The trajectories of five particles are shown, which were found to 
emanate from the same site of the nucleus at short intervals. The time lag between their 
appearances was 42 s, 22 s, 32 s and 47 s, respectively. The particles performed a directional 
motion along identical pathways until they disappeared from the image plane. The average 
instant velocities of the particles ranged between 0.27 and 0.41 µm/s with an average of 0.34 
± 0.04 µm/s. The traveled distances in the cytoplasm varied between 4.7 and 9.3 µm. A highly 
frequented transport route thus seems to be located at this site of the nuclear surface. This 
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Fig. 61: Single particle tracking of mCherry-NP in living infected MDCK II cells (8.5 h p.i., 6.5 h p.t.). Infection 
with Influenza A/FPV (MOI 100) was performed 2 h prior to transfection with mCherry-NP. Living cells were 
monitored by confocal laser scanning fluorescence microscopy at a frame rate of 1 frame/1.1 s. (a) One 
representative cell is shown, displaying major accumulation of mCherry-NP in the cell nucleus and punctate 
mCherry-NP signals in the cytoplasm, which are indicative for successful viral infection. Particle movements 
were analyzed using the Spot Tracker plugin from ImageJ, and selected trajectories were plotted with MTrackJ. 
The trajectories of five particles are described, which emanate from the same site on the nucleus and traveled 
along the same route to the cell periphery in quick succession. The corresponding trajectories are plotted into a 
projection of the analyzed image stack. An enlargement of the indicated section, showing an overlay of the 
tracks, is given in panel (vi). The individual trajectories and the corresponding time of observation are shown in 
panels (i) to (v). The average velocity of the particles (± SEM) was calculated to be 0.34 ± 0.04 µm/s. The track 
lengths varied between 4.7 and 9.3 µm. Scale bar, 10 µm.  
could be the exit of a nuclear pore and/or the path of a cytoskeletal structure (e.g. 
microtubule) passing in very close proximity to the nucleus.  
Fluorescent particle movements were detected throughout the cytoplasm. Some of the 
particles moved in and out of the pericentriolar region where Rab11 concentrates, and part of 
them traveled in more peripheral regions of the cytoplasm. Both anterograde and retrograde 
transport were observed. The average instant velocities measured for individual fast saltatory 
movements as depicted in Fig. 62 ranged from 0.3 to 1.2 µm/s with peaks up to 1.7 µm/s. The 
values are consistent with the velocities reported for microtubule- and motor protein-
dependent transport [511,512,513] and further excellently match the results that were obtained 
by Amorim et al. [280] for microtubule-dependent transport of GFP-tagged reconstituted 
vRNPs in the absence of infection. 
Particularly in regions with high spot densities, the tracking of single particles was difficult to 
realize. Trajectories were masked by numerous overlapping signals. The continuous path of 
one single particle was therefore difficult to trace. It is a general issue of SPT that two signals 
which merge and separate again cannot be unambiguously assigned. Tracks in Fig. 59 are 
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Fig. 62: Long-range movements of mEYFP-NP particles display a saltatory character. (a) A trajectory from SPT 
of mEYFP-NP particles in infected cells shown in Fig. 59 was selected (Fig. 59b, left trajectory, bright yellow), 
and it was analyzed for (b) the instant velocity and (c) the square distance to the start point of the trajectory , 
which were plotted over time. The average instant velocities of the two fast motile events were calculated to be 
0.81 ± 0.09 µm/s and 58.8 ± 0.12 µm/s, respectively. Scale bar, 1 µm.  
therefore preferentially shown in regions with low particle densities at some distance from the 
MTOC. Nevertheless, highly mobile particles were also observed in the vicinity of the 
MTOC.   
Most long-range movements can be described as intermittent movements (Fig. 62). They were 
found to be subdivided into several short movements, covering distances of a few 
micrometers and being interrupted by a sudden halt. Breakpoints of movements were often 
located at sites to which also other particles were targeted, indicating nodal points of unknown 
nature where Rab11-positive transport vesicles (with NP load) transiently accumulate. 
Numerous events of merging and splitting of signals were accordingly observed. When an 
encounter between particles comprised not more than two particles, different signal intensities 
could help to trace the particles.  
When mEYFP-NP and Rab11-RFP cotraveled in form of double-labeled particles as shown in 
Fig. 59, the signals of the two fluorophores were generally not found to separate over time. It 
has to be considered though that the observation period for each particle was limited since 
moving particles tended to escape from the image plane. It was therefore not possible under 
the given conditions to follow one single particle throughout the cell. A fast three dimensional 
imaging technique would overcome this limitation.  
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Fig. 63: Single particle tracking of mEYFP-NP at the plasma membrane of infected MDCK II cells (9 h p.i., 
7 h p.t.). The cells were infected with Influenza A/FPV (MOI 100) and subsequently transfected with mEYFP-NP 
at 2 h p.i. Time-lapse imaging was performed at 9 h p.i. and 7 h p.t. (A) by confocal laser scanning microscopy or 
(B) by epifluorescence microscopy. Images were acquired every 1.6 s or 0.5 s, respectively. SPT was performed 
using the ImageJ Sport Tracker plugin. Particles were selected which moved close to the plasma membrane, and 
their trajectories were plotted into a single optical section of the respective image stack. (A) Particles were 
found to move along the plasma membrane, but also orthogonal movements towards the plasma membrane 
and back to the cell center were observed. A large fraction of temporarily “immobile” (non-processive) particles 
is not represented. (B) Particle movements are shown – moving towards and departing from the plasma 
membrane – which are followed by or precede a period of locally restricted non-processive movement at the 
plasma membrane. Arrows next to trajectories indicate the direction of the movement. Scale bar, 10 µm. 
Long-range movements of mEYFP-NP and Rab11-RFP complexes were unexpectedly more 
frequently observed to run parallel to the cell boundaries than to target straight to the plasma 
membrane (Fig. 59). Nevertheless, it occured occasionally that particles moved straight to the 
cell periphery where they came to stop. Particles which could be traced also after arrival at the 
plasma membrane tended to remain relatively static for a while and to disappear over time. 
The simultaneous disappearance of Rab11-RFP signals indicates that these particles had 
moved out of the image plane rather than having undergone virus budding. This is consistent 
with observations made in cells where mEYFP-NP particles accumulated along the plasma 
membrane (Fig. 63A). Single particles that were targeted to the plasma membrane were 
quickly lost in the crowd of other particles, but the sum of particle movements demonstrated 
that there was significant movement beneath the plasma membrane. Processive and random 
movements of different velocities were observed. Particles seemed to move two-
dimensionally and in close proximity underneath the plasma membrane. Yet, static particles 
were frequently found to undergo sudden and rapid transport back towards the cell nucleus 
(Fig. 63B). Together, the data suggest that mEYFP-NP complexes arrive at the plasma 
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membrane via microtubule- and recycling endosome-dependent transport where the cargo 
might be released from microtubules and change to another transportation mode along the 
plasma membrane before reaching the budding site. Considering the role of the peripheral 
actin network for transporting endocytic vesicles during viral uptake, an analogous 
mechanism might be assumed [110]. If this transition fails, the cargo might be redirected into 
the cell body.  
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5  Discussion 
5.1 The role of vRNP membrane binding for virus assembly 
5.1.1 Characterization of purified vRNPs 
The first aim of this study was to analyze the intrinsic and M1-mediated interaction capacity 
of vRNPs with membranes. To this end, vRNPs had to be purified from Influenza A virus 
particles and to be scrutinized prior to application in experiments. Purification was performed 
according to an established protocol [117]. Yet, in contrast to that report, M1 was detected in 
purified vRNP fractions, but could be selectively removed (Fig. 8F). The purity of the 
proteins was validated by SDS-PAGE (Fig. 8C). The presence of RNA bound to NP in 
purified samples could be demonstrated indirectly by the novel combinatorial use of two 
nucleic acid stains with different properties, propidium iodide (PI) and acridine orange (AO), 
and by spectrofluorometric analysis (4.1.1, Fig. 10). To the best of my knowledge, this 
approach has not been used before, detecting the presence of single-stranded (ss) nucleic acids 
by PI and simultaneously verifying protein binding to these nucleic acids via electrostatic 
phosphate backbone interactions by the use of AO.  
PI fluorescence spectra clearly demonstrated the presence of nucleic acids in the samples by 
characteristic spectral shifts caused by intercalation of the dye molecules, whereas AO 
fluorescence (a double-strand intercalating and single-strand backbone binding dye [470,471]) 
lacked any spectral changes and thus indicated the absence of ds nucleic acids and the 
inaccessibility of the phosphate backbone. Together, the results suggest that the purified 
samples contained ss nucleic acids with a phosphate backbone fully shielded from interaction 
with AO. These results are consistent with the model of NP-vRNA complexes that was 
postulated in 1994 by Baudin et al. based on the inaccessibility of the RNA backbone and on 
the exposure of the ribonucleotide bases as measured by their chemical reactivities [87]. This 
concept of RNA binding to NP by electrostatic interactions with the phosphate backbone was 
further supported by the finding that NP binds to RNA with high affinity but without sequence 
specificity [87,91,514] and by NP crystal structures displaying a highly positively charged 
arginine-rich groove which could be shown to be crucial for RNA binding by mutational 
analysis [93,333]. Very early studies in this field further demonstrated that RNA can be 
efficiently released from NP by competitive addition of the polyanion polyvinylsulfate 
[82,338]. Based on this set of experimental evidence for a backbone-mediated interaction 
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between RNA and NP, the data obtained here by PI and AO fluorescence analysis of the 
purified vRNP samples strongly support that RNA and NP were co-purified and preserved as 
RNP complexes (Fig. 10). Electron microscopy studies additionally confirmed the presence of 
intact, elongated flexible structures of appropriate size within these preparations (Fig. 9). 
vRNPs were previously reported to range  from about 30 to 120 nm [8,52,53]. It was thus 
ensured that the results obtained in flotation experiments reflect properties of intact vRNP 
complexes.  
5.1.2 vRNPs do not directly bind to lipid membranes 
Using these purified native vRNPs, the membrane binding capacity of the genomic segments 
was examined to address the question if vRNPs can potentially use membrane interaction or 
lipid recognition for specific targeting and association with the budding site (4.1.2, 4.1.3). For 
Influenza viruses, membrane interactions and targeting motifs (raft targeting and apical 
targeting) have been well studied in case of the three transmembrane proteins (HA, NA, M2) 
and in case of the matrix protein M1 (reviewed in [21], [41]). Specific interactions of all four 
proteins with cellular membranes constitute intrinsic signals that can either independently 
target these proteins to the apical plasma membrane or contribute to membrane attachment, 
thereby facilitating their recruitment to the budding site. The role of membrane interactions 
for the assembly of genomic vRNPs has however not been addressed before. Direct or 
indirect membrane association might similarly contribute to vesicular trafficking of the 
vRNPs or to the attachment of vRNPs to the viral budzone. Elucidating this aspect was the 
goal of the first part of this study.  
A first observation indicating the presence of intrinsic targeting signals in vRNPs was made 
by Carrasco et al. [299] and Elton et al. [515], who described a lipid raft-dependent apical 
localization of NP when expressed alone in polarized cells, suggesting that NP as the major 
vRNP component might contribute to vRNP targeting to the viral budding site. In more recent 
studies, it has been shown that transport of vRNPs from the nucleus to the apical plasma 
membrane is mediated by recycling endosomes (RE) [280,297,298]. Even though recruitment 
of vRNPs to RE seems to be through interaction of PB2 with endosomal Rab11 [280], a 
contributory effect of other interactions, e.g. membrane interactions, to support the transport 
of the large vRNP complexes can be imagined. 
 In the present study, the ability of vRNPs to interact with pure lipid bilayers or with specific 
lipid species was carefully investigated. Yet, no interaction could be detected (Fig. 11, Fig. 
13). A variety of lipid compositions, representing the most abundant phospholipid classes of 
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cellular membranes, were tested, e.g. the inner leaflet plasma membrane lipids DOPS and 
DOPE, the classical raft lipid mixture DOPC, SM and Chol and a total lipid extract from 
native tissue featuring the natural lipid diversity. Since vRNPs are negatively charged 
complexes, also the combination with divalent Ca
2+
 ions and negatively charged DOPS-
containing membranes was tested. The analyzed lipid species represent not only the major 
lipid classes present in permissive host cell lines like MDCK II cells, but also the major lipid 
classes that constitute the Influenza virus envelope [16]. Moreover, this study comprised 
phosphoinositides, an important group of functionally specialized lipids which are involved in 
signaling and definition of subcellular compartment identity [477]. From these experiments, it 
cannot entirely be excluded that vRNPs are able to interact with membranes under 
circumstances that were not covered within this study. However, the examination of a broad 
variety of lipids and lipid compositions strongly supports the conclusion that vRNPs are not 
able to associate with pure lipid membrane and that – most likely – direct vRNP membrane 
interactions do not play a role in viral replication.  
5.1.3 Revisiting membrane binding of uncomplexed NP  
With regard to the intrinsic, lipid raft-dependent apical targeting of NP that was previously 
postulated as underlying mechanism for apical targeting of vRNP complexes [299], it could 
be shown here that neither NP by itself nor vRNP complexes were able to associate with raft 
lipid mixtures (Fig. 11C, D). This finding suggests that the observed lipid raft-dependent 
behavior of NP as described by Carrasco et al. [299] may have been caused by interaction 
with a raft-associated cellular component, but not by direct interaction with raft lipids. It 
should be further considered that the effect of cholesterol depletion, causing perturbation of 
NP apical distribution (which was interpreted as raft-dependent behavior of NP [299]), might 
have also been due to a general perturbation of cellular trafficking in cholesterol-depleted 
cells. In line with this interpretation, NP apical localization in the same study was only 
slightly affected by cholesterol depletion, whereas apical localization of raft-associated HA 
was completely impaired by membrane raft disruption. Further, only 12 % of total 
cytoplasmic NP was shown to be membrane-associated in NP-expressing cells, while apical 
localization was shown for the vast majority of NP. Taken together, the data provided by 
Carrasco et al. seem to allow another interpretation aside from the one proposed, namely that 
apical targeting or retention of NP in transfected cells might be determined by factors other 
than membrane rafts. 
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The results that were obtained here by flotation of NP with liposomes indicate an alternative 
contributory factor for the apical localization of NP. NP as a highly positively charged protein 
could be shown to partially associate with negatively charged liposomes (Fig. 11D). 
Transferring this finding to a cellular context, this property might be one determinant for NP 
behavior when NP is expressed in the absence of infection and when its positive charges are 
not neutralized by vRNA binding. This assumption is based on the work of Yeung et al. [286]. 
They have shown that the subcellular localization of proteins with a polybasic cluster is 
influenced by electrostatic interaction with cellular membranes. Proteins with a moderately 
positive charge are directed to endosomal compartments, whereas strongly cationic proteins 
with charges of about +8 are directed to the plasma membrane. The plasma membrane is 
considered to feature the most-negative surface charge among the cytoplasmic membrane 
leaflets due to the presence of PS and phosphoinositides. Low cationic, hydrophobic probes 
localize preferentially to membranes of the secretory pathway instead [286]. This leads me to 
the assumption that NP, bearing a positive charge of +14 at pH 6.5 [327] and being able to 
associate with PS-containing liposomes in vitro, might be driven towards the cell periphery 
when localized in the cytoplasm. Details on the specific surface charges of apical and 
basolateral membrane domains are not known. Cosegregation of negatively charged PS with 
sphingolipid- and cholesterol-enriched liquid-ordered domains of cellular membranes was 
described by Fairn and coworkers [476] and might provide a connection between the formerly 
suggested, partially raft-dependent behavior of NP in cells and the here observed interaction 
of NP with negatively charged liposomes in vitro.   
In conclusion, electrostatic membrane interactions might have contributed to NP targeting to 
the apical plasma membrane as described by Carrasco and coworkers and might further have 
partially maintained the NP subcellular distribution even after cholesterol depletion [299]. It 
should be considered, though, that exposure of the highly positively charged RNA-binding 
groove of NP and the net positive charge of RNA-free cytoplasmic NP represent artifacts of 
NP expression in the absence of virus infection, since NP is rapidly imported into the nucleus 
during infection and re-exported into the cytosol mainly in an RNA-bound form [297], 
carrying a net negative charge. Thus, NP targeting if driven by electrostatic interactions would 
be only of limited significance for virus infection and in particular during virus assembly. 
Since important electrostatic effects can generally not be excluded when studying NP in the 
absence of virus infection, data obtained for NP in an RNA-free state have to be interpreted 
carefully, particularly with regard to the transferability of NP behavior to infection. 
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Carrasco et al. studied the NP distribution in transfected cells at 48 h p.t., which is a relatively 
late time point for standard analysis of exogenously expressed proteins. It may thus be 
possible that the reported apical distribution of NP established only very slowly, implying a 
passive process, which is in line with the here proposed electrostatic targeting of NP and with 
the overall low cytoplasmic mobility of NP that was demonstrated in the present study (Fig. 
47A, B). Slow NP diffusion and apical retention due to weak interactions could possibly 
explain a slow manifestation of NP apical targeting. Due to the timescale, this mechanism 
would however be hardly relevant for apical targeting of vRNPs during infection. Variation of 
NP apical targeting in different cell lines was further reported and suggests cell line-specific 
interactions with the apical compartment. 
For a balanced view, it should furthermore be noted that other studies which investigated 
various cell lines and NP subtypes [44,118,363] did not report intrinsic apical localization of 
NP, which in accordance with NP expression experiments of the present study (see 4.3.3). 
Instead, a homogenous cytosolic NP distribution was described for various time points of 
observation, which could be confirmed here also for 48 h p.t. (Fig. 37). One experimental 
approach within the present study therefore aimed at verifying the reproducibility of NP 
apical localization in polarized cells. NP constructs were hence expressed in polarized 
MDCK II cells (Fig. 52). NP was expressed as wt protein or equipped with a nuclear export 
signal (NES) for increased amounts of cytosolic protein. The proteins were detected as 
intrinsically fluorescent fusion proteins or by immunofluorescence. However, none of the 
constructs displayed apical accumulation after 13 days of polarized growth. Expressed 
proteins distributed homogenously throughout the cytoplasm, whereas the viral control 
protein HA, which is known to contain an apical targeting signal [41], was exclusively sorted 
to the apical plasma membrane (Fig. 52f). The uniform cytoplasmic distribution of NP was 
the same as in non-polarized cells at 7, 24 and 48 h p.t. Taken together, apical targeting of NP 
as presented in [299] could not be reproduced, even though analysis was performed under 
basically comparable conditions, including the same cell line and the same time point. A 
difference was made by using NP from Influenza A/FPV virus instead of the NP sequence 
from Influenza A/PR/8 virus. The two proteins share 94 % sequence identity, and a 
fundamental mechanism like genome targeting should be independent from strain-specific 
differences. As MDCK II cells are permissive for Influenza virus infection, they are generally 
suitable to study mechanisms crucial to viral replication. MDCK II cells were one of the cell 
lines reported to show preferential accumulation of NP at the apical surface. However, the 
results obtained in the present study imply that NP apical targeting as observed by Carrasco et 
DISCUSSION 
206 
 
al. [299] cannot be generalized and thus might play a minor role in Influenza virus 
replication. Factors that might have driven NP apical accumulation in previously reported 
cases could not be further investigated due to non-reproducibility. A significant influence of 
membrane surface charges on NP subcellular localization was furthermore not detectable in 
the context of these experiments. 
Finally, it should be mentioned that immunofluorescence stainings in particular for NP have 
been found to be prone to artifacts as shown in Fig. 42. Special attention has to be paid when 
analyzing polarized distributions, as immunofluorescence stainings can give rise to false-
positive detections and may have influenced former analyses of NP apical localization. 
5.1.4 vRNPs bind to lipid membranes via M1 in vitro 
A general conclusion can be drawn from in vitro membrane binding studies of NP in 
comparison with vRNPs (Fig. 11C, D). The ability of NP to interact directly with negatively 
charged liposomes is apparently not relevant for membrane binding of complete vRNP 
complexes as these failed to associate with the same liposome species. 
According to these results, direct interaction of vRNPs with cellular membranes is unlikely to 
occur and to contribute to processes like vesicular transport or association with the nascent 
viral envelope. Other factors have to be considered for targeting and anchoring of vRNPs to 
the viral envelope. M1 is a promising candidate to play a key role in the assembly of virus 
particles as it is known to be able to interact with all viral components including lipid 
membranes, the viral membrane proteins and the vRNP complexes (reviewed in [20,41,300]). 
Topologically, it has been shown to form a layer between the genomic complexes and the 
viral envelope in intact virus particles. Even though electron microscopy data do not show a 
tight interaction between M1 and vRNPs in virus particles [8,31], numerous studies have 
demonstrated efficient vRNP-M1 interaction biochemically by purification of complexes from 
infected cells [29], from intact virus particles [51,68,113] or by in vitro reconstitution 
[42,275]. However, simultaneous interaction of M1 with the different viral components has 
not been shown yet, and a temporal and spatial characterization of these interactions during 
the viral replication cycle is still missing.  
In the present study, M1 was analyzed for its ability to mediate association of vRNPs with 
lipid membranes, and it could be demonstrated that M1 is in fact able to connect vRNPs with 
lipid bilayers. Despite some technical limitations of the method as outlined in 4.1.2, M1, 
which is able to interact efficiently with negatively charged membranes by itself (Fig. 12B; 
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[42,45,445]), was able to attach a fraction of vRNPs to negatively charged liposomes, 
containing DOPS or total brain lipid extract (Fig. 12A, B). Notably, when M1 was bound to 
the phosphoinositide PtdIns(4)P in the presence of vRNPs, vRNPs did not associate with the 
PtdIns(4)P-bound M1 (Fig. 13). Specific binding of M1 to PtdIns(4)P was demonstrated in a 
binding screen using a lipid-spotted support (PIP strip). This interaction was further 
confirmed by the work of Nadine Jungnick, using PtdIns(4)P presented in form of a liposomal 
bilayer and recombinantly generated M1 [445]. Circular dichroism measurements in the same 
study showed that M1 undergoes differential conformational changes upon binding to DOPS- 
or PtdIns(4)P-containing liposomes, indicating the formation of different conformational 
subpopulations of M1 when bound either to DOPS or PtdIns(4)P. These forms of M1 might 
differ by their ability to interact with vRNPs and thus by their ability to connect vRNPs and 
membranes. Intriguingly, this assumption is consistent with the previously reported 
differential subcellular behavior of the two viral components during viral replication [516]. 
M1 is targeted to the Golgi membrane of transfected and infected cells [38,449] where 
PtdIns(4)P is known to be localized [477], whereas vRNPs do not localize to the Golgi 
apparatus during infection [280]. PtdIns(4)P is known to be a functionally defining lipid of the 
Golgi apparatus [517]. Its interaction with M1 is thus likely to explain the previously reported 
prominent recruitment of M1 to the Golgi apparatus in transfected and infected cells, although 
this remains to be demonstrated. Even though M1 is abundantly present and various models 
postulated that it mediates membrane association of the genomic segments [20,34,41], vRNPs 
do not colocalize with the Golgi complex (or with HA [298]) during infection [280]. Instead, 
vRNPs undergo cytoplasmic transport using the endosomal recycling system [280,297,298]. A 
close proximity of vRNPs to M1 at cellular membranes could so far solely be shown by 
electron microscopy at the newly forming viral envelope or in intact virus particles [8,35]. 
This site-specific aspect of (co-)localization of M1 and vRNPs in situ might reflect a selective 
binding mode of M1 to vRNPs depending on the type of lipid interaction that M1 experiences, 
which is in analogy to observations from in vitro experiments (4.1.2 and 4.1.3). This model 
provides an explanation how M1 can possibly support the attachment of vRNPs to specific 
sites like the budding site, but not to others like the Golgi apparatus.  
In cells, the lipid PS is predominantly present on endosomal membranes and on the inner 
plasma membrane leaflet [518,519], i.e. on those membranes that are known to recruit vRNPs 
during viral infection. PS is however hardly found on the cytoplasmic membrane leaflets of 
the secretory pathway [286,476,519]. Net negative surface charges of subcellular membranes 
correlate with the presence of PS and phosphoinositides, making the plasma membrane the 
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most negatively charged and the secretory system the least negatively charged cytosolic 
membranes [286]. PtdIns(4)P is prevalent on the Golgi membrane. The ability to bind 
electrostatically to negatively charged membranes [45] and to bind specifically to PtdIns(4)P-
containing membranes [445] should enable M1 to interact with most subcellular membranes. 
Notably, the conformational switch of M1 due to interaction with a compartment-specific 
lipid most likely allows M1 to distinguish between different subcellular compartments and to 
exercise coordinated and site-specific functions like interactions with the genomic complexes. 
5.1.5 Model for the role of M1 during the infection cycle 
Combining these aspects, a model can be formulated describing vRNPs, M1 and their 
interplay during viral assembly. The first step to assemble the viral core components into 
progeny virus particles is their export from the cell nucleus. It is a generally accepted model 
that vRNPs associate with M1 to form vRNP-M1-NEP-CRM1 export complexes to access the 
cellular nuclear export machinery [269,270,292]. There is convincing evidence for the 
formation of these ‘daisy-chain’ complexes: vRNP nuclear export is critically dependent on 
M1 [116,260], NEP [66,264,270] and CRM1 [266,267], and suitable binary interactions 
among these components have been demonstrated [42,269,270]. 
It is not clear, though, if vRNPs remain attached to M1 during the following cytoplasmic 
transport. Fluorescence microscopy studies convey the impression that M1 and vRNPs might 
take separate routes [516], vRNPs being targeted to recycling endosomes by specific 
interaction of PB2 with Rab11 [280], but they do not colocalize with the Golgi apparatus or 
HA [280,298], whereas M1was shown to accumulate at the Golgi complex together with HA 
[38]. Yet, M1 is abundantly expressed and can be found diffusely throughout the entire cell, 
which makes it difficult to assign a specific localization pattern to M1 [520,521,522]. Even 
though the importance of M1 for vRNP nuclear export and further for the prevention of vRNP 
reimport [29,124] is well characterized, prominent colocalization of M1 with exported vRNPs 
or a shift in M1 distribution during infection has not been reported [116,266]. Similarly, M1 
was not found to be enriched with peripheral cytoplasmic vRNPs [516], which typically 
colocalize with the recycling endosomal compartment [297]. Due to the diffuse overall 
distribution, it cannot be excluded though that a small fraction of M1 remains associated with 
vRNPs during cytoplasmic transport. Biochemically, M1 could not be coprecipitated with 
Rab11-vRNP transport complexes [280,298], although M1 is efficiently coprecipitated with 
vRNPs from infected cells [29]. It is generally believed that the dissociation of M1 from 
vRNPs is triggered by acidic pH only at the stage of viral entry during endocytosis. The 
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results obtained here from in vitro experiments showing M1-mediated vRNP attachment to 
DOPS-containing liposomes (Fig. 12) now provide evidence that M1 is potentially able to 
support vRNP attachment to the negatively charged recycling endosomes by electrostatic 
interaction during cytoplasmic transport. The electrostatic nature of M1 membrane binding 
and the fact that high net negative charges on cytoplasmic membranes are limited to 
endosomes and the plasma membrane might confer a certain degree of specificity to M1-
mediated vRNP membrane interaction.  
For many years, studies have shown that M1 efficiently associates with membranes in vitro 
and in cells.  However, work on virus-like particle (VLP) production with M1 suggests that a 
membrane anchor is needed to target M1 to the plasma membrane for efficient membrane 
binding and VLP formation [257,288,289]. Combined with the observation that M1 lacks a 
clear plasma membrane localization when expressed alone [257], these findings seem to 
indicate that M1 is not able to target itself or vRNPs to specific cellular membranes like the 
recycling endosomal or the plasma membrane, despite their negative surface charges. Instead, 
M1 recruitment to HA, NA or M2 cytoplasmic tails or the recruitment of vRNP-bound M1 by 
primary targeting of vRNPs to endosomal membranes might be necessary to initiate or 
stabilize M1 membrane binding, and only then, M1 might be able to efficiently contribute to 
virus bud formation or to attachment of vRNPs to recycling endosomal transport vesicles.  
Most interestingly, apart from its role in virus assembly, electrostatic membrane binding 
might furthermore enable M1 to exert a regulatory function on recycling endosomal 
trafficking. This assumption is based on a study by Uchida and coworkers, demonstrating that 
competitive displacement of the cellular PS-binding protein evectin-2 from recycling 
endosomes disrupts specifically retrograde transport from recycling endosomes to the trans-
Golgi network [518]. In infection, inhibition of retrograde transport might contribute to 
efficient delivery of vRNPs to the plasma membrane by impeding alternative transport routes. 
It might further reduce retrograde transport of viral membrane proteins from the plasma 
membrane. Whether M1 binding to negatively charged PS in infection can compete with 
specific evectin-2 binding to PS on recycling endosomes – and thus interferes with recycling 
endosomal trafficking – remains to be tested. 
Unlike M1 interactions with the plasma membrane and endosomal membranes, targeting of 
M1 to the Golgi complex is relatively pronounced and independent from other viral proteins. 
The function of M1 targeting to the Golgi complex is still unclear, though. On the one hand, it 
would be obvious to assume that M1 may interact with the cytoplasmic tails of the viral 
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transmembrane proteins during infection and that they might preform an early budzone 
together with nascent raft domains. On the other hand, by specific targeting of PtdIns(4)P, M1 
might interfere with cellular processes to the benefit of viral replication. PtdIns(4)P is known 
to be involved in the regulation of membrane trafficking from the Golgi complex to the 
plasma membrane and in sphingolipid metabolism, thereby playing a central role in the 
control of the plasma membrane composition [517,523]. These functions form a highly 
interesting connection to Influenza virus replication and make PtdIns(4)P a promising 
candidate to be targeted by the viral machinery. It can be speculated that, by interaction with 
PtdIns(4)P, M1 might be able to promote efficient transport of the viral transmembrane 
proteins to the plasma membrane. Further, it might be able to modulate the lipid composition 
at the level of the Golgi complex and consequently at the level of the plasma membrane from 
which the viral envelope is then formed. It was only recently shown that the SM biosynthetic 
pathway is essential for the transport of viral glycoproteins from the Golgi to the plasma 
membrane during infection and for the efficient release of virus particles [524]. The activity 
of the sphingomyelin synthase at the Golgi membrane is furthermore known to require 
PtdIns(4)-dependent delivery of ceramide [517]. Assuming that M1 interaction with 
PtdIns(4)P can indeed affect sphingolipid synthesis, this might be a mechanism to supply high 
levels of SM to match the specific requirements for the formation of the budding site. 
According to this hypothesis, the Influenza viral envelope may not be specifically enriched in 
raft lipids in comparison to the lipid composition of the apical plasma membrane as it was 
previously suggested [16]. Instead, the overall composition of the apical plasma membrane 
may be changed in infected cells. The study of Gerl and coworkers recently compared the 
lipidome of the viral envelope with the lipidome of the apical plasma membrane of uninfected 
cells [16]. Data on the lipid composition of the apical membrane of infected cells was not 
provided. It could be shown however that whole-cell lipid extracts from Influenza virus-
infected cells display a relative reduction in PC and an increase in PI as the most prominent 
changes in comparison to uninfected control cells. Also an increase of SM was reported with a 
concomitant decrease of ceramide. A remarkable increase was furthermore reported for 
dihydro-SM. It might be considered though that effects of altered lipid metabolism and effects 
of lipid depletion due to virus budding might overlap in infected cells. To verify the above-
proposed hyposthesis that M1 interferes with the cellular lipid metabolism, changes in the 
lipid content of M1-expressing cells may be analyzed.   
It was previously reported that mutations within a highly conserved basic amino acid 
sequence of M1 (residues 76–78) caused aberrant localization of M1 in transfected and 
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infected cells [520]. The high conservation of this short sequence and the non-viability of 
mutants with single amino acid changes into acidic residues indicate an essential function of 
this site, which is obviously furthermore related to intrinsic subcellular targeting of M1. The 
specific interaction affected by these mutations remains to be determined. As the critical 
sequence is a cluster of three successive basic amino acids (R/K RR), an interaction with the 
negatively charged PtdIns(4)P might be considered. 
The two above proposed functions for the association of M1 with the Golgi apparatus do not 
include the presence of vRNPs. A conformational change of M1 presumably allows M1 to 
interact selectively with vRNPs, which might further allow precluding vRNPs from 
association with the Golgi complex and with preassembled viral components via M1. It is yet 
unclear which factor initiates budding and release of virus particles, but the presence of 
genomic vRNPs should constitute an important checkpoint for efficient formation of 
infectious progeny virus particles. The premature assembly of vRNPs with other viral 
components at an early stage at the Golgi complex might bear the risk to initiate processes for 
bud formation and release before the components reach the plasma membrane. Under this 
assumption, separate transport of envelope and core components would be an important 
aspect in viral replication and require regulatory mechanisms that allow independent actions 
of viral components at an early stage and recognition and assembly at later stages. The 
decrease of PtdIns(4)P content of membranes in the transition from the Golgi complex to the 
plasma membrane might restore the ability of M1 to interact with vRNPs and to connect them 
to the budding site, and it might further enable M1 to polymerize and drive bud formation 
along with the viral glycoproteins. During this transition, M1 would change from the Golgi-
specific PtdIns(4)P-bound conformation to an electrostatic membrane association by 
interaction with PS, phosphatidic acid and other negatively charged lipids that are present on 
the plasma membrane inner leaflet. When the two distinct trafficking pathways, transporting 
vRNPs and viral membrane proteins, join together at the plasma membrane, all components 
should be able to assemble as a complete set and initiate bud formation. Here, M1 might 
support vRNP attachment to the viral budzone. Specific incorporation of one set of vRNPs 
was previously implied by electron microscopy studies, reporting attachment of vRNPs by 
one terminal end of the segments to one point at the budding tip [31,53,306]. M1 might 
contribute to stabilize the contact with the envelope and support bud formation along the 
length of the vRNPs as M1 is a determinant of particle size and shape [31,69]. 
This model implies that two types of M1 membrane interaction spatially and functionally 
define different modes of M1 action during replication. They are spatially separated by the 
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strictly controlled, distinct lipid compositions of subcellular membranes. vRNP complexes 
appear to be transported and to associate predominantly with negatively charged membranes, 
possibly supported by interaction with M1. The Golgi membrane, being selectively enriched 
in PtdIns(4)P, but without a prominent negative surface charge, seems to allow specific 
recruitment of M1 to PtdIns(4)P, thereby presumably excluding vRNP attachment and 
enabling M1 functions other than the shuttling of vRNPs. Electrostatic membrane binding at 
the plasma membrane might furthermore finally allow M1 polymerization and bud formation. 
This model is an example on how the specific lipid environment at different subcellular 
locations can influence the functions and the functional interplay of viral components for the 
spatial coordination of interactions and processes during viral replication. 
5.1.6 Summarizing remarks 
It could be demonstrated that vRNPs were not able to bind to pure lipid membranes by 
themselves. Instead, it was shown that M1 was able to mediate association of vRNPs to 
negatively charged membranes. This is the first time that a simultaneous interaction between 
M1, vRNPs and membranes was demonstrated and that the requirements for this ternary 
interaction were characterized with regard to the lipid species. Moreover, it was found that 
binding of M1 to lipids does not automatically lead to the attachment of vRNPs as in case of 
M1 binding to PtdIns(4)P. These findings were intensely compared with previous reports on 
in vitro and in-cell studies and set into context with the current knowledge on subcellular 
organization and virus replication. The generally assumed involvement of M1 in many steps 
of vRNPs in viral replication – ranging from their nuclear export over the cytoplasmic 
transport to incorporation into budding virions – was transferred into a more detailed model 
taking into consideration the coordination of different processes, the local conditions within 
the cell and the transferability of data from in vitro experiments into a cellular context.  
Besides the role of M1 in vRNP nuclear export, which is functionally well characterized, the 
here obtained in vitro data on vRNP-M1 membrane binding now provide evidence that M1 
can indeed potentially contribute to processes like transport along with negatively charged 
vesicles and attachment to the plasma membrane. The specificity of targeting might however 
be additionally conferred by other factors. The mechanism of M1 interaction with lipid 
membranes via PS – that was characterized as electrostatic by previous studies and that was 
shown here to be relevant also for vRNP membrane association – indicates to which cellular 
membranes this interaction may be restricted in infected cells and where M1-mediated 
attachment of vRNPs to membranes can be accomplished, i.e. at the endosomal and the 
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plasma membrane. The reported prominent binding of M1 to the Golgi membrane, which 
does not match the criteria for electrostatic interaction [286], was further suggested to be due 
to the specific interaction of M1 with the predominatly Golgi-resident lipid PtdIns(4)P. Based 
on a reported conformational change of M1 upon PtdIns(4)P-binding and on the here 
observed concurrent inability to bind vRNPs, differing functions of M1 membrane binding 
were postulated, depending on the specific composition of subcellular membranes. Further, 
the possibility was deduced that M1-mediated membrane binding of vRNPs can be regulated 
and coordinated by a conformational switch in M1. 
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5.2 Generation of recombinant Influenza A virus encoding TC-
tagged NP to label progeny vRNP complexes in infection 
 
5.2.1 TC-tag insertions within NP interfere with viral replication 
In order to generate a recombinant mutant virus that allows specific labeling of newly formed 
vRNP complexes during infection for analysis of viral assembly in living cells, various NP 
variants were engineered containing the TC-tag, a six amino acid sequence (CCPGCC). Based 
on structure and sequence information of NP as illustrated in 4.2.1, and considering the 
segment 5 vRNA packaging signal, six different sites in flexible loop regions of NP were 
selected for insertion of the TC-tag sequence. Two of the constructs failed already preliminary 
tests of protein expression and subcellular targeting in the absence of infection (Fig. 15): NP-
TC100 did not enter the nucleus indicating misfolding or impaired targeting function, even 
though the nearby inserted TC-tag in NP-TC372 did not disturb nuclear localization. The 
second construct that clearly differed from NP wt behaviour in transfection by cytoplasmic 
accumulation was NP-TC247, the only mutant carrying the insertion in the NP head domain, 
which is more conserved than the NP body domain [331]. This site of insertion between 
residues 247 and 248 is spatially close to the classical bipartite nuclear localization sequence 
(aa 198–216), which has been shown to play only a minor role in nuclear import of NP though 
[123].  
The other four constructs NP-TC125, NP-TC288, NP-TC292 and NP-TC372 were efficiently 
targeted to the nucleus similar to wt NP (Fig. 16). This was considered as a prerequisite for 
use in reverse genetics. However, none of these virus mutants encoding one of the TC-tagged 
NP variants could be recovered as replication-competent virus (4.2.2). Supplementation with 
WSN wt virus nevertheless enabled replication and incorporation of the mutated 
segment 5 vRNAs into progeny virus particles, and TC-tagged NP was expressed in newly 
infected cells and successfully labeled with FlAsH (Fig. 20). Thereby, it was demonstrated 
that TC-tag insertion in vRNA encoding NP-TC125, NP-TC288, NP-TC292 or NP-TC372 did 
not impair genome packaging, but caused a defect on the level of protein function that could 
be restored by the presence of wt NP. However, efficient incorporation of TC-tagged NP into 
functional vRNP complexes in mixed infections was apparently not achieved. Characteristic 
punctate cytoplasmic NP signals that appear late in infection typically represent newly formed 
vRNPs which are being transported from the nucleus to the plasma membrane [297]. These 
structures were detectable in WSN TC125/wt, WSN TC292/wt and WSN TC372/wt virus-
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infected cells by immunofluorescence, but not by FlAsH labeling, indicating that TC-tagged 
NP variants did not efficiently compete with wt NP for incorporation into vRNPs or had major 
defects in vRNP formation. In conclusion, the here described virus mutants, which encode 
TC-tagged NP, could be rescued by superinfection with WSN wt virus, but were not suitable 
to generate TC-tagged vRNP complexes for fluorescence labeling and live-cell studies during 
infection.  
Influenza virus NP is a highly conserved protein [309,328,329,330], and it is involved in 
numerous interactions with viral RNA, the viral polymerase, M1 and cellular factors. Many 
regions within the NP structure have been identified as highly conserved and critically 
important for viral replication [183,317] or have been assigned to specific functions like RNA 
binding [333,337] or nuclear transport [123]. Even though the sites for TC-tag insertion were 
carefully selected in this study, it was not possible to insert the short sequence without 
critically affecting functions essential for viral replication. An alternative approach by 
choosing a terminal TC-tag for NP was therefore realized (see 4.2.3 and 5.2.3). 
5.2.2 NP-TC288 impairs vRNA replication in infection 
Despite the failure to generate recombinant virus mutants with TC-tag insertion within NP 
(4.2.2), valuable information could be extracted from reverse genetics experiments. 
Careful analysis of the attempts to generate recombinant virus mutants with TC-tag insertion 
demonstrated that recombinant WSN TC288 virus differed from the other virus mutants. 
WSN TC288 virus was the only virus mutant described here that could be successfully 
recovered from the initial step of plasmid-based virus generation as infectious virus particles 
(Fig. 18). Its failure to replicate in newly infected cells though provides interesting and 
relatively detailed information about the type of function that is apparently impaired by TC-
tag insertion at position G288/Y289 in NP.  
The successful recovery of infectious WSN TC288 virus particles from transfected cells was 
verified by infection of MDCK II cells and subsequent immunofluorescence analysis of NP 
expression (Fig. 18, Fig. 19). Evidently, WSN TC288 virus particles were efficiently produced 
by synthesis of viral mRNA and genomic vRNA from transfected plasmid DNA. The 
produced set of viral components (with NP-TC288 substituting wt NP) was obviously 
competent for virus assembly and virus release as well as for subsequent cell entry and viral 
protein expression in newly infected cells. The mutant protein NP-TC288 therefore can be 
considered to be a functional protein with regard to many processes of the viral replication 
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cycle, e.g. encapsidation of viral RNA, nuclear export and transport of vRNP complexes, 
genome packaging into progeny virus, nuclear import of incoming vRNPs and mRNA 
synthesis. Accomplishment of various NP functions implies correct folding of NP-TC288. 
Expression of NP-TC288 in WSN TC288 virus-infected cells moreover demonstrated the 
efficient incorporation of modified segment 5 vRNA into recombinant virus particles. Yet, 
infection with WSN TC288 virus turned out to be abortive. 
To identify the function that is disabled by TC-tag insertion into NP between residues G288 
and Y289, one has to look at those viral processes that are exceptionally carried out by the 
cellular machinery when producing virus particles by reverse genetics.  
The plasmid-based production of viral components in reverse genetics substitutes the viral 
polymerase functions; viral mRNA and vRNA synthesis are carried out by cellular RNA 
polymerases and are hence independent of the viral polymerase complex. As WSN TC288 
virus assembly, release and uptake were shown to be fully functional once mRNA and vRNA 
are synthesized from plasmid DNA, the failure of WSN TC288 virus to replicate in infected 
cells is apparently caused by an impairment of viral polymerase functions in infection and 
thus most likely by a failure of mRNA or vRNA synthesis. Since expression of NP-TC288 in 
WSN TC288 virus-infected cells could be verified by NP immunostaining (Fig. 19), viral 
mRNA synthesis was obviously not inhibited, implying that a failure of WSN TC288 virus 
replication is most probably caused by a defect specific for full-length cRNA and/or vRNA 
synthesis. This conclusion is consistent with the finding that nuclear export of progeny vRNP 
complexes could not be observed at any time during WSN TC288 virus infection, despite 
detection of abundant amounts of NP in the nucleus (Fig. 19). Since NP-TC288-containing 
vRNPs are efficiently exported from the nucleus during WSN TC288 virus production from 
plasmid DNA, a defect of these vRNPs in assembly or nuclear export can be excluded. A 
failure of vRNP formation due to impaired vRNA synthesis, however, can explain the absence 
of cytoplasmic vRNPs in WSN TC288 virus-infected cells and the inhibition of viral 
replication, and this defect can furthermore be overcome by plasmid-based vRNA synthesis. 
Remarkably, a significantly reduced nuclear export of vRNPs was also observed in mixed 
infections with WSN TC288 and WSN wt virus (Fig. 20). In such double-infected cells, not 
only the mutant protein NP-TC288, but also wt NP was prevented from nuclear export as 
shown by NP immunodetection. This indicates an impairment of vRNP formation even in the 
presence of wt NP. Along with a relatively low CPE observed for mixed WSN TC288 and 
WSN wt virus infections, these findings suggest that the modified protein NP-TC288 is not 
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only unable to support vRNA replication in infection, but it even appears to dominantly 
inhibit cRNA and/or vRNA synthesis in the presence of wt NP.  
In conclusion, there is evidence that the modification of NP by TC-tag insertion at position 
G288/Y289 affects the viral polymerase function. The data further suggest that this 
modification selectively affects full-length genomic RNA replication.  
During infection, the viral polymerase complex mediates both the production of 5′ capped and 
3′ polyadenylated mRNA (transcription) and the unprimed, full-length RNA synthesis 
(replication) from vRNP templates. Various models have proposed a regulatory function of 
NP for switching the viral polymerase activity from transcription to replication (reviewed in 
[54]). Other studies suggest however an NP-independent, stochastic initiation of mRNA and 
cRNA synthesis and show a stabilizing effect of NP on viral full-length RNA replication 
products instead [181,186,343]. Nevertheless, direct interactions between NP and viral 
polymerase subunits were demonstrated [182,184,343], and various studies have shown the 
importance of NP and NP-polymerase interactions for the viral polymerase activity 
[183,188,343,525]. NP-polymerase interactions have further been suggested to be regulated 
by host-specific factors and to affect polymerase activity and virulence in a host-dependent 
manner [344,525,526]. 
An interaction site of NP for the viral polymerase was only very recently identified and 
located to residues R204, W207, and R208 [188]. This site is situated at the top of the NP 
head domain, whereas the site of TC-tag insertion in NP-TC288 is located in the body 
domain. Unlike the mutation in NP-TC288 which seems to selectively impair viral full-length 
RNA synthesis, residues R204, W207 and R208 were shown to be essential for both mRNA 
and cRNA synthesis. Accordingly, these two different sites on NP seem to be involved in 
distinct functional interactions with the viral transcription/replication machinery. In support of 
the existence of several sites on NP to be involved in the NP-polymerase interplay, other 
studies reported mutations of NP which affect viral polymerase activity and which localize to 
the body domain [182,183] or to the RNA-binding groove of NP [525]. 
Very similar to the here proposed selective inhibitory effect of NP-TC288 on viral full-length 
RNA synthesis, Mena et al. [183] reported four NP mutants which are able to encapsidate 
viral full-length RNA, but which interfere with cRNA synthesis while being fully functional 
for mRNA (and vRNA) synthesis. All four mutations (M331K, D340H, F488G, Δ494–498) 
are situated close to each other inside the NP body domain. Although they are not directly 
neighbouring the site of TC-tag insertion between residues 288 and 289 at the surface of the 
NP body domain, they might contribute to conformational changes that impair the same 
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functional interaction with the viral polymerase as possibly the TC-tag insertion. The work of 
Mena et al. [183] implies that NP is able to selectively affect cRNA synthesis, which is in 
accordance with the above-derived interpretation of the failure of NP-TC288 to support viral 
replication due to a defect in viral full-length RNA synthesis. It cannot be distinguished here 
however between a defect in cRNA or vRNA synthesis. The possibility for a selective 
regulation of cRNA and vRNA synthesis is supported by another study that demonstrated 
different initiation mechanisms of viral full-length RNA synthesis on cRNA and vRNA 
promoters [197]. The role of NP in this context has however not been addressed yet. 
The subtype-specific sequence of NP was previously shown to be important for the interaction 
with the polymerase subunit PB2 and for the host-range adaptation of PB2 [344,527]: Two 
different NP proteins (from A/swan/Germany/R65/2006(H5N1) [DQ464359.1] and from 
 
Fig. 64: Comparison of the site of TC-tag insertion in NP-TC288 (red) with residues potentially involved in 
host-range adaption of polymerase subunit PB2 (blue). The NP sequences of two Influenza virus subtypes 
(A/swan/Germany/R65/2006 and A/Hong Kong/156/ 97) which were shown to differentially affect adaption of 
PB2 in mammalian cells differ by 16 amino acids (highlighted in blue). These residues are illustrated within a 
crystal structure of NP (PDB 2IQH, [93]). Only one subunit of the NP trimer structure is represented. The site of 
TC-tag insertion in NP-TC288 (residues 288 and 289) is labled in red. The structure was edited with PyMol. (A) 
Front view of NP. Surface representation (left) and cartoon of the secondary structure elements (right). (B) View 
of the NP body domain from the bottom site. Surface representation (left) and cartoon of the secondary 
structure elements (right). (C) Section of the NP secondary structure illustrating residues G288/Y289 and 
neighbouring residues. (D) Surface representation of a section of NP surrounding residues G288/Y289.  
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A/Hong Kong/156/ 97(H5N1) [AF036359.1]) which were shown to support replication 
preferentially with either PB2 K627 or PB2 E627 [527] differ by only 16 amino acids. The 
sequence alignment was performed using EMBOSS Needle (http://www.ebi.ac.uk/ 
Tools/psa/emboss_needle/). When mapping these residues onto the NP structure to locate 
residues potentially involved in NP-PB2 interactions (Fig. 64), ten of them are situated in the 
NP body domain, nine being surface residues (residues 33, 34, 52, 283, 319, 353, 371, 377 
and 482). The residues are not clustered, but the majority of them is located at the bottom of 
the NP body domain (Fig. 64B), as is also the TC-tag in NP-TC288. Especially residues 33, 
34 and 283 are structurally close to the site of TC-tag insertion between amino acids 288 and 
289 (Fig. 64C, D), supporting a possible role of this site for the NP-polymerase interplay. 
In summary, the analysis of the replication defect of WSN TC288 virus in this study supports 
a model of viral replication in which the polymerase activity is regulated by NP independently 
of its ability to encapsidate viral RNA and in which NP is critically required to promote viral 
full-length RNA synthesis [183,332,343]. For future studies, residues G288 and Y289 seem to 
be a promising site to further investigate the regulatory function of NP that selectively affects 
viral RNA replication and to elucidate the molecular mechanism of this regulation.  
Mutant WSN TC288 virus will represent a useful tool to study the role of NP for viral 
replication in more detail: Quantitative RT-PCR analysis of RNA species synthesized in WSN 
TC288 virus infection can provide information on the relative amounts of mRNA, cRNA and 
vRNA products and help to verify the specific defect. In order to figure out further whether 
the inhibitory effect of NP-TC288 is specific for either cRNA or vRNA synthesis or whether it 
affects synthesis of both RNA species, infected cells might be supplemented with cRNA to 
check if cRNA can compensate the replication defect. Alternatively, a minireplicon assay 
(analogous to [188]) using NP-TC288 with either cRNA or vRNA as template RNA might be 
performed. Furthermore, affinity purification of wt NP and NP-TC288 from virus-infected 
cells should allow the comparative analysis of cellular and viral interaction partners of wt NP 
and NP-TC288. 
5.2.3 Successful recovery of recombinant Influenza A virus encoding NP with 
an N-terminal tetracysteine motif 
As it was not possible to introduce the six amino acid sequence of the TC-tag into the NP 
sequence without critically affecting the protein functions, the TC-tag was instead fused to the 
N-terminus of NP. To accomplish this in the genomic background of Influenza A virus, a more 
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complicated procedure was necessary than simple insertion of the tag into the genomic 
sequence since modifications of the terminal sequences of the viral ORFs do not only affect 
the translation products, but also the cis-acting functions of the viral RNA. At the protein 
level, the N-terminus of NP is a flexible sequence which is not resolved in the two known 
crystal structures of NP [93,331] and which contains an unconventional NLS (residues 3 to 
13) responsible for nuclear import of NP [118,121,123]. At the genomic level, the 3′ end of 
the NP ORF is part of the packaging signal of segment 5, which is important for efficient 
incorporation of the segment into progeny virus particles (reviewed in [100]). The 
approximate size of the packaging signals can be inferred from naturally occurrin g, internally 
deleted defective-interfering (DI) vRNAs that incorporate efficiently into virus particles 
[528]. Furthermore, the redundancy of the genetic code giving rise to nucleic acid codon 
variability allows unraveling evolutionary pressure on the RNA sequences independent of 
amino acid conservation [309]. By studying incorporation of reporter gene constructs of 
segment 5 into virus particles, Ozawa et al. [123] defined a minimal packaging sequence at 
the 3′ end, spanning nucleotides 1 to 105, which still allows efficient incorporation of the 
segment into progeny virus particles. Analogous to the work of Ozawa et al., a vRNA 
construct was engineered in the present study which allowed the conservation of the 3′ 
packaging signal, while modifications could be introduced into the NP ORF. This was 
achieved by duplicating the first 60 nucleotides encoding NP as described in 4.2.3. While 
Ozawa et al. used this approach to introduce point mutations, it could be demonstrated here 
that also insertions of 30 or 39 nt are tolerated by recombinant virus. Two different virus 
mutants were successfully recovered, WSN nTC and WSN FLN virus, encoding the 10 aa 
nTC-tag or the 13 aa FLN-tag, respectively. These virus mutants demonstrate that a 3′ 
terminal insertion into segment 5 vRNA and expression of NP with an N-terminal tag is 
basically possible in the viral context. This approach might be transferred to other genomic 
segments.  
Since the TC-tag sequence might not be stably maintained in the virus genome in the absence 
of any selection pressure, passaging of TC-tagged recombinant virus has to be kept to a 
minimum. The high error rate of the viral RNA-polymerase is expected to foster the loss of 
the TC-tag [6]. However, when relatively freshly prepared, TC-tagged recombinant mutant 
viruses will allow studying Influenza virus infection using the TC-tag.  
Even though the size of the two TC-tags introduced into WSN nTC and WSN FLN virus, 
respectively, differed by only nine nucleotides (i.e. by three amino acids at the protein level), 
differences in viral replication were observed. Replication of WSN FLN virus seemed to be 
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more attenuated than replication of WSN nTC virus; the titer was typically lower and 
decreased more rapidly upon serial passaging than the titer of WSN nTC virus (4.2.3, 4.2.5). 
In infection experiments with FlAsH- and ReAsH-labeled virus particles, the infectivity of 
WSN FLN virus was clearly lower than that of WSN nTC virus (Fig. 32). Furthermore, the 
occurrence of cytoplasmic vRNPs late in WSN FLN virus infection was rarely observed 
(4.2.4.3). For these reasons, WSN FLN virus is evidently less suitable than WSN nTC virus to 
study vRNPs during infection. It remains unclear if these differences among the two strains 
are caused at the genomic level or at the level of protein function. The flanking amino acids of 
the FLN-tag include aromatic, charged and cyclic amino acids, whereas the nTC-tag is 
encompassed by mainly small and non-polar residues, indicating differing characteristics at 
the protein level which might affect the functionality of NP during infection.   
Both recombinant mutant viruses were found to be attenuated compared to WSN wt virus 
regarding virus yield and plaque formation, thereby indicating the impairment of one or more 
processes involving NP or segment 5 vRNA. It is possible that the selected 3′ terminal 
sequence, which was preserved by duplication, did not cover the complete, optimal packaging 
signal. Naturally occurring DI RNA of segment 5 which efficiently compete with full-length 
vRNA for incorporation into virus particles were previously reported to be at least 58 nt larger 
than the here-applied minimal sequence for efficient incorporation of a reporter gene as 
defined by Ozawa et al., suggesting a possible contribution of additional nucleotides for 
optimal genome packaging [528]. Besides the cis-acting function of segment 5 vRNA for 
genome assembly, its translation product NP is the major structural constituent of the genomic 
vRNP complexes. Modification of NP by TC-tag insertion therefore affects all eight genomic 
vRNP complexes at the protein level and might thereby generally interfere with genome 
assembly.  
Various observations indeed indicated a packaging defect of the viral genome of WSN nTC 
and WSN FLN virus: A comparably high degree of CPE was observed relative to the 
detectable number of infected, NP-expressing cells (Fig. 28D), and in case of WSN nTC 
virus, a non-linear correlation between the number of plaque-forming units (or the CPE) and 
the applied virus concentration was noticed (Fig. 28B). Furthermore, there was an 
unexpected, disproportionate decrease of the number of infected cells upon dilution of WSN 
nTC or WSN FLN virus (4.2.5, Tab. 8). It remains however unknown if the packaging defect 
is specific for a subset of vRNAs or if all vRNA segments are equally affected. It is further 
unclear to what extent each virus particle is affected and how large the fraction of incomplete, 
packaged genomes may be. To reduce the fraction of abortive infections when working with 
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WSN nTC and WSN FLN virus, infections with a low MOI are hence to be avoided. 
Depending on the question to be examined and the experimental set-up, this aspect might 
have to be specified for a solid interpretation of the experimental data. 
As vRNPs constitute the template structure for the viral polymerase complex, replication and 
transcription processes might also be affected by TC-tagged NP and thus contribute to the 
attenuated phenotype of the mutant viruses. However, when comparing a time series of 
infection with wt and mutant virus on the basis of NP detection (Fig. 28), NP expression 
levels did not notably differ, indicating that at least transcription was not exceptionally 
reduced by TC-tagged NP. Furthermore, nTC-NP and FLN-NP nuclear import was apparently 
not prevented (Fig. 22), even though both TC-tags were fused to NP in the immediate vicinity 
of the N-terminal nuclear localization sequence. However, reduced amounts of cytoplasmic 
vRNPs late in mutant virus infection compared to the wild-type situation might indicate 
interference of the TC-tag with vRNP formation or with the formation of the nuclear export 
complex of vRNPs (Fig. 28, Fig. 25).   
In summary, two (attenuated) mutant viruses encoding TC-tagged NP could be generated by 
reverse genetics which are able to undergo several rounds of replication while maintaining the 
TC-tag sequence. WSN nTC virus was found to be better suitable to study virus infection than 
WSN FLN virus. A possible genome packaging defect has to be taken into consideration 
though, particularly when investigating cells at the single-cell level. At this point, the 
influence of biarsenical labeling is not yet taken into account. 
5.2.4 Biarsenical labeling of TC-tagged NP in WSN nTC and WSN FLN virus 
infection 
After having studied the consequences of TC-tag insertion for virus replication, furthermore, 
biarsenical labeling was scrutinized qualitatively and quantitatively in the context of infection 
to assess the potential and the limitations of this experimental system.  
Despite numerous advantages of the small genetically encoded TC-tag – including the 
spectral variability of its ligands enabling pulse-chase experiments in living cells and the 
option for application in electron microscopy (reviewed in [529]) –, the general and major 
drawback of the biarsenical-tetracysteine system is the unspecific background labeling in cells 
and the resulting poor signal-to-noise (S/N) ratio for low-expression TC-tagged proteins 
[530,531,532]. Multiple approaches to improve this technical deficit have been accomplished, 
either by improving the properties of the fluorescent ligands or by increasing the affinity of 
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the peptide tag for its biarsenical ligands in order to allow for more stringent washes with 
competing dithiols to reduce the unspecific background binding [457,481,484]. Some of these 
optimized features were considered when designing the TC-tag in the present study. The 
helix-breaking amino acids proline and glycine were inserted as spacing residues between the 
two pairs of cysteines, as they were reported to increase the affinity of the tag substantially 
[457]. Furthermore, the flanking residues FLN and MEP were introduced into one construct 
(FLN-NP) according to Martin et al. [481] for improved affinity and fluorescence quantum 
yield. 
Because unspecific background staining is nonetheless an issue, the labeling specificity was 
carefully assessed in the context of recombinant mutant virus infection. Since NP is 
abundantly expressed in infected cells, ReAsH labeling of TC-tagged NP yielded excellent 
S/N ratios; lower but still acceptable S/N ratios were achieved with FlAsH (Fig. 22, Fig. 24). 
Being part of the characteristic pattern of cytoplasmic vRNP complexes, nTC-NP furthermore 
yielded bright, punctate cytoplasmic signals which distinctly stood out from the diffuse 
cellular background (Fig. 25). The quality of the results was however found to be strongly 
dependent on labeling conditions, i.e. on dye concentration, incubation time and temperature. 
Best results were achieved with confocal fluorescence microscopy upon labeling with 1 µM 
dye for 1 h at RT. When analyzing the cells by epifluorescence microscopy and more sensitive 
detection, conditions of 0.01 µM dye for 1.5 h at 37 °C were found to be optimal. 
Concentrations of more than 1 µM, however, caused high background staining, and 
incubation times longer than 3 h at 37 °C led to considerable accumulation of punctate 
ReAsH signals which presumably presented endocytosed, vesicular ReAsH and were equally 
found in control cells infected with WSN wt virus. Optimized labeling conditions for TC-
tagged NP in living cells were in agreement with previously reported in vitro association and 
dissociation rate constants of FlAsH with TC model peptides (in the range of 10
5 
M
−1
s
−1
 and 
10
−6 
s
−1
, KD ~10
−11
 M) [457], when considering additional time for accumulation and 
distribution of the dye within living cells. FlAsH and ReAsH signals were consistently found 
to be stable over days.  
The specificity of the obtained biarsenical signals under optimized conditions was confirmed 
by comparison with immunofluorescence detection of NP (Fig. 22, Fig. 25). With the 
exception of nucleolar staining, the biarsenical dyes did not cause unspecific labeling of 
cellular structures within the detected range and stained total cellular NP equivalently to 
immunostaining. The aspect of unspecific labeling of nucleoli in WSN virus-infected cells 
will be further discussed in section 5.2.6. As nucleoli represent discrete structures which can 
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be identified even in transmitted light images, they can be easily excluded from analysis. 
Hence, under optimized labeling conditions, efficient and specific labeling of TC-tagged NP 
in the cytoplasm and the nucleoplasm of infected cells could be demonstrated, suggesting that 
recombinant virus strains were generated which allow for the specific detection of NP in 
living infected cells. However, even though labeling of the constructs was further optimized 
to establish a well-characterized, versatile experimental system, biarsenical labeling of TC-
tagged NP eventually failed to produce fully functional, fluorescently labeled genomic 
complexes in living cells (see discussion 5.2.5).  
The approaches to optimize labeling of TC-tagged NP in infected cells revealed sequence-
specific as well as compartment-specific labeling efficiencies. Concentration-independent 
comparison of the fluorescence signals of each dye when bound to either of the two tag 
sequences, nTC or FLN, showed that the labeling efficiency was distinctly affected by the 
amino acid residues adjacent to the core TC sequence. FlAsH labeled nTC-NP more 
efficiently than FLN-NP, whereas ReAsH yielded higher normalized signal intensities for 
FLN-NP than for nTC-NP (1224.2.4.2). These differences might be due to sequence-specific 
binding affinities and/or to a varying fluorescence brightness of the fluorophores depending 
on the specific molecular environment.  
Further, when exploring a labeling strategy specifically for cytoplasmic vRNPs late in 
infection, also compartment-specific differences of FlAsH and ReAsH labeling were observed 
based on comparison with NP immunofluorescence signals (Fig. 26). Relative to the 
immunofluorescence signal, ReAsH labeled cytoplasmic nTC-NP more efficiently than 
nuclear nTC-NP. FlAsH on the contrary labeled cytoplasmic nTC-NP less efficiently than 
nuclear nTC-NP. Compartment-specific different states of NP are assumed to be the reason for 
these distinct labeling efficiencies (4.2.4.3). Yet, differential compartment-specific recognition 
of the NP epitope by the monoclonal antibody cannot be entirely excluded as a contributing 
factor to these results; however, opposite behavior of FlAsH and ReAsH labeling relative to 
the immunofluorescence signals strongly suggests that the observed compartment-specific 
labeling efficiencies are due to different characteristics of the two dyes. 
 
In infected cells, NP exists as a newly synthesized monomeric or oligomeric protein that is 
rapidly imported into the cell nucleus and, in the nucleus, it forms the core of actively 
transcribed and nascent vRNP complexes. Furthermore, vRNPs form nuclear export 
complexes in which vRNPs associate with M1, NEP and the nuclear export machinery for 
transport into the cytoplasm [270,292]. M1 most likely remains bound to vRNPs in the 
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cytoplasm as it prevents the reimport of vRNPs into the nucleus [29,116]. It has been 
suggested that by association with vRNPs M1 masks the NLS responsible for vRNP nuclear 
import [117], which resides at the N-terminus of NP [120] and is in close vicinity to the N-
terminal TC-tag of nTC-NP and FLN-NP. It is hence not unlikely that the accessibility of the 
TC-tag may vary in the different conformational states of NP and with varying degree of 
complexation. In cytoplasmic vRNP complexes, the TC-tag is presumably more constricted 
than in uncomplexed NP or in actively transcribed vRNPs in the nucleus, and considering the 
differing molecular size of FlAsH (664.5 Da) and ReAsH (545.4 Da), a sterical constriction of 
the TC-tag can be expected to affect binding of the larger FlAsH more severely than that of 
ReAsH. This is consistent with the results of biarsenical labeling (Fig. 26). Besides sterical 
restrictions and modulation of the binding affinity, also the fluorescence brightness of the 
complexed biarsenical dye might be influenced by compartment-specific conformational 
states of NP. For instance, the phosphorylation state of serine 3 [332] or the conformational 
state of the surrounding residues might affect the electron systems of the nearby fluorophore 
and thereby alter its spectral characteristics, like quantum yield, extinction coefficient or 
excitation maximum.  
These analyses of biarsenical labeling demonstrate the importance of various factors 
influencing fluorescence labeling of the TC-tag with biarsenical dyes: the labeling conditions, 
the dye-specific cellular background staining, the flanking amino acids of the TC-tag, the 
specific tag-dye combination and furthermore, the changeable in situ conformational states of 
the tagged protein in a biologically relevant context.   
In the present study, ReAsH labeling was found to be favourable to study transport and 
assembly of progeny vRNPs in infection with mutant virus as it provides a considerably better 
S/N ratio in MDCK II cells than FlAsH and is furthermore better capable of labeling 
specifically cytoplasmic vRNP complexes in infection. Both FlAsH and ReAsH labeling were 
found to be suitable for virus entry studies, when the virus particles but not the cells are 
labeled and cellular background staining is therefore not an issue. In this experimental setup, 
FlAsH signals were shown to be clearly detectable with an excellent S/N ratio (Fig. 31). 
Efficient labeling of vRNP complexes in intact virus particles with either dye was 
demonstrated by SDS-PAGE analysis (Fig. 29). Basically, both dyes are hence suitable to 
label NP and vRNP complexes. The application of FlAsH is however limited by high cellular 
background staining. 
Yet, in addition to labeling characteristics, virological features needed to be considered for the 
choice of the mutant virus strain to be used in experiments: The use of WSN FLN virus, even 
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though yielding better fluorescence signals with ReAsH than nTC-NP, was limited to virus 
entry experiments since cells infected with WSN FLN virus displayed hardly any cytoplasmic 
vRNP signals (4.2.4.3). WSN nTC virus was therefore favored for experiments addressing 
virus assembly.  
5.2.5 Interference of biarsenical labeling with nTC-NP and FLN-NP in infection  
Two types of experiments were performed in living cells using recombinant TC-tagged 
mutant viruses for fluorescence detection. However, both experiments indicated that 
biarsenical labeling interferes with infection in a TC-tag-dependent manner.  
First, ReAsH or FlAsH labeling of nTC-NP late in WSN nTC virus infection to study the 
transport of progeny vRNPs to the site of virus assembly resulted in the detection of mainly 
immobile cytoplasmic punctate nTC-NP signals (4.2.7). It is unlikely though that such 
immobility of cytoplasmic NP structures represents standard conditions in infected cells. The 
TC-tag- and ReAsH-dependent aggregation of cytoplasmic nTC-NP, which was observed 
upon ReAsH-labeling (Fig. 25), rather suggests that TC-tags were crosslinked through the 
bifunctional ReAsH molecules. The issue of cross-linking of TC-tags has been reported 
previously [484], but was interpreted as the formation of intermolecular disulfide linkages. 
Intermolecular cross-linking under the experimental conditions of the present study might be 
promoted by the close proximity of polymerized NP molecules in the vRNP structure and by 
the formation of multisegmental genomic complexes. Immobilization as a result of cross-
linking would indicate close proximity or frequent contacts of vRNP segments during 
transport and/or frequent encounters of their transport vesicles, leading finally to aggregation 
of large numbers of vRNP complexes and vesicles. In support of this interpretation of the 
data, results of single particle tracking experiments obtained by another experimental 
approach within this study (using mEYFP-tagged NP) demonstrated highly dynamic 
cytoplasmic NP structures in infection (see 4.4.2). At all times, a fraction of mEYFP-tagged 
cytoplasmic NP complexes was found to perform fast saltatory movements. Data on vRNP 
transport that was published while the present work was in progress similarly describes 
dynamic behavior of cytoplasmic NP complexes with fast saltatory movements [280,298]. 
This transport was further reported to be microtubule-dependent and to be mediated by 
Rab11-positive recycling endosomes. The results of three different experimental approaches 
hence provide a consistent picture of the dynamics of cytoplasmic vRNPs and suggest that the 
accumulation of predominantly immobile nTC-NP in the cytoplasm of WSN nTC virus-
infected cells after biarsenical labeling is an artifact induced by the TC-tag and/or biarsenical 
DISCUSSION 
227 
 
labeling. Disruption of the cytoskeleton by biarsenical labeling – possibly an issue for ReASH 
[482] – was ruled out to be critical when the effect of labeling on WSN wt virus was studied 
(see 5.2.6). This is consistent with the above-derived hypothesis that cross-linking of nTC-NP 
might affect the mobility of cytoplasmic nTC-NP structures, but accumulation of non-
functional nTC-tagged vRNPs or a transport defect of nTC-tagged vRNPs cannot be 
excluded. However, aggregation of small punctate cytoplasmic nTC-NP signals into larger 
structures was observed only after biarsenical labeling. Therefore, it is supposed that 
biarsenical labeling is the critical factor that induces aggregation and immobilization due to 
cross-linking of the TC-tags. Extensive formation of disulfide bonds between TC-tags is not 
expected to occur due to the reducing conditions of the cytoplasm. 
Effects of cross-linking are less obvious when studying fixed cells as described in 4.2.4, but 
become crucial when analyzing dynamic processes. Hence, WSN nTC virus was considered 
unsuitable to study the dynamic assembly of the viral genome in living cells by means of 
fluorescence imaging. For WSN FLN, cross-linking between the FLN-tags is expected to 
occur similarly since the site of the tag on NP is the same.  
The second experimental approach using TC-tagged virus for fluorescence imaging of living 
infected cells was tracking of the viral genome during virus entry (4.2.6). WSN nTC and 
WSN FLN virus particles were purified and labeled with FlAsH or ReAsH. Successful 
labeling of TC-tagged NP in intact virus particles was confirmed by SDS-PAGE analysis and 
fluorescence detection of NP (Fig. 29). When FlAsH-labeled particles were visualized in 
infected cells by fluorescence microscopy within the first hour after infection, FlAsH signals 
were clearly detectable and colocalized with the membrane dye DiD, which was used to label 
the viral envelope (Fig. 31). Separation of the FlAsH-labeled genome from the viral envelope 
and accumulation of the vRNPs in the cell nucleus was however not observed within the 
expected time (within 1 h after infection [115]), indicating an impairment at this stage of viral 
infection. In spite of the apparent uptake of one or more virus particles per cell, abortive 
infection was confirmed by analyzing the infected cells for NP expression at 17 or 20 h p.i. 
(Fig. 32). Labeled WSN FLN virus was basically unable to infect the cells, except for some 
rare cases in which NP expression levels were barely detectable. Labeled WSN nTC virus was 
able to infect up to > 50 % of the cells depending on the experimental conditions and the virus 
preparation. A considerable fraction of these cells, however, displayed clearly attenuated NP 
expression. For comparison, infections with FlAsH- or ReAsH-labeled WSN wt virus were 
analyzed. The same amount of virus protein was applied for infection with WSN wt and WSN 
mutant viruses in each experiment and in contrast to WSN nTC and WSN FLN virus, WSN 
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wt virus infected 100 % of the cells and caused a pronounced CPE due to the high viral load 
(Fig. 32). It should be noted here that the virus preparations were not filtrated prior to 
infection. The number of endocytosed virus particles was therefore presumably higher than 
perceived from single particle studies of virus entry as shown in Fig. 31, where the virus had 
been filtrated for infection.  
The considerably reduced infectivity of labeled TC-tagged mutant viruses compared to wt 
virus (Fig. 32B) can basically have two reasons: First, the fraction of defective virus particles 
in WSN nTC and WSN FLN virus preparations might be larger than in case of WSN wt virus. 
Second, biarsenical labeling of the TC-tagged vRNPs might interfere with infection. Both 
aspects might contribute synergistically to the obtained results. The observation of impaired 
release of labeled TC-tagged vRNPs from the endosomes (Fig. 31) is consistent with the 
detection of a very low number of infected cells at 20 h p.i. relative to the observed number of 
endocytosed viral particles. From this data, however, it cannot be ultimately distinguished if 
impairment of infection and genome release is generally caused by the TC-tag itself or by the 
biarsenical labeling of TC-tagged NP. The almost complete failure of labeled WSN FLN virus 
to infect cells can however hardly be explained by reduced infectivity only since it was 
possible to rescue this virus in the first place. Analogous to the above-postulated cross-linking 
of TC-tags by the biarsenical labeling (causing immobilization and aggregation of 
cytoplasmic nTC-NP in infection), it is attractive to suppose that biarsenical labeling induces 
cross-linking of TC-tagged genomic segments in intact virus particles as well and thereby 
interferes with endosomal release and nuclear transport of vRNPs during virus entry. In SDS-
PAGE analysis, the formation of dimeric NP due to cross-linking with biarsenical dyes was 
not observed. It is possible though that cross-linking of TC-tags by biarsenical dyes represents 
a rather weak interaction compared to the specific complexation of the dye by a single TC-
tag. Therefore, unlike complexation, cross-linking might be not stable under the denaturing 
conditions of the SDS-PAGE when vRNP complexes completey disintegrate. Under 
physiological conditions in infected cells, however, cross-linking might become a relevant 
factor when TC-tags are naturally arranged in close proximity in vRNPs, and a high number 
of crosslinks can occur synergistically. Formation of intermolecular crosslinks through 
biarsenical dyes is further consistent with another observation: Cross-linking of TC-tagged 
NP within or between vRNP complexes would be expected to interfere with transcription and 
replication in a random way, and indeed, cells infected with labeled WSN nTC virus 
displayed widely differing NP expression levels at 20 h p.i. (Fig. 32A) with a considerable 
fraction of cells displaying clearly attenuated NP expression (Fig. 32B). Expression of TC-
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tagged NP was shown to be not generally attenuated in infection compared to wt NP (Fig. 
28D). Hence, biarsenical labeling of the virus particles has apparently a random inhibitory 
effect on later transcription in infected cells, basically consistent with a random inactivation 
of the viral genome. Such inactivation of vRNPs by biarsenical labeling might be verified 
using a minigenome assay by reconstitution of vRNPs with TC-tagged NP and analysis of 
transcription and replication in the presence and absence of biarsenical dyes. 
In summary, both live-cell imaging approaches assessed here, where recombinant mutant 
viruses encoding TC-tagged NP were used for fluorescence detection of the viral genome 
during infection, encountered fundamental drawbacks. The dynamic processes to be 
investigated were not observable, being apparently non-functional under the experimental 
conditions. As both mutant virus strains are basically replication-competent, albeit attenuated, 
the distinct inhibition of fundamental processes like vRNP transport and nuclear entry 
suggests a critical role of biarsenical labeling, which is believed to induce intermolecular 
cross-linking of TC-tagged NP.  
5.2.6 The biarsenical-tetracysteine system as a general tool to study Influenza 
virus infection  
The general applicability of the biarsenical-tetracysteine system to study Influenza virus 
infection was assessed using WSN wt virus-infected cells. Transient labeling of infected cells 
did not lead to a reduction of the virus production (Fig. 27). In another experiment, when 
plaque assays were performed by infection of cells with WSN wt virus in the presence or 
absence of FlAsH, plaque formation was not affected by labeling of the cells (data not 
shown). This observation suggests efficient infection and progression of infection in the 
presence of the dye also at early stages of infection. In conclusion, biarsenical labeling per se 
does not interfere with Influenza virus replication and can therefore generally be applied to 
study Influenza virus infection. 
When investigating the specificity of biarsenical labeling in Influenza virus-infected cells, 
unexpected prominent labeling of nucleoli was detected in a fraction of wt virus-infected 
cells, which was obviously independent of the presence TC-tags (Fig. 23). As these prominent 
signals were not found in uninfected cells, WSN virus apparently induced association of 
FlAsH and ReAsH with the nucleolar structure in MDCK II cells. This unspecific labeling 
was also induced in cells infected with WSN nTC virus independent of the presence of nTC-
NP in the nucleoli (Fig. 23B). It is not known whether accumulation of viral proteins in 
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nucleoli led to unspecific labeling through FlAsH and ReAsH or whether cellular components 
being able to bind biarsenical molecules were recruited to nucleoli during infection. Even 
though M1 was found to associate with biarsenical dyes in SDS-PAGE analysis (Fig. 29), M1 
is not targeted to nucleoli during infection, but remains homogenously distributed in the 
nucleoplasm. NS1, a viral protein which is targeted to nucleoli in infected cells, is however 
abundantly present also in the nucleoplasm of infected cells and is therefore unlikely to cause 
confined nucleolar labeling. Amongst cellular proteins, zinc finger motifs – which are 
typically found in DNA and RNA binding proteins – contain two, four or six cysteine residues 
to coordinate a central zinc ion. These proteins present an example of native cellular motifs 
which might have an intrinsic ability to bind biarsenical molecules under certain conditions 
and which are expected to be present in the cell nucleus.  
The use of the biarsenical-tetracysteine system to examine aspects of Influenza virus infection 
was reported by only one other study before [480]. Li et al. successfully inserted the TC-tag 
in the NS1 segment of recombinant Influenza A virus and visualized nuclear import of NS1 in 
infected cells in real time as well as nucleolar localization of NS1. However, they did not 
report unspecific biarsenical labeling of the nucleoli using Influenza A/PR8 virus and A549 
cells. It is thus possible that unspecific biarsenical labeling of nucleoli is strain-specific or cell 
type-specific.  
Extensive remodeling of the nucleolar structure during Influenza virus infection was 
described by electron microscopic studies already in the 1960s to 1980s (reviewed in [131]). 
Only very recently, different patterns of nucleolar remodeling were reported and demonstrate 
a strain-specific signature of Influenza virus-induced ultrastructural changes [132]. The 
infection-induced association of the biarsenical dyes with nucleoli, which was observed 
within the present work, might be related to these infection-induced changes in nucleoli. The 
strain-specific patterns of nucleolar disruption might further reflect different types of 
reorganization which are differently prone to unspecific labeling with biarsenical dyes. This 
can possibly explain the varying results between the present study and the work of Li et al. 
regarding the specificity of biarsenical labeling in infected cells.  
Studying nucleolar proteins during Influenza virus infection using the biarsenical-
tetracysteine system is therefore presumably conditionally feasible, however, when studying 
WSN virus-infected MDCK II cells as in the present study, nucleolar processes cannot be 
investigated by biarsenical labeling. 
Another feature of the biarsenical-tetracysteine system was tested for its applicability to study 
Influenza virus infection: ReAsH being able to mediate photoconversion of diaminobenzidine 
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(DAB) allows performing correlated fluorescence and electron microscopy. The approach to 
study ReAsH-labeled TC-tagged vRNPs by high-resolution imaging in infected cells did 
however not yield the expected results: Even though efficient polymerization of DAB after 
the photoconversion procedure was visible in form of dark brown precipitates, the specific 
formation of electron-dense structures in ReAsH-positive cells could not be demonstrated. 
Electron-dense structures were instead detected in ReAsH-labeled virus-infected cells, 
irrespective of whether WSN wt or WSN nTC virus was employed, thus independent of a 
virally encoded TC-tag (Fig. 33). The correlation of electron-dense structures with ReAsH 
fluorescence signals was possible by comparative analysis of the same selection of cells by 
fluorescence imaging and electron microscopy. ReAsH-labeled nTC-NP did apparently not 
induce additional DAB precipitation. Various distinct, infection-induced, electron-dense 
structures were observed in infected cells: rounded and spindle-shaped cytoplasmic inclusions 
surrounded by ribosome-like structures, elongated nuclear structures and irregular disruption 
of the nucleolar structure (Fig. 34). These findings are consistent with previously described 
ultrastructural changes in Influenza virus-infected cells and WSN virus-specific patterns 
[132,533]. Consequently, the assignment of electron-dense structures as specific products of 
ReAsH-mediated photoconversion in infection is complicated by the variety of naturally 
occurring, infection-induced structures that are observed in Influenza virus-infected cells. The 
application of ReAsH photoconversion is hence not convenient to specifically detect TC-
tagged proteins in Influenza virus-infected cells. Further improvement of ReAsH 
photoconversion using TC-tagged NP for examination of vRNPs in infected cells was 
therefore abandoned in the course of this study. 
5.2.7 Summarizing remarks 
The approach to generate recombinant Influenza A virus in which a TC-tag is inserted into 
internal regions of the NP sequence did not yield replication-competent virus particles. 
However, within associated experiments, a region on NP was identified, comprising residues 
288 and 289, a disruption of which critically affects the polymerase function by a yet 
unknown mechanism.  
In a second approach, recombinant virus strains were then successfully generated which 
encode NP with an N-terminal TC-tag. This was achieved by partial duplication of the vRNA 
packaging signal. Among the two generated viruses, WSN nTC virus was found to be 
favorable compared to WSN FLN virus for any type of experiment due to (1) a better 
replication efficiency, (2) better infectivity after labeling of the virus particles and (3) higher 
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fractions of infected cells with detectable amounts of cytoplasmic vRNPs late in infection.  
Following the primary goal to study fluorescently labeled vRNPs during assembly and virus 
entry, the feasibility of biarsenical labeling was analyzed, and even though biarsenical 
labeling did not generally interfere with Influenza virus infection, interference of biarsenical 
dyes with infection occurred in a TC-tag-dependent manner. The qualitative results of TC-tag 
labeling were satisfactory, yielding high signal-to-noise ratios and signal specificity. However, 
as soon as dynamic processes were under investigation, dynamics seemed to be greatly 
impaired by biarsenical labeling. Labeling apparently affected the release of the viral genome 
from endosomes during virus entry and prevented virus replication. It further affected 
cytoplasmic transport of progeny vRNPs by almost complete inhibition of any particle 
mobility. Together with the apparent aggregation of cytoplasmic NP following biarsenical 
labeling, these findings indicate the formation of intermolecular crosslinks by biarsenical dye 
molecules. Extensive cross-linking within individual vRNPs and between different vRNP 
segments might not only impair transport mechanisms, but also replication and transcription 
processes. Thus, even though virus mutants with TC-tagged NP are replication-competent, 
labeling during infection seems to impose artifacts rendering these mutant viruses 
inapplicable for dynamic fluorescence imaging in living cells. However, other applications 
making use of TC-tagged NP in the context of infection may be feasible if they  do not require 
biarsenical labeling, e.g. affinity purification of TC-tagged NP from lysates of infected cells 
for analysis of associated proteins or the presence of multisegmental complexes.  
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5.3 Characterization of intrinsic subcellular targeting of NP 
  
5.3.1 NP adopts a non-polarized nuclear-cytoplasmic distribution in the 
absence of virus infection 
The import of Influenza A virus NP into the nucleus is essential for virus replication, namely 
for the delivery of incoming, newly infecting genomic segments [119] and for the formation 
of progeny vRNP complexes in ongoing viral replication. NP is known to accumulate in the 
cell nucleus due to at least one nuclear localization sequence (NLS) [93,118,120,123,361]. 
Nuclear targeting and a predominantly nuclear localization of NP could be confirmed in this 
study for the expression of wild-type NP and fluorescent NP fusion proteins (Fig. 35, Fig. 38 
& Fig. 41).  
A role of NP also in the bidirectional transport of genomic vRNP complexes has repeatedly 
been proposed. Intrinsic signals that drive nuclear export and apical targeting were suggested 
[265,299]. The previously reported nuclear export and accumulation of NP in the cytoplasm 
between 16 and 48 h p.t. [363] could however not be confirmed here. At 48 h p.t., NP-mEYFP 
was still found predominantly in the cell nucleus of CHO-K1 cells (Fig. 37), and also at 
13 d p.t., wild-type NP as well as mEYFP-tagged NP fusion proteins remained primarily in 
the nucleus of polarized MDCK II cells (Fig. 52 a–c). Nevertheless, a slight increase of the 
cytoplasmic fraction was observed as compared to 24 h p.t. (Fig. 35, Fig. 41).  
Cytoplasmic accumulation of NP was previously reported to be promoted by factors like a 
high cell density, upregulation of phosphorylation [362] and high NP expression levels [339]. 
However, even though protein expression was consistently analyzed in densely grown cells 
(90–100 % confluency) in the present study, a predominantly cytoplasmic localization was not 
observed.  
Discrepancies between the previously reported cytoplasmic localization of NP and the here 
obtained data, which show nuclear retention of NP, might possibly arise from the use of 
different experimental systems. Bui et al. [362] studied the localization of NP from Influenza 
A/PR/8/34 strain in cells stably expressing NP together with the three viral polymerase 
subunits PA, PB1 and PB2. Digard et al. [339] also used NP from Influenza A/PR/8/34, but 
studied transient expression in BHK cells under the control of a T7 RNA polymerase 
promoter in the presence of recombinant vaccinia virus infection. Neumann et al. [363] 
analyzed expression of NP from Influenza A/WSN/33 in COS-1, MDCK II and HeLa cells 
under the control of a chicken β-actin promoter, and in the present study, NP from Influenza 
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A/FPV was expressed in CHO-K1 and MDCK II cells under the control of the CMV 
promoter. NP expression levels, NP sequences, the cell lines and the absence or presence of 
other viral proteins are hence not comparable between the different studies.  
A general intrinsic property of NP to localize to the cytoplasm cannot be confirmed here. A 
delayed nuclear export of NP specifically in MDCK II cells compared to other cell lines was 
furthermore reported by Neumann et al. [363]. As MDCK II cells are highly permissive for 
Influenza virus infection, this does not seem to critically affect virus replication.  
A polarized distribution of NP within transfected cells was previously reported in two studies. 
Elton et al. [515] suggested an “hitherto unrecognized polarity of the cell nucleus” and 
described a polarized peripheral localization of Influenza A/PR/8/34 NP in nuclei of BHK 
cells at 16 h p.t. However, BHK cells are non-polarizing fibroblasts, and polarity referred to 
the distribution of NP towards the upper surface of adherent cells in this case. The second 
work describing apical targeting of NP was realized by the same group and reported the 
polarized localization of Influenza A/PR/8/34 NP to the apical surface in 293T and BHK cells 
at 48 h p.t. [299]. The same tendency was also indicated for MDCK II cells. It should be 
stressed though that a complete polarization of BHK or 293T cells comparable to epithelial 
cell polarization cannot be expected to occur.  
On the contrary, fully polarized MDCK II cells were analyzed in the present work (at 
13 d p.t). These cells featured differentiated apical and basolateral membranes as verified by 
apical sorting of HAmYFP. Yet, they did not show a polarized distribution of NP or mEYFP-
tagged NP fusion proteins (Fig. 52).  
Strain- and cell type-specific differences cannot be ruled out to be responsible for differing 
results (compare section 5.1.3), but also differences between the detection methods should be 
considered, particularly in the light of the results obtained by comparative analysis of mEYFP 
detection and NP-specific immunodetection of an mEYFP-tagged NP construct (Fig. 42). 
High expression levels of NP constructs were shown to be prone to the detection of peripheral 
and polarized immunostaining of NP in nuclei and the cytoplasm, whereas parallel detection 
of the intrinsically fluorescent protein moiety indicated an even distribution of the construct. 
Thus, there is a chance that in the immunostaining-based studies of Carrasco et al. [299] and 
Elton et al. [515], immunostaining artifacts could have occurred which are very similar to the 
reported NP distribution, in particular at high expression levels, which were according to 
those studies the preferred conditions to detect nuclear export and a polarized distribution of 
NP.    
DISCUSSION 
235 
 
In the present study, in fully polarized MDCK II cells at 13 d p.t, very low expression levels 
of wild-type NP precluded overexpression-induced immunostaining artifacts of NP. Here, 
neither immunodetection of wild-type NP nor mEYFP fluorescence detection of fluorescent 
NP fusion proteins showed any polarity in NP distribution (Fig. 52a–c). In order to increase 
the amount of cytoplasmic NP, NP with a C-terminal nuclear export signal (NES) was further 
expressed in polarized cells, but also then a preferential localization of NP to the apical 
plasma membrane could not be observed (Fig. 52d). mEYFP-tagged NP constructs, which 
apparently yielded better transfection efficiencies and higher expression levels than non-
tagged NP (see also Western blot results, Fig. 40), confirmed the non-polarized distribution.      
In summary, an intrinsic property of NP to adopt a polarized distribution in the nucleus or in 
the cytoplasm of transfected cells could not be confirmed, even though various NP constructs 
and time points post-transfection were tested, and fully polarized epithelial MDCK II cells 
were used which are highly permissive for Influenza virus replication.  
It is possible that the ability for polarized targeting is specific for NP from Influenza 
A/PR/8/34. However, NP from the same strain was studied in the work of Bui et al. [362], 
where cytoplasmic accumulation, but no polarized distribution of NP was reported. Polarized 
distribution of NP in the absence of infection might hence occur under very specific 
conditions, but cannot be regarded as a general feature of NP. For further discussion, see also 
section 5.1.3. 
In conclusion, the experimental data obtained in this study does not support a role of NP in 
targeting the genomic segments to the apical plasma membrane. This is consistent with recent 
reports which picture an alternative model for apical targeting of vRNPs. They showed that 
coexpression of M1 and NEP is required for nuclear export of reconstituted vRNPs in living 
cells [280] and that apical transport in infection is mediated by Rab11-positive recycling 
endosomes [297,298]. It was furthermore suggested that association with this apical 
compartment is mediated by the polymerase subunit PB2, but not by NP, since only PB2 can 
directly interact with Rab11 [280,296].  
5.3.2 NP specifically targets subnuclear domains 
For many years, NP has been regarded primarily as a structural protein of vRNP complexes 
with related functions as a shuttling protein, mediating the transport of the viral genome, or as 
a regulatory factor of viral replication and transcription. It is only in recent times that a role of 
NP in the virus-host interplay has more clearly emerged, and functional (non-transport-
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related) interactions of NP with host cell proteins have been described, e.g. with Hsp40 and  
UAP56 [177,347,534]. 
5.3.2.1 NP extensively interacts with the nuclear compartment 
Characterization of NP expression in the present study revealed that NP is involved in 
extensive interactions with the nucleus in the absence of virus infection. 
For analysis of NP expression, various intrinsically fluorescent NP fusion proteins were 
generated and allowed the characterization of NP in living cells (4.3.1). Expression of NP 
fusion proteins was found to be essentially comparable to the expression of wild-type NP, 
displaying a predominantly nuclear localization and a non-homogeneous subnuclear 
distribution of NP (Fig. 41). Direct comparison of intrinsic fluorescence and 
immunofluorescence of NP fusion proteins, however, revealed fundamental qualitative and 
quantitative differences between the two detection methods and suggested the creation of 
artifacts by immunofluorescence staining (Fig. 42). It is shown here that in particular 
subnuclear structures enriched with NP could be visualized more clearly by intrinsic protein 
fluorescence than by immunofluorescence detection, implying that association of NP with 
nucleoli as well as its accumulation in punctate and irregular structures in the nucleoplasm are 
more reliably represented by intrinsic protein fluorescence than by external labeling. The use 
of intrinsically fluorescent constructs thus provides advantages over immunofluorescence 
detection of NP in addition to their suitability for live-cell imaging. 
The choice of a photoactivatable fluorescent protein tag furthermore opened up the possibility 
to perform dynamic measurements and to characterize the effect of mutations in NP, not only 
with regard to the subcellular localization, but also with regard to site-specific affinities (Fig. 
47). 
As expected for fusion proteins whose localization is unaffected by the protein tag, no 
differences were observed between the subcellular distributions of C- and N-terminally tagged 
NP (4.3.1.1). Nevertheless, while the presence of truncated fusion proteins was undetectable 
in case of N-terminally tagged NP, the formation of free fluorescent protein and minor 
amounts of truncated protein during expression of C-terminally tagged NP strongly suggested 
the preferred use of the N-terminal fluorescent protein tag in this study and in future work 
(Fig. 40).  
Together, the results from analysis of intrinsically fluorescent NP fusion proteins corroborate 
that these are an appropriate and powerful tool for the characterization of NP within cells, in 
particular for the detailed analysis of NP subnuclear targeting. 
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Analyzing NP expression in the absence of virus infection, using NP or NP fusion proteins, 
NP was found to distribute non-homogeneously in the nucleus and to accumulate specifically 
in the interchromatin space, indicating preferential association of NP with specific sites in the 
nucleoplasm (Fig. 35–Fig. 38, Fig. 41 & Fig. 44). Consistently, fluorescence photoactivation 
measurements demonstrated a very slow nuclear mobility of NP (Fig. 46 & Fig. 47) and 
thereby confirmed the slow nuclear dynamics of NP that were previously reported by 
Loucaides et al. using FRAP experiments [507]. By expression of especially generated 
monomeric mutant constructs of NP, it was furthermore possible to verify that the formation 
of prominent local enrichments of NP in the nucleus and the remarkably slow nuclear 
mobility of NP were independent of NP polymerization (Fig. 39, Fig. 47C). Also sterical 
restrictions can be excluded to be responsible for localized accumulations and low mobility of 
(monomeric) NP, since average-sized proteins up to 100 kDa were previously shown to 
diffuse freely within the nuclear space, unimpeded by the chromatin network [495,498]. 
Together, these findings demonstrate that NP is involved in extensive interactions with the 
nuclear compartment and that it targets distinct sites in the interchromatin space by intrinsic 
affinity.  
The observations are further consistent with a large number of potential nuclear interaction 
partners that have been identified by proteomic and yeast-two-hybrid screens [103,358] and 
with other previously identified nuclear interaction partners [177,347,349,351,353]. With a 
few exceptions, the relevance of most of these interactions for viral replication is not yet clear 
though, and the knowledge on NP-host cell interactions is still fragmentary.  
In the present study, the overall strong association of NP with the nuclear compartment 
evidently underlines the relevance of NP interaction partners in a cellular context and further 
provides information on the cellular localization and overall strength of these interactions. 
The kinetic data obtained by photoactivation measurements with NP constructs (monomeric 
or wild-type) moreover comprise information on the fraction of NP actually being involved in 
interactions with cellular components. Remarkably, fractions of freely diffusing, fast 
molecules of NP constructs were not detected (Fig. 47). The vast majority of NP obviously 
associates with cellular components, displaying a reduced mobility.  
As a consequence of the strong association of NP with the nuclear compartment, a particularly 
high affinity of NP for viral RNA might be required for efficient formation of genomic vRNP 
complexes in infection. Consistently, a high RNA-binding affinity of NP was previously 
reported with KD values in the range of 20 nM [87,187,333,339]. It was furthermore observed 
by Loucaides et al. [507] that the mobility of nuclear NP increased in case of vRNP 
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reconstitution in the presence of vRNA and viral polymerase, indicating competitive binding 
of viral and cellular components to NP. Transferring this into the context of virus infection 
and considering that viral protein synthesis precedes cRNA and vRNA formation [181,535], 
NP might associate with cellular components early in infection until adequate levels of cRNA, 
vRNA and the viral polymerase are available and then participate in cRNP and vRNP 
formation. It was previously suggested that NP might be specifically recruited to viral RNA 
by the viral polymerase that is bound to the 5’ end of nascent cRNA or vRNA, which thereby 
initiates RNA-encapsidation followed by further recruitment of NP by NP-NP oligomerization 
[175,177]. Other studies indicate that oligomerization of NP might be a regulated process 
which is coupled to viral RNA binding and that the cooperativity of RNA-binding and NP 
oligomerization further enhances viral RNA encapsidation [92,176]. This might enable viral 
RNA to compete efficiently with cellular interaction partners for NP-binding. 
A cytopathic effect of NP in transfection experiments due to nuclear accumulation and 
extensive interactions with the cells was not observed. Cells transfected with NP constructs 
remained viable up to 48 h p.t. (Fig. 37).  
Summing up, extensive interactions of NP with cellular components together with previous 
evidence for cellular interaction partners [103,358] support a role of NP in the virus-host 
interplay and indicate that interactions of NP with viral factors and cellular components might 
have to be closely coordinated, e.g. by different affinities, by temporal aspects of protein and 
vRNA synthesis or by involvement and action of other viral proteins.  
It could be helpful to be aware of these aspects when studying RNA- or polymerase-binding 
mutants of NP and their impact on virus replication. Phenotypic effects in cells might not be 
directly related to the RNA- or polymerase-binding function of NP, but could be indirectly 
effectuated by an altered availability of NP for cellular interaction partners and for the viral 
replication machinery, i.e. phenotypic effects might be caused by perturbation of the NP 
interaction network. This could further give rise to discrepancies between in vitro and in-cell 
measurements. 
5.3.2.2 Subnuclear sites display different affinities for NP 
Even though it is known that the cell nucleus is a highly organized compartment, which is 
structured into functionally specialized domains [487,490], it remains unclear what causes the 
heterogeneous distribution of NP and its localized accumulation.  
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What, at first glance, may appear as precipitates due to (over)expression of NP in the absence 
of virus infection, could be shown to be neither due to NP polymerization (Fig. 39) nor to 
steric hindrance of NP distribution within the nucleus as based on findings from previous 
studies [495,498]. Fluorescence photoactivation measurements, monitoring protein dynamics, 
could be effectively applied to distinguish between subnuclear structures that dynamically 
associate with NP and NP precipitates. Large micrometer-sized subnuclear accumulations 
highly enriched with NP thus could be shown to consist of immobilized protein that had 
apparently precipitated within these structures (Fig. 46, 2
nd
 row). Consistently, such structures 
were absent from nuclei when the local nuclear NP concentration was decreased by 
expression of NP with an artificial nuclear export sequence (NES) (Fig. 45). This shows that 
enrichment of NP within this type of structure is unlikely to result from high-affinitiy 
association with large micrometer-sized nuclear domains, but rather seems to be the result of 
precipitation due to high local NP concentrations within nuclei. The absence of such compact 
local accumulations of NP in virus-infected cells (Fig. 43) furthermore indicates that these 
structures are artifacts of NP (over)expression, as is also the major chromatin rearrangement 
that is observed upon local accumulation of NP (Fig. 44d).  
On the contrary, small punctate accumulations of NP, which measure typically not more than 
a micrometer in diameter, were shown to dynamically exchange (monomeric) NP with the 
surrounding nucleoplasm, albeit at very low rate, indicating association of NP with high 
affinity (Fig. 47C). It was thus possible by application of fluorescence photoactivation 
measurements to distinguish between different types of subnuclear accumulations and to 
verify site-specific dynamic associations of NP with subnuclear domains.  
Since concurrence of protein precipitation and high-affinity interactions of NP as well as the 
overall high concentration of NP in nuclei of transfected cells complicated the interpretation 
of NP subnuclear behavior, two types of NP constructs were generated within this study to 
facilitate analysis of NP in the nucleus: On the one hand, the obligate monomeric NP mutants 
E339A and R416A were generated, and on the other hand, the above mentioned NP-NES, a 
construct that is targeted to nuclear export by a C-terminal NES.  
Obligate monomeric NP allowed excluding effects of NP polymerization on the subcellular 
distribution of NP. It confirmed that local accumulations of NP formed independently from 
NP self-association and that the overall subcellular distribution was essentially unaffected by 
the ability of NP to oligomerize (Fig. 39). It furthermore permitted to monitor the dynamics of 
a uniformly monomeric population of NP, ensuring that the monitored mobilities of NP were 
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determined primarily by site-specific interactions with cellular components rather than by 
self-association. Application of obligate monomeric NP in photoactivation studies hence 
allowed differentiating subnuclear sites according to their affinities for NP and enabled an 
overall picture of the subcellular interactions of NP.  
It could be shown that throughout transfected cells, NP experiences a considerable retardation 
of diffusion as compared to the diffusion of the free fluorescent protein (Fig. 47). Among the 
measured mobilities, the mobility of cytoplasmic NP was the highest, very similar to that of 
the diffuse and homogeneously distributed NP in the nucleoplasm (Fig. 47 (B, C) right). This 
observation indicates comparably weak interactions with cytoplasmic and nucleoplasmic 
structures, but also binding of NP to mobile components of the cytoplasm and the 
nucleoplasm could occur. Substantially lower mobilities were observed for NP which 
localized in nucleoli or within small punctate subnuclear domains (Fig. 47 (B, C) left).  
In case of the small punctate subnuclear domains, the highest local NP concentrations and the 
lowest mobilities of NP within cells were found to coincide, indicating that a multitude of 
strong interactions between these domains and NP leads to enrichment and retention of NP. In 
case of nucleolar NP, however, an equally low mobility of NP was observed, but it was 
accompanied by the presence of relatively low concentrations of NP. Even though the 
nucleolar NP mobility was among the lowest measured within the cells, nucleoli frequently 
appeared depleted of NP relative to the surrounding nucleoplasm. This observation implied 
strong interactions between NP and nucleolar components, but only a limited number of 
interaction partners or, alternatively, a limited accessibility of these interaction partners within 
nucleoli.  
Fluorescence photoactivation measurements thus demonstrate that local NP concentrations do 
not necessarily correlate with local affinities for NP. Nucleoli in general might be particularly 
prone to the detection of unexpectedly low protein concentration. They seem to have a 
reduced accessible volume as compared to the surrounding nucleoplasm, which was 
previously reported for freely diffusing proteins (like EGFP) [494,495] and which was also 
discussed here before as a possible reason for immunostaining artifacts (Fig. 42, 4.3.1.2). This 
circumstance might explain the limited accumulation of NP in nucleoli, despite obviously 
high affinity of NP for this compartment.  
The results that were further obtained in nuclear depletion experiments using NP nuclear 
export constructs excellently match the findings that were obtained by photoactivation 
measurements with monomeric NP. By expression of NP constructs with an artificial NES 
sequence, the local nuclear NP concentration could be efficiently decreased in a subset of 
DISCUSSION 
241 
 
cells, thereby preventing protein precipitation and revealing sites of high affinity for NP more 
clearly (Fig. 45). Two distinct structures were thus found to accumulate NP even at low 
nuclear concentrations: small punctate interchromatin structures, which were highly enriched 
with NP, and nucleoli, which displayed comparably low NP concentrations. This was 
consistent with the results from photoactivation studies as described above, which identified 
nucleoli and punctate nucleoplasmic structures as subnuclear domains with the highest 
detectable subcellular affinities for NP and differing NP concentrations. Monitored protein 
dynamics confirmed very slow NP exchange rates between these domains and the surrounding 
nucleoplasm (Fig. 47 (B, C) left). Accordingly, in nuclear depletion experiments, NP 
constructs which were associated with either of the two structures resisted nuclear export 
more than any other nuclear NP population and remained bound under conditions of ongoing 
nuclear export in nuclei that were otherwise largely devoid of NP. Apparently, NP-NES 
constructs had a higher affinity for these specific domains than for the nuclear export 
machinery. Expression of a reference construct further ascertained that accumulation of NP 
within these structures was not induced by the NES sequence itself, but in fact by the NP 
moiety of the construct (Fig. 45c). 
While photoactivation studies provided insight into the various local cellular affinities for NP 
and were able to distinguish NP-binding domains from protein precipitates, nuclear depletion 
experiments additionally allowed a more detailed description of subnuclear domains with 
particularly high affinity for NP, thereby facilitating their further characterization. Especially 
the small interchromatin domains with high affinity for NP, which are – unlike nucleoli – 
difficult to assign, became more clearly exposed and more easily identifiable at low nuclear 
NP concentrations and in the absence of NP precipitation (Fig. 45). Up to eight distinct, small 
interchromatin domains enriched with NP were detected within one cell. They typically 
measured less than 1.2 µm in diameter. Size and number of the NP-binding domains as well 
as their localization in the interchromatin space were reminiscent of a class of subnuclear 
structures known as “nuclear bodies” (NBs), which were thus suspected to form the cellular 
target structures for NP.  
In subsequent experiments, similar patterns of local enrichment of NP were recognized also in 
cells expressing wild-type NP at low expression levels (Fig. 50). The equivalence of these 
domains was supported by results of colocalization analysis. They demonstrated that punctate 
subnuclear accumulations that were formed either by wild-type NP or by residual nuclear 
NES-tagged NP localized in close proximity to the same specific cellular domains, namely 
CB and PML NBs (Fig. 49, Fig. 50). These findings thus strongly support that NP-binding 
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structures which were uncovered by nuclear depletion of NP are representative for structures 
which accumulate also wild-type NP. The highly speckled nuclear appearance of wild-type 
NP that is observed at higher expression levels moreover suggests association of NP also with 
other subnuclear structures (Fig. 38a, b). These might however display lower binding 
affinities for NP and therefore not be visualized in nuclear depletion experiments.  
It should be mentioned that a crystal structure of the obligate monomeric NP-R416A, which 
was used in this work, was very recently reported and provides a structural basis to 
understand the connection between the monomeric conformation of NP and a reduced RNA-
binding affinity [176]. A model was proposed according to which oligomerization and RNA-
binding of NP might be coordinated by phosphorylation of a highly conserved serine residue. 
Another novel report further showed that NP has a low self-association activity in the absence 
of RNA, supporting that NP oligomerization might be coupled to RNA-binding [92]. On this 
basis, it was suggested that wild-type NP may exist primarily as a monomeric protein before 
incorporation into cRNPs and vRNPs in infection.  
Extrapolating these findings to NP expression experiments of the present study, NP might be 
inherently monomeric in the absence of virus infection. Consistently, neither the subcellular 
distribution nor the subcellular dynamics of wild-type NP were found to differ significantly 
from the obligate monomeric NP mutant in transfected cells (Fig. 38, Fig. 39, Fig. 47B). A 
definitive prediction on the conformational state(s) of wild-type NP within cells is however 
not made here and would require more detailed analyses. 
In summary, the combination of three approaches within this study – the use of monomeric 
NP mutants, the decrease of the local nuclear NP concentration by fusion of NP to a nuclear 
export sequence and photoactivation measurements to monitor site-specific protein dynamics 
– permitted to distinguish protein precipitates from dynamic structures and to differentiate 
between different NP-binding sites according to their affinities for NP. Identification of 
subnuclear structures with particularly high affinity for NP furthermore enabled the 
phenotypic description and subsequent colocalization analyses with known cellular structures 
(for discussion see 5.3.2.4).  
5.3.2.3 The role of site-specific affinities during NP expression and functional 
implications for virus infection  
The following scenario for NP expression is suggested, based on the information obtained on 
subcellular affinities for NP (4.3.2 and 5.3.2.2):  
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Newly synthesized NP is rapidly transported into the nucleus and first targets the subnuclear 
domains with the highest affinities, namely nucleoli and specific, yet unidentified, small 
interchromatin domains. The latter should become rapidly highly enriched with NP. While the 
nucleoplasmic level of NP continually increases with increasing nuclear accumulation of NP, 
the nucleolar concentration, however, will remain constant at some point due to limited 
accessible space. This will cause nucleoli to appear depleted of NP with increasing NP 
expression levels. A transient interaction between NP and nucleoli was reported in literature 
[123], but according to the data obtained here, only a shift of the relative local concentrations 
can be confirmed. The nucleoplasm features extensive interactions with NP and can 
accumulate large amounts of NP. With constantly increasing NP levels in the absence of virus 
infection, at some point, precipitation of NP then occurs in the nucleoplasm. This might partly 
be due to NP self-association, but since precipitation is also observed for obligate monomeric 
NP, weak NP-NP interactions, which might occur only at high local concentrations, or a 
multitude of interactions with cellular components might further contribute to NP 
precipitation. It is possible that NP becomes entrapped in a growing network of interactions 
with diverse interaction partners, eventually leading to precipitation, whether or not NP is able 
to oligomerize. 
Since the formation of large nuclear NP precipitates is not observed in virus infection, the 
timely beginning of vRNP formation might prevent the accumulation of free NP in the nuclei 
of infected cells, implying that NP expression levels might be somehow coordinated with 
vRNA synthesis in infection. This conclusion is in accordance with previous studies reporting 
that NP is involved in regulating the switch from viral mRNA synthesis to the efficient 
formation of full-length cRNA and vRNA [90,177,181,187,343]. Even though the studies 
indicate that NP is not solely responsible for directing the switch from viral transcription to 
replication, NP seems to act as an important auxiliary factor for this transition by stabilizing 
nascent viral full-length RNA [90,187] and by stimulating elongation and promoter escape of 
the viral polymerase through direct interactions [177,343]. Initiation of the switch was 
suggested to be due to other mechanisms, though, involving e.g. the presence of free viral 
polymerase complexes, small viral RNAs, the viral protein NEP or specific metabolic 
conditions (reviewed in [54], [177]). Nevertheless, since the presence of NP was shown to 
significantly promote viral full-length RNA synthesis [177,181,187,343], NP itself contributes 
to the down-regulation of free NP levels in infection. 
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The ability of NP to associate with specific subcellular structures even at very low nuclear 
concentrations most likely ensures targeting of NP to these domains very early during 
infection. This could indicate a regulatory role of NP, which, just like NS1, is an early protein 
in infection and might modulate host cell processes according to the viral needs. In addition, 
the extraordinarily high affinity of nucleoli and small punctate interchromatin domains for NP 
might ensure that the association with NP persists during infection and can efficiently 
compete with the recruitment of NP for cRNP and vRNP formation. Consistently, it was only 
recently reported that bright nuclear foci enriched with NP can be found late in infection and 
that these are furthermore devoid of vRNA [280]. Nucleoli, on the contrary, were found to 
disintegrate during infection, which is not due to the presence of NP alone though [132] (Fig. 
41). Nucleolar targeting of NP was demonstrated to be critically required for viral 
transcription [123], but it is unclear if a tight association with the nucleolar compartment 
persists during infection. The ultimate fate of nucleolar NP might depend on the interplay 
with other viral components which are involved in nucleolar remodeling during infection 
[132].  
It is further possible that high-affinity association of NP with nucleoli or with small 
interchromatin domains is a transient event in infection which enables posttranslational 
modifications or the recruitment of cellular factors to NP before NP is subsequently targeted 
to the viral replication machinery. In line with this hypothesis, relocalization of the cellular 
vRNP-binding protein nucleophosmin from nucleoli to sites of viral replication in the 
nucleoplasm of infected cells was previously reported [103].  
The implications for high-affinity targeting of NP most likely differ for subnuclear domains 
according to their role in infection. 
It remains to be investigated if NP is able to target these specific domains also in form of 
vRNP complexes. Since no vRNA was previously found to colocalize with nucleoli during 
infection [280], nucleoli apparently do not harbor vRNPs and thus do not represent sites of 
viral transcription or replication. Nucleolar targeting of NP might therefore rather aim at 
interference with cellular processes or at the recruitment of cellular factors by NP alone, 
possibly in concert with other viral proteins as indicated by the work of Terrier et al. [132]. As 
for the small punctate interchromatin domains which are targeted by NP, colocalization with 
vRNPs during infection has not been addressed so far. It is conceivable though that by 
targeting these domains, NP might help to direct the incoming viral genome in infection to 
subnuclear sites that provide an optimal molecular environment for subsequent transcription 
and replication. Considering that Influenza virus transcription and replication require 
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numerous cellular factors [127,128,149] and considering further that the nucleus is partitioned 
into regions of actively transcribed chromatin and transcriptionally inactive regions [488,489], 
efficient targeting of the Influenza virus genome to subnuclear sites enriched with factors for 
active transcription might be important for the functioning of the viral transcription and 
replication machinery. Yet, the sites of active cellular transcription, also known as 
transcription factories or Pol II sites, do not resemble the distinct punctate subnuclear domains 
which are preferentially targeted by NP (compare Fig. 3 in [127] with Fig. 45 and Fig. 50). 
Instead, NBs, which were previously shown to localize in close proximity to sites of active 
transcription [536,537,538], more closely resemble the punctate NP-binding domains than 
Pol II sites, and moreover, harbor also numerous enzymes which are involved in cellular 
transcription and RNA processing. They might therefore represent target structures for NP and 
RNPs and provide a favorable environment for viral transcription and/or replication.  
Since Influenza virus-infected cells are arrested in the G0/G1 phase of the cell cycle [539], 
targeting of NP or vRNPs to cellular replication sites during infection is rather unlikely. In the 
present study, NP expression in the absence of virus infection was performed under conditions 
of serum starvation, which also leads to accumulation of the cells in G1 phase [540]. NP 
subnuclear targeting was thus investigated under cell cycle conditions comparable to 
infection. It is therefore excluded that the observed heterogeneous distribution of NP is related 
to cellular replication sites.  
Only a small fraction of total expressed NP localizes within nucleoli or NB-like 
interchromatin domains. While, above, the targeting of subpopulations of NP to subnuclear 
sites with high affinity for NP is discussed, colocalization of NP with Pol II sites is not 
generally ruled out. The vast majority of NP in transfected cells is heterogeneously distributed 
due to interactions with the nuclear compartment and has a granular or speckled appearance. 
Whether it partially colocalizes with Pol II sites when expressed alone remains to be 
demonstrated. There is evidence for a tight interplay between the cellular transcription 
machinery that is associated with Pol II transcription and the viral machinery [127], but a 
physical association of NP with Pol II sites has not been shown yet.  
Already in 1982, viral RNA synthesis in infection was reported to occur in “nuclear cages” 
where also cellular RNA is synthesized [140]. By biochemical fractionation experiments, it 
was shown later on that vRNP complexes in infected cells tightly associate with chromatin 
and the nuclear matrix fraction [140,260,292,541], and that also the actively transcribing form 
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of cellular Pol II associates mainly with the nuclear matrix fraction [127]. Consistently, viral 
RNA synthesis activity was detectable in the nuclear matrix fraction as well [542].  
Intriguingly, even when expressed alone, NP was found to associate with the nuclear matrix 
fraction and with the chromatin fraction. Only little NP was found in the DNAse-sensitive 
fraction though, which is believed to be obtained from interchromatin components and 
loosely packed chromatin [541]. In infected cells, however, part of NP just like part of the 
cRNA and the vRNA could be detected additionally in the DNAse-sensitive fraction [541]. 
These results from previous studies seem to correspond to the observation reported here that 
the entire NP is tightly associated with the nuclear compartment when expressed alone (Fig. 
47) and to the observation described by Loucaides et al. [507] that the nuclear mobility of NP 
increases when it forms vRNPs in the presence of viral polymerase and vRNA.  
It is not clear from these data, though, how association of NP with chromatin and nuclear 
matrix fractions in biochemical fractionation experiments correlates with the here-observed 
subnuclear distribution of NP monitored by fluorescence microscopy. According to 
fluorescence imaging, the majority of NP accumulates in the interchromatin space of 
transfected cells and only a small fraction of NP seems to colocalize with chromatin (Fig. 44). 
It has to be considered that the interchromatin space and the chromatin as defined by 
fluorescence microscopy might differ significantly from the chromatin-derived fraction by 
high-salt extraction and from the DNAse-sensitive interchromatin fraction as defined by 
biochemical fractionation.  
The nuclear matrix fraction, which is not clearly relatable to the nuclear topology as defined 
by DNA staining, most likely forms part of both the interchromatin space and the chromatin 
regions. It comprises cellular transcription machinery like Pol II and cellular splicing factors. 
The splicing factor UAP56, which is assumed to be a constituent of the nuclear matrix 
fraction [541], was previously shown to be part of the cellular transcription/export (TREX) 
complex, which associates with sites of active Pol II transcription and couples cellular 
transcription, pre-mRNA splicing and mRNA nuclear export [543,544,545]. UAP56 was 
moreover shown to be an interaction partner of RNA-free viral NP [534] and to play an 
important role for the efficient replication of Influenza A virus [350]. It was proposed to act as 
a chaperone facilitating NP incorporation into viral RNPs [177]. UAP56 thus might be a 
potential candidate to be responsible for association of NP with the nuclear matrix fraction 
upon biochemical fractionation and for the heterogeneous interchromatin distribution of NP in 
the absence of virus infection. In fact, the subnuclear distribution of UAP56 has a striking 
similarity to the distribution of NP. Both concentrate within numerous speckled domains and 
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extend also diffusely outside of these domains (Fig. 2 in [546] & Fig. 44b, c). It is further 
known that UAP56 partially colocalizes with splicing speckles [546]. These data indicate that 
NP, even when expressed alone, might be targeted to sites that are related to cellular 
transcription. It can be furthermore speculated that the sites enriched with NP and its 
chaperone might define the sites of viral replication, which appear as granular pattern 
throughout the nucleus as well. According to current knowledge, colocalization analysis of 
UAP56 and Influenza virus NP was thus far not performed. Further analysis will be required.  
In the context of NP mobility studies, UAP56 might be a contributing factor to the low 
mobility of NP, linking NP to the nuclear matrix. UAP56 and splicing speckles might be sites 
with medium affinity for NP, which are responsible for the retardation of NP diffusion within 
the nucleoplasm, but which do not retain NP upon nuclear export induced by a C-terminal 
NES (as reported in section 4.3.2.). Since UAP56 was proposed to act as a chaperone [177], 
less tight association of NP with these sites and a better availability of NP and UAP56 might 
be favorable for viral RNP formation as compared to NP that is tightly associated with 
subnuclear structures with high affinity.  
In the following last part of this section, chromatin targeting of NP is discussed. Even though, 
by fluorescence imaging, only a small fraction of NP was found to colocalize with chromatin 
(Fig. 44), it was previously shown that NP as well as vRNPs are able to bind to histone tails of 
nucleosomes [352] and that NP specifically recognizes modifications which are characteristic 
for histone tails in transcriptionally inactive and condensed chromatin [353]. The interaction 
of NP with histone tails was demonstrated in vitro [352,353], and association of NP with 
chromatin was suggested based on biochemical fractionation and high-salt extraction, which 
is considered to solubilize the chromatin-binding proteins from tightly packed chromatin 
[541]. Nonetheless, it is possible that within the native cellular context, interactions of NP 
with interchromatin structures are prevalent, and only a small fraction of NP might actually 
associate with heterochromatin.  
It is known that structure and function of chromatin can be modulated by modifications of the 
histone tails why it was suggested that also NP-binding to histone tails might have a 
regulatory function during infection [352]. The dramatic rearrangement of chromatin that was 
observed here upon (over)expression of NP could be one consequence of this interaction (Fig. 
44d). It is an artifact of NP (over)expression though. Yet, it could be related to a functional 
molecular mechanism which – during infection – targets progeny vRNPs for nuclear export to 
heterochromatin in the nuclear periphery, as it was previously suggested [292]. Chromatin 
rearrangement by NP might furthermore indicate a viral mechanism to change the cellular 
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transcription pattern or promote host-cell shut-off [352]. In any case, the observed chromatin 
reorganization clearly demonstrates that NP can affect cellular chromatin, even when the 
degree of colocalization is relatively low. 
Considering the discrepancy between NP subnuclear localization and its chromatin binding 
capacity, it seems furthermore possible that interactions of NP might be modulated during 
infection, e.g. by specific protein modifications like phosphorylation [261], ubiquitination 
[547], sumoylation [548] or caspase-dependent cleavage [549], or simply by incorporation of 
NP into vRNP complexes, which might increase the affinity of NP for chromatin and thus 
specifically promote targeting of vRNPs and cRNPs to heterochromatin. Various reasons for 
the targeting of vRNPs to heterochromatin were previously suggested, e.g. the efficient 
recruitment of heterochromatin-associated factors for the formation of vRNP nuclear export 
complexes [292] or, alternatively, the association of vRNPs and cRNPs with heterochromatin 
as a subnuclear platform for viral transcription and replication processes [541]. The role of 
NP-chromatin interactions for RNP targeting to chromatin remains to be determined, though. 
The requirement for a specific regulation of RNP targeting is supported by the finding that 
cRNA and vRNA associate with chromatin fractions, but only vRNA can be found in the 
nuclear matrix fraction [541]. This indicates a selective involvement of different subnuclear 
sites in viral replication and transcription processes. How far NP and regulation of NP 
interactions might be involved in the selective targeting of viral RNPs is unknown and 
remains to be investigated. 
In general, the modulation of NP affinities might create different populations of NP, enabling 
NP to associate with chromatin and to be further available for other functional interactions, 
either as a free protein or as part of viral RNPs. It would not be unexpected for NP to fulfill 
multiple functions during infection since most of the Influenza virus proteins have various 
functions due to the limited coding capacity of the viral genome. 
Summarizing this paragraph, the distinct affinities of NP for the different subcellular locations 
are suggested to have functional implications and to reflect the diversity of NP interactions 
and functions. It is postulated that the sites with the highest affinity for NP accumulate NP 
early during infection in form of incoming vRNPs or newly synthesized NP. It is suggested 
that site-specific targeting might support viral replication by interference with cellular 
processes or by recruitment of cellular factors, but also posttranslational modifications of NP 
within functionally specialized domains might be an important function of NP subnuclear 
targeting. The vast majority of NP, however, which associates heterogeneously and with 
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comparably low affinity with the interchromatin space, is assumed to represent the pool of NP 
which is available for viral RNP formation. As for the cellular chromatin, its role in the 
interplay with NP is not obvious, given by colocalization studies and comparison with 
biochemical data. A regulation of NP affinities by posttranslational modifications or RNP 
formation during infection is thus suggested. 
5.3.2.4 NP specifically targets subnuclear domains in close proximity to PML and 
Cajal bodies 
Nuclear depletion of NP by expression of NP with NES-tag revealed nucleoli and punctate 
interchromatin domains of yet unknown identity as subnuclear structures with the highest 
subcellular affinities for NP (Fig. 45). Exposure of these high-affinity domains by nuclear 
depletion moreover enormously facilitated subsequent colocalization studies to characterize 
the cellular context of these structures. In case of wild-type NP, these domains might have 
previously been unnoticed as they might be mostly obscured by excess amounts of nuclear NP 
and by the typically speckled distribution of NP.  
Immunostaining of potential target structures of NP revealed that not only residual nuclear 
NES-tagged NP, but also wild-type NP accumulated in subnuclear domains (termed NP 
bodies) which were frequently found in close proximity to PML bodies and Cajal bodies 
(CBs) (Fig. 48–Fig. 51). The results strongly support that NP bodies do not randomly form 
within the nucleus. This is further consistent with photoactivation studies which provide 
evidence that NP dynamically associates with punctate subnuclear domains with high affinity. 
By expression of a control protein, it could be ruled out that accumulation of NP in subnuclear 
domains is an artifact of the NES-tag (Fig. 45). It is furthermore unlikely that accumulation of 
NP in interchromatin domains is due to targeting of NP to nuclear proteasome assemblies, 
termed clastosomes, which colocalize with a subset of PML bodies. In previous work, an 
unfolded NP mutant that is targeted for degradation was shown to colocalize together with 
PML within clastosomes [550]. This differs from the NP constructs in the present study which 
typically localized adjacent to PML bodies. 
As outlined in section 4.3.2, the likelihood of a completely random association of two 
domains within the nucleoplasm is unknown due to the non-assessable effect of nuclear 
crowding and limited interchromatin space. Yet, PML and CBs were previously shown to 
associate non-randomly with each other by direct physical interaction [505]. Here, 68 % of 
the CBs were found to associate with PML bodies, and only slightly less, 58 %, were involved 
in triplet arrangements with both PML and NP bodies, indicating a non-random association 
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with NP bodies as well. Furthermore, close association of NP bodies with PML domains and 
CBs was observed even at low densities of these structures (Fig. 49c, Fig. 50b), whereas the 
more numerous splicing speckles displayed only a low degree of colocalization and hardly 
any overlap with NP bodies (Fig. 48). It was further observed that PML NBs and CBs 
colocalized more frequently with NP bodies than with each other. It cannot be excluded 
though that this might be partly due to the larger number of distinct NP bodies compared to 
PML bodies and a higher probability of colocalization. Nevertheless, the largest fraction of 
each of the structures was part of a triplet arrangement with the two other structures, and 
almost the same fraction of NP bodies was found to colocalize pairwise with either PML 
bodies or CBs (4.3.2.3).  
According to these results, PML NBs and CBs seem to localize at subnuclear sites with a high 
probability of being preferentially targeted by NP. Since one third of NP bodies was further 
detected as solitary domains, NP apparently targets structures often related to, but not strictly 
dependent on the presence of PML or CBs. This is not unusual for subnuclear domains since 
also cellular structures like PML bodies and CBs [504] (or CBs and gemini of CBs (Gems) 
[551,552]) can be found to correlate with each other, even though they do not depend on each 
other, indicating a certain heterogeneity among subnuclear domains. In case of PML bodies, it 
is known that there are different subtypes of PML bodies which differ in ultrastructure and in 
protein composition, yet, all of them possess the PML protein as a common feature [553,554]. 
Since NBs are typically defined by marker proteins, also other classes of NBs might comprise 
a variety subtypes which differ in their specific functions and protein compositions. Similarly, 
also NP might target to a heterogeneous class of subnuclear domains. 
Further analysis will be required to identify the interchromatin domains that are targeted by 
NP with high affinity. Potential candidates will be subnuclear domains that were previously 
shown to localize adjacent to PML and CBs, e.g. Gems and cleavage bodies. Both domains 
are spatially and functionally related to CBs [552,555]. They are involved in snRNP assembly 
and in cleavage and polyadenlylation steps of pre-mRNA processing, respectively.  
5.3.3 Pondering potential biological functions of NP subnuclear targeting in 
the context of nuclear organization and viral infection 
The cell nucleus is known to be highly organized, and even though membraneless, the 
interchromatin space is compartmentalized into functionally specialized domains [488,489]. 
Prominent features of the nuclear architecture are the nuclear bodies (NBs). These are 
proteinaceous structures which assemble and maintain themselves either as constitutive parts 
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of the nucleus or in response to the metabolic state, to signaling events or to cell cycle 
progression. NBs are considered to control key cellular processes and represent therefore host 
cell machinery that can be either targeted or recruited by viruses to promote viral replication 
[556].  Structural rearrangements, disruption or altered numbers of NBs have been reported in 
the context of viral infections, although the reasons for these alterations remain often unclear. 
Specific subnuclear domains are further known to be targeted by Influenza virus protein M1 
[277] and by proteins of other nuclear replicating viruses [491,492]. It is shown here that also 
NP is directed to specific subnuclear domains by intrinsic affinity, namely nucleoli and yet 
unidentified small punctate interchromatin domains. This work was thus aiming at the 
identification of these subnuclear structures accessed by NP to enable conclusions on cellular 
processes that might be targeted by NP and on potential strategies of NP to interfere with or 
recruit host cell machinery.  
The general perception of nuclear bodies in current literature is that of subnuclear organelles 
[538,557] which carry out specific functions by concentrating substrates for efficient 
biological reactions in related metabolic processes or reaction chains [558]. They are known 
as sites for posttranslational modifications of proteins, posttranscriptional modifications and 
processing of RNA, assembly of RNP complexes and regulation of gene loci. Well studied 
examples are nuclear speckles, paraspeckles, Polycomb bodies, CBs, Gems, cleavage bodies, 
PML bodies, clastosomes and nucleoli (for an overview see [502]). They differ in protein 
composition and are enriched with proteins that can jointly act on biological processes. A non-
random spatial correlation among these domains within the nuclear compartment is assumed 
to have functional implications [486] and to contribute to regulated and efficient gene 
expression [559,560,561,562]. 
It is shown in this work that two types of NBs, CBs and PML bodies, frequently localize 
adjacent to the subnuclear domains that are targeted by NP. Intriguingly, it was previously 
reported that these domains themselves are affected by Influenza virus infection, and also 
infections by other viruses reportedly affect CBs and PML bodies. 
5.3.3.1 CBs and the related nucleolar compartment 
CBs are small punctate interchromatin domains. They are known to be involved in biogenesis 
of the spliceosomal machinery and posttranscriptional modification of RNAs [563]. They are 
sites of small nuclear (sn) RNP assembly and of maturation of spliceosomal snRNA. To this 
end, they harbor scaRNPs, a Cajal body-specific class of small nucleolar (sno) RNPs, which 
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guide modifications, in particular methylation and pseudouridylation, of snRNAs. They are 
further involved in nuclear export of precursor U snRNA [564] and in trafficking of proteins 
in and out of nucleoli [559,565,566]. CBs are related to nucleoli in protein composition and 
space and can further be found in close proximity to Gems, cleavage bodies, transcriptionally 
active U snRNA gene loci, PML bodies [563] and histone locus bodies [567]. Although a 
direct function in cellular stress response has not been assigned, CBs contain further many 
stress-related components like the tumor suppressor p53, the dsRNA-activated protein kinase 
R (PKR) and peroxiredoxin V [563]. 
Implication of CBs in viral infections has so far been described only for a few viruses. CBs 
reportedly accumulate proteins from picorna-like potato virus [568], groundnut rosette virus 
[566] and from an avian herpesvirus [569]. Further, they are disrupted by herpesvirus proteins 
[556] and rearranged in adenovirus infection [570]. Interestingly, the interplay of these viruses 
with CBs is not reported in the context of cellular antiviral activity, but rather in the context of 
nucleolar localization of viral proteins [568], trafficking pathways involving CBs [566] and 
viral protein expression [570].   
Also Influenza virus infection was shown to induce changes to the morphology of CBs, 
increasing the number of CBs while simultaneously decreasing their size [164]. The relevance 
of viral interference with CBs and the underlying mechanism are still unknown, though. The 
effect could not be linked to the direct action of the NS1 protein, which is typically considered 
to be the main actor in the virus-host interplay. Expression of NP constructs in the present 
study was furthermore not sufficient to induce morphological changes to CBs either. Based on 
the close functional and compositional relation between CBs and nucleoli [571], a connection 
between the disintegration of nucleoli [132] and redistribution of CBs during infection might 
be hypothesized. The reasons for the morphological changes of nucleoli have not been 
clarified to date either. It is tempting to speculate that the association of NP with nucleoli and 
in close proximity to CBs might be functionally related to infection-induced processes 
occurring in these compartments. Even though highly speculative, it is imaginable that 
dispersal of CBs and targeting of NP to sites in the vicinity of CBs enables the virus to hijack 
the RNA modifying machinery or components of transport pathways that are located in CBs.  
Yet, the mere inhibition of cellular protein synthesis was shown to lead likewise to the 
redistribution of CBs [572], similarly as in virus infection. Altered morphology of CBs in 
virus-infected cells thus could be an indirect effect of the Influenza virus-induced host cell 
shut-off. In case of adenovirus infection, morphological changes of CBs were previously 
assumed to be side effects of metabolic changes as well, but this point of view was later 
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replaced by a functional interpretation of adenoviral interference with CBs, and disruption of 
CBs was then considered as coordinated rearrangement instead [570]. In Influenza virus 
infection, the infection-induced disassembly of the related nucleolar compartment and the fact 
that CBs localize in the vicinity of domains that are specifically targeted by Influenza virus 
proteins (like NP bodies and PML bodies [277]) support a functional implication of CBs in 
viral replication as well. 
With PARP1 (poly(ADP-ribose)-polymerase 1), CBs further contain a protein that was 
previously shown to be essential for Influenza virus replication and that is furthermore a 
cellular interaction partner of the trimeric viral polymerase and of reconstituted vRNPs [103]. 
PARP1 is an obligatory resident of CBs and crucial for the maintenance of CB integrity [565]. 
Substantial amounts of PARP1 localize also in nucleoli. It has functions in DNA repair, 
chromatin remodeling, transcription regulation and ribosome biogenesis. By catalyzing 
posttranslational modification of proteins with poly(ADP-ribose), PARP1 can induce the 
assembly and activation of multiprotein complexes. It enables the recruitment of DNA repair 
proteins to sites of DNA damage, thereby initiating DNA repair pathways [573], and it targets 
proteins essential for rRNA processing to nucleoli [574]. Most interestingly, abolishing 
PARP1 enzymatic activity leads to disintegration of nucleoli and to aberrant localization of 
nucleolar proteins, suggesting that the PARP1 reaction product poly(ADP-ribose) might act as 
a scaffold that is crucial for the recruitment rRNA-processing proteins to sites of rRNA 
formation, and thus, for the formation of the nucleolar compartment [574,575]. It is possible 
that this mechanism of nucleolar assembly provides the still missing explanation for the 
disintegration of nucleoli (and CBs) in Influenza virus-infected cells: The recruitment of 
PARP1 by the viral polymerase and by vRNP complexes as indicated by Mayer et al. [103] 
might cause depletion of poly(ADP-ribose) in nucleoli and in CBs and thereby lead to the 
disintegration or dispersal of these domains. 
This hypothesis is in accordance with experiments performed by Terrier et al. [132], showing 
that separate expression of NP, M1 or NS1 does not induce disruption of nucleoli. Only 
reconstitution of viral RNP complexes, including coexpression of the viral polymerase, could 
be shown to induce nucleolar fragmentation. Intriguingly, the viral polymerase complex is not 
recruited to nucleoli during infection [139,576,577], supporting its here postulated role to 
induce nucleolar fragmentation by recruitment of PARP1 from nucleoli to sites of viral 
polymerase and RNP localization.  
Notably, Terrier et al. further reported that NS1 was found to contribute to nucleolar 
remodeling when coexpressed with viral RNP complexes [132]. Even though NS1 is targeted 
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to nucleoli by an intrinsic signal [578], structural rearrangements by NS1 were only observed 
in the context of vRNP-induced nucleolar fragmentation, but not in the absence of viral RNP 
components, implying the possibility that nucleolus-related functions of NS1 may require 
nucleolar fragmentation. Subtype-specific nucleolar targeting of NS1 was earlier shown to 
modulate the pathogenicity of Influenza A viruses [579]. 
Generally, it is not clear if fragmentation of nucleoli is only a side effect of the specific 
recruitment of nucleolar proteins like PARP1 by the viral machinery. In this case, the 
fragmentation itself would not fulfill any purpose. Alternatively, nucleolar fragmentation 
could be also especially induced by depletion of scaffolding proteins like PARP1 to trigger the 
release of other nucleolar components (compare [574]) in order to interfere with cellular 
processes or to subsequently recruit nucleolar proteins. In this context, nucleolar 
fragmentation might enable viral proteins like NP to recruit nucleolar components that are 
usually tightly associated to the nucleolar matrix. In case of NP, this would be consistent with 
the strong association that could be demonstrated between nucleoli and NP in the absence of 
infection (Fig. 47), and it would furthermore couple the recruitment of nucleolar factors by 
NP to the presence of the viral polymerase. In a third scenario, disassembly of nucleoli might 
represent the coordinated reorganization of the nucleolar architecture to optimize nucleolar 
processes in favor of viral replication. This could further facilitate interference by viral 
proteins like NS1 or NP.  
Findings from previous studies support the second hypothesis that disassembly of nucleoli 
during infection could be related to the release of nucleolar components for subsequent 
recruitment by the viral machinery: Several nucleolar proteins have been shown to be 
interaction partners of reconstituted vRNPs [103]. Besides PARP1, also nucleolin, 
nucleophosmin and some ribosomal proteins could be identified. They are apparently 
recruited to the viral complexes even in the absence of infection. Intriguingly, nucleolin, 
nucleophosmin and fibrillarin, which is another pre-rRNA processing protein and NS1-
binding protein, share the same mechanism for nucleolar targeting [574]. The three proteins 
could be shown to be targeted to nucleoli by PARP1 enzymatic reaction, apparently through 
attachment to a PARP1-generated poly(ADP-ribose) matrix. Therefore, PARP1 represents a 
central factor that allows regulating the localization of these proteins in concert, suggesting 
that the virus might induce the release of selected proteins by interaction with PARP1 for 
subsequent recruitment by the viral machinery.  
For nucleophosmin, it was moreover confirmed that it relocalizes indeed from nucleoli to the 
nucleoplasm late in infection, where it partially colocalizes with NP at sites of viral 
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replication [103]. Nucleophosmin was furthermore shown to increase the viral polymerase 
activity, supporting the relevance of nucleophosmin relocalization to viral replication sites. 
Interestingly, also NS1 nucleolar targeting is mediated by two proteins, whose localization 
was shown to depend on PARP1 enzymatic activity, namely fibrillarin and nucleolin [578]. 
The effect of NS1 on the morphology of nucleoli upon fragmentation, as described by Terrier 
et al. [132], thus might be related to the here proposed mechanism of nucleolar fragmentation 
by depletion of PARP1 and concomittant redistribution of the respective NS1-binding 
proteins.  
Finally, another interesting connection between PARP1 and a virus-related cellular factor 
should be mentioned. High-mobility-group box protein 1 (HMGB1), a chromatin binding 
protein, was shown to interact directly with NP and to promote viral polymerase activity 
[351]. It was further shown to be firmly bound to chromatin in apoptotic cells [580] and to be 
released from chromatin by PARP1 activity in necrotic cells [581]. Since the DNA-binding 
function of HMGB1 was shown to be required to enhance viral replication, release of 
HMGB1 from chromatin by PARP1 enzymatic activity in infection might seem unlikely. 
However, HMGB1 and PARP1 could work as antagonistic pair. HMGB1 could potentially 
contribute to the targeting of NP and vRNPs to cellular chromatin, as discussed in section 
5.3.2.3, and the polymerase-associated PARP1 in turn could provide a mechanism to regulate 
the release of progeny vRNPs. This model suggests that PARP1 itself has a specific function 
during infection, but it does not exclude the possibility that recruitment of PARP1 further 
induces the release of other nucleolar and CB-specific factors during viral replication, 
enabling their recruitment by the viral machinery. Lack of PARP1 leading to a considerable 
decrease of the virus titer underlines the general importance and critical role of PARP1 for 
viral replication [103]. 
Even though more data is available (and thus presented here) on nucleolar-related processes 
and components than on CBs, the close functional and compositional relation between the two 
subnuclear compartments [571] implies that viral interference with nucleolar functions might 
also affect or possibly even functionally involve CBs. Specific attention should thus be given 
also to CBs when studying nucleolar components in the context of virus infection.  
In support of the tight connection between nucleoli and CBs, previous work shows that the 
protein PARP1 is involved in trafficking between the two compartments. It is required for 
protein delivery into CBs and for interactions between key components of CBs [565]. It has 
therefore been suggested that the PARP1 machinery plays a role in the biogenesis of CBs by 
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shuttling proteins from nucleoli to CBs and by regulating protein-protein interactions. Hence, 
by recruitment of PARP1, the Influenza virus polymerase might not only affect nucleoli, as it 
was hypothesized above, but it might also affect the size and the number of CBs [164]. 
For Influenza virus NP, on the other hand, it could be shown in this work that it targets 
nucleoli with high affinity, but apparently does not accumulate within CBs by intrinsic 
affinity. It is tempting to speculate though that the targeting of NP to subnuclear domains 
which partially overlap with CBs might be related to the targeting of NP to nucleoli. Since 
both NP-binding structures display similar and remarkably high affinities for NP, they might 
share the same interaction partner for NP (Fig. 47). Interference with the previously identified 
nucleolar targeting signal of NP (aa 213–216) [123] might help to address this aspect. The 
nucleolar targeting signal was shown to be essential for viral transcription, even though the 
precise function of nucleolar targeting is not known. 
Apart from recruitment of nucleolar factors to the viral machinery, the reasons for a viral 
interplay with the nucleolar compartment can be diverse. Nucleoli are multifunctional 
compartments [582]. They play a significant role not only in ribosome biogenesis, but also in 
cell cycle control [583], stress response and apoptosis regulation [584,585,586], genome 
organization [587], RNA processing and RNA trafficking [588,589,590,591]. Due to these 
central cellular functions, nucleoli apparently represent an attractive target for many different 
viruses [592].  
The nucleolar localization of different viral proteins like HIV-1 Tat [593], HIV-1 Rev [594], 
herpesvirus ORF56 [595] and Influenza virus NP [123] was shown to be essential for the 
replication of these viruses. In case of HIV-1 and herpesvirus, nucleoli were further 
demonstrated to be critically involved in trafficking of viral mRNA [595,596,597]. Since 
sequestration of cell cycle-related proteins in nucleoli is a common mechanism for cell cycle 
regulation, also cell cycle control mechanisms have been suggested to be targeted by viruses 
through interference with the nucleolar compartment [598]. It was shown that various viruses 
induce changes of the nucleolar proteome during infection [577,599,600]. Each of the studied 
viruses apparently affects a different subset of nucleolar proteins though. It has been 
suggested that by regulating the nucleolar composition, viral proteins can adapt nucleolar 
activities to support virus production. For HIV-1, it was reported that expression of the 
regulatory nucleolar protein Tat induces significant changes in the composition of the 
nucleolar proteome even in the absence of virus infection [601]. Affecting particularly 
biosynthetic activities and metabolic pathways, it was suggested that Tat modulates the 
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metabolic profile of the host cell to meet the energetic and biosynthetic needs for efficient 
virus production. 
Compositional changes of the nucleolar proteome were found also during Influenza virus 
infection [577]. However, only a relatively small number of nucleolar proteins showed 
significant changes in abundance, in particular subunits of the histone H3 methyltransferase 
complex MLL1, which is a regulator of chromatin structure and transcription, and proteins 
involved in RNA processing like components of the RNAse P complex and components of 
paraspeckles. How far nucleolar NP, other viral proteins or virus-induced processes like 
nucleolar fragmentation are involved in these changes has not been addressed so far. The 
complex interplay of Influenza viruses with the nucleolar compartment remains elusive. 
Besides NP and NS1, also M1, HA, PB2 and NEP were previously reported to associate with 
nucleolar fractions of infected cells [577]. Nevertheless, an intrinsic nucleolar localization 
signal has been identified so far only for NP and NS1. While nucleolar targeting of NS1 as 
well as association of NEP and PB2 with nucleolar fractions was shown to be strain-specific 
[577,602,603], the nucleolar targeting signal of NP on the other hand is highly conserved 
among Influenza A strains (residues 213 to 216) [120,328].  
NP alone or in concert with other viral proteins or virus-induced processes might be able to 
interfere with one of the central nucleolar functions like stress response, cell cycle regulation, 
ribosome biogenesis or RNA trafficking. High affinity-binding of NP to nucleoli (as it was 
demonstrated in this work) seems to suggest that NP might inhibit dynamic nucleolar 
processes or cause sequestration of nucleolar proteins (e.g. interfering with the cell cycle). 
Intriguingly, however, the NP nucleolar targeting signal was previously shown to be critically 
required for efficient protein expression from vRNPs even in the absence of virus infection, 
which was demonstrated by functional reconstitution of vRNPs in a mini-replicon assay 
[123]. Thus, it appears that nucleolar targeting of NP is essential for the transcriptional 
activity of vRNP complexes. It is difficult to imagine though that NP might be able to 
promote viral protein expression by interference with nucleolar processes. Instead, it might be 
assumed that the association of NP with nucleoli becomes more dynamic in the presence of 
functional vRNPs to allow the recruitment of nucleolar components to the viral machinery. In 
future experiments, analysis of the nucleolar dynamics of NP in the context of a minireplicon 
assay might help to understand the role of NP nucleolar targeting for viral transcription in 
more detail, while NP bodies might be included in these analyses. 
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5.3.3.2 PML bodies 
PML bodies are the second structure apart from CBs that was identified to localize frequently 
adjacent to or partly overlapping with NP bodies (4.3.2.3). Interestingly, PML bodies are 
targeted by many viruses [604]. The functions of PML bodies seem rather diverse and less 
specific than those of other NBs, presumably because they represent a structurally and 
functionally heterogeneous class of NBs. PML bodies have been reported to be involved in 
tumor suppression, control of apoptosis, response to DNA damage, antiviral activity, IFN 
response, proteasomal degradation, maintenance of genome stability, transcription regulation, 
eIF4E-dependent mRNA export and posttranslational protein modifications [506,553].  
Accordingly, the reports on the subnuclear environment of PML bodies are similarly diverse: 
A subset of PML bodies was found to associate tightly with CBs due to the physical 
interaction [504,505], and a close correlation was also described with cleavage bodies, 
splicing speckles and active sites of transcription [504,605,606]. Furthermore, PML bodies 
were found adjacent to the MHC class I gene cluster, regulating chromatin architecture and 
transcription [607,608]. The interplay between the PML protein and nucleoli and the 
formation of a nucleolus-associated PML compartment was moreover suggested to play an 
important role in tumor suppression and cell cycle regulation [609,610]. PML bodies can be 
further sites of proteasomal degradation [611,612] and accumulate ubiquitinated proteins and 
proteasome components [611,613,614]. Also extensive contacts between PML bodies and 
chromatin were previously described. It could be shown that the stability of PML bodies is 
affected by changes in chromatin structure due to stress, DNA damage or transcription 
inhibition, leading to fission of PML bodies and formation of microbodies [491,615,616].  
The multiple roles of PML NBs are enabled by the dynamic recruitment of proteins in 
response to various stimuli like stress or cell cycle progression. Some proteins e.g. PML or 
SP100 are permanently associated with PML NBs, while other proteins like the tumor 
suppressor p53 transiently associate with PML NBs under certain conditions [617,618,619]. 
The PML NB interactome could be described by a network of 166 known PML NB 
components [620]. Many of these proteins are known to be posttranslationally modified by a 
small ubiquitin-like modifier (SUMO), or contain SUMO-interaction motifs (SIMs).  
Assembly of PML bodies has been suggested to be coordinated by SUMOylated PML protein 
[554,620,621,622]. SUMOylation and SIM of the PML protein were shown to be necessary 
for PML NB formation and for the recruitment of other proteins to PML NBs. The death 
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domain-associated protein 6 (DAXX), a major PML NB component, was shown to be 
targeted to PML NBs through its SIM domain [623].  
Most notably, PML NBs are considered to be also hot spots of cellular SUMOylation since 
they were shown to be one of two main sites of active SUMOylation within cells [624] and 
since they harbor all components of the SUMOylation machinery which are necessary for a 
complete SUMOylation cycle. They contain the three SUMO isoforms SUMO1, SUMO2, 
SUMO3, a SUMO-activating enzyme, a SUMO-conjugating enzyme, several SUMO ligases 
and SUMO-specific proteases [620]. SUMOylation can alter the activity, the stability, the 
intracellular localization or the intermolecular interactions of the target proteins, acting as a 
regulatory factor of many cellular pathways [625]. This might explain the involvement of 
PML NBs in very different cellular functions. PML NBs harbor also numerous other protein-
modifying enzymes, catalyzing e.g. phosphorylation, dephosphorylation, acetylation, 
deacetylation, ubiquitination and deubiquitination, why it was suggested that PML NBs might 
provide a general platform for posttranslational protein modifications, leading to activation, 
sequestration or degradation of proteins [626]. As a consequence, the reasons for viruses to 
target PML bodies can be diverse.   
PML bodies have been extensively studied in the context of virus infections [604,617]. The 
interplay between PML NBs and viruses is complex. Numerous studies have reported that the 
PML protein and PML NBs are implicated in antiviral defense and apoptosis regulation. There 
is accumulating evidence that they help to mediate the cellular IFN response and to establish 
the cellular antiviral state. It could be shown that IFN upregulates expression of several PML 
NB-associated proteins including the major PML NB constituents PML and SP100, leading to 
higher numbers and increased size of these structures [627,628,629]. The genes encoding 
PML and SP100 were shown to be directly regulated through IFN-stimulated response 
elements and IFN-gamma activated sequences in their promoter regions [630,631]. Also 
during Influenza virus infection, expression of SP100 was found to be upregulated, and the 
number of PML NBs increases [277,628]. Notably, the knockout of PML in mice and in cell 
culture renders mice and cells more susceptible to viral infections, while overexpression of 
PML could be shown to restrict replication of human cytomegalovirus (HCMV), adenovirus 5 
and several RNA viruses [604,617,632]. The capacity of IFN to protect cells against viral 
infection was furthermore found to be reduced in PML-knockout cells, consistent with the 
hypothesis that PML and its partner proteins represent an IFN-induced pathway. Also in case 
of Influenza viruses, overexpression of different PML isoforms led to inhibition viral 
replication, while silencing of PML isoforms resulted in enhanced Influenza virus replication 
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[633,634,635]. The antiviral effect of PML was found to depend on the Influenza virus strain 
though [635]. 
The specific function of PML in antiviral defense remains largely unclear. PML was shown to 
interfere with the replication of viruses through different mechanisms (reviewed in 
[604,617]). In poliovirus infection, PML recruits p53 to PML NBs, leading to its activation 
and induction of apoptosis. In case of HCMV and rabies virus, PML inhibits viral mRNA 
synthesis, while during herpes simplex virus type 1 (HSV-1) infection, the splicing of PML 
pre-mRNA is altered, leading to inhibition of viral replication. In case of Influenza viruses, 
the mechanism of PML-mediated antiviral defense is still unknown. Two PML NB-associated 
proteins, DAXX and SP100, have futher been shown to display antiviral activity. DAXX was 
shown to suppress replication of adenovirus and HCMV, while SP100 could be shown to be 
involved in repression of HSV-1.  
Viruses have evolved different strategies to counteract the antiviral activity that is mediated 
by PML and PML NB-associated proteins. Numerous viruses target regulatory proteins to 
PML NBs and cause the disruption of the NB structure. This is assumed to be part of the viral 
strategy to antagonize the cellular immune response (reviewed in [604,617]). The best studied 
example is HSV-1, but also other viruses like HCMV, adenovirus, Epstein Barr virus, human 
papilloma virus, rabies virus, encephalomyocarditis virus, lymphocytic choriomeningitis 
virus, hepatitis delta virus and hepatitis C virus adopt this strategy. Regulatory proteins of 
these viruses were shown to target PML NBs via different mechanisms and components. 
Some of the proteins cause delocalization of PML or SP100, others induce degradation of 
PML or DAXX, and still others induce loss of PML SUMOylation. Each of these mechanisms 
leads to the disorganization of PML NBs. 
Influenza viruses encode three proteins that have been shown to localize to PML NBs during 
infection, namely M1, NS1 and NEP [277]. Major disruption of PML NBs has however not 
been reported for Influenza viruses, and the role for the targeting of NS1 and NEP to PML 
NBs is still unknown. For M1, though, an anti-apoptotic function was only recently reported 
which depends on the interaction of M1 with DAXX [636]. DAXX is one of the major PML 
NB components and a transcriptional repressor. DAXX together with the NF-κb family 
member RelB controls epigenetic silencing of RelB-responsive anti-apoptotic genes 
[637,638]. By binding to DAXX, M1 prevents the repressional function of DAXX. It prevents 
complex formation between DAXX and RelB, thus impairing promoter binding of DAXX 
and the recruitment of DNA methyltransferases to RelB-regulated genes. This leads to 
DISCUSSION 
261 
 
activation of anti-apoptotic genes early during Influenza virus infection as demonstrated by 
Halder et al. [636]. Whether targeting of M1 to PML NBs is required for this regulatory 
transcriptional function of M1 during infection is not known though since DAXX can be 
found also diffusely in the nucleoplasm. While the association of M1 with PML NBs was 
shown to depend on infection [277], the binding of M1 to DAXX and efficient inhibition of 
DAXX-mediated gene repression can be detected also in the absence of virus infection [636]. 
It thus remains to be clarified if infection-dependent localization of M1 in PML NBs is a side-
effect of its ability to interact with DAXX, or if M1 association with PML NBs during 
infection has an additional functional significance.  
Considering the central role of PML NBs in SUMOylation, it is possible that targeting of the 
various Influenza virus proteins to PML bodies might be related to the targeting of the host 
cell SUMOylation machinery. Indeed, there is accumulating evidence for an extensive 
interplay of Influenza viruses with the host cell SUMOylation system [548]. The three viral 
proteins being targeted to PML NBs (M1, NS1, NEP) and further NP and PB1 have been 
shown to be authentic SUMOylation targets [548]. Previous reports indicate that 
SUMOylation motifs found in avian and human strains are evolutionary relatively well 
conserved [639]. For M1 and NS1, it was confirmed that they become SUMOylated during 
virus infection, and also for NP and PB1 evidence suggests that they are SUMOylated in 
infected cells [548,640]. The detection of protein SUMOylation can be difficult (as in case of 
NP and PB1) due to the rapid turnover of SUMO-conjugation and due to low endogeneous 
levels of SUMOylated protein fractions.   
For NS1, it was first reported that SUMOylation contributes to the stability of NS1 in cells 
[641], while a more recent study suggests that SUMOylation regulates the abundance of NS1 
dimers and trimers in infected cells, thereby affecting the function of NS1 as IFN antagonist 
[642]. In case of M1, SUMOylation was shown to be required for the interaction between M1 
and vRNPs and for vRNP nuclear export during infection, indicating a role of SUMOylation 
for the formation of M1-vRNP nuclear export complexes [276]. Virus mutants deficient in M1 
or NS1 SUMOylation display reduced virus titers, accordingly.  
For NP, NEP and PB1, a potential role for SUMOylation has not been addressed so far. 
Analysis of the NP primary sequence by SUMOplot (http://www.abgent.com/sumoplot) 
predicts a SUMOylation site at position K198 which appears to be well accessible at the 
surface of the highly conserved NP head domain (refer to NP crystal structure PDB: 2IQH). 
The SUMOylation consensus motif ψKXE/G/D [643], where ψ stands for a hydrophobic 
residue and X for any amino acid, spans amino acids 197 to 200 of NP (IKRG). This is an 
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interesting site for regulatory posttranslational protein modifications since it is located in 
close proximity to two important functional sites of NP. NP residues R204, W207, R208 
within a neighbouring loop were shown to be involved in the interaction between NP and the 
viral polymerase and to be essential for viral polymerase activity [188]. The second functional 
site close to K198 is a nucleolar localization signal that was further shown to be essential for 
the transcriptional activity of vRNPs (residues 213–216) [123]. Accordingly, the accumulation 
of NP in NP bodies adjacent to PML NBs might be related to the acquisition of SUMOylation 
by a small fraction of NP molecules for a regulatory purpose.   
Considering further the role of M1 SUMOylation during infection, it is also possible that by 
targeting to the vicinity of PML NBs, NP might be able to target vRNPs close to sites of M1 
SUMOylation for the efficient formation of nuclear export complexes. In this context, it is 
interesting to note that also NEP as an important component of the nuclear export complex 
locates to PML NBs and is – just like PB1 – another component that is SUMOylated in vivo, 
supporting the here suggested involvement of these sites in both viral protein SUMOylation 
and vRNP nuclear export complex formation. Considerable support for a model of vRNP 
nuclear export complex formation at PML NBs was also provided by the work of Kawaguchi 
et al. [295], showing that vRNA accumulates in PML NBs during infection when the CRM1-
dependent nuclear export of vRNPs is inhibited by leptomycin B. Also cellular vRNP-
interacting protein YB-1 was shown to be recruited to PML NBs prior to nuclear export 
together with vRNPs and to be required for subsequent cytoplasmic vRNP transport. 
Consistent with the requirement for SUMOylation during Influenza virus infection, PML NBs 
do not become disrupted in infected cells, but become more numerous instead [277,628]. 
Remarkably, even a global increase of cellular SUMOylation is observed during Influenza 
virus infection, while overall cellular protein syntheses are downregulated [548]. In 
comparison, in HSV-1 infection, disruption of PML NBs is accompanied by a decrease of 
cellular SUMOylation [625]. And while downregulation of SUMOylation was reported to be 
a common feature of most studied pathogens [644], an intact SUMOylation system could be 
shown to be essential for efficient Influenza virus replication: the knockdown of the SUMO-
conjugating enzyme Ubc9 dramatically reduces Influenza virus production [276], and large-
scale siRNA screenings identified components of the cellular SUMOylation machinery as 
critical factors for viral replication [645].  
In summary, the data suggest that by targeting to sites in the vicinity of PML NBs, NP targets 
a subnuclear region of general importance during Influenza virus infection. A functional 
connection between NP bodies and PML NBs remains to be demonstrated though.  
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How the antiviral effect of PML protein expression can be reconciled with the increasing 
number of PML NBs during infection and with the requirement for a functional cellular 
SUMOylation system remains to be further clarified. 
Finally, it should be taken into consideration that other data on PML NB-related domains are 
available which suggest a different view on NP bodies. These data indicate the possibility that 
the formation of NP bodies adjacent to PML NBs might be induced by cellular antiviral 
activity. The implied underlying mechanims are discussed in the following: 
First, the tripartite motif-containing protein 22 (TRIM22) is an antiviral protein with E3 
ubiquitin ligase activity that localizes partially within NBs [646]. TRIM22 was very recently 
shown to interact directly with Influenza virus NP, causing NP polyubiquitination and 
proteasomal degradation [647]. It is induced by IFN and p53. The subcellular distribution of 
TRIM22 seems to vary, depending on the conditions of expression. Very similar to NP bodies, 
endogenous TRIM22 in HeLa cells was shown to localize in subnuclear domains adjacent to 
CBs. It interacts with coilin. Its distribution however is cell cycle-dependent and, particularly 
in G0/G1 phase when exogenously expressed, TRIM22 bodies seem to be more numerous and 
rather different from the appearance of NP bodies [646] (Fig. 48). In MDCK and A549 cells, 
which are both permissive for Influenza virus infections, TRIM22 was reported to be barely 
detectable. It appears to be rather cytoplasmic in MDCK cells when overexpressed [647], 
while NP bodies, on the other hand, can be clearly observed in the nuclei of MDCK II cells 
(Fig. 45). A potential connection between NP bodies and TRIM22 NBs therefore will have to 
be further investigated by direct colocalization analysis.  
The second observation, which might help to explain the formation of NP bodies in proximity 
to PML NBs, is the reported association of PML NBs with the genomes of several DNA 
viruses, including HSV-1, HCMV and adenovirus 5. While early studies suggested that PML 
NBs might provide a favorable environment to promote viral transcription and replication and 
help to establish a viral replication compartment [605] (reviewed in [491,492]), it was 
demonstrated later on that PML NB-like structures rapidly form de novo in association with 
incoming viral genomes by deposition of PML NB components [648]. According to the 
current view, this is part of a cellular response leading to repression of viral transcription and 
replication [604,649]. Hence, in analogy to DNA viruses, NP as a major component of the 
genomic complexes of Influenza viruses might stimulate the recruitment of PML NB 
components by an evolutionary conserved mechanism. Yet, the origin of replication of viral 
DNA was reported to be a requirement (aside from viral proteins) for the association of PML 
NBs with various viral DNA genomes [491,492], indicating an antiviral mechanism that 
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might be restricted to DNA viruses. Moreover, recognition of viral DNA as “foreign” DNA, 
which differs from cellular chromatin, and the involvement of the cellular DNA damage 
response machinery were suggested to be implicated in the recruitment of PML NB 
components to viral genomes [649,650]. According to these considerations, the RNA genome 
from Influenza virus does not match the pattern that seems to be recognized by this type of 
nuclear antiviral defense. Considering that DNA viruses, but not RNA viruses, typically 
replicate in the nucleus of infected cells, recruitment of PML NBs might have evolved as an 
evolutionary conserved mechanism of nuclear antiviral activity that is directed against 
common characteristic features of DNA viruses. Following this line of argument, it is unlikely 
that NP bodies are targeted by PML NB components through the same mechanism as the 
replication compartments of DNA viruses. Furthermore, targeting of PML NB components to 
NP bodies would not be able to explain the intrinsic affinity of NP for NP bodies, the 
additional proximity of NP bodies to CBs or the neglectable role of the more abundant 
nucleoplasmic NP for PML NB recruitment. Unlike the replication compartments of DNA 
viruses, Influenza virus NP and vRNPs are spread throughout the nucleus during infection 
[134,280] and thus do not represent a distinct target structure for PML NBs. A small 
subpopulation of NP might therefore rather be directed to sites in proximity to PML NBs by 
intrinsic affinity than PML NBs being targeted to NP, which is in accordance with the results 
of the present study. In conclusion, a relation between NP bodies and PML NBs in analogy to 
replication compartments of DNA viruses is considered most unlikely. 
To summarize this part of the discussion, there are a number of possible implications for NP 
bodies and how they might be engaged in an interplay with the here identified neighbouring 
domains during infection. Three major hypotheses could be derived by analysis of the 
subnuclear context based on data from previous publications:     
In case of CBs, there is so far hardly any data supporting a direct involvement of CBs in virus 
replication. However, considering the functions of CBs, it is speculated here that NP might 
target vRNPs to NP bodies close-by CBs to connect viral processes like transcription or 
replication to cellular processes like RNA modification, RNP assembly or nuclear-
cytoplasmic transport pathways, which are located in CBs. Yet, there is no evidence to 
substantiate this hypothesis so far. A second hypothesis suggests that NP body formation 
could be the result of cellular antiviral activity of TRIM22, which is based on evidence for a 
direct physical interaction. The most interesting and favored hypothesis, though, evolved from 
the combination of variety of data, leading to the most complex picture on the potential role 
of NP bodies. It suggests that PML NBs might be sites of viral protein SUMOylation, which 
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subsequently enables vRNP nuclear export complex formation depending on SUMOylation of 
one or more of its components. This hypothesis further includes the assumption that (by 
targeting to NP bodies) NP might be able to target vRNPs into the vicinity of PML NBs for 
efficient formation of vRNP export complexes. It suggests moreover that NP undergoes 
SUMOylation itself to regulate the transcription and replication activity of vRNPs which are 
destined for nuclear export. It is thus assumed here that NP bodies might be part of a 
relatively complex infection-induced process, in which adjacent nuclear domains might be 
jointly involved.  
The main focus of the current paragraph was accordingly to figure out connecting factors 
between NP, CBs, PML NBs and infection-relevant processes. However, the possibility has to 
be considered that – even though the cellular compartment underlying NP bodies has not been 
identified yet – NP might interfere with or hijack processes of the subnuclear domain itself 
independently from the subnuclear context. The identification of this domain is required for 
further assumptions.  
Concerning the nucleolar compartment, it is one important finding of this study that NP 
displays a remarkably high affinity for nucleoli. This might be crucial information when 
trying to understand the processes connecting NP nucleolar targeting, the relocalization of 
nucleolar NP to the nucleoplasm, nucleolar fragmentation and the requirement of NP 
nucleolar targeting for vRNP transcription. It further underlines the importance to understand 
the varying dynamics of NP and their regulation within the nucleus for coordinated function. 
Based on previous studies, coincidences between vRNP interaction partners and nucleolar 
components, in particular PARP1, seem to indicate a complex interplay between the presence 
of vRNPs, the recruitment of nucleolar factors, nucleolar fragmentation and the localization of 
NP. Intriguingly, these data support speculations that recruitment of nucleolar components by 
NP might be coupled to the presence of the viral polymerase and transcription-competent 
vRNP complexes. 
5.3.4 Summarizing remarks 
In this study, analysis of NP subcellular targeting was performed using photoactivation 
measurements and colocalization analysis. It was demonstrated that NP extensively interacts 
with cellular structures, in particular with the nuclear compartment. The work focused on the 
topology of NP interactions taking into account the spatial and functional organization of the 
nucleus. Distinct populations of NP could be identified differing by subcellular localization 
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and distinct site-specific affinities. Highest affinities of NP were found within the nucleolus 
and within small interchromatin domains that were frequently detected in the context of CBs 
and PML NBs, but which could not be identified. These three subnuclear compartments are 
known to be affected during Influenza virus infections, suggesting NP targeting to be part of 
more complex infection-relevant processes. Recruitment of nucleolar proteins upon nucleolar 
fragmentation or acquisition of posttranslational protein modifications are two of the potential 
functions of site-specific NP targeting which are proposed here. Based on the small (catalytic) 
amount of NP which is recruited to these domains, a primarily regulatory function of NP high-
affinity targeting to nucleoli and NP bodies is assumed. 
The majority of NP was found to be involved in comparably low, but still considerable 
interactions with the nucleoplasm. It is heterogeneously distributed throughout the 
nucleoplasm and has a speckled appearance. It is suggested that this fraction of NP might 
represent the pool of NP that is available for vRNP and cRNP formation during infection. It is 
further assumed – based on biochemical and microscopy data from literature – that interaction 
with the splicing factor and NP chaperone UAP56 might be responsible for association of 
major parts of NP with the nuclear matrix and for the characteristic nuclear distribution of NP 
in the absence of infection. Further experiments are required for validation.  
This study was conducted on NP in the absence of virus infection providing insight into the 
potential role of NP apart from its function as part of viral RNP complexes. The overall 
extensive interactions of NP with the nuclear compartment and site-specific affinities strongly 
imply yet unrecognized functions of NP in the virus-host-interplay. The results further 
indicate an NP interaction network that might require temporal and spatial regulation during 
infection, but which might also help to coordinate the replication cycle of vRNPs.  
Various models for the potential role of intrinsic site-specific NP subnuclear targeting which 
were proposed in this work might indicate directions for future investigations. 
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5.4 Single particle tracking of fluorescent NP constructs in 
Influenza virus infection 
5.4.1 Fluorescent NP constructs can be successfully introduced into virus 
infection and be traced during Rab11-dependent vesicular transport to 
the plasma membrane  
In this work, an experimental approach was established which allows coexpressing 
fluorescent NP fusion proteins in Influenza virus infection (4.4.1). Since infection and 
transfection were found to have a mutually inhibitory effect on each other, the experimental 
conditions had to be carefully optimized (Fig. 53 & Fig. 54). It was suspected that both the 
virus-induced host cell shut-off and the premature presence of NP in infection were 
responsible for these effects. It was further assumed that infection and exogenous NP 
expression had to be initiated in very close succession so that the infection state of the cell 
and exogenous NP expression levels could evolve in parallel.  
Experimental conditions were accordingly optimized by modulating the delay between 
infection and transfection. It was found that transfection could be efficiently established in 
infected cells, but only if not performed later than 3 h p.i., and infection became more 
robustly established the more time it was allowed to proceed before transfection was 
performed. The critical time to establish exogenous NP expression in infected cells thus could 
be localized between 1 h p.i and 3 h p.i. Best results for coexpression of fluorescent NP 
constructs in the context of virus infection were obtained when transfection was performed at 
2 h p.i. (Fig. 55).  
According to expectations, successful infection of mEYFP-NP coexpressing cells induced 
relocalization of the NP construct to the cytoplasm (Fig. 55). The relocalization was specific 
for infected cells. mEYFP-NP then displayed a characteristic punctate cytoplasmic pattern 
comparable to the one of vRNPs in infection [280,297], and just like native vRNPs, mEYFP-
NP became associated with Rab11-positive recycling endosomes (Fig. 58). Targeting to the 
asymmetrically organized recycling endosomal compartment apparently determines the 
characteristic speckled and laterally polarized distribution of both mEYFP-NP and native 
vRNPs in the cytoplasm of infected cells, reaching from the MTOC in the perinuclear region 
to the plasma membrane. While association of mEYFP-NP with recycling endosomes was 
shown to be infection-dependent (Fig. 57 & Fig. 58), it was previously shown that vRNPs 
colocalize with Rab11 even when reconstituted in the absence of infection, potentially 
through PB2 [280].  
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Being aware that no direct evidence is provided for incorporation of mEYFP-NP into vRNPs 
in infected cells, a variety of findings and reports support though that mEYFP-NP becomes 
indeed functionally incorporated into newly forming vRNPs during infection and undergoes 
cytoplasmic transport: (i) N-terminally GFP-tagged NP is reportedly able to form 
transcription-competent vRNP complexes in cells and in the presence of wt NP [280,507]. (ii) 
Reconstituted GFP-tagged vRNPs are exported to the cytoplasm upon coexpression of the 
viral nuclear export factors M1 and NEP, and they associate with Rab11-positive recycling 
endosomes just like vRNPs in virus infection [280]. (iii) The association of vRNPs with 
Rab11 is mediated by the viral polymerase, not by NP [280,296,298]. (iv) mEYFP-NP 
colocalizes with Rab11 only in the context of virus infection, (Fig. 57 & Fig. 58). 
Based on these findings, it is postulated that mEYFP-NP and analogous fluorescent NP 
constructs like mCherry-NP are incorporated into newly forming vRNPs during infection and 
that the fluorescent protein tag does not critically interfere with processes of viral replication 
like transcription or nuclear-cytoplasmic transport. It is further postulated that the so formed 
mEYFP-tagged vRNPs are exported from the nucleus, which leads to their detection as 
distinct punctate signals in the cytoplasm with a characteristic distribution, as described in 
section 4.4.2. In analogy to native vRNPs, it is assumed that the viral polymerase is 
responsible for targeting the fluorescently labeled vRNPs to recycling endosomes (Fig. 58) 
and that the genomic segments then undergo Rab11-dependent cytoplasmic trafficking to the 
viral budding site at the plasma membrane, which is in agreement with the monitored 
cotrafficking of mEYFP-NP and Rab11-RFP (Fig. 59).  
It is accordingly claimed that the here established experimental system provides a tool to 
study the dynamics of vRNP transport in infection and to characterize the different steps of 
the transport pathway in living cells. 
Long-range movements of cytoplasmic mEYFP-NP particles (covering distances between 2 
and 20 µm in length) could be described as fast saltatory movements with average velocities 
between 0.3 and 1.2 µm/s and peaks up to 1.7 µm/s. This is in accordance with values that 
were determined in other studies using different experimental approaches. Amorim et al. 
[280] reported an overall average velocity of 0.81 µm/s for fast saltatory movements of GFP-
tagged Influenza vRNPs in the absence of infection. They further showed that instant 
velocities ranged between 0.2 and 1.4 µm/s, with single data points reaching up to nearly 3 
µm/s. Momose et al. [298] on the other hand measured velocities of vRNPs in the context of 
virus infection. Yet, they applied a different labeling strategy, using transfection to introduce 
vRNP-specific antibodies into living infected cells, and they determined a mean velocity of 
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1.45 µm/s. The most recent study addressing the dynamics of vRNPs (conducted by Avilov et 
al. [296]) was based on a recombinant virus strain encoding split-GFP tagged PB2 to label 
and track vRNPs. The authors reported rapid velocities around 1 µm/s, pointing out though 
that the motion of the vast majority of vRNP particles was slow (<0.25 µm/s). 
The best agreement was obtained with the data from Amorim et al. who adopted the same 
labeling strategy as in the present work, labeling vRNPs by incorporation of a fluorescent NP 
fusion protein. As a major difference, though, the measurements by Amorim et al. were 
performed in the absence of infection using a plasmid-based minireplicon assay, while 
measurements in the current work were conducted in infected cells. Apparently, it did not 
make a difference for the observed velocities of rapid saltatory movements whether they 
occurred in the presence or absence of virus infection.  
The slightly higher velocities reported by Momose et al. might be due to differences between 
the experimental conditions. It is possible that incoporation of unknown numbers of 
GFP/mEYFP-tags (27 kDa) and binding of fluorescently labeled antibodies (150 kDa) affect 
the dynamics of vRNPs differently. Alternatively, also transfection of plasmid DNA, as 
performed in the present study and in the work of Amorim et al., and transfection of 
antibodies, as performed by Momose et al., might have affected the cells or the vesicular 
transport differently. In all three cases, lipid-based transfection reagents were used, which are 
thought to be internalized by endocytosis [651]. In case of vRNP reconstitution experiments, 
24 h had elapsed between transfection and measurements, while the transfection of antibodies 
in infected cells was peformed only 3.5 h prior to measurements. Here in this work, SPT was 
performed with a time lag of 4–6 h to transfection.   
In the study by Avilov et al., the use of a genetically encoded split-GFP-tagged PB2 is likely 
to overcome artifacts that can be potentially introduced by transfection or by high numbers of 
large fluorescent labels like the fluorescent NP antibodies or the fluorescent NP protein tags. 
Yet, the results are basically in agreement with the velocities obtained by other approaches, in 
particular with the data of Momose et al., tending to velocities higher than 1 µm/s and 
reaching up to more than 5 µm/s. The authors stress though that fast intermittent movements 
in comparison to slow movements (<0.25 µm/s) were only rarely observed and that the effect 
of microtubule depolymerizing drugs on rapid motions was limited, while a more dramatic 
effect was detected in the work of Amorim et al. Since the split-GFP tag of recombinant 
viruses was attached to the PB2 subunit of the viral polymerase, which also links vRNPs to 
Rab11 and the transport vesicles, it cannot be entirely excluded that the vesicular transport of 
vRNPs might be affected and slightly biased towards more actin-dependent movements. Since 
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only a single fluorophore was further attached to each vRNP complex, it might not always be 
possible to distinguish a free PB2 molecule from an RNP-bound form. The selection of 
objects to be traced might further be biased towards a selection of several colocalizing 
vRNPs.  
The bottom line is that all four approaches to study progeny vRNPs in living cells might have 
potential limitations, but their results are in satisfying agreement supporting each others 
findings, and they might well serve as complementary approaches to address certain issues of 
Influenza virus infection.  
Using the here established experimental approach, it was not only possible to determine 
kinetic parameters of vRNP transport, which could be verified with previous studies, but it 
was also possible to describe site-specific processes like vRNP nuclear-cytoplasmic transport 
and the targeting to the plasma membrane, two processes which are still very incompletely 
understood. 
Considerable mobility of mEYFP-NP complexes was detected underneath the plasma 
membrane (Fig. 63A), which indicates that vRNPs might be first transported to the cell 
periphery and then continue to move along the membrane in search for the viral budding site. 
Yet, also relatively immobile vRNPs were detected at the plasma membrane, lingering for a 
while, followed by sudden and fast retrograde transport back into the cytoplasm (Fig. 63B). 
This could represent a trial and error mechanism. If the transported cargo does not meet the 
requirements for attachment to the plasma membrane or for further progression to an 
appropriate target site, it might be recaptured to the microtubular transportation network, 
move back to the cell center and be again targeted to a different site of the cell periphery. In 
order to be actually able to trace the trajectories of individual vRNPs or vRNP assemblies 
during the entire process of targeting to the viral budding site, fast three-dimensional time-
lapse imaging would be required. This might further help to investigate the question how far 
recycling endosomes are involved in delivering vRNPs to the budding site and whether this 
requires fusion with the plasma membrane or the viral budding site. 
The second type of site-specific movements which could be characterized by time-lapse 
imaging are the nuclear-cytoplasmic transport events and the subsequent movements of 
vRNPs in the perinuclear space (Fig. 60 & Fig. 61). mEYFP-NP particles were found to 
undergo unexpectedly fast movements across the nuclear boundaries, immediately followed 
by relatively rapid long-range directional movements into the cytoplasm with velocities 
around 0.3–0.4 µm/s. These velocities are not clearly characteristic for one specific mode of 
transportation. They could represent rapid actin-mediated transport or relatively slow 
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microtubule-based transport [110,509,510,512,652,653]. Yet, the curvilinear appearance of 
these movements and the considerable lengths, covering distances of several micrometers, 
suggest a microtubule-dependent transport.  
It is well established that progeny vRNPs are exported through nuclear pore complexes 
(NPCs) using the CRM1-dependent nuclear export machinery [264,266,267], but aside from 
extensive biochemical analyses not much is known on the kinetics of vRNP export. Here, the 
nuclear-cytoplasmic transition was found to be surprisingly rapid, since the observed 
translocations were not accompanied by an obvious interruption of the movement when 
images were acquired at intervals as fast as 0.5 s. Yet, this observation is in line with a 
previously reported average translocation velocity of 0.65 µm/s, measured for model mRNPs 
of comparable size, and with a NPC translocation time of 0.5 s [654]. Assuming an export rate 
of one event per 36 s as seen in Fig. 61 and assuming further about 2000 NPCs per nucleus 
(as reported for CHO cells [655]), one vRNP could theoretically be exported every 18 ms. 
However, a similarly high frequency of export events of mEYFP-NP complexes was not 
observed for other nuclear exit sites and it is further not clear if all existent NPCs are 
functionally equivalent. Considering that not more than five nuclear translocation sites were 
typically observed per image plane, representing roughly about 1/10 of the nuclear surface, 
not all potentially available NPCs seem to mediate mEYFP-NP export or to be constantly 
active. Again, a three-dimensional imaging approach would help to address this issue and give 
site-specific information on NPCs all over the nucleus. 
Similarly unexpected as the fast and apparently uninterrupted movement through NPCs is the 
directed movement that was observed subsequent to nuclear-cytoplasmic translocations (Fig. 
61). It suggests that the translocation through the nuclear pore complexes is directly linked to 
active cytoskeleton-assisted cytoplasmic transport. For many years, nuclear import and export 
have been considered to be mediated by soluble import and export receptors through diffusion 
along molecular concentration gradients [656]. The formation and disintegration of import 
and export complexes was generally assumed to occur in the vicinity of the nuclear envelope 
by diffusion limited reactions between freely diffusing substrates and receptors. Also for 
incoming Influenza vRNPs, it was previously suggested that they are transported to NPCs on 
the nuclear envelope by diffusion [117].  However, only in 2011, it was shown that nuclear 
import and microtubule-dependent transport can be closely connected [657]. A microtubule 
association sequence (MTAS) was identified within proteins, which binds to both 
microtubules and nuclear import factors so that the protein can be displaced from 
microtubules by binding to import factors and thus be transferred from the cytoskeleton to the 
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nuclear import machinery. Even though this was reported specifically for the nuclear import 
process, an analogous mechanism is conceivable for nuclear export. In the present study, the 
nuclear-cytoplasmic transport of mEYFP-NP complexes in combination with long-range 
cytoplasmic movements could be observed in both directions (Fig. 63A). Accordingly, nuclear 
import and export events seem to be directly linked to cytoskeleton- and motor protein-
dependent transport processes, which is an interesting observation also in the light of a recent 
description that vRNPs themselves can associate with microtubules through interaction with 
the cellular protein YB-1 [295]. YB-1 was shown to be recruited to vRNPs in the nucleus, 
most likely involved in nuclear export complex formation, and even though it is not crucial 
for vRNP export, it was shown to be required to target vRNPs to the perinuclear region 
around the MTOC. 
Very little is so far known on the step of vRNP transport from the nucleus to recycling 
endosomes. Together though, the observations from SPT in the present study, suggesting 
cytoskeleton-assisted transport to be directly coupled to vRNP nuclear export, the previously 
suggested association of a microtubule-binding factor with vRNP nuclear export complexes 
[295] and further localization of individual vRNPs in close proximity to microtubules after 
nuclear export [134], indicate two stages of microtubule-based transport. First, the exported 
progeny vRNPs might be targeted to microtubules independent from vesicular transport and 
travel towards the MTOC where they then become associated with Rab11-dependent 
recycling endosomes, which mediate the second stage of transport to the apical plasma 
membrane [280,297,298]. Recycling endosomes, which procure the information for apical 
targeting of viral genomes, further mediate transport of the viral protein M2, which was 
shown to be essential for membrane scission and virus release [30], so that recycling 
endosomal transport of viral components might be an important determinant of apical virus 
budding [252]. It remains to be investigated how important the here postulated first stage of 
microtubule-based transport and initial targeting of vRNPs to recycling endosomes is for 
efficient apical transport. 
It is further poorly understood how and at which stage of the viral replication cycle vRNPs 
assemble into multisegmental complexes, which finally become packaged into progeny 
virions. It has been suggested that recycling endosomes might provide a platform for vRNPs 
to preassemble prior to association with the viral budding site [134,297,298]. Due to the size 
of multisegmental complexes consisting of eight different segments [306], it seems obvious to 
assume that assembly takes place only after transport through the NPC. Individual vRNP 
segments might be targeted to recycling endosomes where they accumulate in close proximity 
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to each other and become oriented relative to the membrane surface, facilitating coordinated 
interaction. Dynamics measurements as through the current approach will provide the 
opportunity to verify this hypothesis and follow individual particles from nuclei to recycling 
endosomes. Further refinement of the approach, including three-dimensional image 
information and selective labeling of a subset of particles using photoactivatable fluorophores 
instead of mEYFP, might enable a coherent picture of vRNP transport from the nucleus to the 
site of virus assembly and budding. 
5.4.2 Summarizing remarks and perspectives 
In order to study newly formed vRNPs in Influenza virus infection by fluorescence 
microscopy, a method was established for fluorescence labeling of vRNPs in living cells. 
Therefore, an experimental approach was developed which allows coexpression of fluorescent 
NP fusion proteins in infected cells. Exogeneously expressed NP could be shown to behave 
similar to native viral NP in infection. It undergoes cytoplasmic transport and targets to the 
plasma membrane, indicating incorporation of fluorescent NP constructs into vRNP 
complexes. The experimental system was validated by demonstrating infection-induced 
cotransport of NP with recycling endosomes, which is specific for vRNP complexes, and by 
showing that the kinetics of cytoplasmic transport were consistent with previously published 
data on vRNP transport.  
Using SPT, not only transport velocities could be determined, but it was also possible to 
address site-specific aspects and different stages of vRNP transport. Nucleocytoplasmic 
transport could be monitored, revealing unexpected details of fast directional transport 
subsequent to nuclear export, leading to the hypothesis of a two-stage microtubule-based 
cytoplasmic transport of progeny vRNPs, including vesicular and non-vesicular transport, in 
line with the recent finding of a vRNP interacting protein that targets vRNPs directly to 
microtubules and to the MTOC. Furthermore, also plasma membrane targeting of mEYFP-
NP-tagged complexes could be studied. Considerable mobility underneath the plasma 
membrane demonstrated that accumulating vRNPs in the cell periphery, as detected also by 
FISH and immunostainings in fixed cells (Fig. 43, [280,297]), were not static, but rather 
indicate a third stage of vRNP transport underneath the plasma membrane. vRNPs might 
move in close proximity to the membrane until they associate with the viral budding site or 
become reinternalized into the cell. This hypothesis requires however further investigations, 
since the particle trajectories are limited by two-dimensional image information.  
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While the SPT approach has a great potential to study vRNP transport and virus budding and 
could already provide valuable information, which complements findings from biochemical 
analyses and fluorescence imaging in fixed cells and adds new aspects to the current model, 
the approach will have to be further developed to be able to exploit the full potential of this 
technique. In future experiments, the use of a spinning disc microscope will enable fast three-
dimensional time-lapse imaging and permit to follow continuous movements of single 
particles throughout the cells. This will allow characterizing processes in more detail like the 
transport from the nucleus to the MTOC, the assembly of vRNPs with recycling endosomes, 
the targeting to the plasma membrane and the association with the viral budzone, but also 
virus budding itself possibly can be monitored. Further refinement, like coexpression of 
fluorescent marker proteins for the plasma membrane, the nuclear envelope, recycling 
endosomes, microtubules or actin filaments will help to substantiate the results to come to 
solid conclusions.  
In order to reconstruct full-length three-dimensional particle trajectories, another limitation 
further has to be overcome, which is an inherent problem of single particle tracking. High 
particle densities like the high local concentrations of vRNPs at the MTOC, at the plasma 
membrane or in the nucleus do not allow to unambiguously trace individual particles, which 
complicates data analysis and impairs the reconstruction of tracks. The here established 
experimental approach provides the important advantage to be relatively flexible with the 
choice of the fluorescent protein tag, offering the possibility to use photoactivatable 
fluorescent proteins instead of mEYFP or mCherry. Fluorescent proteins, including 
photoactivatable fluorescent proteins, are all very similar in size and structure. Fluorescence 
photoactivation can be applied to selectively label individual particles or a small subset of 
particles by irradiation, which then can be distinguished and identified throughout the 
measurement. The versatility of the fluorescent protein tag might be an important advantage 
of this approach in comparison to the approach using recombinant viruses encoding split-GFP. 
It is postulated that an experimental approach could be established here which has the 
potential to provide a coherent picture of vRNP transport from the nucleus to the site of virus 
assembly and to substantially contribute to characterize the mechanisms and kinetics of virus 
assembly and virus budding.  
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